0001493152-23-040107.txt : 20231109 0001493152-23-040107.hdr.sgml : 20231109 20231109171041 ACCESSION NUMBER: 0001493152-23-040107 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 52 CONFORMED PERIOD OF REPORT: 20230930 FILED AS OF DATE: 20231109 DATE AS OF CHANGE: 20231109 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BTCS Inc. CENTRAL INDEX KEY: 0001436229 STANDARD INDUSTRIAL CLASSIFICATION: FINANCE SERVICES [6199] IRS NUMBER: 262477977 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-40792 FILM NUMBER: 231393711 BUSINESS ADDRESS: STREET 1: 9466 GEORGIA AVENUE #124 CITY: SILVER SPRING STATE: MD ZIP: 20910 BUSINESS PHONE: 202-430-6576 MAIL ADDRESS: STREET 1: 9466 GEORGIA AVENUE #124 CITY: SILVER SPRING STATE: MD ZIP: 20910 FORMER COMPANY: FORMER CONFORMED NAME: Bitcoin Shop, Inc. DATE OF NAME CHANGE: 20150422 FORMER COMPANY: FORMER CONFORMED NAME: BITCOIN SHOP INC. DATE OF NAME CHANGE: 20140204 FORMER COMPANY: FORMER CONFORMED NAME: TouchIT Technologies, Inc. DATE OF NAME CHANGE: 20100524 10-Q 1 form10-q.htm
false Q3 --12-31 0001436229 P3Y P5Y P5Y 0001436229 2023-01-01 2023-09-30 0001436229 2023-11-07 0001436229 2023-09-30 0001436229 2022-12-31 0001436229 BTCS:SeriesVPreferredStockMember 2023-09-30 0001436229 BTCS:SeriesVPreferredStockMember 2022-12-31 0001436229 2023-07-01 2023-09-30 0001436229 2022-07-01 2022-09-30 0001436229 2022-01-01 2022-09-30 0001436229 us-gaap:PreferredStockMember BTCS:SeriesVPreferredStockMember 2022-12-31 0001436229 us-gaap:CommonStockMember 2022-12-31 0001436229 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001436229 us-gaap:RetainedEarningsMember 2022-12-31 0001436229 us-gaap:CommonStockMember 2021-12-31 0001436229 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001436229 us-gaap:RetainedEarningsMember 2021-12-31 0001436229 2021-12-31 0001436229 us-gaap:PreferredStockMember BTCS:SeriesVPreferredStockMember 2023-06-30 0001436229 us-gaap:CommonStockMember 2023-06-30 0001436229 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001436229 us-gaap:RetainedEarningsMember 2023-06-30 0001436229 2023-06-30 0001436229 us-gaap:CommonStockMember 2022-06-30 0001436229 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001436229 us-gaap:RetainedEarningsMember 2022-06-30 0001436229 2022-06-30 0001436229 us-gaap:PreferredStockMember BTCS:SeriesVPreferredStockMember 2023-01-01 2023-09-30 0001436229 us-gaap:CommonStockMember 2023-01-01 2023-09-30 0001436229 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-09-30 0001436229 us-gaap:RetainedEarningsMember 2023-01-01 2023-09-30 0001436229 us-gaap:CommonStockMember 2022-01-01 2022-09-30 0001436229 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-09-30 0001436229 us-gaap:RetainedEarningsMember 2022-01-01 2022-09-30 0001436229 us-gaap:PreferredStockMember BTCS:SeriesVPreferredStockMember 2023-07-01 2023-09-30 0001436229 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001436229 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001436229 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001436229 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001436229 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001436229 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001436229 us-gaap:PreferredStockMember BTCS:SeriesVPreferredStockMember 2023-09-30 0001436229 us-gaap:CommonStockMember 2023-09-30 0001436229 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001436229 us-gaap:RetainedEarningsMember 2023-09-30 0001436229 us-gaap:CommonStockMember 2022-09-30 0001436229 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001436229 us-gaap:RetainedEarningsMember 2022-09-30 0001436229 2022-09-30 0001436229 srt:MaximumMember 2023-09-30 0001436229 srt:MinimumMember 2023-09-30 0001436229 us-gaap:PreferredStockMember BTCS:SeriesVPreferredStockMember 2023-06-02 2023-06-02 0001436229 BTCS:BoardOfDirectorsMember 2022-01-05 0001436229 us-gaap:WarrantMember 2023-01-01 2023-09-30 0001436229 us-gaap:WarrantMember 2022-01-01 2022-09-30 0001436229 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-09-30 0001436229 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-09-30 0001436229 BTCS:NonVestedRestrictedStockAwardsUnitsMember 2023-01-01 2023-09-30 0001436229 BTCS:NonVestedRestrictedStockAwardsUnitsMember 2022-01-01 2022-09-30 0001436229 us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-09-30 0001436229 us-gaap:FairValueInputsLevel1Member 2023-09-30 0001436229 us-gaap:FairValueInputsLevel2Member 2023-09-30 0001436229 us-gaap:FairValueInputsLevel3Member 2023-09-30 0001436229 us-gaap:FairValueInputsLevel1Member 2022-12-31 0001436229 us-gaap:FairValueInputsLevel2Member 2022-12-31 0001436229 us-gaap:FairValueInputsLevel3Member 2022-12-31 0001436229 BTCS:SecuritiesPurchaseAgreementMember 2021-03-01 2021-03-02 0001436229 BTCS:SecuritiesPurchaseAgreementMember 2021-03-02 0001436229 us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001436229 us-gaap:FairValueInputsLevel3Member 2021-12-31 0001436229 us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-09-30 0001436229 us-gaap:FairValueInputsLevel3Member 2022-09-30 0001436229 2023-07-11 0001436229 2023-07-12 0001436229 BTCS:AtTheMarketOfferingAgreementMember BTCS:HCWainwrightCoLLCMember 2021-09-13 2021-09-14 0001436229 BTCS:AtTheMarketOfferingAgreementMember BTCS:HCWainwrightCoLLCMember 2021-09-14 0001436229 BTCS:AtTheMarketOfferingAgreementMember 2023-01-01 2023-09-30 0001436229 BTCS:AtTheMarketOfferingAgreementMember 2023-09-30 0001436229 BTCS:EachIndependentDirectorMember 2023-01-18 2023-01-19 0001436229 BTCS:EachIndependentDirectorMember BTCS:FourEqualInstallmentsMember 2023-01-18 2023-01-19 0001436229 BTCS:IndependentDirectorsMember 2023-01-01 2023-09-30 0001436229 srt:OfficerMember us-gaap:CommonStockMember 2023-01-01 2023-09-30 0001436229 BTCS:SeriesVPreferredStockMember 2023-01-01 2023-09-30 0001436229 us-gaap:PreferredStockMember BTCS:SeriesVPreferredStockMember 2023-05-12 0001436229 BTCS:TwoThousandAndTwentyOneEquityIncentivePlanMember 2022-06-13 0001436229 BTCS:TwoThousandAndTwentyOneEquityIncentivePlanMember 2023-07-11 0001436229 BTCS:TwoThousandAndTwentyOneEquityIncentivePlanMember BTCS:NonExecutiveEmployeesMember 2023-01-01 2023-09-30 0001436229 BTCS:RestrictedStockUnitsRSUOneMember 2022-01-02 2022-01-02 0001436229 BTCS:RestrictedStockUnitsRSUTwoMember 2022-01-02 2022-01-02 0001436229 BTCS:RestrictedStockUnitsRSUThreeMember 2022-01-02 2022-01-02 0001436229 BTCS:RestrictedStockUnitsRSUFourMember 2022-01-02 2022-01-02 0001436229 BTCS:RestrictedStockUnitsRSUOneMember 2023-01-01 2023-01-01 0001436229 BTCS:RestrictedStockUnitsRSUTwoMember 2023-01-01 2023-01-01 0001436229 BTCS:RestrictedStockUnitsRSUThreeMember 2023-01-01 2023-01-01 0001436229 BTCS:RestrictedStockUnitsRSUFourMember 2023-01-01 2023-01-01 0001436229 us-gaap:RestrictedStockUnitsRSUMember BTCS:ChiefTechnologyOfficerMember BTCS:OneYearAnniversaryMember 2023-01-01 2023-01-01 0001436229 us-gaap:RestrictedStockUnitsRSUMember BTCS:ChiefTechnologyOfficerMember BTCS:FourYearAnniversaryMember 2023-01-01 2023-01-01 0001436229 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-09-30 0001436229 BTCS:NonExecutiveEmployeesMember us-gaap:RestrictedStockMember 2022-12-08 2022-12-09 0001436229 BTCS:TwoThousandAndTwentyOneEquityIncentivePlanMember 2023-01-01 2023-09-30 0001436229 BTCS:TwoThousandAndTwentyOneEquityIncentivePlanMember 2023-09-30 0001436229 BTCS:TwoThousandAndTwentyOneEquityIncentivePlanMember 2022-09-30 0001436229 BTCS:TwoThousandAndTwentyOneEquityIncentivePlanMember 2022-01-01 2022-09-30 0001436229 srt:MinimumMember 2022-09-30 0001436229 srt:MaximumMember 2022-09-30 0001436229 srt:ChiefExecutiveOfficerMember 2022-01-02 2022-01-02 0001436229 BTCS:MarketCapVestingThresholdsOneMember srt:ChiefExecutiveOfficerMember 2022-01-02 2022-01-02 0001436229 BTCS:MarketCapVestingThresholdsTwoMember srt:ChiefExecutiveOfficerMember 2022-01-02 2022-01-02 0001436229 BTCS:MarketCapVestingThresholdsThreeMember srt:ChiefExecutiveOfficerMember 2022-01-02 2022-01-02 0001436229 BTCS:MarketCapVestingThresholdsFourMember srt:ChiefExecutiveOfficerMember 2022-01-02 2022-01-02 0001436229 srt:ChiefOperatingOfficerMember 2022-01-02 2022-01-02 0001436229 BTCS:MarketCapVestingThresholdsOneMember srt:ChiefOperatingOfficerMember 2022-01-02 2022-01-02 0001436229 BTCS:MarketCapVestingThresholdsTwoMember srt:ChiefOperatingOfficerMember 2022-01-02 2022-01-02 0001436229 BTCS:MarketCapVestingThresholdsThreeMember srt:ChiefOperatingOfficerMember 2022-01-02 2022-01-02 0001436229 BTCS:MarketCapVestingThresholdsFourMember srt:ChiefOperatingOfficerMember 2022-01-02 2022-01-02 0001436229 srt:ChiefFinancialOfficerMember 2022-01-02 2022-01-02 0001436229 BTCS:MarketCapVestingThresholdsOneMember srt:ChiefFinancialOfficerMember 2022-01-02 2022-01-02 0001436229 BTCS:MarketCapVestingThresholdsTwoMember srt:ChiefFinancialOfficerMember 2022-01-02 2022-01-02 0001436229 BTCS:MarketCapVestingThresholdsThreeMember srt:ChiefFinancialOfficerMember 2022-01-02 2022-01-02 0001436229 BTCS:MarketCapVestingThresholdsFourMember srt:ChiefFinancialOfficerMember 2022-01-02 2022-01-02 0001436229 BTCS:ChiefTechnologyOfficerMember 2022-02-22 2022-02-22 0001436229 BTCS:MarketCapVestingThresholdsOneMember BTCS:ChiefTechnologyOfficerMember 2022-02-22 2022-02-22 0001436229 BTCS:MarketCapVestingThresholdsTwoMember BTCS:ChiefTechnologyOfficerMember 2022-02-22 2022-02-22 0001436229 BTCS:MarketCapVestingThresholdsThreeMember BTCS:ChiefTechnologyOfficerMember 2022-02-22 2022-02-22 0001436229 BTCS:MarketCapVestingThresholdsFourMember BTCS:ChiefTechnologyOfficerMember 2022-02-22 2022-02-22 0001436229 BTCS:MarketCapVestingThresholdsOneMember 2023-01-01 2023-09-30 0001436229 BTCS:MarketCapVestingThresholdsTwoMember 2023-01-01 2023-09-30 0001436229 BTCS:MarketCapVestingThresholdsThreeMember 2023-01-01 2023-09-30 0001436229 BTCS:MarketCapVestingThresholdsFourMember 2023-01-01 2023-09-30 0001436229 BTCS:EmployeeBonusStockAwardsMember 2023-07-01 2023-09-30 0001436229 BTCS:EmployeeBonusStockAwardsMember 2022-07-01 2022-09-30 0001436229 BTCS:EmployeeBonusStockAwardsMember 2023-01-01 2023-09-30 0001436229 BTCS:EmployeeBonusStockAwardsMember 2022-01-01 2022-09-30 0001436229 us-gaap:EmployeeStockOptionMember 2023-07-01 2023-09-30 0001436229 us-gaap:EmployeeStockOptionMember 2022-07-01 2022-09-30 0001436229 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-09-30 0001436229 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-09-30 0001436229 us-gaap:RestrictedStockUnitsRSUMember 2023-07-01 2023-09-30 0001436229 us-gaap:RestrictedStockUnitsRSUMember 2022-07-01 2022-09-30 0001436229 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-09-30 0001436229 BTCS:NonEmployeeRestrictedStockAwardsMember 2023-07-01 2023-09-30 0001436229 BTCS:NonEmployeeRestrictedStockAwardsMember 2022-07-01 2022-09-30 0001436229 BTCS:NonEmployeeRestrictedStockAwardsMember 2023-01-01 2023-09-30 0001436229 BTCS:NonEmployeeRestrictedStockAwardsMember 2022-01-01 2022-09-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2023

 

or

 

TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _______________ to _______________.

 

Commission file number: 001-40792

 

BTCS Inc.

(Exact name of registrant as specified in its charter)

 

Nevada   90-1096644
(State or other jurisdiction of incorporation or organization)   (I.R.S. Employer Identification No.)

 

9466 Georgia Avenue #124, Silver Spring, MD   20910
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code (202) 430-6576

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.001   BTCS   The Nasdaq Stock Market
        (The Nasdaq Capital Market)

 

Indicate by check mark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ Accelerated filer ☐
Non-accelerated filer Smaller reporting company
Emerging growth company  

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No

 

As of November 7, 2023, there were 14,373,186 shares of Common Stock, par value $0.001, issued and outstanding.

 

 

 

   
 

 

BTCS INC.

TABLE OF CONTENTS

 

    Page
     
PART I - FINANCIAL INFORMATION  
     
ITEM 1 Financial Statements 4
     
  Condensed Balance Sheets as of September 30, 2023 (unaudited) and December 31, 2022 4
     
  Condensed Statements of Operations for the Three and Nine months Ended September 30, 2023 and 2022 (unaudited) 5
     
  Condensed Statements of Changes in Stockholders’ Equity for the Three and Nine months Ended September 30, 2023 and 2022 (unaudited) 6
     
  Condensed Statements of Cash Flows for the Nine months Ended September 30, 2023 and 2022 (unaudited) 7
     
  Notes to the Unaudited Condensed Financial Statements 8-21
     
ITEM 2 Management’s Discussion and Analysis of Financial Condition and Results of Operations 22
     
ITEM 3 Quantitative and Qualitative Disclosures About Market Risk 28
     
ITEM 4 Controls and Procedures 28
     
PART II - OTHER INFORMATION  
     
ITEM 1 Legal Proceedings 29
     
ITEM 1A Risk Factors 29
     
ITEM 2 Unregistered Sales of Equity Securities and Use of Proceeds 29
     
ITEM 3 Defaults Upon Senior Securities 29
     
ITEM 4 Mine Safety Disclosures 29
     
ITEM 5 Other Information 29
     
ITEM 6 Exhibits 29
     
  Signature 30

 

 2 

 

 

BTCS INC.

 

As used in this Quarterly Report on Form 10-Q, the terms “we,” “us,” “our,” the “Company,” the “Registrant,” and “BTCS Inc.,” mean BTCS Inc., unless otherwise indicated.

 

 3 

 

 

PART I - FINANCIAL INFORMATION

 

ITEM 1 Financial Statements

 

BTCS Inc.

Balance Sheets

 

   September 30, 2023   December 31, 2022 
   (Unaudited)     
Assets:          
Current assets:          
Cash and cash equivalents  $753,233   $2,146,783 
Stablecoins   29,794    - 
Crypto assets   101,387    982 
Staked crypto assets   7,811,809    1,826,307 
Investments, at value (Cost $100,000)   100,000    100,000 
Prepaid expense   107,429    123,727 
Total current assets   8,903,652    4,197,799 
           
Other assets:          
Property and equipment, net   12,001    11,152 
Staked crypto assets - long term   -    5,708,624 
Total other assets   12,001    5,719,776 
           
Total Assets  $8,915,653   $9,917,575 
           
Liabilities and Stockholders’ Equity:          
Accounts payable and accrued expense  $92,659   $76,727 
Accrued compensation   321,144    295,935 
Warrant liabilities   71,250    213,750 
Total current liabilities   485,053    586,412 
           
Stockholders’ equity:          
Preferred stock: 20,000,000 shares authorized at $0.001 par value:   -    - 
Series V Preferred stock: 14,542,803 and 0 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively   2,559,533    - 
Common stock, 97,500,000 shares authorized at $0.001 par value, 14,373,186 and 13,107,149 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively   14,374    13,108 
Additional paid in capital   160,410,794    160,800,263 
Accumulated deficit   (154,554,101)   (151,482,208)
Total stockholders’ equity   8,430,600    9,331,163 
           
Total Liabilities and Stockholders’ Equity  $8,915,653   $9,917,575 

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

 4 

 

 

BTCS Inc.

Statements of Operations

(Unaudited)

 

   2023   2022   2023   2022 
   For the Three Months Ended   For the Nine Months Ended 
   September 30,   September 30, 
   2023   2022   2023   2022 
                 
Revenues                    
Validator revenue (net of fees)  $316,242   $344,196   $1,013,503   $1,421,560 
Total revenues   316,242    344,196    1,013,503    1,421,560 
                     
Cost of revenues                    
Validator expenses   83,100    82,203    278,726    313,972 
Gross profit   233,142    261,993    734,777    1,107,588 
                     
Operating expenses:                    
General and administrative  $283,239   $432,956   $1,510,637   $1,595,296 
Research and development   148,525    126,857    531,053    448,579 
Compensation and related expenses   409,960    669,792    1,450,546    2,731,713 
Marketing   2,155    8,765    11,121    74,249 
Impairment loss on crypto assets   372,441    145,247    1,251,950    12,347,472 
Realized gains on crypto asset transactions   (58,107)   (20,126)   (806,137)   (489,682)
Total operating expenses   1,158,213    1,363,491    3,949,170    16,707,627 
                     
Other income (expenses):                    
Change in fair value of warrant liabilities   285,000    71,250    142,500    1,140,000 
Distributions to warrant holders   -    -    -    (35,625)
Total other income (expenses)   285,000    71,250    142,500    1,104,375 
                     
Net loss  $(640,071)  $(1,030,248)  $(3,071,893)  $(14,495,664)
                     
Net loss per share attributable to common stockholders, basic and diluted  $(0.04)  $(0.08)  $(0.22)  $(1.15)
                     
Weighted average number of common shares outstanding, basic and diluted   14,317,750    12,952,645    13,957,097    12,616,805 

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

 5 

 

 

BTCS Inc.

Statements of Changes in Stockholders’ Equity

(Unaudited)

 

For the Nine Months Ended September 30, 2023

 

   Shares   Amount   Shares   Amount   Capital   Deficit   Equity 
   Series V Preferred Stock   Common Stock  

Additional

Paid-in

   Accumulated  

Total

Stockholders’

 
   Shares   Amount   Shares   Amount   Capital   Deficit   Equity 
Balance December 31, 2022   -   $-    13,107,149   $13,108   $160,800,263   $(151,482,208)  $9,331,163 
Issuance of common stock, net of offering cost / At-the-market offering   -    -    803,054    803    1,113,015    -    1,113,818 
Issuance of Series V preferred stock   14,542,803    2,559,533    -    -    (2,559,533)   -    - 
Stock-based compensation   -    -    462,983    463    1,057,049    -    1,057,512 
Net loss   -    -    -    -    -    (3,071,893)   (3,071,893)
Balance September 30, 2023   14,542,803   $2,559,533    14,373,186   $14,374   $160,410,794   $(154,554,101)  $8,430,600 

 

For the Nine Months Ended September 30, 2022

 

   Shares   Amount   Capital   Deficit   Equity 
   Common Stock  

Additional

Paid-in

   Accumulated  

Total

Stockholder’

(Deficit)

 
   Shares   Amount   Capital   Deficit   Equity 
Balance December 31, 2021   10,528,212   $10,529   $147,682,384   $(135,589,470)  $12,103,443 
Issuance of common stock, net of offering cost / At-the-market offering   2,148,658    2,149    11,092,983    -    11,095,132 
Stock-based compensation   376,842    377    2,233,231    -    2,233,608 
Dividend distributions   -    -    (634,557)   -    (634,557)
Net loss   -    -    -    (14,495,664)   (14,495,664)
Balance September 30, 2022   13,053,712   $13,055   $160,374,041   $(150,085,134)  $10,301,962 

 

For the Three Months Ended September 30, 2023

 

   Shares   Amount   Shares   Amount   Capital   Deficit   Equity 
   Series V Preferred Stock   Common Stock  

Additional

Paid-in

   Accumulated  

Total

Stockholders’

 
   Shares   Amount   Shares   Amount   Capital   Deficit   Equity 
Balance June 30, 2023   14,542,803   $2,559,533    14,181,410   $14,182   $159,955,610   $(153,914,030)  $8,615,295 
Issuance of common stock, net of offering cost / At-the-market offering   -    -    151,882    152    187,165    -    187,317 
Stock-based compensation   -    -    39,894    40    268,019    -    268,059 
Net loss   -    -    -    -    -    (640,071)   (640,071)
Balance September 30, 2023   14,542,803   $2,559,533    14,373,186   $14,374   $160,410,794   $(154,554,101)  $8,430,600 

 

For the Three Months Ended September 30, 2022

 

   Shares   Amount   Capital   Deficit   Equity 
   Common Stock  

Additional

Paid-in

   Accumulated  

Total

Stockholders’

 
   Shares   Amount   Capital   Deficit   Equity 
Balance June 30, 2022   12,703,794   $12,705   $159,432,894   $(149,054,886)  $10,390,713 
Issuance of common stock, net of offering cost / At-the-market offering   318,070    318    490,374    -    490,692 
Stock-based compensation   31,848    32    450,773    -    450,805 
Dividend distributions   -    -    -    -    - 
Net loss   -    -    -    (1,030,248)   (1,030,248)
Balance September 30, 2022   13,053,712   $13,055   $160,374,041   $(150,085,134)  $10,301,962 

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

 6 

 

 

BTCS Inc.

Statements of Cash Flows

(Unaudited)

 

   2023   2022 
   For the Nine Months Ended 
   September 30, 
   2023   2022 
         
Net Cash flows used from operating activities:          
Net loss  $(3,071,893)  $(14,495,664)
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation expense   3,521    2,862 
Stock-based compensation   1,057,512    2,233,608 
Validator revenue   (1,013,503)   (1,421,560)
Blockchain network fees (non-cash)   -    1,321 
Change in fair value of warrant liabilities   (142,500)   (1,140,000)
Sale of non-productive crypto assets   -    2,547,322 
Realized gain on crypto assets transactions   (806,137)   (489,682)
Impairment loss on crypto assets   1,251,950    12,347,472 
Changes in operating assets and liabilities:          
Stablecoins   (29,794)   - 
Prepaid expenses and other current assets   16,298    117,473 
Accounts payable and accrued expenses   15,932    (37,842)
Accrued compensation   25,209    205,237 
Net cash used in operating activities   (2,693,405)   (129,453)
           
Cash flows from investing activities:          
Purchase of productive crypto assets for validating   (1,804,482)   (9,274,055)
Sale of productive crypto assets   1,994,890    432,716 
Purchase of property and equipment   (5,276)   (5,408)
Sale of property and equipment   905    - 
Net cash provided by (used in) investing activities   186,037    (8,846,747)
           
Cash flows from financing activities:          
Dividend distributions   -    (630,801)
Net proceeds from issuance common stock/ At-the-market offering   1,113,818    11,095,132 
Net cash provided by financing activities   1,113,818    10,464,331 
           
Net (decrease)/increase in cash   (1,393,550)   1,488,131 
Cash, beginning of period   2,146,783    1,400,867 
Cash, end of period  $753,233   $2,888,998 
           
           
Supplemental disclosure of non-cash financing and investing activities:          
Series V Preferred Stock Distribution  $2,559,533   $- 

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

 7 

 

 

BTCS Inc.

Notes to Unaudited Condensed Financial Statements

 

Note 1 - Business Organization and Nature of Operations

 

BTCS Inc. (formerly Bitcoin Shop, Inc.), a Nevada corporation (“BTCS” or the “Company”) was incorporated in 2008 and is an early entrant in the crypto asset (also referred to “cryptocurrencies”, “crypto”, or “tokens”) market with a primary focus on blockchain infrastructure and staking. The Company operates validator nodes on various proof-of-stake (“PoS”) and delegated proof-of-stake (“DPoS”) based blockchain networks and stakes the native crypto assets on those blockchains to earn rewards. The Company’s Staking-as-a-Service (“StaaS”) business allows crypto asset holders to earn rewards by participating in network consensus mechanisms through staking and delegating their crypto assets to Company-operated validator nodes (or “nodes”). The Company believes that StaaS provides a more accessible and cost-effective way for crypto asset holders to participate in blockchain networks’ consensus mechanisms, thereby promoting the growth and adoption of blockchain technology.

 

The Company’s proprietary digital asset platform StakeSeeker (“StakeSeeker”) is currently in beta. StakeSeeker is a personal finance software and education center with a comprehensive crypto dashboard for crypto asset holders to connect, monitor, track, and analyze their crypto portfolios across exchanges and wallets in a single analytics platform. The internally-developed dashboard reads user data from digital wallets and utilizes application programming interfaces (APIs) to read data from crypto exchanges and does not allow for the trading or custody of crypto assets. StakeSeeker’s Stake hub is an education center for users to learn how to earn crypto rewards by delegating to our non-custodial validator nodes. Crypto asset holders are able to delegate to our validator nodes without signing up for the StakeSeeker platform; conversely, crypto asset holders can delegate to validator nodes not operated by the Company and sign up for StakeSeeker to utilize our software. The Company is not a broker-dealer or an investment advisor and does not provide any such related services.

 

The Company has addressed the majority of outstanding matters pertaining to its StakeSeeker platform and anticipates its transition from the beta phase on or before the conclusion of the first quarter of 2024. The current functionality allows for crypto asset holders to connect, monitor, track, and analyze their crypto portfolios across exchanges and wallets in a single analytics platform. In the future, the Company may expand support for additional blockchains and introduce additional analytic tools, with associated costs expected to align with historical research and development expenses.

 

The Company’s business is subject to various risks and uncertainties, including risks associated with the evolving regulatory landscape for crypto assets, risks associated with the volatility of crypto asset prices, and risks associated with the development and adoption of blockchain technology. The Company’s future success is dependent on various factors, including the growth of the crypto asset market, the adoption of blockchain technology, and the Company’s ability to effectively operate and grow its blockchain infrastructure operations and StaaS business.

 

The Company plans to expand its PoS operations to secure other disruptive blockchain protocols that also allow for delegating and asset leveraging. The growth of both StakeSeeker’s user base as well as the number and size of staked crypto assets by delegators to Company-run validator nodes are critical to the Company’s strategy and success.

 

Note 2 - Basis of Presentation

 

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information, the instructions to Form 10-Q and the rules and regulations of the SEC. Accordingly, since they are interim statements, the accompanying unaudited condensed financial statements do not include all of the information and notes required by GAAP for annual financial statements, but in the opinion of the Company’s management, reflect all adjustments consisting of normal, recurring adjustments, that are necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods presented. Interim results for the three and nine months ended September 30, 2023 are not necessarily indicative of results for the full year ended December 31, 2023. The unaudited condensed financial statements and notes should be read in conjunction with the financial statements and notes for the year ended December 31, 2022.

 

 8 

 

 

 

Note 3 - Summary of Significant Accounting Policies

 

There have been no material changes in the Company’s significant accounting policies to those previously disclosed in the 2022 Annual Report.

 

Basis of presentation

 

The accompanying financial statements have been prepared in accordance with United States generally accepted accounting principles (“GAAP”).

 

Reclassifications

 

Certain prior period amounts have been reclassified in order to conform with the current period presentation. These reclassifications have no impact on the Company’s previously reported net income (loss).

 

Cash and cash equivalents

 

The Company considers all highly liquid investments with original maturities of three months or less when purchased to be cash and cash equivalents. The Company maintains cash and cash equivalent balances at financial institutions that are insured by the FDIC. As of September 30, 2023 and December 31, 2022, the Company had approximately $753,000 and $2,147,000 in cash. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk on cash.

 

Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash deposits. Accounts at each institution are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. As of September 30, 2023 and December 31, 2022, the Company had approximately $102,000 and $1,682,000 in excess of the FDIC insured limit, respectively.

 

Stablecoins

 

The Company holds stablecoins, such as USDT (Tether) and USDC (USD Coin), which are crypto assets that are pegged to the value of one U.S. dollar and can be redeemed on demand for one U.S. dollar. Our stablecoins are typically held in secure digital wallets or on crypto asset exchanges. The Company acquires and holds stablecoins primarily to facilitate crypto asset transactions, including, but not limited to, payments to third-party vendors. While not accounted for as cash or cash equivalents, these stablecoins are considered a liquidity resource.

 

Revenue Recognition

 

The Company recognizes revenue under Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers. The core principle of the new revenue standard is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. The following five steps are applied to achieve that core principle:

 

  Step 1: Identify the contract with the customer
  Step 2: Identify the performance obligations in the contract
  Step 3: Determine the transaction price
  Step 4: Allocate the transaction price to the performance obligations in the contract
  Step 5: Recognize revenue when the Company satisfies a performance obligation

 

Revenue is recognized when control of the promised goods or services is transferred to the customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. The Company generates revenue through staking rewards.

 

The Company has entered into network-based smart contracts by running its own crypto asset validator nodes as well as by staking crypto assets on nodes run by third-party operators (either directly or through crypto exchanges). Through these contracts, the Company provides crypto assets to stake on a node for the purpose of validating transactions and adding blocks to a respective blockchain network. The term of a smart contract can vary based on the rules of the respective blockchain and typically last a few weeks to months after it is cancelled by the operator and requires that the crypto assets staked remain locked up during the duration of the smart contract. In exchange for staking the crypto assets and validating transactions on blockchain networks, the Company is entitled to all of the fixed crypto asset award for running the Company’s own node and is entitled to a fractional share of the fixed crypto asset award a third-party node operator receives (less crypto asset transaction fees payable to the node operator or exchanges, which are immaterial and are recorded as a deduction from revenue), for successfully validating or adding a block to the blockchain. The Company’s fractional share of awards received from delegating to a third-party validator node is based on the proportion of crypto assets the Company staked to the node to the total crypto assets staked by delegators to the node.

 

 9 

 

 

The provision of validating blockchain transactions is an output of the Company’s ordinary activities. Each separate block creation or validation under a smart contract with a network represents a performance obligation. The transaction consideration the Company receives - the crypto asset award - is a non-cash consideration, which the Company measures at fair value on the date received. The fair value of the crypto asset award received is determined using the quoted price of the related crypto assets on the date of receipt. The satisfaction of the performance obligation for processing and validating blockchain transactions occurs at a point in time when confirmation is received from the network indicating that the validation is complete, and the awards are available for transfer. At that point, revenue is recognized.

 

Cost of Revenues

 

The Company’s cost of revenue primarily includes direct production costs associated with transaction validation on the network, cloud-based server hosting expenses related to our validator nodes, and allocated employee salaries dedicated to node maintenance and support. Additionally, the cost of revenue encompasses fees, including equity compensation stock-based fees, paid to third parties for their assistance in software maintenance and node operations.

 

Crypto Assets Translations and Remeasurements

 

The Company accounts for its crypto assets as indefinite-lived intangible assets in accordance with ASC 350, Intangibles – Goodwill and Other. An intangible asset with an indefinite useful life is not amortized but assessed for impairment annually, or more frequently, when events or changes in circumstances occur indicating that it is more likely than not that the indefinite-lived asset is impaired. Impairment exists when the carrying amount exceeds its fair value. In testing for impairment, the Company has the option to first perform a qualitative assessment to determine whether it is more likely than not that an impairment exists. If it is determined that it is not more likely than not that an impairment exists, a quantitative impairment test is not necessary. If the Company concludes otherwise, it is required to perform a quantitative impairment test. To the extent an impairment loss is recognized, the loss establishes the new cost basis of the asset. Subsequent reversal of impairment losses is not permitted.

 

Crypto assets held are included in the balance sheets as either current assets or other assets if they are staked and locked up for over one year. The Company’s crypto assets are initially recorded at fair value upon receipt (or “carrying value”). The fair value of crypto assets is determined using the U.S. dollar spot price of the related crypto asset. On a quarterly basis, crypto assets are measured at carrying value, net of any impairment losses incurred since receipt. The Company will record impairment losses as the fair value falls below the carrying value of the crypto assets at any time during the period, as determined using the lowest intraday U.S. dollar spot price of the related crypto asset subsequent to its acquisition. The crypto assets can only be marked down when impaired and not marked up when their value increases.

 

Such impairment in the value of crypto assets is recorded as a component of costs and expenses in our Statements of Operations. The Company recorded impairment losses related to crypto assets of approximately $1,252,000 and $12,347,000 during the nine months ended September 30, 2023, and 2022, respectively.

 

Impairment losses cannot be recovered for any subsequent increase in fair value until the sale or disposal of the asset. Realized gain (loss) on sale of crypto assets are included in other income (expense) in the Statements of Operations. The Company recorded realized gains (losses) on crypto assets of approximately $806,000 and $490,000 during the nine months ended September 30, 2023 and 2022, respectively.

 

The presentation of purchases and sales of crypto assets on the Statement of Cash Flows is determined by the nature of the crypto assets, which can be characterized as productive (i.e. purchased for purposes of staking) or non-productive. The purchase of non-productive crypto assets and currencies are included as an operating activity, whereas the purchase of productive crypto assets and currencies are included as investing activities in accordance with ASC 230-10-20 Investing activities. Productive crypto assets that are staked with a lock-up period of less than 12 months are presented on the Balance Sheet as current assets. Staked crypto assets with remaining lock-up periods of greater than 12 months are presented as long-term other assets on the Balance Sheet.

 

 10 

 

 

Internally Developed Software

 

Internally developed software consists of the core technology of the Company’s StakeSeeker platform, which is being designed to allow users to track, monitor and analyze their aggregate crypto asset portfolio holdings by connecting their crypto exchanges and digital wallets as well as providing a non-custodial delegation process to earn staking rewards on crypto asset holdings. For internally developed software, the Company uses both its own employees as well as the services of external vendors and independent contractors. The Company accounts for computer software used in the business in accordance with ASC 985-20 and ASC 350.

 

ASC 985-20, Software-Costs of Computer Software to Be Sold, Leased, or Otherwise Marketed, requires that software development costs incurred in conjunction with product development be charged to research and development expense until technological feasibility is established. Thereafter, until the product is released for sale, software development costs must be capitalized and reported at the lower of unamortized cost or net realizable value of the related product. Some companies use a “tested working model” approach to establishing technological feasibility (i.e., beta version). Under this approach, software under development will pass the technological feasibility milestone when the Company has completed a version that contains essentially all the functionality and features of the final version and has tested the version to ensure that it works as expected.

 

ASC 350, Intangibles-Goodwill and Other, requires computer software costs associated with internal use software to be charged to operations as incurred until certain capitalization criteria are met. Costs incurred during the preliminary project stage and the post-implementation stages are expensed as incurred. Certain qualifying costs incurred during the application development stage are capitalized as property, equipment and software. These costs generally consist of internal labor during configuration, coding, and testing activities. Capitalization begins when (i) the preliminary project stage is complete, (ii) management with the relevant authority authorizes and commits to the funding of the software project, and (iii) it is probable both that the project will be completed, and that the software will be used to perform the function intended.

 

Property and Equipment

 

Property and equipment consists of computer, equipment and office furniture and fixtures, all of which are recorded at cost. Depreciation and amortization are recorded using the straight-line method over the respective useful lives of the assets ranging from three to five years. Long-lived assets are reviewed for impairment whenever events or circumstances indicate that the carrying amount of these assets may not be recoverable.

 

Use of Estimates

 

The accompanying financial statements have been prepared in conformity with U.S. GAAP. This requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the period. The Company’s significant estimates and assumptions include the recoverability and useful lives of indefinite life intangible assets, stock-based compensation, and the valuation allowance related to the Company’s deferred tax assets. Certain of the Company’s estimates, including the carrying amount of the indefinite life intangible assets, could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible that these external factors could have an effect on the Company’s estimates and could cause actual results to differ from those estimates and assumptions.

 

Income Taxes

 

The Company recognizes income taxes on an accrual basis based on tax positions taken or expected to be taken in its tax returns. A tax position is defined as a position in a previously filed tax return or a position expected to be taken in a future tax filing that is reflected in measuring current or deferred income tax assets and liabilities. Tax positions are recognized only when it is more likely than not (i.e., likelihood of greater than 50%), based on technical merits, that the position would be sustained upon examination by taxing authorities. Tax positions that meet the more likely than not threshold are measured using a probability-weighted approach as the largest amount of tax benefit that is greater than 50% likely of being realized upon settlement. Income taxes are accounted for using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the Company’s financial statements or tax returns. A valuation allowance is established to reduce deferred tax assets if all, or some portion, of such assets will more than likely not be realized. Should they occur, the Company’s policy is to classify interest and penalties related to tax positions as income tax expense. Since the Company’s inception, no such interest or penalties have been incurred.

 

 11 

 

 

Accounting for Warrants

 

The Company accounts for the issuance of Common Stock purchase warrants issued in connection with the equity offerings in accordance with the provisions of ASC 815, Derivatives and Hedging (“ASC 815”). The Company classifies as equity any contracts that (i) require physical settlement or net-share settlement or (ii) gives the Company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement). The Company classifies as assets or liabilities any contracts that (i) require net-cash settlement (including a requirement to net-cash settle the contract if an event occurs and if that event is outside the control of the Company) or (ii) gives the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement). In addition, Under ASC 815, registered Common Stock warrants that require the issuance of registered shares upon exercise and do not expressly preclude an implied right to cash settlement are accounted for as derivative liabilities. The Company classifies these derivative warrant liabilities on the balance sheet as a current liability.

 

The Company assessed the classification of Common Stock purchase warrants as of the date of each offering and determined that such instruments originally met the criteria for equity classification; however, as a result of the Company no longer being in control of whether the warrants may be cash settled, the instruments no longer qualify for equity classification. Accordingly, the Company classified the warrants as a liability at their fair value and adjusts the instruments to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until the warrants are exercised or expired, and any change in fair value is recognized as “change in the fair value of warrant liabilities” in the statements of operations. The fair value of the warrants has been estimated using a Black-Scholes valuation model (see Note 4).

 

Stock-based compensation

 

The Company accounts for stock-based compensation in accordance with ASC 718 Compensation – Stock Compensation (“ASC 718”). ASC 718 addresses all forms of share-based payment awards including shares issued under employee stock purchase plans and stock incentive shares. Under ASC 718 awards result in a cost that is measured at fair value on the awards’ grant date, based on the estimated number of awards that are expected to vest and will result in a charge to operations.

 

Share-based payment awards exchanged for services are accounted for at the fair value of the award on the estimated grant date.

 

Options

 

Stock options issued under the Company’s long-term incentive plans are granted with an exercise price equal to no less than the market price of the Company’s stock at the date of grant and expire up to ten years from the date of grant. These options often vest over a one-year period.

 

The Company estimates the fair value of stock option grants using the Black-Scholes option pricing model and the assumptions used in calculating the fair value of stock-based awards represent management’s best estimates and involve inherent uncertainties and the application of management’s judgment.

 

 12 

 

 

Restricted Stock Units (RSUs)

 

For awards vesting upon the achievement of a service condition, compensation cost measured on the grant date will be recognized on a straight-line basis over the vesting period. Stock-based compensation expense for the market-based restricted stock units with explicit service conditions is recognized on a straight-line basis over the longer of the derived service period or the explicit service period, regardless of whether the market condition is satisfied. However, in the event that the explicit service period is not met, previously recognized compensation cost would be reversed. Market-based restricted stock units subject to market-based performance targets require achievement of the performance target as well as a service condition in order for these RSUs to vest.

 

The Company estimates the fair value of market-based RSUs as of the grant date and expected derived term using a Monte Carlo simulation that incorporates pricing inputs covering the period from the grant date through the end of the derived service period.

 

Dividends

 

Effective January 27, 2023, the Company’s Board of Directors (the “Board”) approved the issuance of a newly designated Series V Preferred Stock (“Series V”) on a one-for-one basis to the Company’s shareholders (including restricted stock unit holders and warrant holders who were entitled to such distribution). The distribution of Series V shares was approved and completed on June 2, 2023 to shareholders as of the record date of May 12, 2023. The Series V: (i) is non-convertible, (ii) has a 20% liquidation preference over the shares of common stock, (iii) is non-voting and (iv) has certain rights to dividends and distributions (at the discretion of the Board). A total of 14,542,803 shares of Series V Preferred Stock were distributed to shareholders on June 2, 2023.

 

On January 5, 2022, the Board declared a non-recurring special dividend of $0.05 for each outstanding share of Common Stock of the Company, payable to holders of record as of the close of business on March 17, 2022. The dividend distributions were considered a return of capital as the distributions were in excess of the Company’s current and accumulated earnings and profits. The return of capital distribution reduces the Company’s additional paid in capital balance. Dividend distributions amounted to $0 and $635,000 during the nine months ended September 30, 2023 and 2022, respectively.

 

The Company will evaluate the appropriateness of potential future dividends as the Company continues to grow its operations.

 

Advertising Expense

 

Advertisement costs are expensed as incurred and included in marketing expenses. Advertising and marketing expenses amounted to approximately $11,000 and $74,000 for the nine months ended September 30, 2023 and 2022, respectively.

 

Net Loss per Share

 

Basic loss per share is computed by dividing the net income or loss applicable to common shares by the weighted average number of common shares outstanding during the period. Diluted earnings per share is computed using the weighted average number of common shares and, if dilutive, potential common shares outstanding during the period. Potential common shares consist of the Company’s convertible preferred stock, convertible notes, restricted stock units, options and warrants. Diluted loss per share excludes the shares issuable upon the conversion of preferred stock, notes and warrants from the calculation of net loss per share if their effect would be anti-dilutive.

 

The following financial instruments were not included in the diluted loss per share calculation as of September 30, 2023 and 2022 because their effect was anti-dilutive:

 

   2023   2022 
   As of September 30, 
   2023   2022 
Warrants to purchase common stock   712,500    945,837 
Options   1,150,000    1,285,000 
Non-vested restricted stock awards units   1,631,399    1,612,350 
Total   3,493,899    3,843,187 

 

Recent Accounting Pronouncements

 

We have evaluated all recently issued accounting pronouncements and believe such pronouncements do not have a material effect on our financial statements.

 

 13 

 

 

Note 4 – Fair Value of Financial Assets and Liabilities

 

The Company measures certain assets and liabilities at fair value. The Company defines fair value as the price that would be received from selling an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market in an orderly transaction between market participants at the measurement date. Fair value is estimated by applying the following hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement:

 

Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.

 

Level 2 – Observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

 

Level 3 – Inputs that are generally unobservable and typically reflect management’s estimate of assumptions that market participants would use in pricing the asset or liability.

 

Financial instruments, including cash and cash equivalents, accounts and other receivables, accounts payable and accrued liabilities are carried at cost, which management believes approximates fair value due to the short-term nature of these instruments.

 

The following tables present the Company’s assets and liabilities that are measured at fair value on a recurring basis and the Company’s estimated level within the fair value hierarchy of those assets and liabilities as of September 30, 2023 and December 31, 2022:

   Fair Value Measured at September 30, 2023 
  

Total at

September 30,

2023

   Quoted prices in active markets (Level 1)   Significant other observable inputs (Level 2)   Significant unobservable inputs (Level 3) 
                     
Assets                    
Investments  $100,000   $      -   $          -   $100,000 
Liabilities                    
Warrant Liabilities  $71,250   $-   $-   $71,250 

 

   Fair Value Measured at December 31, 2022 
  

Total at

December 31,

2022

   Quoted prices in active markets (Level 1)   Significant other observable inputs (Level 2)   Significant unobservable inputs (Level 3) 
                     
Assets                    
Investments  $100,000   $      -   $          -   $100,000 
Liabilities                    
Warrant Liabilities  $213,750   $-   $-   $213,750 

 

The Company did not make any transfers between the levels of the fair value hierarchy during the nine months ended September 30, 2023 and 2022.

 

 14 

 

 

Level 3 Valuation Techniques

 

Level 3 financial assets consist of private equity investments for which there is no current public market for these securities such that the determination of fair value requires significant judgment or estimation. As of September 30, 2023 and December 31, 2022, the Company’s Level 3 investments were carried at original cost of the investments, with a value of $100,000. The Company has elected to apply the measurement alternative under ASC 321, Investments—Equity Securities, for these investments.

 

Level 3 financial liabilities consist of the warrant liabilities for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation.

 

Changes in fair value measurements categorized within Level 3 of the fair value hierarchy are analyzed each period based on changes in estimates or assumptions and recorded as appropriate.

 

A significant decrease in the volatility or a significant decrease in the Company’s stock price, in isolation, would result in a significantly lower fair value measurement. Changes in the values of the warrant liabilities are recorded in “change in fair value of warrant liabilities” in the Company’s statements of operations.

 

On March 2, 2021, the Company entered into a securities purchase agreement with certain purchasers which closed on March 4, 2021 pursuant to which the Company sold an aggregate of (i) 950,000 shares of Common Stock, and (ii) Common Stock warrants (the “Warrants”) to purchase up to 712,500 shares of Common Stock for gross proceeds of $9.5 million in a private placement offering.

 

The Warrants require, at the option of the holder, a net-cash settlement following certain fundamental transactions (as defined in the Warrants) at the Company. At the time of issuance, the Company maintained control of certain fundamental transactions and as such the Warrants were initially classified in equity. As of December 31, 2022, the Company no longer maintained control of certain fundamental transactions as they did not control a majority of shareholder votes. As such, the Company may be required to cash settle the Warrants if a fundamental transaction occurs which is outside the Company’s control. Accordingly, the Warrants are classified as liabilities. The Warrants have been recorded at their fair value using the Black-Scholes valuation model, and will be recorded at their respective fair value at each subsequent balance sheet date. This model incorporates transaction details such as the Company’s stock price, contractual terms, maturity, risk-free rates, as well as volatility.

 

The Warrants require the issuance of registered shares upon exercise, do not expressly preclude an implied right to cash settlement and are therefore accounted for as derivative liabilities. The Company classifies these derivative warrant liabilities on the balance sheet as a current liability.

 

 15 

 

 

A summary of quantitative information with respect to the valuation methodology and significant unobservable inputs used for the Company’s warrant liabilities that are categorized within Level 3 of the fair value hierarchy at the date of issuance and, as of September 30, 2023 and December 31, 2022, is as follows:

   September 30, 2023   December 31, 2022 
Risk-free rate of interest   5.03%   3.99%
Expected volatility   108.3%   152.8%
Expected life (in years)   2.43    3.18 
Expected dividend yield   -    - 

 

The risk-free interest rate was based on rates established by the Federal Reserve Bank. For the Warrants, the Company estimates expected volatility giving primary consideration to the historical volatility of its Common Stock. The general expected volatility is based on the standard deviation of the Company’s underlying stock price’s daily logarithmic returns. The expected life of the warrants was determined by the expiration date of the warrants. The expected dividend yield was based on the fact that the Company has not historically paid dividends on its Common Stock and does not expect to pay recurring dividends on its Common Stock in the future.

 

The following table sets forth a summary of the changes in the fair value of the Company’s Level 3 financial assets and liabilities for the nine months ended September 30, 2023 and 2022, that are measured at fair value on a recurring basis:

   Fair Value of Level 3 Financial Assets 
   September 30, 2023   September 30, 2022 
Beginning balance  $100,000   $- 
Purchases   -    - 
Unrealized appreciation (depreciation)   -    - 
Ending balance  $100,000   $            - 

 

   Fair Value of Level 3 Financial Liabilities 
   September 30, 2023   September 30, 2022 
Beginning balance  $213,750   $1,852,500 
Warrant liabilities classification   -    - 
Fair value adjustment of warrant liabilities   (142,500)   (1,140,000)
Ending balance  $71,250   $712,500 

 

Note 5 – Stockholders’ Equity

 

Common Stock

 

The Company received shareholder approval on July 11, 2023 to amend our Articles of Incorporation to increase the number of authorized shares of common stock from 97,500,000 shares to 975,000,000. On July 12, 2023, the Company filed a Certificate of Amendment to the Articles of Incorporation to effectuate the increase of our authorized shares of common stock to 975,000,000.

 

At-The-Market Offering Agreement

 

On September 14, 2021, the Company entered into an At-The-Market Offering Agreement (the “ATM Agreement”) with H.C. Wainwright & Co., LLC, as agent (“H.C. Wainwright”), pursuant to which the Company may offer and sell, from time-to-time through H.C. Wainwright, shares of the Company’s Common Stock having an aggregate offering price of up to $98,767,500 (the “Shares”). The Company will pay H.C. Wainwright a commission rate equal to 3.0% of the aggregate gross proceeds from each sale of Shares.

 

 16 

 

  

During the nine months ended September 30, 2023, the Company sold a total of 803,054 shares of Common Stock under the ATM Agreement for aggregate total gross proceeds of approximately $1,161,000 at an average selling price of $1.45 per share, resulting in net proceeds of approximately $1,114,000 after deducting commissions and other transaction costs.

 

Share Based Payments

 

Effective January 19, 2023, The Board of Directors of the Company approved the issuance of $50,000 of common stock to each independent director. The shares will be issued in four equal installments ($12,500) at the end of each calendar quarter beginning March 31st, subject to continued service on each applicable issuance date. The number of shares issuable will be based on the closing price of the Company’s common stock on the last trading day prior to the end of the applicable calendar quarter. For the nine months ended September 30, 2023, 99,117 shares of common stock were issued to independent directors.

 

For the nine months ended September 30, 2023, 410,317 shares of common stock were issued to officers related to payment of 2022 accrued bonus compensation. 

 

Preferred Stock

 

Series V

 

Effective January 27, 2023, the Board approved the issuance of a newly designated Series V Preferred Stock (“Series V”) on a one-for-one basis to the Company’s shareholders (including restricted stock unit holders and warrant holders). The distribution of Series V shares was approved and completed on June 2, 2023 to shareholders as of the record date of May 12, 2023. The Series V: (i) is non-convertible, (ii) has a 20% liquidation preference over the shares of common stock, (iii) is non-voting and (iv) has certain rights to dividends and distributions (at the discretion of the Board of Directors). A total of 14,542,803 shares of Series V Preferred Stock were distributed to shareholders on June 2, 2023. The Series V is listed to trade on Upstream, the trading app for digital securities and NFTs powered by Horizon Fintex and MERJ Exchange Limited, under the ticker symbol BTCSP.

 

The fair value of the Preferred stock as of the record date, May 12, 2023, amounted to approximately $2,560,000. The Company used a probability valuation model to determine the fair value of the preferred stock.

 

2021 Equity Incentive Plan

 

The Company’s 2021 Equity Incentive Plan (the “2021 Plan”) was effective on January 1, 2021 and approved by shareholders on March 31, 2021 and amended on June 13, 2022. The Company received shareholder approval on July 11, 2023 to increase the authorized amount under the 2021 Plan from 7,000,000 shares to 12,000,000 shares.

 

Options

 

During the nine months ended September 30, 2023, the Company granted 35,000 stock options with a weighted average exercise price of $0.81 to non-executive employees.

 

The following weighted-average assumptions were used to estimate the fair value of options granted on the deemed grant date during the nine months ended September 30, 2023 and 2022 for both the Black-Scholes formula:

  

Nine Months Ended

September 30,

 
   2023   2022 
Exercise price  $0.81   $1.51 
Term (years)   5.00    5.00 
Expected stock price volatility   151.6%   165.8%
Risk-free rate of interest   4.15%   2.77%

 

Expected Volatility: The Company uses historical volatility as it provides a reasonable estimate of the expected volatility. Historical volatility is based on the most recent volatility of the stock price over a period of time equivalent to the expected term of the option.

 

Risk-Free Interest Rate: The risk-free interest rate is based on the U.S. treasury zero-coupon yield curve in effect at the time of grant for the expected term of the option.

 

Expected Term: The Company’s expected term represents the weighted-average period that the Company’s stock options are expected to be outstanding. The expected term is based on the expected time to post-vesting exercise of options by employees. The Company uses historical exercise patterns of previously granted options to derive employee behavioral patterns used to forecast expected exercise patterns.

 

 17 

 

 

For awards vesting upon the achievement of the market conditions which were met at the date of grant, compensation cost measured on the date of grant was immediately recognized. For awards vesting upon the achievement of the market conditions which were not met at the date of grant, compensation cost measured on the grant date will be recognized on a straight-line basis over the vesting period based on estimation using a Monte-Carlo simulation.

 

A summary of option activity under the Company’s stock option plan for nine months ended September 30, 2023 is presented below:

   Number of Shares   Weighted Average Exercise Price   Total Intrinsic Value   Weighted Average Remaining Contractual Life (in years) 
Outstanding as of December 31, 2022   1,150,000   $2.15   $-    3.3 
Employee options granted   35,000    0.81    -    4.9 
Employee options forfeited   (35,000)   1.02    11,100    - 
Outstanding as of September 30, 2023   1,150,000   $2.14   $-    2.5 
Options vested and exercisable as of September 30, 2023   1,135,000   $2.16   $-    2.5 

 

RSUs

 

Effective January 2, 2022, the Board of Directors of the Company ratified the following arrangements approved by its Compensation Committee:

 

The Company’s executive officers were granted RSUs as part of a long-term incentive plan (“LTI”), with vesting terms set for when the Company’s market capitalization reaches and sustains a market capitalization for 30 consecutive days above four defined market capitalization thresholds of $100 million, $150 million, $200 million and $400 million.

 

Effective February 22, 2022, upon appointment of Manish Paranjape as Chief Technology Officer of the Company, Mr. Paranjape was also granted RSUs as part of the LTI plan, with consistent vesting terms set for when the Company’s market capitalization above the same four defined market capitalization thresholds.

 

Effective January 1, 2023 (the “LTI RSU Amendment Date”), upon recommendation of the Compensation Committee of the Board of Directors approved an amendment to the LTI plan, whereby the market capitalization threshold targets were lowered to $50 million, $100 million, $150 million, and $300 million.

 

The RSUs granted to each executive employee are as follows:

         Total   Market Cap Vesting Thresholds 
Officer Name  Title  Grant
Date
  RSUs
Granted
   $ 50
million
   $ 100
million
   $ 150
million
   $ 300
million
 
Charles Allen  Chief Executive Officer  1/2/2022   694,444    173,611    173,611    173,611    173,611 
Michal Handerhan  Chief Operations Officer  1/2/2022   444,444    111,111    111,111    111,111    111,111 
Michael Prevoznik  Chief Financial Officer  1/2/2022   222,224    55,556    55,556    55,556    55,556 
Manish Paranjape  Chief Technology Officer  2/22/2022   160,184    40,046    40,046    40,046    40,046 
            1,521,296      380,324      380,324      380,324      380,324 

 

To the extent any market capitalization targets set forth above for Mr. Prevoznik and Mr. Paranjape are achieved, the RSUs will also be subject to the following five-year vesting schedule: 20% of the LTI RSUs which have met a market capitalization criteria will vest on the one-year anniversary of the grant date, and the remaining 80% of the LTI RSUs which have met a market capitalization criteria will vest annually on each subsequent calendar year-end date over the four years following the one year anniversary of the grant date.

 

 18 

 

 

For awards vesting upon the achievement of a service condition, compensation cost measured on the grant date will be recognized on a straight-line basis over the vesting period. Stock-based compensation expense for the market-based restricted stock units with explicit service conditions is recognized on a straight-line basis over the longer of the derived service period or the explicit service period, regardless of whether the market condition is satisfied. However, in the event that the explicit service period is not met, previously recognized compensation cost would be reversed. Market-based restricted stock units subject to market-based performance targets require achievement of the performance target as well as a service condition in order for these RSUs to vest.

 

The Company estimates the fair value of market-based RSUs as of the grant date and expected derived term using a Monte Carlo simulation that incorporates pricing inputs covering the period from the grant date through the end of the derived service period. As of the LTI RSU Amendment Date, the Company determined the pre-modification and post-modification estimated fair value of the LTI RSUs accounting for the amended market cap criteria. The increase in fair value of the LTI RSUs attributable to the modification was added to the related unrecognized compensation expense in accordance with ASC 718 – Share-Based Compensation, whereby any previously recognized compensation cost that has not vested as of the modification date should be adjusted to reflect the new fair value of the equity awards on the date of the modification.

 

The following weighted-average assumptions were used to estimate the fair value of options granted during the nine months ended September 30, 2023 and 2022 for the Monte-Carlo simulation:

 

   Valuation Dates 
   January 1, 2023
(Modification)
   January 2, 2022
(Original Issuance)
 
Vesting Hurdle Price  $3.81 - $30.52    $8.07 - $36.99  
Term (years)   4.00    5.00 
Expected stock price volatility   97.30%   103.72%
Risk-free rate of interest   4.10%   1.32%

 

Expected Volatility: The Company uses historical volatility as it provides a reasonable estimate of the expected volatility. Historical volatility is based on the most recent volatility of the stock price over a period of time equivalent to the expected term of the RSUs.

 

Risk-Free Interest Rate: The risk-free interest rate is based on the U.S. treasury zero-coupon yield curve in effect at the time of grant for the expected term of the RSUs.

 

Expected Term: The Company’s expected term represents the weighted-average period that the Company’s RSUs are expected to be outstanding. The expected term is based on the stipulated five-year period from the grant date until the market-based criteria are achieved. If the market-based criteria are not achieved within the five-year period from the grant date, the RSUs will not vest and shall expire.

 

Vesting Hurdle Price: The vesting hurdle price is determined as the average of the vesting Market Cap criteria divided by the shares outstanding as of the valuation dates.

 

 19 

 

 

On December 9, 2022, upon recommendation of the Compensation Committee, the Board of Directors approved the grant of 25,000 RSUs to Mr. Prevoznik and Mr. Paranjape each, effective January 1, 2023, which vest annually over a five-year period with the first vesting date being on the one-year anniversary of the execution date of the effective grant date, subject to continued employment on each applicable vesting date.

 

A summary of the Company’s restricted stock units granted under the 2021 Plan during the nine months ended September 30, 2023 are as follows:

 

   Number of
Restricted
Stock Units
   Weighted Average
Grant Day
Fair Value
 
Nonvested at December 31, 2022   1,590,552   $3.34 
Granted   50,000    0.63 
Vested   (9,153)   4.37 
Forfeited   -    - 
Nonvested at September 30, 2023   1,631,399   $3.25 

 

Stock Based Compensation

 

Stock-based compensation expense is recorded as a part of selling, general and administrative expenses, compensation expenses and cost of revenues. Stock-based compensation expense for the three and nine months ended September 30, 2023 and 2022 was as follows:

 

 

   2023   2022   2023   2022 
  

For the Three Months Ended

September 30,

  

For the Nine Months Ended

September 30,

 
   2023   2022   2023   2022 
Employee bonus stock awards  $-   $-   $-   $894,027 
Employee stock option awards   441    16,455    (4,871)   98,901 
Employee restricted stock unit awards   230,118    434,349    726,409    1,182,053 
Non-employee restricted stock awards   21,536    30,480    45,777    202,218 
Stock-based compensation  $252,095   $481,284   $767,315   $2,377,199 

 

 20 

 

 

Note 6 – Accrued Expenses

 

Accrued expenses consist of the following:

   September 30, 2023   December 31, 2022 
Accrued compensation  $321,144   $295,935 
Accounts payable and accrued expenses   92,659    76,727 
Accrued Expenses  $413,803   $372,662 

 

Accrued compensation includes approximately $321,000 and $284,000 related to performance bonus accruals as of September 30, 2023 and December 31, 2022, respectively.

 

Note 7 – Employee Benefit Plans

 

The Company maintains defined contribution benefit plans under Section 401(k) of the Internal Revenue Code covering substantially all qualified employees of the Company (the “401(k) Plan”). Under the 401(k) Plan, the Company may make discretionary contributions of up to 100% of employee contributions. For the nine months ended September 30, 2023 and 2022, the Company made contributions to the 401(k) Plan of $95,000 and $45,000, respectively.

 

Note 8 – Liquidity

 

The Company follows “Presentation of Financial Statements—Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern”. The Company’s financial statements have been prepared assuming that it will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business.

 

As reflected in the financial statements, the Company has historically incurred a net loss and has an accumulated deficit of approximately $154,554,000 at September 30, 2023, a net loss for the nine months ended September 30, 2023 of approximately $3,072,000 and net cash used in operating activities of approximately $2,693,000 for the reporting period then ended. The Company is implementing its business plan and generating revenue; however, the Company’s cash position and liquid crypto assets are sufficient to support its daily operations over the next twelve months.

 

Note 9 – Subsequent Events

 

The Company evaluates events that have occurred after the balance sheet date but before the financial statements are issued. Based upon the evaluation, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the financial statements other than disclosed.

 

 21 

 

 

ITEM 2 Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

The following discussion and analysis of financial condition and results of operations should be read in conjunction with our historical financial statements and the notes to those statements that appear elsewhere in this report. Certain statements in the discussion contain forward-looking statements based upon current expectations that involve risks and uncertainties, such as plans, objectives, expectations and intentions. Actual results and the timing of events could differ materially from those anticipated in these forward-looking statements as a result of a number of factors, including those discussed in the Risk Factors contained in our Annual Report on Form 10-K for the year ended December 31, 2022. When we refer to the “2023 Quarter” and the “2022 Quarter” we are referring to the three months ended September 30, 2023 and September 30, 2022, respectively. When we refer to the “2023 Period” and the “2022 Period” we are referring to the nine months ended September 30, 2023 and September 30, 2022, respectively.

 

Company Overview

 

BTCS Inc. is an early entrant in the crypto asset market and a publicly-traded U.S. company focused on blockchain infrastructure and staking. The Company specializes in operating validator nodes on various Delegated proof-of-stake (“DPoS”) and proof-of-stake (“PoS”) based blockchain networks and stakes the native crypto assets on the validator nodes it operates to earn rewards in connection with the validation of transactions occurring on those blockchain networks. Subject to available capital and the restrictions of certain blockchains BTCS plans to expand its PoS operations to secure other disruptive blockchain protocols that allow for delegating, which presents a significant growth opportunity for the Company. We evaluate blockchain networks through various due diligence procedures, including consideration of blockchain quality, reward potential, and technical difficulty of running a validator node. Considerations of the quality of a blockchain include inspection of i) market and on-chain statistics, ii) liquidity, iii) potential blockchain utility, iv) history and milestones, v) growth and development roadmap, vi) use cases, vii) community interest, vii) quality of documentation, viii) decentralization, and ix) any other publicly available information.

 

BTCS’s business model is focused on Staking-as-a-Service (“StaaS”), allowing crypto asset holders to earn rewards by participating in network consensus mechanisms through staking and delegating their crypto assets to Company operated validator nodes. As a non-custodial validator operator, the Company receives a percentage of token holders’ staking rewards generated as a validator node fee, for our ministerial role in hosting the validator node. This creates an opportunity for scalable revenue and business growth with limited additional costs. The Company’s StaaS strategy provides a more accessible and cost-effective alternative for crypto asset holders to participate in blockchain networks’ consensus mechanisms, promoting the growth and adoption of blockchain technology. The Company’s internally-developed dashboard, StakeSeeker, is a non-custodial platform that allows users to learn how to earn staking rewards through direct participation in blockchain consensus algorithms and analyze their crypto portfolios across exchanges and wallets through a comprehensive crypto dashboard and education center.

 

 22 

 

 

The table below describes BTCS’s quarterly crypto asset holdings as of the 2022 Quarter through the 2023 Quarter.

 

Crypto Assets Held at Period End

 

Asset   2022 Q3   2022 Q4   2023 Q1   2023 Q2   2023 Q3
Ethereum (ETH)   8,380    8,454    8,524    7,833    7,748 
Cardano (ADA)   262,860    262,860    262,860    263,293    264,751 
Kusama (KSM)   6,297    6,493    6,767    6,946    7,246 
Tezos (XTZ)   72,578    73,486    74,765    25,375    25,760 
Solana (SOL)   7,238    7,371    7,493    7,621    7,752 
Polkadot (DOT)   23,905    7,280    7,526    7,882    8,284 
Cosmos (ATOM)   91,181    96,318    102,298    243,472    256,784 
Polygon (MATIC)   474,207    480,825    486,806    492,965    499,548 
Avalanche (AVAX)   14,888    17,178    17,178    17,824    17,824 
Algorand (ALGO)   51,201    -    -    -    - 
Axie Infinity (AXS)   37,402    42,030    46,482    50,955    55,584 
Kava (KAVA)   280,293    290,909    304,968    315,362    327,862 
Band Protocol (BAND)   992    992    992    992    992 
Mina (MINA)   71,297    74,177    79,937    81,377    84,257 
Oasis Network (ROSE)   349,661    359,607    2,569,991    2,600,279    2,626,600 
Akash (AKT)   103,730    107,405    110,213    113,063    115,735 
NEAR Protocol (NEAR)        74,702    75,724    77,389    79,067 
Evmos (EVMOS)        -    -    295,422    322,693 

 

Fair Value of Crypto Assets at Period End

 

Asset   2022 Q3   2022 Q4   2023 Q1   2023 Q2   2023 Q3
Ethereum (ETH)   11,128,675    10,117,237    15,530,133    15,141,859    12,948,491 
Cardano (ADA)   114,190    64,786    104,861    75,553    67,259 
Kusama (KSM)   265,505    149,981    236,070    175,352    138,166 
Tezos (XTZ)   103,210    52,720    83,614    20,452    17,569 
Solana (SOL)   240,377    73,426    158,625    144,010    165,849 
Polkadot (DOT)   150,964    31,410    47,720    40,763    34,009 
Cosmos (ATOM)   1,186,824    900,440    1,144,459    2,261,411    1,859,407 
Polygon (MATIC)   368,671    364,714    544,815    325,857    266,400 
Avalanche (AVAX)   256,021    187,286    304,341    231,941    164,759 
Algorand (ALGO)   18,044    -    -    -    - 
Axie Infinity (AXS)   470,116    253,943    389,893    302,966    254,967 
Kava (KAVA)   423,326    166,752    270,486    305,501    207,289 
Band Protocol (BAND)   1,215    1,396    1,857    1,260    1,121 
Mina (MINA)   42,085    32,187    62,101    39,579    32,095 
Oasis Network (ROSE)   21,330    12,291    156,698    128,686    109,516 
Akash (AKT)   26,881    19,938    34,510    63,311    94,686 
NEAR Protocol (NEAR)        93,785    150,854    107,088    89,660 
Evmos (EVMOS)        -    -    26,069    24,089 
Total   14,817,434    12,522,292    19,221,037    19,391,658    16,475,332 
QoQ Change   24%   -15%   53%   1%   -15%
YoY Change   -51%   -66%   -54%   63%   11%

 

 23 

 

 

Prices of Crypto Assets at Period End

 

Asset   2022 Q3   2022 Q4   2023 Q1   2023 Q2   2023 Q3
Ethereum (ETH)  $1,328   $1,197   $1,822   $1,933   $1,671 
Cardano (ADA)  $0.43   $0.25   $0.40   $0.29   $0.25 
Kusama (KSM)  $42.16   $23.10   $34.89   $25.24   $19.07 
Tezos (XTZ)  $1.42   $0.72   $1.12   $0.81   $0.68 
Solana (SOL)  $33.21   $9.96   $21.17   $18.90   $21.40 
Polkadot (DOT)  $6.32   $4.31   $6.34   $5.17   $4.11 
Cosmos (ATOM)  $13.02   $9.35   $11.19   $9.29   $7.24 
Polygon (MATIC)  $0.78   $0.76   $1.12   $0.66   $0.53 
Avalanche (AVAX)  $17.20   $10.90   $17.72   $13.01   $9.24 
Algorand (ALGO)  $0.35   $0.17   $0.23   $0.12   $0.10 
Axie Infinity (AXS)  $12.57   $6.04   $8.39   $5.95   $4.59 
Kava (KAVA)  $1.51   $0.57   $0.89   $0.97   $0.63 
Band Protocol (BAND)  $1.22   $1.41   $1.87   $1.27   $1.13 
Mina (MINA)  $0.59   $0.43   $0.78   $0.49   $0.38 
Oasis Network (ROSE)  $0.06   $0.03   $0.06   $0.05   $0.04 
Akash (AKT)  $0.26   $0.19   $0.31   $0.56   $0.82 
NEAR Protocol (NEAR)       $1.26   $1.99   $1.38   $1.13 
Evmos (EVMOS)       $-   $-   $0.09   $0.07 

 

* The prices have been rounded to the nearest whole dollar for prices above $100

 

The following table presents the Fair Value of Crypto Assets held compared to the GAAP Book Value reported on the Company’s balance sheet.

 

   September 30, 2023   December 31, 2022 
   Book Value   Fair Value   Book Value   Fair Value 
Ethereum (ETH)   5,081,581    12,948,491    5,708,624    10,117,237 
Cardano (ADA)   61,026    67,259    63,178    64,786 
Kusama (KSM)   127,522    138,166    142,242    149,981 
Tezos (XTZ)   16,270    17,569    51,651    52,720 
Solana (SOL)   64,883    165,849    60,012    73,426 
Polkadot (DOT)   32,491    34,009    30,859    31,410 
Cosmos (ATOM)   1,558,867    1,859,407    568,359    900,440 
Polygon (MATIC)   167,358    266,400    161,293    364,714 
Avalanche (AVAX)   155,089    164,759    182,964    187,286 
Algorand (ALGO)   -    -    -    - 
Axie Infinity (AXS)   227,623    254,967    245,443    253,943 
Kava (KAVA)   172,960    207,289    165,426    166,752 
Band Protocol (BAND)   874    1,121    982    1,396 
Mina (MINA)   30,148    32,095    32,002    32,187 
Oasis Network (ROSE)   95,677    109,516    12,045    12,291 
Akash (AKT)   21,366    94,686    17,993    19,938 
NEAR Protocol (NEAR)   82,466    89,660    92,840    93,785 
Evmos (EVMOS)   16,994    24,089    -    - 
Total  $7,913,195   $16,475,332   $7,535,913   $12,522,292 

 

 24 

 

 

Results of Operations for the Three and Nine Months Ended September 30, 2023 and 2022

 

The following tables reflect our operating results for the three and nine months ended September 30, 2023 and 2022:

 

  

For the Three Months Ended

September 30,

   $ Change   % Change 
   2023   2022   2023   2023 
                 
Revenues                    
Validator revenue  $316,242   $344,196   $(27,954)   (8)%
Total revenues   316,242    344,196    (27,954)   (8)%
                     
Cost of revenues                    
Validator expense   83,100    82,203    897    1%
Gross profit   233,142    261,993    (28,851)   (11)%
                     
Operating expenses:                    
General and administrative  $283,239   $432,956   $(149,717)   (35)%
Research and development   148,525    126,857    21,668    17%
Compensation and related expenses   409,960    669,792    (259,832)   (39)%
Marketing   2,155    8,765    (6,610)   (75)%
Impairment loss on digital assets   372,441    145,247    227,194    156%
Realized gains on digital asset transactions   (58,107)   (20,126)   (37,981)   189%
Total operating expenses   1,158,213    1,363,491    (205,278)   (15)%
                     
Other income (expenses):                    
Change in fair value of warrant liabilities   285,000    71,250    213,750    300%
Total other income (expenses)   285,000    71,250    213,750    300%
                     
Net loss  $(640,071)  $(1,030,248)   390,177    (38)%

 

  

For the Nine Months Ended

September 30,

   $ Change   % Change 
   2023   2022   2023   2023 
                 
Revenues                    
Validator revenue  $1,013,503   $1,421,560   $(408,057)   (29)%
Total revenues   1,013,503    1,421,560    (408,057)   (29)%
                     
Cost of revenues                    
Validator expense   278,726    313,972    (35,246)   (11)%
Gross profit   734,777    1,107,588    (372,811)   (34)%
                     
Operating expenses:                    
General and administrative  $1,510,637   $1,595,296   $(84,659)   (5)%
Research and development   531,053    448,579    82,474    18%
Compensation and related expenses   1,450,546    2,731,713    (1,281,167)   (47)%
Marketing   11,121    74,249    (63,128)   (85)%
Impairment loss on crypto assets   1,251,950    12,347,472    (11,095,522)   (90)%
Realized gains on crypto asset transactions   (806,137)   (489,682)   (316,455)   65%
Total operating expenses   3,949,170    16,707,627    (12,758,457)   (76)%
                     
Other income (expenses):                    
Change in fair value of warrant liabilities   142,500    1,140,000    (997,500)   (88)%
Distributions to warrant holders   -    (35,625)   35,625    N/A  % 
Total other income (expenses)   142,500    1,104,375    (961,875)   87%
                     
Net loss  $(3,071,893)  $(14,495,664)   11,423,771    (79)%

 

 25 

 

 

Validator Revenue

 

The decrease in revenue during the 2023 Period as compared to the 2022 Period is primarily due to a drop in the fair value of our crypto assets earned as rewards for staking since the market’s highs in the first quarter of 2022. Although we believe the number of tokens we earn from staking and revenue recognized will increase as we continue to expand our blockchain infrastructure efforts, we recognize that volatility in the crypto asset markets may impact the market prices of the crypto assets we earn from staking.

 

Cost of Revenues

 

The decrease in cost of revenues during the 2023 Period as compared to the 2022 Period is due to efficiencies realized in our blockchain infrastructure validating operating costs, including streamlining of web service hosting fees and reduction of services provided by vendors. We believe our cost of revenues will increase as we continue to ramp up our business. However, we believe gross margin will improve as we add scale to our blockchain infrastructure operations and reduce costs as a result of increased operational efficiencies, leading to improved gross profits.

 

Operating Expenses

 

General and administrative expenses consist of director compensation, legal and professional fees and other personnel and related costs. The decrease in the 2023 Period was primarily due to a decrease of $0.3 million in investor relation related costs compared to the 2022 Period as the Company focused on cost management and transitioning related efforts in-house from third-party engagements. These decreases were partially offset by a $0.2 million increases in legal service costs during the 2023 Period compared to the 2022 Period, driven primarily by services surrounding the Series V Preferred Distribution and related listing on Upstream Exchange.

 

Research and development expenses increased during the 2023 Period as the Company focused on the beta release of our proprietary StakeSeeker platform in the first quarter 2023, including responding to user feedback and continued planned feature development and incorporation onto the platform. We anticipate research and development costs to remain consistent as we continue to expand on technological solutions in the blockchain sector with a focus on cost management of our third-party development team.

 

Compensation and related expenses decreased during the 2023 Period primarily due non-cash $2.2 million equity-based contingent bonuses granted to employees and our non-employee directors during the 2022 Period for the achievement of performance milestones compared to only $0.7 million equity-based compensation during the 2023 Period. We believe our compensation expenses will increase slightly from those reported in the 2023 Period as the Company continues to utilize equity-based compensation incentives as a core part of our compensation strategy.

 

Marketing costs decreased during the 2023 Period as the Company focused on cost reduction efforts.

 

The decrease in operating expenses in the 2023 Period is primarily due to the impairment loss on crypto assets (which we refer to as a “Crypto Asset Impairment”) of $12.3 million during the 2022 Period, compared to only a $1.3 million Crypto Asset Impairment during the 2023 Period. Impairment charges are based on volatility in the crypto asset market and cannot be accurately predicted, but may subject the Company to the possibility of additional impairment charges on its crypto asset holdings.

 

The realized gain on crypto transactions increased during the 2023 Period as the Company sold approximately 968 ETH earned as rewards from our staking operations after liquidity was unlocked in April 2023 as part of Ethereum’s Shanghai upgrade.

 

Other Income (Expenses)

 

The changes in other income for the periods reported were primarily due to the decrease in the fair value of warrant liabilities. This non-cash expense is driven by the value of our stock price at the end of each quarter, which we cannot predict.

 

Net loss

 

The decrease in our net loss for the 2023 Period was primarily due to the decrease in operating expenses and changes in other income (expenses) as discussed above. We believe that our net loss may increase as the Company incurs increased costs related to the development of its StakeSeeker platform and incurs additional Crypto Asset Impairment losses due to volatility in the crypto asset markets.

 

 26 

 

 

Liquidity and Capital Resources

 

ATM Financing

 

On September 14, 2021, the Company entered into an At-The-Market Offering Agreement (the “ATM Agreement”) with H.C. Wainwright & Co., LLC, as agent (“H.C. Wainwright”), pursuant to which the Company may offer and sell, from time-to-time through H.C. Wainwright, shares of the Company’s Common Stock having an aggregate offering price of up to $98,767,500. From the period September 14, 2021 through November 7, 2023, the Company sold a total of 3,442,181 shares of Common Stock under the ATM Agreement for aggregate total gross proceeds of approximately $15,626,000 at an average selling price of $4.54 per share, resulting in net proceeds of approximately $15,122,000 after deducting commissions and other transaction costs.

 

Liquidity

 

The Company’s financial statements have been prepared assuming that it will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business.

 

Liquidity is the ability of a company to generate funds to support its current and future operations, satisfy its obligations, and otherwise operate on an ongoing basis. As of September 30, 2023, the Company had approximately $0.8 million of cash and working capital of approximately $8.4 million.

 

We view our crypto assets as long-term holdings and we do not plan to engage in regular trading of crypto assets other than for meeting operational cash needs. Further certain of our staked crypto assets may be locked up depending on the specific blockchain protocol and we may be unable to unstake them in a timely manner in order to liquidate to the extended desired. During times of instability in the market of crypto assets, we may not be able to sell our crypto assets at reasonable prices or at all. As a result, our crypto assets may not be able to serve as a source of liquidity for us to the same extent as cash and cash equivalents.

 

As of November 7, 2023, the Company had approximately $0.6 million of cash and cash equivalents and the fair value of the Company’s liquid crypto assets was approximately $19.3 million. The Company has no outstanding debt. As of November 7, 2023, the Company also has approximately $5.8 million available under the ATM Agreement over the next twelve months under the Form S-3 baby shelf rules, although, the amount that we may raise under the Form S-3 may increase or decrease based upon our stock price. The Company believes that the existing cash and liquid crypto assets held by us, in addition to the funds available to the Company from the issuance of additional stock through the ATM Agreement, provide sufficient liquidity to meet working capital requirements, anticipated capital expenditures and contractual obligations for at least the next 12 months.

 

Cash Flows

 

Cash used in operating activities was approximately $2.6 million during the 2023 Period compared to approximately $129,000 for the 2022 Period. The sale of our remaining bitcoin holdings by the end of 2022 was the primary contributor to the $2.6 million operating cash inflows from the sale of non-productive crypto assets during the 2022 Period compared to $0 in the 2023 Period. We do not anticipate any future material cash inflows from the sale of non-productive assets, as our blockchain infrastructure strategy focuses primarily on acquiring and staking productive proof-of-stake blockchain networks. Additional non-cash adjustments to our operating cash flows consisted of approximately $1.3 million impairment loss on crypto assets (“Crypto Asset Impairment”) during the 2023 Period compared to approximately $12.3 million Crypto Asset Impairment during the 2022 Period. Impairment charges are based on volatility in the crypto asset market and cannot be accurately predicted. This is partially offset by the approximately $2.2 million equity-based contingent bonuses granted to employees and our non-employee directors during the 2022 Period for the achievement of performance milestones compared to only approximately $1.1 million equity-based compensation in the 2023 Period. We anticipate similar levels of equity-based compensation in future periods as reported in the 2023 Period.

 

Cash used in investing activities was approximately $186,000 during the 2023 Period compared to approximately $8.8 million for the 2022 Period. Net cash outflow for investing activities was used primarily for the purchase of crypto assets for our blockchain infrastructure operations. We anticipate purchase activity to remain lower and consistent with the levels reported during the 2023 Period as we focus our strategies on technical developments. The 2022 Period included large purchases of productive crypto assets to build on our blockchain infrastructure operations.

 

Cash provided by financing activities was approximately $1.1 million during the 2023 Period compared to approximately $10.5 million for the 2022 Period. The cash inflows from financing activities were entirely from proceeds from the Common Stock sold pursuant to the ATM Agreement during the 2023 Period. The cash inflows from financing activities during the 2022 Period was partially offset by a one-time return of capital distribution of approximately $631,000 made to record holders as of March 17, 2022. The Company plans to continue to raise proceeds from the sale of Common Stock to fund operations as needed.

 

 27 

 

 

Off Balance Sheet Transactions

 

As of September 30, 2023, there were no off-balance sheet arrangements and we were not a party to any off-balance sheet transactions. We have no guarantees or obligations other than those which arise out of normal business operations.

 

Critical Accounting Policies and Estimates

 

We discussed the material accounting policies that are critical in making the estimates and judgments in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022, under the caption “Management’s Discussion and Analysis—Critical Accounting Policies and Estimates”. There has been no material change in critical accounting policies or estimates during the period covered by this report.

 

RECENT ACCOUNTING PRONOUNCEMENTS

 

For information on recent accounting pronouncements, see Note 3 to the Unaudited Condensed Financial Statements.

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This report contains forward-looking statements, including our liquidity, our belief that our blockchain infrastructure efforts will form the core growth for our StakeSeeker platform, our plans and development of our StakeSeeker platform and the integration of Staking-as-a-Service, increase in the number of tokens we earn, plans to expand our PoS operations, growth opportunities for the Company, consistent purchase activity, our belief regarding blockchain, expected increase in our revenues and gross margins and future business plans. Forward-looking statements can be identified by words such as “anticipates,” “intends,” “may,” “potential,” “continues,” “plans,” “seeks,” “believes,” “estimates,” “expects” and similar references to future periods.

 

Forward-looking statements are based on our current expectations and assumptions regarding our business, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Our actual results may differ materially from those contemplated by the forward-looking statements. We caution you therefore against relying on any of these forward-looking statements. They are neither statements of historical fact nor guarantees or assurances of future performance. The results anticipated by any or all of these forward-looking statements might not occur. Important factors that could cause actual results to differ materially from those in the forward-looking statements include the rewards and costs associated with staking or validating transactions on blockchains, regulatory issues related to our business model, a drop in the price of our crypto assets, significant decrease in the value of our crypto assets and rewards, loss or theft of the private withdrawal keys resulting in the complete loss of crypto assets and reward, and others which are contained in our filings with the SEC, including our Form 10-K for the year ended December 31, 2022. Any forward-looking statement made by us speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.

 

ITEM 3 Quantitative and Qualitative Disclosures About Market Risk

 

Not applicable.

 

ITEM 4 Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

Our management, with the participation of our Chief Executive Officer and our Chief Financial Officer, have evaluated the effectiveness of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of September 30, 2023. Our disclosure controls and procedures are designed to provide reasonable assurance that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the rules and forms of the SEC. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Based on this evaluation, management concluded that our disclosure controls and procedures were effective as of September 30, 2023.

 

Changes in Internal Control over Financial Reporting

 

There were no changes in our internal control over financial reporting, as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

 28 

 

 

PART II - OTHER INFORMATION

 

ITEM 1 Legal Proceedings

 

None.

 

ITEM 1A Risk Factors

 

Not applicable to smaller reporting companies.

 

ITEM 2 Unregistered Sales of Equity Securities and Use of Proceeds

 

None.

 

ITEM 3 Defaults Upon Senior Securities

 

None.

 

ITEM 4 Mine Safety Disclosures

 

Not applicable.

 

ITEM 5 Other Information

 

Effective November 1, 2023, Upstream, in response to the current regulatory landscape in the U.S., announced its decision to suspend the ability for U.S. individuals to engage in securities trading activities including buying, selling, or depositing securities on Upstream. As a result, U.S. holders of Series V are now unable to transfer their shares of Series V to Upstream. Any U.S. holders who previously transferred their Series V shares onto Upstream have had their shares returned to our Transfer Agent (Equity Stock Transfer). We are in discussions with Upstream regarding potential options.

 

ITEM 6 Exhibits

 

The exhibits listed in the accompanying “Exhibit Index” are filed or incorporated by reference as part of this Form 10-Q.

 

 29 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  BTCS Inc.
     
November 9, 2023    
  By:  /s/ Charles Allen
    Charles W. Allen
    Chief Executive Officer
    (Principal Executive Officer)

 

 30 

 

 

EXHIBIT INDEX

 

        Incorporated by Reference   Filed or Furnished
Exhibit #   Exhibit Description   Form   Date   Number   Herewith
2.1   Articles of Merger   8-K/A   7/31/15   3.1    
2.2   Agreement and Plan of Merger   8-K/A   7/31/15   3.2    
3.1   Amended and Restated Articles of Incorporation, as of May 2010   10-K   3/31/11   3.1    
3.1(a)   Certificate of Amendment to Articles of Incorporation - Increase Authorized Capital   8-K   3/25/13   3.1    
3.1(b)   Certificate of Amendment to Articles of Incorporation - Increase Authorized Capital   8-K   2/5/14   3.1    
3.1(c)   Certificate of Amendment to Articles of Incorporation - Reverse Stock Split   8-K   2/16/17   3.1    
3.1(d)   Certificate of Amendment to Articles of Incorporation - Reverse Stock Split   8-K   4/9/19   3.1    
3.1(e)   Certificate of Change – Reverse Stock Split   8-K   8/17/21   3.1    
3.1(f)   Certificate of Designation – Series V   8-K   1/31/23   3.1    
3.1(g)   Certificate of Amendment to the Series V Certificate of Designation   8-K   4/19/23   3.1    
3.1 (h)   Certificate of Amendment to Articles of Incorporation – Increase Authorized Capital   8-K   7/13/23   3.1    
4.1   BTCS Inc. 2021 Equity Incentive Plan, as amended   10-Q   8/11/23    4.1    
3.2   Bylaws   S-1   5/29/08   3.2    
3.2(a)   Amendment No. 1 to the Bylaws   8-K   4/12/22   3.1    
31.1   Certification of Principal Executive Officer (302)               Filed
31.2   Certification of Principal Financial Officer (302)               Filed
32.1   Certification of Principal Executive and Principal Financial Officer (906)               Furnished**
101.INS   Inline XBRL Instance Document                
101.SCH   Inline XBRL Taxonomy Extension Schema Document                
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document                
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document                
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document                
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document                
104   Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).                

 

** This exhibit is being furnished rather than filed and shall not be deemed incorporated by reference into any filing, in accordance with Item 601 of Regulation S-K.

 

Copies of this report (including the financial statements) and any of the exhibits referred to above will be furnished at no cost to our shareholders who make a written request to BTCS Inc., 9466 Georgia Avenue #124, Silver Spring, MD 20910, Attention: Corporate Secretary.

 

 31 

 

EX-31.1 2 ex31-1.htm

 

EXHIBIT 31.1

 

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND

PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Charles Allen, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of BTCS Inc. for the fiscal quarter ended September 30, 2023.
   
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
   
3. Based on my knowledge, the financial statements, and other financial information included in this interim report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
   
4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, is made known to us by others, particularly during the period in which this report is being prepared;
     
  b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
  c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
     
  d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting;

 

5. I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the registrant’s board of directors:

 

  a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
  b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

 

Dated: November 9, 2023 By: /s/ Charles Allen
    Charles Allen
    Chief Executive Officer
    (Principal Executive Officer)

 

 

 

EX-31.2 3 ex31-2.htm

 

EXHIBIT 31.2

 

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND

PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Michael Prevoznik, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of BTCS Inc. for the fiscal quarter ended September 30, 2023.
   
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
   
3. Based on my knowledge, the financial statements, and other financial information included in this interim report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
   
4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, is made known to us by others, particularly during the period in which this report is being prepared;
     
  b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
  c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
     
  d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting;

 

5. I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the registrant’s board of directors:

 

  a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
  b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

 

Dated: November 9, 2023 By: /s/ Michael Prevoznik
    Michael Prevoznik
    Chief Financial Officer
    (Principal Financial Officer)

 

 

 

EX-32.1 4 ex32-1.htm

 

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO

18 USC, SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of BTCS Inc. (the “Company”) on Form 10-Q for the quarter ended September 30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Charles Allen, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1) The Report fully complies with the requirements of Sections 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) Information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated: November 9, 2023 By: /s/ Charles Allen
    Charles Allen
    Chief Executive Officer
    (Principal Executive Officer)

 

A signed original of this written statement required by Section 906 has been provided to BTCS Inc. and will be retained by BTCS Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

 

In connection with the Quarterly Report of BTCS Inc. (the “Company”) on Form 10-Q for the quarter ended September 30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Michael Prevoznik, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1) The Report fully complies with the requirements of Sections 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) Information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated: November 9, 2023 By: /s/ Michael Prevoznik
    Michael Prevoznik
    Chief Financial Officer
    (Principal Financial Officer)

 

A signed original of this written statement required by Section 906 has been provided to BTCS Inc. and will be retained by BTCS Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

 

 

 

EX-101.SCH 5 btcs-20230930.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Statements of Changes in Stockholders' Equity (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Business Organization and Nature of Operations link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Fair Value of Financial Assets and Liabilities link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Stockholders’ Equity link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Accrued Expenses link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Employee Benefit Plans link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Liquidity link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Fair Value of Financial Assets and Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Stockholders’ Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Accrued Expenses (Tables) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Schedule of Earnings Per Share Anti-diluted (Details) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Schedule of Fair Value of Assets and Liabilities Valued on Recurring Basis (Details) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Summary of Valuation Methodology and Significant Unobservable Inputs Warrant Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Schedule of Changes in Fair Value and Other Adjustments of Warrants (Details) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Fair Value of Financial Assets and Liabilities (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Schedule of Weighted-Average Assumptions Used to Estimate Fair Value (Details) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Summary of Option Activity (Details) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Schedule of Restricted Stock Units (Details) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Summary of Restricted Stock (Details) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Schedule of Stock-based Compensation Expense (Details) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Stockholders’ Equity (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Schedule of Accrued Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Accrued Expenses (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Employee Benefit Plans (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - Liquidity (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 6 btcs-20230930_cal.xml XBRL CALCULATION FILE EX-101.DEF 7 btcs-20230930_def.xml XBRL DEFINITION FILE EX-101.LAB 8 btcs-20230930_lab.xml XBRL LABEL FILE Class of Stock [Axis] Series V Preferred Stock [Member] Equity Components [Axis] Preferred Stock [Member] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Statistical Measurement [Axis] Maximum [Member] Minimum [Member] Title of Individual [Axis] Board of Directors [Member] Antidilutive Securities [Axis] Warrant [Member] Share-Based Payment Arrangement, Option [Member] Non-vested Restricted Stock Awards Units [Member] Fair Value Hierarchy and NAV [Axis] Fair Value, Inputs, Level 3 [Member] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 2 [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Securities Purchase Agreement [Member] At-the-Market Offering Agreement [Member] Legal Entity [Axis] H.C. Wainwright and Co., LLC [Member] Each Independent Director [Member] Scenario [Axis] Four Equal Installments [Member] Independent Directors [Member] Officer [Member] Plan Name [Axis] 2021 Equity Incentive Plan [Member] Non-Executive Employees [Member] Award Type [Axis] Restricted Stock Units (RSUs) One [Member] Restricted Stock Units (RSUs) Two [Member] Restricted Stock Units (RSUs) Three [Member] Restricted Stock Units (RSUs) Four [Member] Restricted Stock Units (RSUs) [Member] Chief Technology Officer [Member] Vesting [Axis] One-Year Anniversary [Member] Four-Year Anniversary [Member] Restricted Stock [Member] Chief Executive Officer [Member] Market Cap Vesting Thresholds $50 Million [Member] Market Cap Vesting Thresholds $100 Million [Member] Market Cap Vesting Thresholds $150 Million [Member] Market Cap Vesting Thresholds $300 Million [Member] Chief Operating Officer [Member] Chief Financial Officer [Member] Employee Bonus Stock Awards [Member] Non-Employee Restricted Stock Awards [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement [Table] Statement [Line Items] Assets: Current assets: Cash and cash equivalents Stablecoins Crypto assets Staked crypto assets Investments, at value (Cost $100,000) Prepaid expense Total current assets Other assets: Property and equipment, net Staked crypto assets - long term Total other assets Total Assets Liabilities and Stockholders’ Equity: Accounts payable and accrued expense Accrued compensation Warrant liabilities Total current liabilities Stockholders’ equity: Preferred stock value Common stock, 97,500,000 shares authorized at $0.001 par value, 14,373,186 and 13,107,149 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively Additional paid in capital Accumulated deficit Total stockholders’ equity Total Liabilities and Stockholders’ Equity Cost of investment Preferred stock, shares authorized Preferred stock, par value Preferred stock, shares issued Preferred stock, shares outstanding Common stock, shares authorised Common stock, par value Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Revenues Validator revenue (net of fees) Total revenues Cost of revenues Validator expenses Gross profit Operating expenses: General and administrative Research and development Compensation and related expenses Marketing Impairment loss on crypto assets Realized gains on crypto asset transactions Total operating expenses Other income (expenses): Change in fair value of warrant liabilities Distributions to warrant holders Total other income (expenses) Net loss Net loss per share attributable to common stockholders, basic Net loss per share attributable to common stockholders, diluted Weighted average number of common shares outstanding, basic Weighted average number of common shares outstanding, diluted Balance Balance, shares Issuance of common stock, net of offering cost / At-the-market offering Issuance of common stock, net of offering cost / At-the-market offering, shares Issuance of Series V preferred stock Issuanceof Series V preferred stock, shares Stock-based compensation Stock-based compensation, shares Net loss Dividend distributions Issuance of common stock, net of offering cost / At-the-market offering Issuance of common stock, net of offering cost / At-the-market offering, shares Balance Balance, shares Statement of Cash Flows [Abstract] Net Cash flows used from operating activities: Adjustments to reconcile net loss to net cash used in operating activities: Depreciation expense Stock-based compensation Validator revenue Blockchain network fees (non-cash) Change in fair value of warrant liabilities Sale of non-productive crypto assets Realized gain on crypto assets transactions Changes in operating assets and liabilities: Stablecoins Prepaid expenses and other current assets Accounts payable and accrued expenses Accrued compensation Net cash used in operating activities Cash flows from investing activities: Purchase of productive crypto assets for validating Sale of productive crypto assets Purchase of property and equipment Sale of property and equipment Net cash provided by (used in) investing activities Cash flows from financing activities: Dividend distributions Net proceeds from issuance common stock/ At-the-market offering Net cash provided by financing activities Net (decrease)/increase in cash Cash, beginning of period Cash, end of period Supplemental disclosure of non-cash financing and investing activities: Series V Preferred Stock Distribution Organization, Consolidation and Presentation of Financial Statements [Abstract] Business Organization and Nature of Operations Accounting Policies [Abstract] Basis of Presentation Summary of Significant Accounting Policies Fair Value Disclosures [Abstract] Fair Value of Financial Assets and Liabilities Equity [Abstract] Stockholders’ Equity Payables and Accruals [Abstract] Accrued Expenses Retirement Benefits [Abstract] Employee Benefit Plans Liquidity Subsequent Events [Abstract] Subsequent Events Basis of presentation Reclassifications Cash and cash equivalents Stablecoins Revenue Recognition Cost of Revenues Crypto Assets Translations and Remeasurements Internally Developed Software Property and Equipment Use of Estimates Income Taxes Accounting for Warrants Stock-based compensation Dividends Advertising Expense Net Loss per Share Recent Accounting Pronouncements Schedule of Earnings Per Share Anti-diluted Fair Value, Recurring and Nonrecurring [Table] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Schedule of Fair Value of Assets and Liabilities Valued on Recurring Basis Summary of Valuation Methodology and Significant Unobservable Inputs Warrant Liabilities Schedule of Changes in Fair Value and Other Adjustments of Warrants Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Schedule of Weighted-Average Assumptions Used to Estimate Fair Value Summary of Option Activity Schedule of Restricted Stock Units Summary of Restricted Stock Schedule of Stock-based Compensation Expense Schedule of Accrued Expenses Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Anti-dilutive securities Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Cash Cash, FDIC insured amount Impairment losses Realized investment gains losses Property, plant and equipment, estimated useful lives Income tax likelihood percentage description Liquidation preference Number of shares issued Dividend per share Payments of dividends Advertising and marketing expenses Investments Warrant liabilities Risk-free rate of interest Expected volatility Expected life (in years) Expected dividend yield Investment, beginning balance Purchases Unrealized appreciation (depreciation) Investment, ending balance Warrant liabilities, beginning balance Warrant liabilities classification Fair value adjustment of warrant liabilities Warrant liabilities, ending balance Investments fair value Shares of common stock Common stock warrants Gross proceeds from private placement Exercise price Term (years) Expected stock price volatility Number of shares outstanding, beginning balance Weighted average exercise price, beginning balance Total Intrinsic value, beginning balance Weighted average remaining contractual life (in years), beginning balance Number of shares outstanding, Employee options granted Weighted average exercise price, employee options granted Total intrinsic value, employee options granted Weighted average remaining contractual life (in years), employee options granted Number of shares outstanding, Employee options forfeited Weighted average exercise price, employee options forfeited Total intrinsic value, employee options forfeited Number of shares outstanding, ending balance Weighted average exercise price, ending balance Total Intrinsic value, ending balance Weighted average remaining contractual life (in years), ending balance Number of shares outstanding, options vested and exercisable Weighted average exercise price, options vested and exercisable Total intrinsic value, options vested and exercisable Weighted average remaining contractual life (in years), options vested and exercisable Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table] Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items] Officer Name Grant Date Number of restricted stock units granted and vested, shares Number of restricted stock units nonvested, beginning balance Weighted average grant day fair value nonvested, beginning balance Number of restricted stock units, granted Weighted average grant day fair value, granted Number of restricted stock units, vested Weighted average grant day fair value, forfeited Number of restricted stock units, forfeited Weighted average grant day fair value, vested Number of restricted stock units nonvested, ending balance Weighted average grant day fair value nonvested, ending balance Stock-based compensation Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Line Items] Common stock, shares authorized Sale of stock, consideration received on transaction Percentage of gross proceeds of offerings Sale of stock, number of shares issued in transaction Gross proceeds from issuance of common stock Shares issued, price per share Proceeds from issuance initial public offering, net Stock option grant date fair value Share based payment issued Share based compensation Number of additional shares authorized Stock option granted Weighted average exercise price Market cap vesting thresholds, value Vesting rights, percentage Vesting period Accrued compensation Accounts payable and accrued expenses Accrued Expenses Accrued bonuses current and non current Percentage of defined comtribution plan employee Defined comtribution plan employee Accumulated deficit Net income loss Operating activities Staked crypto assets/currencies. Stable coins. Staked digital assets currencies non-current. Series V Preferred Stock [Member] Realized gains on crypto asset/currency transactions. Distributions to warrant holders. Stable Coins Policy [Text Block] Accounting For Warrants Policy [Text Block] Dividends Policy [Text Block] Board of Directors [Member] Securities Purchase Agreement [Member] Investment purchases. Investment owned unrecognized unrealized appreciation depreciation. Warrant liabilities classification. At-the-Market Offering Agreement [Member] H.C. Wainwright and Co., LLC [Member] Percentage of gross proceeds of offerings. Gross proceeds from issuance of common stock. Each Independent Director [Member] Four Equal Installments [Member] Independent Directors [Member] 2021 Equity Incentive Plan [Member] Non-Executive Employees [Member] Issuance of common stock net of offering cost atthemarket offering. Issuance of common stock net of offering cost at the market offering shares. Share based compensation arrangement by share based payment award options outstanding weighted average remaining contractual term grants in period. Share based compensation arrangement by share based payment award options outstanding weighted average remaining contractual term. Defined market capitalization thresholds, value. Restricted Stock Units (RSUs) One [Member] Restricted Stock Units (RSUs) Two [Member] Restricted Stock Units (RSUs) Three [Member] Restricted Stock Units (RSUs) Four [Member] Validator revenue. Blockchain network fees. It denotes the name of the officer. Chief Technology Officer [Member] Sale of non-productive crypto assets. Stock issued during period restricted stock award grant date. Realized gain on crypto assets transactions. Market Cap Vesting Thresholds $50 Million [Member] Market Cap Vesting Thresholds $100 Million [Member] Purchase of productive crypto assets/currencies for validating. Sale of productive crypto assets/currencies. Market Cap Vesting Thresholds $150 Million [Member] Market Cap Vesting Thresholds $300 Million [Member] Series V preferred stock distribution. One-Year Anniversary [Member] Four-Year Anniversary [Member] Increase decrease in stable coins. Crypto assets/currencies. Non-vested Restricted Stock Awards Units [Member] Employee Bonus Stock Awards [Member] Non-Employee Restricted Stock Awards [Member] Assets, Current Assets, Noncurrent Assets Liabilities, Current Equity, Attributable to Parent Liabilities and Equity Revenues [Default Label] Gross Profit RealizedGainsOnCryptoAssetCurrencyTransactions Operating Expenses DistributionsToWarrantHolders Nonoperating Income (Expense) Shares, Outstanding IssuanceOfCommonStockNetOfOfferingCostAtthemarketOffering IssuanceOfCommonStockNetOfOfferingCostAtthemarketOfferingShare Share-Based Payment Arrangement, Noncash Expense ValidatorRevenue RealizedGainOnCryptoAssetsTransactions IncreaseDecreaseInStableCoins Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Accrued Salaries Net Cash Provided by (Used in) Operating Activities PurchaseOfProductiveCryptoAssetsCurrenciesForValidating Payments to Acquire Property, Plant, and Equipment Net Cash Provided by (Used in) Investing Activities Payments of Ordinary Dividends, Common Stock Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Cash and Cash Equivalents, Policy [Policy Text Block] Stable Coins Policy [Text Block] Share-Based Payment Arrangement [Policy Text Block] Derivative Liability Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Share-Based Payment Arrangement, Expense Accrued Employee Benefits, Current Other Accounts Payable and Accrued Liabilities Accrued Liabilities, Current EX-101.PRE 9 btcs-20230930_pre.xml XBRL PRESENTATION FILE XML 10 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Cover - shares
9 Months Ended
Sep. 30, 2023
Nov. 07, 2023
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Sep. 30, 2023  
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2023  
Current Fiscal Year End Date --12-31  
Entity File Number 001-40792  
Entity Registrant Name BTCS Inc.  
Entity Central Index Key 0001436229  
Entity Tax Identification Number 90-1096644  
Entity Incorporation, State or Country Code NV  
Entity Address, Address Line One 9466 Georgia Avenue #124  
Entity Address, City or Town Silver Spring  
Entity Address, State or Province MD  
Entity Address, Postal Zip Code 20910  
City Area Code (202)  
Local Phone Number 430-6576  
Title of 12(b) Security Common Stock, par value $0.001  
Trading Symbol BTCS  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   14,373,186
XML 11 R2.htm IDEA: XBRL DOCUMENT v3.23.3
Balance Sheets - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 753,233 $ 2,146,783
Stablecoins 29,794
Crypto assets 101,387 982
Staked crypto assets 7,811,809 1,826,307
Investments, at value (Cost $100,000) 100,000 100,000
Prepaid expense 107,429 123,727
Total current assets 8,903,652 4,197,799
Other assets:    
Property and equipment, net 12,001 11,152
Staked crypto assets - long term 5,708,624
Total other assets 12,001 5,719,776
Total Assets 8,915,653 9,917,575
Liabilities and Stockholders’ Equity:    
Accounts payable and accrued expense 92,659 76,727
Accrued compensation 321,144 295,935
Warrant liabilities 71,250 213,750
Total current liabilities 485,053 586,412
Stockholders’ equity:    
Preferred stock value
Common stock, 97,500,000 shares authorized at $0.001 par value, 14,373,186 and 13,107,149 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively 14,374 13,108
Additional paid in capital 160,410,794 160,800,263
Accumulated deficit (154,554,101) (151,482,208)
Total stockholders’ equity 8,430,600 9,331,163
Total Liabilities and Stockholders’ Equity 8,915,653 9,917,575
Series V Preferred Stock [Member]    
Stockholders’ equity:    
Preferred stock value $ 2,559,533
XML 12 R3.htm IDEA: XBRL DOCUMENT v3.23.3
Balance Sheets (Parenthetical) - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Cost of investment $ 100,000 $ 100,000
Preferred stock, shares authorized 20,000,000 20,000,000
Preferred stock, par value $ 0.001 $ 0.001
Common stock, shares authorised 97,500,000 97,500,000
Common stock, par value $ 0.001 $ 0.001
Common stock, shares issued 14,373,186 13,107,149
Common stock, shares outstanding 14,373,186 13,107,149
Series V Preferred Stock [Member]    
Preferred stock, shares issued 14,542,803 0
Preferred stock, shares outstanding 14,542,803 0
XML 13 R4.htm IDEA: XBRL DOCUMENT v3.23.3
Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Revenues        
Validator revenue (net of fees) $ 316,242 $ 344,196 $ 1,013,503 $ 1,421,560
Total revenues 316,242 344,196 1,013,503 1,421,560
Cost of revenues        
Validator expenses 83,100 82,203 278,726 313,972
Gross profit 233,142 261,993 734,777 1,107,588
Operating expenses:        
General and administrative 283,239 432,956 1,510,637 1,595,296
Research and development 148,525 126,857 531,053 448,579
Compensation and related expenses 409,960 669,792 1,450,546 2,731,713
Marketing 2,155 8,765 11,121 74,249
Impairment loss on crypto assets 372,441 145,247 1,251,950 12,347,472
Realized gains on crypto asset transactions (58,107) (20,126) (806,137) (489,682)
Total operating expenses 1,158,213 1,363,491 3,949,170 16,707,627
Other income (expenses):        
Change in fair value of warrant liabilities 285,000 71,250 142,500 1,140,000
Distributions to warrant holders (35,625)
Total other income (expenses) 285,000 71,250 142,500 1,104,375
Net loss $ (640,071) $ (1,030,248) $ (3,071,893) $ (14,495,664)
Net loss per share attributable to common stockholders, basic $ (0.04) $ (0.08) $ (0.22) $ (1.15)
Net loss per share attributable to common stockholders, diluted $ (0.04) $ (0.08) $ (0.22) $ (1.15)
Weighted average number of common shares outstanding, basic 14,317,750 12,952,645 13,957,097 12,616,805
Weighted average number of common shares outstanding, diluted 14,317,750 12,952,645 13,957,097 12,616,805
XML 14 R5.htm IDEA: XBRL DOCUMENT v3.23.3
Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
Preferred Stock [Member]
Series V Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2021   $ 10,529 $ 147,682,384 $ (135,589,470) $ 12,103,443
Balance, shares at Dec. 31, 2021   10,528,212      
Issuance of common stock, net of offering cost / At-the-market offering   $ 2,149 11,092,983 11,095,132
Issuance of common stock, net of offering cost / At-the-market offering, shares   2,148,658      
Stock-based compensation   $ 377 2,233,231 2,233,608
Stock-based compensation, shares   376,842      
Net loss   (14,495,664) (14,495,664)
Dividend distributions   (634,557) (634,557)
Balance at Sep. 30, 2022   $ 13,055 160,374,041 (150,085,134) 10,301,962
Balance, shares at Sep. 30, 2022   13,053,712      
Balance at Jun. 30, 2022   $ 12,705 159,432,894 (149,054,886) 10,390,713
Balance, shares at Jun. 30, 2022   12,703,794      
Stock-based compensation   $ 32 450,773 450,805
Stock-based compensation, shares   31,848      
Net loss   (1,030,248) (1,030,248)
Dividend distributions  
Issuance of common stock, net of offering cost / At-the-market offering   $ 318 490,374 490,692
Issuance of common stock, net of offering cost / At-the-market offering, shares   318,070      
Balance at Sep. 30, 2022   $ 13,055 160,374,041 (150,085,134) 10,301,962
Balance, shares at Sep. 30, 2022   13,053,712      
Balance at Dec. 31, 2022 $ 13,108 160,800,263 (151,482,208) 9,331,163
Balance, shares at Dec. 31, 2022 13,107,149      
Issuance of common stock, net of offering cost / At-the-market offering $ 803 1,113,015 1,113,818
Issuance of common stock, net of offering cost / At-the-market offering, shares   803,054      
Issuance of Series V preferred stock $ 2,559,533 (2,559,533)
Issuanceof Series V preferred stock, shares 14,542,803        
Stock-based compensation $ 463 1,057,049 1,057,512
Stock-based compensation, shares   462,983      
Net loss (3,071,893) (3,071,893)
Balance at Sep. 30, 2023 $ 2,559,533 $ 14,374 160,410,794 (154,554,101) 8,430,600
Balance, shares at Sep. 30, 2023 14,542,803 14,373,186      
Balance at Jun. 30, 2023 $ 2,559,533 $ 14,182 159,955,610 (153,914,030) 8,615,295
Balance, shares at Jun. 30, 2023 14,542,803 14,181,410      
Issuance of common stock, net of offering cost / At-the-market offering $ 152 187,165 187,317
Issuance of common stock, net of offering cost / At-the-market offering, shares   151,882      
Stock-based compensation $ 40 268,019 268,059
Stock-based compensation, shares   39,894      
Net loss (640,071) (640,071)
Balance at Sep. 30, 2023 $ 2,559,533 $ 14,374 $ 160,410,794 $ (154,554,101) $ 8,430,600
Balance, shares at Sep. 30, 2023 14,542,803 14,373,186      
XML 15 R6.htm IDEA: XBRL DOCUMENT v3.23.3
Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Net Cash flows used from operating activities:    
Net loss $ (3,071,893) $ (14,495,664)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation expense 3,521 2,862
Stock-based compensation 1,057,512 2,233,608
Validator revenue (1,013,503) (1,421,560)
Blockchain network fees (non-cash) 1,321
Change in fair value of warrant liabilities (142,500) (1,140,000)
Sale of non-productive crypto assets 2,547,322
Realized gain on crypto assets transactions (806,137) (489,682)
Impairment loss on crypto assets 1,251,950 12,347,472
Changes in operating assets and liabilities:    
Stablecoins (29,794)
Prepaid expenses and other current assets 16,298 117,473
Accounts payable and accrued expenses 15,932 (37,842)
Accrued compensation 25,209 205,237
Net cash used in operating activities (2,693,405) (129,453)
Cash flows from investing activities:    
Purchase of productive crypto assets for validating (1,804,482) (9,274,055)
Sale of productive crypto assets 1,994,890 432,716
Purchase of property and equipment (5,276) (5,408)
Sale of property and equipment 905
Net cash provided by (used in) investing activities 186,037 (8,846,747)
Cash flows from financing activities:    
Dividend distributions (630,801)
Net proceeds from issuance common stock/ At-the-market offering 1,113,818 11,095,132
Net cash provided by financing activities 1,113,818 10,464,331
Net (decrease)/increase in cash (1,393,550) 1,488,131
Cash, beginning of period 2,146,783 1,400,867
Cash, end of period 753,233 2,888,998
Supplemental disclosure of non-cash financing and investing activities:    
Series V Preferred Stock Distribution $ 2,559,533
XML 16 R7.htm IDEA: XBRL DOCUMENT v3.23.3
Business Organization and Nature of Operations
9 Months Ended
Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Business Organization and Nature of Operations

Note 1 - Business Organization and Nature of Operations

 

BTCS Inc. (formerly Bitcoin Shop, Inc.), a Nevada corporation (“BTCS” or the “Company”) was incorporated in 2008 and is an early entrant in the crypto asset (also referred to “cryptocurrencies”, “crypto”, or “tokens”) market with a primary focus on blockchain infrastructure and staking. The Company operates validator nodes on various proof-of-stake (“PoS”) and delegated proof-of-stake (“DPoS”) based blockchain networks and stakes the native crypto assets on those blockchains to earn rewards. The Company’s Staking-as-a-Service (“StaaS”) business allows crypto asset holders to earn rewards by participating in network consensus mechanisms through staking and delegating their crypto assets to Company-operated validator nodes (or “nodes”). The Company believes that StaaS provides a more accessible and cost-effective way for crypto asset holders to participate in blockchain networks’ consensus mechanisms, thereby promoting the growth and adoption of blockchain technology.

 

The Company’s proprietary digital asset platform StakeSeeker (“StakeSeeker”) is currently in beta. StakeSeeker is a personal finance software and education center with a comprehensive crypto dashboard for crypto asset holders to connect, monitor, track, and analyze their crypto portfolios across exchanges and wallets in a single analytics platform. The internally-developed dashboard reads user data from digital wallets and utilizes application programming interfaces (APIs) to read data from crypto exchanges and does not allow for the trading or custody of crypto assets. StakeSeeker’s Stake hub is an education center for users to learn how to earn crypto rewards by delegating to our non-custodial validator nodes. Crypto asset holders are able to delegate to our validator nodes without signing up for the StakeSeeker platform; conversely, crypto asset holders can delegate to validator nodes not operated by the Company and sign up for StakeSeeker to utilize our software. The Company is not a broker-dealer or an investment advisor and does not provide any such related services.

 

The Company has addressed the majority of outstanding matters pertaining to its StakeSeeker platform and anticipates its transition from the beta phase on or before the conclusion of the first quarter of 2024. The current functionality allows for crypto asset holders to connect, monitor, track, and analyze their crypto portfolios across exchanges and wallets in a single analytics platform. In the future, the Company may expand support for additional blockchains and introduce additional analytic tools, with associated costs expected to align with historical research and development expenses.

 

The Company’s business is subject to various risks and uncertainties, including risks associated with the evolving regulatory landscape for crypto assets, risks associated with the volatility of crypto asset prices, and risks associated with the development and adoption of blockchain technology. The Company’s future success is dependent on various factors, including the growth of the crypto asset market, the adoption of blockchain technology, and the Company’s ability to effectively operate and grow its blockchain infrastructure operations and StaaS business.

 

The Company plans to expand its PoS operations to secure other disruptive blockchain protocols that also allow for delegating and asset leveraging. The growth of both StakeSeeker’s user base as well as the number and size of staked crypto assets by delegators to Company-run validator nodes are critical to the Company’s strategy and success.

 

XML 17 R8.htm IDEA: XBRL DOCUMENT v3.23.3
Basis of Presentation
9 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
Basis of Presentation

Note 2 - Basis of Presentation

 

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information, the instructions to Form 10-Q and the rules and regulations of the SEC. Accordingly, since they are interim statements, the accompanying unaudited condensed financial statements do not include all of the information and notes required by GAAP for annual financial statements, but in the opinion of the Company’s management, reflect all adjustments consisting of normal, recurring adjustments, that are necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods presented. Interim results for the three and nine months ended September 30, 2023 are not necessarily indicative of results for the full year ended December 31, 2023. The unaudited condensed financial statements and notes should be read in conjunction with the financial statements and notes for the year ended December 31, 2022.

 

 

 

XML 18 R9.htm IDEA: XBRL DOCUMENT v3.23.3
Summary of Significant Accounting Policies
9 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies

Note 3 - Summary of Significant Accounting Policies

 

There have been no material changes in the Company’s significant accounting policies to those previously disclosed in the 2022 Annual Report.

 

Basis of presentation

 

The accompanying financial statements have been prepared in accordance with United States generally accepted accounting principles (“GAAP”).

 

Reclassifications

 

Certain prior period amounts have been reclassified in order to conform with the current period presentation. These reclassifications have no impact on the Company’s previously reported net income (loss).

 

Cash and cash equivalents

 

The Company considers all highly liquid investments with original maturities of three months or less when purchased to be cash and cash equivalents. The Company maintains cash and cash equivalent balances at financial institutions that are insured by the FDIC. As of September 30, 2023 and December 31, 2022, the Company had approximately $753,000 and $2,147,000 in cash. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk on cash.

 

Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash deposits. Accounts at each institution are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. As of September 30, 2023 and December 31, 2022, the Company had approximately $102,000 and $1,682,000 in excess of the FDIC insured limit, respectively.

 

Stablecoins

 

The Company holds stablecoins, such as USDT (Tether) and USDC (USD Coin), which are crypto assets that are pegged to the value of one U.S. dollar and can be redeemed on demand for one U.S. dollar. Our stablecoins are typically held in secure digital wallets or on crypto asset exchanges. The Company acquires and holds stablecoins primarily to facilitate crypto asset transactions, including, but not limited to, payments to third-party vendors. While not accounted for as cash or cash equivalents, these stablecoins are considered a liquidity resource.

 

Revenue Recognition

 

The Company recognizes revenue under Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers. The core principle of the new revenue standard is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. The following five steps are applied to achieve that core principle:

 

  Step 1: Identify the contract with the customer
  Step 2: Identify the performance obligations in the contract
  Step 3: Determine the transaction price
  Step 4: Allocate the transaction price to the performance obligations in the contract
  Step 5: Recognize revenue when the Company satisfies a performance obligation

 

Revenue is recognized when control of the promised goods or services is transferred to the customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. The Company generates revenue through staking rewards.

 

The Company has entered into network-based smart contracts by running its own crypto asset validator nodes as well as by staking crypto assets on nodes run by third-party operators (either directly or through crypto exchanges). Through these contracts, the Company provides crypto assets to stake on a node for the purpose of validating transactions and adding blocks to a respective blockchain network. The term of a smart contract can vary based on the rules of the respective blockchain and typically last a few weeks to months after it is cancelled by the operator and requires that the crypto assets staked remain locked up during the duration of the smart contract. In exchange for staking the crypto assets and validating transactions on blockchain networks, the Company is entitled to all of the fixed crypto asset award for running the Company’s own node and is entitled to a fractional share of the fixed crypto asset award a third-party node operator receives (less crypto asset transaction fees payable to the node operator or exchanges, which are immaterial and are recorded as a deduction from revenue), for successfully validating or adding a block to the blockchain. The Company’s fractional share of awards received from delegating to a third-party validator node is based on the proportion of crypto assets the Company staked to the node to the total crypto assets staked by delegators to the node.

 

 

The provision of validating blockchain transactions is an output of the Company’s ordinary activities. Each separate block creation or validation under a smart contract with a network represents a performance obligation. The transaction consideration the Company receives - the crypto asset award - is a non-cash consideration, which the Company measures at fair value on the date received. The fair value of the crypto asset award received is determined using the quoted price of the related crypto assets on the date of receipt. The satisfaction of the performance obligation for processing and validating blockchain transactions occurs at a point in time when confirmation is received from the network indicating that the validation is complete, and the awards are available for transfer. At that point, revenue is recognized.

 

Cost of Revenues

 

The Company’s cost of revenue primarily includes direct production costs associated with transaction validation on the network, cloud-based server hosting expenses related to our validator nodes, and allocated employee salaries dedicated to node maintenance and support. Additionally, the cost of revenue encompasses fees, including equity compensation stock-based fees, paid to third parties for their assistance in software maintenance and node operations.

 

Crypto Assets Translations and Remeasurements

 

The Company accounts for its crypto assets as indefinite-lived intangible assets in accordance with ASC 350, Intangibles – Goodwill and Other. An intangible asset with an indefinite useful life is not amortized but assessed for impairment annually, or more frequently, when events or changes in circumstances occur indicating that it is more likely than not that the indefinite-lived asset is impaired. Impairment exists when the carrying amount exceeds its fair value. In testing for impairment, the Company has the option to first perform a qualitative assessment to determine whether it is more likely than not that an impairment exists. If it is determined that it is not more likely than not that an impairment exists, a quantitative impairment test is not necessary. If the Company concludes otherwise, it is required to perform a quantitative impairment test. To the extent an impairment loss is recognized, the loss establishes the new cost basis of the asset. Subsequent reversal of impairment losses is not permitted.

 

Crypto assets held are included in the balance sheets as either current assets or other assets if they are staked and locked up for over one year. The Company’s crypto assets are initially recorded at fair value upon receipt (or “carrying value”). The fair value of crypto assets is determined using the U.S. dollar spot price of the related crypto asset. On a quarterly basis, crypto assets are measured at carrying value, net of any impairment losses incurred since receipt. The Company will record impairment losses as the fair value falls below the carrying value of the crypto assets at any time during the period, as determined using the lowest intraday U.S. dollar spot price of the related crypto asset subsequent to its acquisition. The crypto assets can only be marked down when impaired and not marked up when their value increases.

 

Such impairment in the value of crypto assets is recorded as a component of costs and expenses in our Statements of Operations. The Company recorded impairment losses related to crypto assets of approximately $1,252,000 and $12,347,000 during the nine months ended September 30, 2023, and 2022, respectively.

 

Impairment losses cannot be recovered for any subsequent increase in fair value until the sale or disposal of the asset. Realized gain (loss) on sale of crypto assets are included in other income (expense) in the Statements of Operations. The Company recorded realized gains (losses) on crypto assets of approximately $806,000 and $490,000 during the nine months ended September 30, 2023 and 2022, respectively.

 

The presentation of purchases and sales of crypto assets on the Statement of Cash Flows is determined by the nature of the crypto assets, which can be characterized as productive (i.e. purchased for purposes of staking) or non-productive. The purchase of non-productive crypto assets and currencies are included as an operating activity, whereas the purchase of productive crypto assets and currencies are included as investing activities in accordance with ASC 230-10-20 Investing activities. Productive crypto assets that are staked with a lock-up period of less than 12 months are presented on the Balance Sheet as current assets. Staked crypto assets with remaining lock-up periods of greater than 12 months are presented as long-term other assets on the Balance Sheet.

 

 

Internally Developed Software

 

Internally developed software consists of the core technology of the Company’s StakeSeeker platform, which is being designed to allow users to track, monitor and analyze their aggregate crypto asset portfolio holdings by connecting their crypto exchanges and digital wallets as well as providing a non-custodial delegation process to earn staking rewards on crypto asset holdings. For internally developed software, the Company uses both its own employees as well as the services of external vendors and independent contractors. The Company accounts for computer software used in the business in accordance with ASC 985-20 and ASC 350.

 

ASC 985-20, Software-Costs of Computer Software to Be Sold, Leased, or Otherwise Marketed, requires that software development costs incurred in conjunction with product development be charged to research and development expense until technological feasibility is established. Thereafter, until the product is released for sale, software development costs must be capitalized and reported at the lower of unamortized cost or net realizable value of the related product. Some companies use a “tested working model” approach to establishing technological feasibility (i.e., beta version). Under this approach, software under development will pass the technological feasibility milestone when the Company has completed a version that contains essentially all the functionality and features of the final version and has tested the version to ensure that it works as expected.

 

ASC 350, Intangibles-Goodwill and Other, requires computer software costs associated with internal use software to be charged to operations as incurred until certain capitalization criteria are met. Costs incurred during the preliminary project stage and the post-implementation stages are expensed as incurred. Certain qualifying costs incurred during the application development stage are capitalized as property, equipment and software. These costs generally consist of internal labor during configuration, coding, and testing activities. Capitalization begins when (i) the preliminary project stage is complete, (ii) management with the relevant authority authorizes and commits to the funding of the software project, and (iii) it is probable both that the project will be completed, and that the software will be used to perform the function intended.

 

Property and Equipment

 

Property and equipment consists of computer, equipment and office furniture and fixtures, all of which are recorded at cost. Depreciation and amortization are recorded using the straight-line method over the respective useful lives of the assets ranging from three to five years. Long-lived assets are reviewed for impairment whenever events or circumstances indicate that the carrying amount of these assets may not be recoverable.

 

Use of Estimates

 

The accompanying financial statements have been prepared in conformity with U.S. GAAP. This requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the period. The Company’s significant estimates and assumptions include the recoverability and useful lives of indefinite life intangible assets, stock-based compensation, and the valuation allowance related to the Company’s deferred tax assets. Certain of the Company’s estimates, including the carrying amount of the indefinite life intangible assets, could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible that these external factors could have an effect on the Company’s estimates and could cause actual results to differ from those estimates and assumptions.

 

Income Taxes

 

The Company recognizes income taxes on an accrual basis based on tax positions taken or expected to be taken in its tax returns. A tax position is defined as a position in a previously filed tax return or a position expected to be taken in a future tax filing that is reflected in measuring current or deferred income tax assets and liabilities. Tax positions are recognized only when it is more likely than not (i.e., likelihood of greater than 50%), based on technical merits, that the position would be sustained upon examination by taxing authorities. Tax positions that meet the more likely than not threshold are measured using a probability-weighted approach as the largest amount of tax benefit that is greater than 50% likely of being realized upon settlement. Income taxes are accounted for using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the Company’s financial statements or tax returns. A valuation allowance is established to reduce deferred tax assets if all, or some portion, of such assets will more than likely not be realized. Should they occur, the Company’s policy is to classify interest and penalties related to tax positions as income tax expense. Since the Company’s inception, no such interest or penalties have been incurred.

 

 

Accounting for Warrants

 

The Company accounts for the issuance of Common Stock purchase warrants issued in connection with the equity offerings in accordance with the provisions of ASC 815, Derivatives and Hedging (“ASC 815”). The Company classifies as equity any contracts that (i) require physical settlement or net-share settlement or (ii) gives the Company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement). The Company classifies as assets or liabilities any contracts that (i) require net-cash settlement (including a requirement to net-cash settle the contract if an event occurs and if that event is outside the control of the Company) or (ii) gives the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement). In addition, Under ASC 815, registered Common Stock warrants that require the issuance of registered shares upon exercise and do not expressly preclude an implied right to cash settlement are accounted for as derivative liabilities. The Company classifies these derivative warrant liabilities on the balance sheet as a current liability.

 

The Company assessed the classification of Common Stock purchase warrants as of the date of each offering and determined that such instruments originally met the criteria for equity classification; however, as a result of the Company no longer being in control of whether the warrants may be cash settled, the instruments no longer qualify for equity classification. Accordingly, the Company classified the warrants as a liability at their fair value and adjusts the instruments to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until the warrants are exercised or expired, and any change in fair value is recognized as “change in the fair value of warrant liabilities” in the statements of operations. The fair value of the warrants has been estimated using a Black-Scholes valuation model (see Note 4).

 

Stock-based compensation

 

The Company accounts for stock-based compensation in accordance with ASC 718 Compensation – Stock Compensation (“ASC 718”). ASC 718 addresses all forms of share-based payment awards including shares issued under employee stock purchase plans and stock incentive shares. Under ASC 718 awards result in a cost that is measured at fair value on the awards’ grant date, based on the estimated number of awards that are expected to vest and will result in a charge to operations.

 

Share-based payment awards exchanged for services are accounted for at the fair value of the award on the estimated grant date.

 

Options

 

Stock options issued under the Company’s long-term incentive plans are granted with an exercise price equal to no less than the market price of the Company’s stock at the date of grant and expire up to ten years from the date of grant. These options often vest over a one-year period.

 

The Company estimates the fair value of stock option grants using the Black-Scholes option pricing model and the assumptions used in calculating the fair value of stock-based awards represent management’s best estimates and involve inherent uncertainties and the application of management’s judgment.

 

 

Restricted Stock Units (RSUs)

 

For awards vesting upon the achievement of a service condition, compensation cost measured on the grant date will be recognized on a straight-line basis over the vesting period. Stock-based compensation expense for the market-based restricted stock units with explicit service conditions is recognized on a straight-line basis over the longer of the derived service period or the explicit service period, regardless of whether the market condition is satisfied. However, in the event that the explicit service period is not met, previously recognized compensation cost would be reversed. Market-based restricted stock units subject to market-based performance targets require achievement of the performance target as well as a service condition in order for these RSUs to vest.

 

The Company estimates the fair value of market-based RSUs as of the grant date and expected derived term using a Monte Carlo simulation that incorporates pricing inputs covering the period from the grant date through the end of the derived service period.

 

Dividends

 

Effective January 27, 2023, the Company’s Board of Directors (the “Board”) approved the issuance of a newly designated Series V Preferred Stock (“Series V”) on a one-for-one basis to the Company’s shareholders (including restricted stock unit holders and warrant holders who were entitled to such distribution). The distribution of Series V shares was approved and completed on June 2, 2023 to shareholders as of the record date of May 12, 2023. The Series V: (i) is non-convertible, (ii) has a 20% liquidation preference over the shares of common stock, (iii) is non-voting and (iv) has certain rights to dividends and distributions (at the discretion of the Board). A total of 14,542,803 shares of Series V Preferred Stock were distributed to shareholders on June 2, 2023.

 

On January 5, 2022, the Board declared a non-recurring special dividend of $0.05 for each outstanding share of Common Stock of the Company, payable to holders of record as of the close of business on March 17, 2022. The dividend distributions were considered a return of capital as the distributions were in excess of the Company’s current and accumulated earnings and profits. The return of capital distribution reduces the Company’s additional paid in capital balance. Dividend distributions amounted to $0 and $635,000 during the nine months ended September 30, 2023 and 2022, respectively.

 

The Company will evaluate the appropriateness of potential future dividends as the Company continues to grow its operations.

 

Advertising Expense

 

Advertisement costs are expensed as incurred and included in marketing expenses. Advertising and marketing expenses amounted to approximately $11,000 and $74,000 for the nine months ended September 30, 2023 and 2022, respectively.

 

Net Loss per Share

 

Basic loss per share is computed by dividing the net income or loss applicable to common shares by the weighted average number of common shares outstanding during the period. Diluted earnings per share is computed using the weighted average number of common shares and, if dilutive, potential common shares outstanding during the period. Potential common shares consist of the Company’s convertible preferred stock, convertible notes, restricted stock units, options and warrants. Diluted loss per share excludes the shares issuable upon the conversion of preferred stock, notes and warrants from the calculation of net loss per share if their effect would be anti-dilutive.

 

The following financial instruments were not included in the diluted loss per share calculation as of September 30, 2023 and 2022 because their effect was anti-dilutive:

 

   2023   2022 
   As of September 30, 
   2023   2022 
Warrants to purchase common stock   712,500    945,837 
Options   1,150,000    1,285,000 
Non-vested restricted stock awards units   1,631,399    1,612,350 
Total   3,493,899    3,843,187 

 

Recent Accounting Pronouncements

 

We have evaluated all recently issued accounting pronouncements and believe such pronouncements do not have a material effect on our financial statements.

 

 

XML 19 R10.htm IDEA: XBRL DOCUMENT v3.23.3
Fair Value of Financial Assets and Liabilities
9 Months Ended
Sep. 30, 2023
Fair Value Disclosures [Abstract]  
Fair Value of Financial Assets and Liabilities

Note 4 – Fair Value of Financial Assets and Liabilities

 

The Company measures certain assets and liabilities at fair value. The Company defines fair value as the price that would be received from selling an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market in an orderly transaction between market participants at the measurement date. Fair value is estimated by applying the following hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement:

 

Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.

 

Level 2 – Observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

 

Level 3 – Inputs that are generally unobservable and typically reflect management’s estimate of assumptions that market participants would use in pricing the asset or liability.

 

Financial instruments, including cash and cash equivalents, accounts and other receivables, accounts payable and accrued liabilities are carried at cost, which management believes approximates fair value due to the short-term nature of these instruments.

 

The following tables present the Company’s assets and liabilities that are measured at fair value on a recurring basis and the Company’s estimated level within the fair value hierarchy of those assets and liabilities as of September 30, 2023 and December 31, 2022:

   Fair Value Measured at September 30, 2023 
  

Total at

September 30,

2023

   Quoted prices in active markets (Level 1)   Significant other observable inputs (Level 2)   Significant unobservable inputs (Level 3) 
                     
Assets                    
Investments  $100,000   $      -   $          -   $100,000 
Liabilities                    
Warrant Liabilities  $71,250   $-   $-   $71,250 

 

   Fair Value Measured at December 31, 2022 
  

Total at

December 31,

2022

   Quoted prices in active markets (Level 1)   Significant other observable inputs (Level 2)   Significant unobservable inputs (Level 3) 
                     
Assets                    
Investments  $100,000   $      -   $          -   $100,000 
Liabilities                    
Warrant Liabilities  $213,750   $-   $-   $213,750 

 

The Company did not make any transfers between the levels of the fair value hierarchy during the nine months ended September 30, 2023 and 2022.

 

 

Level 3 Valuation Techniques

 

Level 3 financial assets consist of private equity investments for which there is no current public market for these securities such that the determination of fair value requires significant judgment or estimation. As of September 30, 2023 and December 31, 2022, the Company’s Level 3 investments were carried at original cost of the investments, with a value of $100,000. The Company has elected to apply the measurement alternative under ASC 321, Investments—Equity Securities, for these investments.

 

Level 3 financial liabilities consist of the warrant liabilities for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation.

 

Changes in fair value measurements categorized within Level 3 of the fair value hierarchy are analyzed each period based on changes in estimates or assumptions and recorded as appropriate.

 

A significant decrease in the volatility or a significant decrease in the Company’s stock price, in isolation, would result in a significantly lower fair value measurement. Changes in the values of the warrant liabilities are recorded in “change in fair value of warrant liabilities” in the Company’s statements of operations.

 

On March 2, 2021, the Company entered into a securities purchase agreement with certain purchasers which closed on March 4, 2021 pursuant to which the Company sold an aggregate of (i) 950,000 shares of Common Stock, and (ii) Common Stock warrants (the “Warrants”) to purchase up to 712,500 shares of Common Stock for gross proceeds of $9.5 million in a private placement offering.

 

The Warrants require, at the option of the holder, a net-cash settlement following certain fundamental transactions (as defined in the Warrants) at the Company. At the time of issuance, the Company maintained control of certain fundamental transactions and as such the Warrants were initially classified in equity. As of December 31, 2022, the Company no longer maintained control of certain fundamental transactions as they did not control a majority of shareholder votes. As such, the Company may be required to cash settle the Warrants if a fundamental transaction occurs which is outside the Company’s control. Accordingly, the Warrants are classified as liabilities. The Warrants have been recorded at their fair value using the Black-Scholes valuation model, and will be recorded at their respective fair value at each subsequent balance sheet date. This model incorporates transaction details such as the Company’s stock price, contractual terms, maturity, risk-free rates, as well as volatility.

 

The Warrants require the issuance of registered shares upon exercise, do not expressly preclude an implied right to cash settlement and are therefore accounted for as derivative liabilities. The Company classifies these derivative warrant liabilities on the balance sheet as a current liability.

 

 

A summary of quantitative information with respect to the valuation methodology and significant unobservable inputs used for the Company’s warrant liabilities that are categorized within Level 3 of the fair value hierarchy at the date of issuance and, as of September 30, 2023 and December 31, 2022, is as follows:

   September 30, 2023   December 31, 2022 
Risk-free rate of interest   5.03%   3.99%
Expected volatility   108.3%   152.8%
Expected life (in years)   2.43    3.18 
Expected dividend yield   -    - 

 

The risk-free interest rate was based on rates established by the Federal Reserve Bank. For the Warrants, the Company estimates expected volatility giving primary consideration to the historical volatility of its Common Stock. The general expected volatility is based on the standard deviation of the Company’s underlying stock price’s daily logarithmic returns. The expected life of the warrants was determined by the expiration date of the warrants. The expected dividend yield was based on the fact that the Company has not historically paid dividends on its Common Stock and does not expect to pay recurring dividends on its Common Stock in the future.

 

The following table sets forth a summary of the changes in the fair value of the Company’s Level 3 financial assets and liabilities for the nine months ended September 30, 2023 and 2022, that are measured at fair value on a recurring basis:

   Fair Value of Level 3 Financial Assets 
   September 30, 2023   September 30, 2022 
Beginning balance  $100,000   $- 
Purchases   -    - 
Unrealized appreciation (depreciation)   -    - 
Ending balance  $100,000   $            - 

 

   Fair Value of Level 3 Financial Liabilities 
   September 30, 2023   September 30, 2022 
Beginning balance  $213,750   $1,852,500 
Warrant liabilities classification   -    - 
Fair value adjustment of warrant liabilities   (142,500)   (1,140,000)
Ending balance  $71,250   $712,500 

 

XML 20 R11.htm IDEA: XBRL DOCUMENT v3.23.3
Stockholders’ Equity
9 Months Ended
Sep. 30, 2023
Equity [Abstract]  
Stockholders’ Equity

Note 5 – Stockholders’ Equity

 

Common Stock

 

The Company received shareholder approval on July 11, 2023 to amend our Articles of Incorporation to increase the number of authorized shares of common stock from 97,500,000 shares to 975,000,000. On July 12, 2023, the Company filed a Certificate of Amendment to the Articles of Incorporation to effectuate the increase of our authorized shares of common stock to 975,000,000.

 

At-The-Market Offering Agreement

 

On September 14, 2021, the Company entered into an At-The-Market Offering Agreement (the “ATM Agreement”) with H.C. Wainwright & Co., LLC, as agent (“H.C. Wainwright”), pursuant to which the Company may offer and sell, from time-to-time through H.C. Wainwright, shares of the Company’s Common Stock having an aggregate offering price of up to $98,767,500 (the “Shares”). The Company will pay H.C. Wainwright a commission rate equal to 3.0% of the aggregate gross proceeds from each sale of Shares.

 

  

During the nine months ended September 30, 2023, the Company sold a total of 803,054 shares of Common Stock under the ATM Agreement for aggregate total gross proceeds of approximately $1,161,000 at an average selling price of $1.45 per share, resulting in net proceeds of approximately $1,114,000 after deducting commissions and other transaction costs.

 

Share Based Payments

 

Effective January 19, 2023, The Board of Directors of the Company approved the issuance of $50,000 of common stock to each independent director. The shares will be issued in four equal installments ($12,500) at the end of each calendar quarter beginning March 31st, subject to continued service on each applicable issuance date. The number of shares issuable will be based on the closing price of the Company’s common stock on the last trading day prior to the end of the applicable calendar quarter. For the nine months ended September 30, 2023, 99,117 shares of common stock were issued to independent directors.

 

For the nine months ended September 30, 2023, 410,317 shares of common stock were issued to officers related to payment of 2022 accrued bonus compensation. 

 

Preferred Stock

 

Series V

 

Effective January 27, 2023, the Board approved the issuance of a newly designated Series V Preferred Stock (“Series V”) on a one-for-one basis to the Company’s shareholders (including restricted stock unit holders and warrant holders). The distribution of Series V shares was approved and completed on June 2, 2023 to shareholders as of the record date of May 12, 2023. The Series V: (i) is non-convertible, (ii) has a 20% liquidation preference over the shares of common stock, (iii) is non-voting and (iv) has certain rights to dividends and distributions (at the discretion of the Board of Directors). A total of 14,542,803 shares of Series V Preferred Stock were distributed to shareholders on June 2, 2023. The Series V is listed to trade on Upstream, the trading app for digital securities and NFTs powered by Horizon Fintex and MERJ Exchange Limited, under the ticker symbol BTCSP.

 

The fair value of the Preferred stock as of the record date, May 12, 2023, amounted to approximately $2,560,000. The Company used a probability valuation model to determine the fair value of the preferred stock.

 

2021 Equity Incentive Plan

 

The Company’s 2021 Equity Incentive Plan (the “2021 Plan”) was effective on January 1, 2021 and approved by shareholders on March 31, 2021 and amended on June 13, 2022. The Company received shareholder approval on July 11, 2023 to increase the authorized amount under the 2021 Plan from 7,000,000 shares to 12,000,000 shares.

 

Options

 

During the nine months ended September 30, 2023, the Company granted 35,000 stock options with a weighted average exercise price of $0.81 to non-executive employees.

 

The following weighted-average assumptions were used to estimate the fair value of options granted on the deemed grant date during the nine months ended September 30, 2023 and 2022 for both the Black-Scholes formula:

  

Nine Months Ended

September 30,

 
   2023   2022 
Exercise price  $0.81   $1.51 
Term (years)   5.00    5.00 
Expected stock price volatility   151.6%   165.8%
Risk-free rate of interest   4.15%   2.77%

 

Expected Volatility: The Company uses historical volatility as it provides a reasonable estimate of the expected volatility. Historical volatility is based on the most recent volatility of the stock price over a period of time equivalent to the expected term of the option.

 

Risk-Free Interest Rate: The risk-free interest rate is based on the U.S. treasury zero-coupon yield curve in effect at the time of grant for the expected term of the option.

 

Expected Term: The Company’s expected term represents the weighted-average period that the Company’s stock options are expected to be outstanding. The expected term is based on the expected time to post-vesting exercise of options by employees. The Company uses historical exercise patterns of previously granted options to derive employee behavioral patterns used to forecast expected exercise patterns.

 

 

For awards vesting upon the achievement of the market conditions which were met at the date of grant, compensation cost measured on the date of grant was immediately recognized. For awards vesting upon the achievement of the market conditions which were not met at the date of grant, compensation cost measured on the grant date will be recognized on a straight-line basis over the vesting period based on estimation using a Monte-Carlo simulation.

 

A summary of option activity under the Company’s stock option plan for nine months ended September 30, 2023 is presented below:

   Number of Shares   Weighted Average Exercise Price   Total Intrinsic Value   Weighted Average Remaining Contractual Life (in years) 
Outstanding as of December 31, 2022   1,150,000   $2.15   $-    3.3 
Employee options granted   35,000    0.81    -    4.9 
Employee options forfeited   (35,000)   1.02    11,100    - 
Outstanding as of September 30, 2023   1,150,000   $2.14   $-    2.5 
Options vested and exercisable as of September 30, 2023   1,135,000   $2.16   $-    2.5 

 

RSUs

 

Effective January 2, 2022, the Board of Directors of the Company ratified the following arrangements approved by its Compensation Committee:

 

The Company’s executive officers were granted RSUs as part of a long-term incentive plan (“LTI”), with vesting terms set for when the Company’s market capitalization reaches and sustains a market capitalization for 30 consecutive days above four defined market capitalization thresholds of $100 million, $150 million, $200 million and $400 million.

 

Effective February 22, 2022, upon appointment of Manish Paranjape as Chief Technology Officer of the Company, Mr. Paranjape was also granted RSUs as part of the LTI plan, with consistent vesting terms set for when the Company’s market capitalization above the same four defined market capitalization thresholds.

 

Effective January 1, 2023 (the “LTI RSU Amendment Date”), upon recommendation of the Compensation Committee of the Board of Directors approved an amendment to the LTI plan, whereby the market capitalization threshold targets were lowered to $50 million, $100 million, $150 million, and $300 million.

 

The RSUs granted to each executive employee are as follows:

         Total   Market Cap Vesting Thresholds 
Officer Name  Title  Grant
Date
  RSUs
Granted
   $ 50
million
   $ 100
million
   $ 150
million
   $ 300
million
 
Charles Allen  Chief Executive Officer  1/2/2022   694,444    173,611    173,611    173,611    173,611 
Michal Handerhan  Chief Operations Officer  1/2/2022   444,444    111,111    111,111    111,111    111,111 
Michael Prevoznik  Chief Financial Officer  1/2/2022   222,224    55,556    55,556    55,556    55,556 
Manish Paranjape  Chief Technology Officer  2/22/2022   160,184    40,046    40,046    40,046    40,046 
            1,521,296      380,324      380,324      380,324      380,324 

 

To the extent any market capitalization targets set forth above for Mr. Prevoznik and Mr. Paranjape are achieved, the RSUs will also be subject to the following five-year vesting schedule: 20% of the LTI RSUs which have met a market capitalization criteria will vest on the one-year anniversary of the grant date, and the remaining 80% of the LTI RSUs which have met a market capitalization criteria will vest annually on each subsequent calendar year-end date over the four years following the one year anniversary of the grant date.

 

 

For awards vesting upon the achievement of a service condition, compensation cost measured on the grant date will be recognized on a straight-line basis over the vesting period. Stock-based compensation expense for the market-based restricted stock units with explicit service conditions is recognized on a straight-line basis over the longer of the derived service period or the explicit service period, regardless of whether the market condition is satisfied. However, in the event that the explicit service period is not met, previously recognized compensation cost would be reversed. Market-based restricted stock units subject to market-based performance targets require achievement of the performance target as well as a service condition in order for these RSUs to vest.

 

The Company estimates the fair value of market-based RSUs as of the grant date and expected derived term using a Monte Carlo simulation that incorporates pricing inputs covering the period from the grant date through the end of the derived service period. As of the LTI RSU Amendment Date, the Company determined the pre-modification and post-modification estimated fair value of the LTI RSUs accounting for the amended market cap criteria. The increase in fair value of the LTI RSUs attributable to the modification was added to the related unrecognized compensation expense in accordance with ASC 718 – Share-Based Compensation, whereby any previously recognized compensation cost that has not vested as of the modification date should be adjusted to reflect the new fair value of the equity awards on the date of the modification.

 

The following weighted-average assumptions were used to estimate the fair value of options granted during the nine months ended September 30, 2023 and 2022 for the Monte-Carlo simulation:

 

   Valuation Dates 
   January 1, 2023
(Modification)
   January 2, 2022
(Original Issuance)
 
Vesting Hurdle Price  $3.81 - $30.52    $8.07 - $36.99  
Term (years)   4.00    5.00 
Expected stock price volatility   97.30%   103.72%
Risk-free rate of interest   4.10%   1.32%

 

Expected Volatility: The Company uses historical volatility as it provides a reasonable estimate of the expected volatility. Historical volatility is based on the most recent volatility of the stock price over a period of time equivalent to the expected term of the RSUs.

 

Risk-Free Interest Rate: The risk-free interest rate is based on the U.S. treasury zero-coupon yield curve in effect at the time of grant for the expected term of the RSUs.

 

Expected Term: The Company’s expected term represents the weighted-average period that the Company’s RSUs are expected to be outstanding. The expected term is based on the stipulated five-year period from the grant date until the market-based criteria are achieved. If the market-based criteria are not achieved within the five-year period from the grant date, the RSUs will not vest and shall expire.

 

Vesting Hurdle Price: The vesting hurdle price is determined as the average of the vesting Market Cap criteria divided by the shares outstanding as of the valuation dates.

 

 

On December 9, 2022, upon recommendation of the Compensation Committee, the Board of Directors approved the grant of 25,000 RSUs to Mr. Prevoznik and Mr. Paranjape each, effective January 1, 2023, which vest annually over a five-year period with the first vesting date being on the one-year anniversary of the execution date of the effective grant date, subject to continued employment on each applicable vesting date.

 

A summary of the Company’s restricted stock units granted under the 2021 Plan during the nine months ended September 30, 2023 are as follows:

 

   Number of
Restricted
Stock Units
   Weighted Average
Grant Day
Fair Value
 
Nonvested at December 31, 2022   1,590,552   $3.34 
Granted   50,000    0.63 
Vested   (9,153)   4.37 
Forfeited   -    - 
Nonvested at September 30, 2023   1,631,399   $3.25 

 

Stock Based Compensation

 

Stock-based compensation expense is recorded as a part of selling, general and administrative expenses, compensation expenses and cost of revenues. Stock-based compensation expense for the three and nine months ended September 30, 2023 and 2022 was as follows:

 

 

   2023   2022   2023   2022 
  

For the Three Months Ended

September 30,

  

For the Nine Months Ended

September 30,

 
   2023   2022   2023   2022 
Employee bonus stock awards  $-   $-   $-   $894,027 
Employee stock option awards   441    16,455    (4,871)   98,901 
Employee restricted stock unit awards   230,118    434,349    726,409    1,182,053 
Non-employee restricted stock awards   21,536    30,480    45,777    202,218 
Stock-based compensation  $252,095   $481,284   $767,315   $2,377,199 

 

 

XML 21 R12.htm IDEA: XBRL DOCUMENT v3.23.3
Accrued Expenses
9 Months Ended
Sep. 30, 2023
Payables and Accruals [Abstract]  
Accrued Expenses

Note 6 – Accrued Expenses

 

Accrued expenses consist of the following:

   September 30, 2023   December 31, 2022 
Accrued compensation  $321,144   $295,935 
Accounts payable and accrued expenses   92,659    76,727 
Accrued Expenses  $413,803   $372,662 

 

Accrued compensation includes approximately $321,000 and $284,000 related to performance bonus accruals as of September 30, 2023 and December 31, 2022, respectively.

 

XML 22 R13.htm IDEA: XBRL DOCUMENT v3.23.3
Employee Benefit Plans
9 Months Ended
Sep. 30, 2023
Retirement Benefits [Abstract]  
Employee Benefit Plans

Note 7 – Employee Benefit Plans

 

The Company maintains defined contribution benefit plans under Section 401(k) of the Internal Revenue Code covering substantially all qualified employees of the Company (the “401(k) Plan”). Under the 401(k) Plan, the Company may make discretionary contributions of up to 100% of employee contributions. For the nine months ended September 30, 2023 and 2022, the Company made contributions to the 401(k) Plan of $95,000 and $45,000, respectively.

 

XML 23 R14.htm IDEA: XBRL DOCUMENT v3.23.3
Liquidity
9 Months Ended
Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Liquidity

Note 8 – Liquidity

 

The Company follows “Presentation of Financial Statements—Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern”. The Company’s financial statements have been prepared assuming that it will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business.

 

As reflected in the financial statements, the Company has historically incurred a net loss and has an accumulated deficit of approximately $154,554,000 at September 30, 2023, a net loss for the nine months ended September 30, 2023 of approximately $3,072,000 and net cash used in operating activities of approximately $2,693,000 for the reporting period then ended. The Company is implementing its business plan and generating revenue; however, the Company’s cash position and liquid crypto assets are sufficient to support its daily operations over the next twelve months.

 

XML 24 R15.htm IDEA: XBRL DOCUMENT v3.23.3
Subsequent Events
9 Months Ended
Sep. 30, 2023
Subsequent Events [Abstract]  
Subsequent Events

Note 9 – Subsequent Events

 

The Company evaluates events that have occurred after the balance sheet date but before the financial statements are issued. Based upon the evaluation, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the financial statements other than disclosed.

XML 25 R16.htm IDEA: XBRL DOCUMENT v3.23.3
Summary of Significant Accounting Policies (Policies)
9 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
Basis of presentation

Basis of presentation

 

The accompanying financial statements have been prepared in accordance with United States generally accepted accounting principles (“GAAP”).

 

Reclassifications

Reclassifications

 

Certain prior period amounts have been reclassified in order to conform with the current period presentation. These reclassifications have no impact on the Company’s previously reported net income (loss).

 

Cash and cash equivalents

Cash and cash equivalents

 

The Company considers all highly liquid investments with original maturities of three months or less when purchased to be cash and cash equivalents. The Company maintains cash and cash equivalent balances at financial institutions that are insured by the FDIC. As of September 30, 2023 and December 31, 2022, the Company had approximately $753,000 and $2,147,000 in cash. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk on cash.

 

Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash deposits. Accounts at each institution are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. As of September 30, 2023 and December 31, 2022, the Company had approximately $102,000 and $1,682,000 in excess of the FDIC insured limit, respectively.

 

Stablecoins

Stablecoins

 

The Company holds stablecoins, such as USDT (Tether) and USDC (USD Coin), which are crypto assets that are pegged to the value of one U.S. dollar and can be redeemed on demand for one U.S. dollar. Our stablecoins are typically held in secure digital wallets or on crypto asset exchanges. The Company acquires and holds stablecoins primarily to facilitate crypto asset transactions, including, but not limited to, payments to third-party vendors. While not accounted for as cash or cash equivalents, these stablecoins are considered a liquidity resource.

 

Revenue Recognition

Revenue Recognition

 

The Company recognizes revenue under Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers. The core principle of the new revenue standard is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. The following five steps are applied to achieve that core principle:

 

  Step 1: Identify the contract with the customer
  Step 2: Identify the performance obligations in the contract
  Step 3: Determine the transaction price
  Step 4: Allocate the transaction price to the performance obligations in the contract
  Step 5: Recognize revenue when the Company satisfies a performance obligation

 

Revenue is recognized when control of the promised goods or services is transferred to the customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. The Company generates revenue through staking rewards.

 

The Company has entered into network-based smart contracts by running its own crypto asset validator nodes as well as by staking crypto assets on nodes run by third-party operators (either directly or through crypto exchanges). Through these contracts, the Company provides crypto assets to stake on a node for the purpose of validating transactions and adding blocks to a respective blockchain network. The term of a smart contract can vary based on the rules of the respective blockchain and typically last a few weeks to months after it is cancelled by the operator and requires that the crypto assets staked remain locked up during the duration of the smart contract. In exchange for staking the crypto assets and validating transactions on blockchain networks, the Company is entitled to all of the fixed crypto asset award for running the Company’s own node and is entitled to a fractional share of the fixed crypto asset award a third-party node operator receives (less crypto asset transaction fees payable to the node operator or exchanges, which are immaterial and are recorded as a deduction from revenue), for successfully validating or adding a block to the blockchain. The Company’s fractional share of awards received from delegating to a third-party validator node is based on the proportion of crypto assets the Company staked to the node to the total crypto assets staked by delegators to the node.

 

 

The provision of validating blockchain transactions is an output of the Company’s ordinary activities. Each separate block creation or validation under a smart contract with a network represents a performance obligation. The transaction consideration the Company receives - the crypto asset award - is a non-cash consideration, which the Company measures at fair value on the date received. The fair value of the crypto asset award received is determined using the quoted price of the related crypto assets on the date of receipt. The satisfaction of the performance obligation for processing and validating blockchain transactions occurs at a point in time when confirmation is received from the network indicating that the validation is complete, and the awards are available for transfer. At that point, revenue is recognized.

 

Cost of Revenues

Cost of Revenues

 

The Company’s cost of revenue primarily includes direct production costs associated with transaction validation on the network, cloud-based server hosting expenses related to our validator nodes, and allocated employee salaries dedicated to node maintenance and support. Additionally, the cost of revenue encompasses fees, including equity compensation stock-based fees, paid to third parties for their assistance in software maintenance and node operations.

 

Crypto Assets Translations and Remeasurements

Crypto Assets Translations and Remeasurements

 

The Company accounts for its crypto assets as indefinite-lived intangible assets in accordance with ASC 350, Intangibles – Goodwill and Other. An intangible asset with an indefinite useful life is not amortized but assessed for impairment annually, or more frequently, when events or changes in circumstances occur indicating that it is more likely than not that the indefinite-lived asset is impaired. Impairment exists when the carrying amount exceeds its fair value. In testing for impairment, the Company has the option to first perform a qualitative assessment to determine whether it is more likely than not that an impairment exists. If it is determined that it is not more likely than not that an impairment exists, a quantitative impairment test is not necessary. If the Company concludes otherwise, it is required to perform a quantitative impairment test. To the extent an impairment loss is recognized, the loss establishes the new cost basis of the asset. Subsequent reversal of impairment losses is not permitted.

 

Crypto assets held are included in the balance sheets as either current assets or other assets if they are staked and locked up for over one year. The Company’s crypto assets are initially recorded at fair value upon receipt (or “carrying value”). The fair value of crypto assets is determined using the U.S. dollar spot price of the related crypto asset. On a quarterly basis, crypto assets are measured at carrying value, net of any impairment losses incurred since receipt. The Company will record impairment losses as the fair value falls below the carrying value of the crypto assets at any time during the period, as determined using the lowest intraday U.S. dollar spot price of the related crypto asset subsequent to its acquisition. The crypto assets can only be marked down when impaired and not marked up when their value increases.

 

Such impairment in the value of crypto assets is recorded as a component of costs and expenses in our Statements of Operations. The Company recorded impairment losses related to crypto assets of approximately $1,252,000 and $12,347,000 during the nine months ended September 30, 2023, and 2022, respectively.

 

Impairment losses cannot be recovered for any subsequent increase in fair value until the sale or disposal of the asset. Realized gain (loss) on sale of crypto assets are included in other income (expense) in the Statements of Operations. The Company recorded realized gains (losses) on crypto assets of approximately $806,000 and $490,000 during the nine months ended September 30, 2023 and 2022, respectively.

 

The presentation of purchases and sales of crypto assets on the Statement of Cash Flows is determined by the nature of the crypto assets, which can be characterized as productive (i.e. purchased for purposes of staking) or non-productive. The purchase of non-productive crypto assets and currencies are included as an operating activity, whereas the purchase of productive crypto assets and currencies are included as investing activities in accordance with ASC 230-10-20 Investing activities. Productive crypto assets that are staked with a lock-up period of less than 12 months are presented on the Balance Sheet as current assets. Staked crypto assets with remaining lock-up periods of greater than 12 months are presented as long-term other assets on the Balance Sheet.

 

 

Internally Developed Software

Internally Developed Software

 

Internally developed software consists of the core technology of the Company’s StakeSeeker platform, which is being designed to allow users to track, monitor and analyze their aggregate crypto asset portfolio holdings by connecting their crypto exchanges and digital wallets as well as providing a non-custodial delegation process to earn staking rewards on crypto asset holdings. For internally developed software, the Company uses both its own employees as well as the services of external vendors and independent contractors. The Company accounts for computer software used in the business in accordance with ASC 985-20 and ASC 350.

 

ASC 985-20, Software-Costs of Computer Software to Be Sold, Leased, or Otherwise Marketed, requires that software development costs incurred in conjunction with product development be charged to research and development expense until technological feasibility is established. Thereafter, until the product is released for sale, software development costs must be capitalized and reported at the lower of unamortized cost or net realizable value of the related product. Some companies use a “tested working model” approach to establishing technological feasibility (i.e., beta version). Under this approach, software under development will pass the technological feasibility milestone when the Company has completed a version that contains essentially all the functionality and features of the final version and has tested the version to ensure that it works as expected.

 

ASC 350, Intangibles-Goodwill and Other, requires computer software costs associated with internal use software to be charged to operations as incurred until certain capitalization criteria are met. Costs incurred during the preliminary project stage and the post-implementation stages are expensed as incurred. Certain qualifying costs incurred during the application development stage are capitalized as property, equipment and software. These costs generally consist of internal labor during configuration, coding, and testing activities. Capitalization begins when (i) the preliminary project stage is complete, (ii) management with the relevant authority authorizes and commits to the funding of the software project, and (iii) it is probable both that the project will be completed, and that the software will be used to perform the function intended.

 

Property and Equipment

Property and Equipment

 

Property and equipment consists of computer, equipment and office furniture and fixtures, all of which are recorded at cost. Depreciation and amortization are recorded using the straight-line method over the respective useful lives of the assets ranging from three to five years. Long-lived assets are reviewed for impairment whenever events or circumstances indicate that the carrying amount of these assets may not be recoverable.

 

Use of Estimates

Use of Estimates

 

The accompanying financial statements have been prepared in conformity with U.S. GAAP. This requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the period. The Company’s significant estimates and assumptions include the recoverability and useful lives of indefinite life intangible assets, stock-based compensation, and the valuation allowance related to the Company’s deferred tax assets. Certain of the Company’s estimates, including the carrying amount of the indefinite life intangible assets, could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible that these external factors could have an effect on the Company’s estimates and could cause actual results to differ from those estimates and assumptions.

 

Income Taxes

Income Taxes

 

The Company recognizes income taxes on an accrual basis based on tax positions taken or expected to be taken in its tax returns. A tax position is defined as a position in a previously filed tax return or a position expected to be taken in a future tax filing that is reflected in measuring current or deferred income tax assets and liabilities. Tax positions are recognized only when it is more likely than not (i.e., likelihood of greater than 50%), based on technical merits, that the position would be sustained upon examination by taxing authorities. Tax positions that meet the more likely than not threshold are measured using a probability-weighted approach as the largest amount of tax benefit that is greater than 50% likely of being realized upon settlement. Income taxes are accounted for using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the Company’s financial statements or tax returns. A valuation allowance is established to reduce deferred tax assets if all, or some portion, of such assets will more than likely not be realized. Should they occur, the Company’s policy is to classify interest and penalties related to tax positions as income tax expense. Since the Company’s inception, no such interest or penalties have been incurred.

 

 

Accounting for Warrants

Accounting for Warrants

 

The Company accounts for the issuance of Common Stock purchase warrants issued in connection with the equity offerings in accordance with the provisions of ASC 815, Derivatives and Hedging (“ASC 815”). The Company classifies as equity any contracts that (i) require physical settlement or net-share settlement or (ii) gives the Company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement). The Company classifies as assets or liabilities any contracts that (i) require net-cash settlement (including a requirement to net-cash settle the contract if an event occurs and if that event is outside the control of the Company) or (ii) gives the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement). In addition, Under ASC 815, registered Common Stock warrants that require the issuance of registered shares upon exercise and do not expressly preclude an implied right to cash settlement are accounted for as derivative liabilities. The Company classifies these derivative warrant liabilities on the balance sheet as a current liability.

 

The Company assessed the classification of Common Stock purchase warrants as of the date of each offering and determined that such instruments originally met the criteria for equity classification; however, as a result of the Company no longer being in control of whether the warrants may be cash settled, the instruments no longer qualify for equity classification. Accordingly, the Company classified the warrants as a liability at their fair value and adjusts the instruments to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until the warrants are exercised or expired, and any change in fair value is recognized as “change in the fair value of warrant liabilities” in the statements of operations. The fair value of the warrants has been estimated using a Black-Scholes valuation model (see Note 4).

 

Stock-based compensation

Stock-based compensation

 

The Company accounts for stock-based compensation in accordance with ASC 718 Compensation – Stock Compensation (“ASC 718”). ASC 718 addresses all forms of share-based payment awards including shares issued under employee stock purchase plans and stock incentive shares. Under ASC 718 awards result in a cost that is measured at fair value on the awards’ grant date, based on the estimated number of awards that are expected to vest and will result in a charge to operations.

 

Share-based payment awards exchanged for services are accounted for at the fair value of the award on the estimated grant date.

 

Options

 

Stock options issued under the Company’s long-term incentive plans are granted with an exercise price equal to no less than the market price of the Company’s stock at the date of grant and expire up to ten years from the date of grant. These options often vest over a one-year period.

 

The Company estimates the fair value of stock option grants using the Black-Scholes option pricing model and the assumptions used in calculating the fair value of stock-based awards represent management’s best estimates and involve inherent uncertainties and the application of management’s judgment.

 

 

Restricted Stock Units (RSUs)

 

For awards vesting upon the achievement of a service condition, compensation cost measured on the grant date will be recognized on a straight-line basis over the vesting period. Stock-based compensation expense for the market-based restricted stock units with explicit service conditions is recognized on a straight-line basis over the longer of the derived service period or the explicit service period, regardless of whether the market condition is satisfied. However, in the event that the explicit service period is not met, previously recognized compensation cost would be reversed. Market-based restricted stock units subject to market-based performance targets require achievement of the performance target as well as a service condition in order for these RSUs to vest.

 

The Company estimates the fair value of market-based RSUs as of the grant date and expected derived term using a Monte Carlo simulation that incorporates pricing inputs covering the period from the grant date through the end of the derived service period.

 

Dividends

Dividends

 

Effective January 27, 2023, the Company’s Board of Directors (the “Board”) approved the issuance of a newly designated Series V Preferred Stock (“Series V”) on a one-for-one basis to the Company’s shareholders (including restricted stock unit holders and warrant holders who were entitled to such distribution). The distribution of Series V shares was approved and completed on June 2, 2023 to shareholders as of the record date of May 12, 2023. The Series V: (i) is non-convertible, (ii) has a 20% liquidation preference over the shares of common stock, (iii) is non-voting and (iv) has certain rights to dividends and distributions (at the discretion of the Board). A total of 14,542,803 shares of Series V Preferred Stock were distributed to shareholders on June 2, 2023.

 

On January 5, 2022, the Board declared a non-recurring special dividend of $0.05 for each outstanding share of Common Stock of the Company, payable to holders of record as of the close of business on March 17, 2022. The dividend distributions were considered a return of capital as the distributions were in excess of the Company’s current and accumulated earnings and profits. The return of capital distribution reduces the Company’s additional paid in capital balance. Dividend distributions amounted to $0 and $635,000 during the nine months ended September 30, 2023 and 2022, respectively.

 

The Company will evaluate the appropriateness of potential future dividends as the Company continues to grow its operations.

 

Advertising Expense

Advertising Expense

 

Advertisement costs are expensed as incurred and included in marketing expenses. Advertising and marketing expenses amounted to approximately $11,000 and $74,000 for the nine months ended September 30, 2023 and 2022, respectively.

 

Net Loss per Share

Net Loss per Share

 

Basic loss per share is computed by dividing the net income or loss applicable to common shares by the weighted average number of common shares outstanding during the period. Diluted earnings per share is computed using the weighted average number of common shares and, if dilutive, potential common shares outstanding during the period. Potential common shares consist of the Company’s convertible preferred stock, convertible notes, restricted stock units, options and warrants. Diluted loss per share excludes the shares issuable upon the conversion of preferred stock, notes and warrants from the calculation of net loss per share if their effect would be anti-dilutive.

 

The following financial instruments were not included in the diluted loss per share calculation as of September 30, 2023 and 2022 because their effect was anti-dilutive:

 

   2023   2022 
   As of September 30, 
   2023   2022 
Warrants to purchase common stock   712,500    945,837 
Options   1,150,000    1,285,000 
Non-vested restricted stock awards units   1,631,399    1,612,350 
Total   3,493,899    3,843,187 

 

Recent Accounting Pronouncements

Recent Accounting Pronouncements

 

We have evaluated all recently issued accounting pronouncements and believe such pronouncements do not have a material effect on our financial statements.

XML 26 R17.htm IDEA: XBRL DOCUMENT v3.23.3
Summary of Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
Schedule of Earnings Per Share Anti-diluted

The following financial instruments were not included in the diluted loss per share calculation as of September 30, 2023 and 2022 because their effect was anti-dilutive:

 

   2023   2022 
   As of September 30, 
   2023   2022 
Warrants to purchase common stock   712,500    945,837 
Options   1,150,000    1,285,000 
Non-vested restricted stock awards units   1,631,399    1,612,350 
Total   3,493,899    3,843,187 
XML 27 R18.htm IDEA: XBRL DOCUMENT v3.23.3
Fair Value of Financial Assets and Liabilities (Tables)
9 Months Ended
Sep. 30, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Schedule of Fair Value of Assets and Liabilities Valued on Recurring Basis

The following tables present the Company’s assets and liabilities that are measured at fair value on a recurring basis and the Company’s estimated level within the fair value hierarchy of those assets and liabilities as of September 30, 2023 and December 31, 2022:

   Fair Value Measured at September 30, 2023 
  

Total at

September 30,

2023

   Quoted prices in active markets (Level 1)   Significant other observable inputs (Level 2)   Significant unobservable inputs (Level 3) 
                     
Assets                    
Investments  $100,000   $      -   $          -   $100,000 
Liabilities                    
Warrant Liabilities  $71,250   $-   $-   $71,250 

 

   Fair Value Measured at December 31, 2022 
  

Total at

December 31,

2022

   Quoted prices in active markets (Level 1)   Significant other observable inputs (Level 2)   Significant unobservable inputs (Level 3) 
                     
Assets                    
Investments  $100,000   $      -   $          -   $100,000 
Liabilities                    
Warrant Liabilities  $213,750   $-   $-   $213,750 
Summary of Valuation Methodology and Significant Unobservable Inputs Warrant Liabilities

A summary of quantitative information with respect to the valuation methodology and significant unobservable inputs used for the Company’s warrant liabilities that are categorized within Level 3 of the fair value hierarchy at the date of issuance and, as of September 30, 2023 and December 31, 2022, is as follows:

   September 30, 2023   December 31, 2022 
Risk-free rate of interest   5.03%   3.99%
Expected volatility   108.3%   152.8%
Expected life (in years)   2.43    3.18 
Expected dividend yield   -    - 
Fair Value, Inputs, Level 3 [Member]  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Schedule of Changes in Fair Value and Other Adjustments of Warrants

The following table sets forth a summary of the changes in the fair value of the Company’s Level 3 financial assets and liabilities for the nine months ended September 30, 2023 and 2022, that are measured at fair value on a recurring basis:

   Fair Value of Level 3 Financial Assets 
   September 30, 2023   September 30, 2022 
Beginning balance  $100,000   $- 
Purchases   -    - 
Unrealized appreciation (depreciation)   -    - 
Ending balance  $100,000   $            - 

 

   Fair Value of Level 3 Financial Liabilities 
   September 30, 2023   September 30, 2022 
Beginning balance  $213,750   $1,852,500 
Warrant liabilities classification   -    - 
Fair value adjustment of warrant liabilities   (142,500)   (1,140,000)
Ending balance  $71,250   $712,500 
XML 28 R19.htm IDEA: XBRL DOCUMENT v3.23.3
Stockholders’ Equity (Tables)
9 Months Ended
Sep. 30, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Weighted-Average Assumptions Used to Estimate Fair Value

The following weighted-average assumptions were used to estimate the fair value of options granted during the nine months ended September 30, 2023 and 2022 for the Monte-Carlo simulation:

 

   Valuation Dates 
   January 1, 2023
(Modification)
   January 2, 2022
(Original Issuance)
 
Vesting Hurdle Price  $3.81 - $30.52    $8.07 - $36.99  
Term (years)   4.00    5.00 
Expected stock price volatility   97.30%   103.72%
Risk-free rate of interest   4.10%   1.32%
Summary of Option Activity

A summary of option activity under the Company’s stock option plan for nine months ended September 30, 2023 is presented below:

   Number of Shares   Weighted Average Exercise Price   Total Intrinsic Value   Weighted Average Remaining Contractual Life (in years) 
Outstanding as of December 31, 2022   1,150,000   $2.15   $-    3.3 
Employee options granted   35,000    0.81    -    4.9 
Employee options forfeited   (35,000)   1.02    11,100    - 
Outstanding as of September 30, 2023   1,150,000   $2.14   $-    2.5 
Options vested and exercisable as of September 30, 2023   1,135,000   $2.16   $-    2.5 
Schedule of Restricted Stock Units

The RSUs granted to each executive employee are as follows:

         Total   Market Cap Vesting Thresholds 
Officer Name  Title  Grant
Date
  RSUs
Granted
   $ 50
million
   $ 100
million
   $ 150
million
   $ 300
million
 
Charles Allen  Chief Executive Officer  1/2/2022   694,444    173,611    173,611    173,611    173,611 
Michal Handerhan  Chief Operations Officer  1/2/2022   444,444    111,111    111,111    111,111    111,111 
Michael Prevoznik  Chief Financial Officer  1/2/2022   222,224    55,556    55,556    55,556    55,556 
Manish Paranjape  Chief Technology Officer  2/22/2022   160,184    40,046    40,046    40,046    40,046 
            1,521,296      380,324      380,324      380,324      380,324 
Summary of Restricted Stock

A summary of the Company’s restricted stock units granted under the 2021 Plan during the nine months ended September 30, 2023 are as follows:

 

   Number of
Restricted
Stock Units
   Weighted Average
Grant Day
Fair Value
 
Nonvested at December 31, 2022   1,590,552   $3.34 
Granted   50,000    0.63 
Vested   (9,153)   4.37 
Forfeited   -    - 
Nonvested at September 30, 2023   1,631,399   $3.25 
Schedule of Stock-based Compensation Expense

Stock-based compensation expense is recorded as a part of selling, general and administrative expenses, compensation expenses and cost of revenues. Stock-based compensation expense for the three and nine months ended September 30, 2023 and 2022 was as follows:

 

 

   2023   2022   2023   2022 
  

For the Three Months Ended

September 30,

  

For the Nine Months Ended

September 30,

 
   2023   2022   2023   2022 
Employee bonus stock awards  $-   $-   $-   $894,027 
Employee stock option awards   441    16,455    (4,871)   98,901 
Employee restricted stock unit awards   230,118    434,349    726,409    1,182,053 
Non-employee restricted stock awards   21,536    30,480    45,777    202,218 
Stock-based compensation  $252,095   $481,284   $767,315   $2,377,199 
2021 Equity Incentive Plan [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Weighted-Average Assumptions Used to Estimate Fair Value

  

Nine Months Ended

September 30,

 
   2023   2022 
Exercise price  $0.81   $1.51 
Term (years)   5.00    5.00 
Expected stock price volatility   151.6%   165.8%
Risk-free rate of interest   4.15%   2.77%
XML 29 R20.htm IDEA: XBRL DOCUMENT v3.23.3
Accrued Expenses (Tables)
9 Months Ended
Sep. 30, 2023
Payables and Accruals [Abstract]  
Schedule of Accrued Expenses

Accrued expenses consist of the following:

   September 30, 2023   December 31, 2022 
Accrued compensation  $321,144   $295,935 
Accounts payable and accrued expenses   92,659    76,727 
Accrued Expenses  $413,803   $372,662 
XML 30 R21.htm IDEA: XBRL DOCUMENT v3.23.3
Schedule of Earnings Per Share Anti-diluted (Details) - shares
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Anti-dilutive securities 3,493,899 3,843,187
Warrant [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Anti-dilutive securities 712,500 945,837
Share-Based Payment Arrangement, Option [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Anti-dilutive securities 1,150,000 1,285,000
Non-vested Restricted Stock Awards Units [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Anti-dilutive securities 1,631,399 1,612,350
XML 31 R22.htm IDEA: XBRL DOCUMENT v3.23.3
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
9 Months Ended
Jun. 02, 2023
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Jan. 05, 2022
Property, Plant and Equipment [Line Items]          
Cash   $ 753,000   $ 2,147,000  
Cash, FDIC insured amount   102,000   $ 1,682,000  
Impairment losses   1,252,000 $ 12,347,000    
Realized investment gains losses   $ 806,000 490,000    
Income tax likelihood percentage description   Tax positions are recognized only when it is more likely than not (i.e., likelihood of greater than 50%), based on technical merits, that the position would be sustained upon examination by taxing authorities. Tax positions that meet the more likely than not threshold are measured using a probability-weighted approach as the largest amount of tax benefit that is greater than 50% likely of being realized upon settlement.      
Liquidation preference   The Series V: (i) is non-convertible, (ii) has a 20% liquidation preference over the shares of common stock, (iii) is non-voting and (iv) has certain rights to dividends and distributions (at the discretion of the Board).      
Payments of dividends   $ 0 635,000    
Advertising and marketing expenses   $ 11,000 $ 74,000    
Board of Directors [Member]          
Property, Plant and Equipment [Line Items]          
Dividend per share         $ 0.05
Series V Preferred Stock [Member]          
Property, Plant and Equipment [Line Items]          
Liquidation preference   The Series V: (i) is non-convertible, (ii) has a 20% liquidation preference over the shares of common stock, (iii) is non-voting and (iv) has certain rights to dividends and distributions (at the discretion of the Board of Directors).      
Preferred Stock [Member] | Series V Preferred Stock [Member]          
Property, Plant and Equipment [Line Items]          
Number of shares issued 14,542,803        
Maximum [Member]          
Property, Plant and Equipment [Line Items]          
Cash, FDIC insured amount   $ 250,000      
Property, plant and equipment, estimated useful lives   5 years      
Minimum [Member]          
Property, Plant and Equipment [Line Items]          
Property, plant and equipment, estimated useful lives   3 years      
XML 32 R23.htm IDEA: XBRL DOCUMENT v3.23.3
Schedule of Fair Value of Assets and Liabilities Valued on Recurring Basis (Details) - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Sep. 30, 2022
Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Investments $ 100,000 $ 100,000    
Warrant liabilities 71,250 213,750    
Fair Value, Inputs, Level 1 [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Investments    
Warrant liabilities    
Fair Value, Inputs, Level 2 [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Investments    
Warrant liabilities    
Fair Value, Inputs, Level 3 [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Investments 100,000 100,000
Warrant liabilities $ 71,250 $ 213,750 $ 712,500 $ 1,852,500
XML 33 R24.htm IDEA: XBRL DOCUMENT v3.23.3
Summary of Valuation Methodology and Significant Unobservable Inputs Warrant Liabilities (Details)
9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Risk-free rate of interest 4.10% 1.32%  
Expected volatility 97.30% 103.72%  
Expected life (in years) 4 years 5 years  
Fair Value, Inputs, Level 3 [Member]      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Risk-free rate of interest 5.03%   3.99%
Expected volatility 108.30%   152.80%
Expected life (in years) 2 years 5 months 4 days   3 years 2 months 4 days
Expected dividend yield  
XML 34 R25.htm IDEA: XBRL DOCUMENT v3.23.3
Schedule of Changes in Fair Value and Other Adjustments of Warrants (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Investment, beginning balance     $ 100,000  
Investment, ending balance $ 100,000   100,000  
Warrant liabilities, beginning balance     213,750  
Fair value adjustment of warrant liabilities (285,000) $ (71,250) (142,500) $ (1,140,000)
Warrant liabilities, ending balance 71,250   71,250  
Fair Value, Inputs, Level 3 [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Investment, beginning balance     100,000
Purchases    
Unrealized appreciation (depreciation)    
Investment, ending balance 100,000 100,000
Warrant liabilities, beginning balance     213,750 1,852,500
Warrant liabilities classification    
Fair value adjustment of warrant liabilities     (142,500) (1,140,000)
Warrant liabilities, ending balance $ 71,250 $ 712,500 $ 71,250 $ 712,500
XML 35 R26.htm IDEA: XBRL DOCUMENT v3.23.3
Fair Value of Financial Assets and Liabilities (Details Narrative) - USD ($)
Mar. 02, 2021
Sep. 30, 2023
Dec. 31, 2022
Sep. 30, 2022
Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Investments fair value   $ 100,000 $ 100,000    
Securities Purchase Agreement [Member]          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Shares of common stock 950,000        
Common stock warrants 712,500        
Gross proceeds from private placement $ 9,500,000        
Fair Value, Inputs, Level 3 [Member]          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Investments fair value   $ 100,000 $ 100,000
XML 36 R27.htm IDEA: XBRL DOCUMENT v3.23.3
Schedule of Weighted-Average Assumptions Used to Estimate Fair Value (Details) - $ / shares
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Term (years) 4 years 5 years
Expected stock price volatility 97.30% 103.72%
Risk-free rate of interest 4.10% 1.32%
Minimum [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Exercise price $ 3.81 $ 8.07
Maximum [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Exercise price 30.52 36.99
2021 Equity Incentive Plan [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Exercise price $ 0.81 $ 1.51
Term (years) 5 years 5 years
Expected stock price volatility 151.60% 165.80%
Risk-free rate of interest 4.15% 2.77%
XML 37 R28.htm IDEA: XBRL DOCUMENT v3.23.3
Summary of Option Activity (Details)
9 Months Ended
Sep. 30, 2023
USD ($)
$ / shares
shares
Equity [Abstract]  
Number of shares outstanding, beginning balance | shares 1,150,000
Weighted average exercise price, beginning balance $ 2.15
Total Intrinsic value, beginning balance | $
Weighted average remaining contractual life (in years), beginning balance 3 years 3 months 18 days
Number of shares outstanding, Employee options granted | shares 35,000
Weighted average exercise price, employee options granted $ 0.81
Total intrinsic value, employee options granted
Weighted average remaining contractual life (in years), employee options granted 4 years 10 months 24 days
Number of shares outstanding, Employee options forfeited | shares (35,000)
Weighted average exercise price, employee options forfeited $ 1.02
Total intrinsic value, employee options forfeited $ 11,100
Number of shares outstanding, ending balance | shares 1,150,000
Weighted average exercise price, ending balance $ 2.14
Total Intrinsic value, ending balance | $
Weighted average remaining contractual life (in years), ending balance 2 years 6 months
Number of shares outstanding, options vested and exercisable | shares 1,135,000
Weighted average exercise price, options vested and exercisable $ 2.16
Total intrinsic value, options vested and exercisable | $
Weighted average remaining contractual life (in years), options vested and exercisable 2 years 6 months
XML 38 R29.htm IDEA: XBRL DOCUMENT v3.23.3
Schedule of Restricted Stock Units (Details) - shares
9 Months Ended
Feb. 22, 2022
Jan. 02, 2022
Sep. 30, 2023
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]      
Number of restricted stock units granted and vested, shares     1,521,296
Market Cap Vesting Thresholds $50 Million [Member]      
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]      
Number of restricted stock units granted and vested, shares     380,324
Market Cap Vesting Thresholds $100 Million [Member]      
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]      
Number of restricted stock units granted and vested, shares     380,324
Market Cap Vesting Thresholds $150 Million [Member]      
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]      
Number of restricted stock units granted and vested, shares     380,324
Market Cap Vesting Thresholds $300 Million [Member]      
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]      
Number of restricted stock units granted and vested, shares     380,324
Chief Executive Officer [Member]      
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]      
Officer Name   Charles Allen  
Grant Date   Jan. 02, 2022  
Number of restricted stock units granted and vested, shares   694,444  
Chief Executive Officer [Member] | Market Cap Vesting Thresholds $50 Million [Member]      
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]      
Number of restricted stock units granted and vested, shares   173,611  
Chief Executive Officer [Member] | Market Cap Vesting Thresholds $100 Million [Member]      
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]      
Number of restricted stock units granted and vested, shares   173,611  
Chief Executive Officer [Member] | Market Cap Vesting Thresholds $150 Million [Member]      
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]      
Number of restricted stock units granted and vested, shares   173,611  
Chief Executive Officer [Member] | Market Cap Vesting Thresholds $300 Million [Member]      
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]      
Number of restricted stock units granted and vested, shares   173,611  
Chief Operating Officer [Member]      
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]      
Officer Name   Michal Handerhan  
Grant Date   Jan. 02, 2022  
Number of restricted stock units granted and vested, shares   444,444  
Chief Operating Officer [Member] | Market Cap Vesting Thresholds $50 Million [Member]      
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]      
Number of restricted stock units granted and vested, shares   111,111  
Chief Operating Officer [Member] | Market Cap Vesting Thresholds $100 Million [Member]      
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]      
Number of restricted stock units granted and vested, shares   111,111  
Chief Operating Officer [Member] | Market Cap Vesting Thresholds $150 Million [Member]      
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]      
Number of restricted stock units granted and vested, shares   111,111  
Chief Operating Officer [Member] | Market Cap Vesting Thresholds $300 Million [Member]      
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]      
Number of restricted stock units granted and vested, shares   111,111  
Chief Financial Officer [Member]      
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]      
Officer Name   Michael Prevoznik  
Grant Date   Jan. 02, 2022  
Number of restricted stock units granted and vested, shares   222,224  
Chief Financial Officer [Member] | Market Cap Vesting Thresholds $50 Million [Member]      
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]      
Number of restricted stock units granted and vested, shares   55,556  
Chief Financial Officer [Member] | Market Cap Vesting Thresholds $100 Million [Member]      
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]      
Number of restricted stock units granted and vested, shares   55,556  
Chief Financial Officer [Member] | Market Cap Vesting Thresholds $150 Million [Member]      
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]      
Number of restricted stock units granted and vested, shares   55,556  
Chief Financial Officer [Member] | Market Cap Vesting Thresholds $300 Million [Member]      
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]      
Number of restricted stock units granted and vested, shares   55,556  
Chief Technology Officer [Member]      
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]      
Officer Name Manish Paranjape    
Grant Date Feb. 22, 2022    
Number of restricted stock units granted and vested, shares 160,184    
Chief Technology Officer [Member] | Market Cap Vesting Thresholds $50 Million [Member]      
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]      
Number of restricted stock units granted and vested, shares 40,046    
Chief Technology Officer [Member] | Market Cap Vesting Thresholds $100 Million [Member]      
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]      
Number of restricted stock units granted and vested, shares 40,046    
Chief Technology Officer [Member] | Market Cap Vesting Thresholds $150 Million [Member]      
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]      
Number of restricted stock units granted and vested, shares 40,046    
Chief Technology Officer [Member] | Market Cap Vesting Thresholds $300 Million [Member]      
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]      
Number of restricted stock units granted and vested, shares 40,046    
XML 39 R30.htm IDEA: XBRL DOCUMENT v3.23.3
Summary of Restricted Stock (Details)
9 Months Ended
Sep. 30, 2023
$ / shares
shares
Equity [Abstract]  
Number of restricted stock units nonvested, beginning balance | shares 1,590,552
Weighted average grant day fair value nonvested, beginning balance | $ / shares $ 3.34
Number of restricted stock units, granted | shares 50,000
Weighted average grant day fair value, granted | $ / shares $ 0.63
Number of restricted stock units, vested | shares (9,153)
Weighted average grant day fair value, forfeited | $ / shares $ 4.37
Number of restricted stock units, forfeited | shares
Weighted average grant day fair value, vested | $ / shares
Number of restricted stock units nonvested, ending balance | shares 1,631,399
Weighted average grant day fair value nonvested, ending balance | $ / shares $ 3.25
XML 40 R31.htm IDEA: XBRL DOCUMENT v3.23.3
Schedule of Stock-based Compensation Expense (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Stock-based compensation $ 252,095 $ 481,284 $ 767,315 $ 2,377,199
Employee Bonus Stock Awards [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Stock-based compensation 894,027
Share-Based Payment Arrangement, Option [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Stock-based compensation 441 16,455 (4,871) 98,901
Restricted Stock Units (RSUs) [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Stock-based compensation 230,118 434,349 726,409 1,182,053
Non-Employee Restricted Stock Awards [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Stock-based compensation $ 21,536 $ 30,480 $ 45,777 $ 202,218
XML 41 R32.htm IDEA: XBRL DOCUMENT v3.23.3
Stockholders’ Equity (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Jun. 02, 2023
Jan. 19, 2023
Jan. 01, 2023
Dec. 09, 2022
Jan. 02, 2022
Sep. 14, 2021
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Jul. 12, 2023
Jul. 11, 2023
May 12, 2023
Dec. 31, 2022
Jun. 13, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Common stock, shares authorized             97,500,000   97,500,000   975,000,000 975,000,000   97,500,000  
Liquidation preference                 The Series V: (i) is non-convertible, (ii) has a 20% liquidation preference over the shares of common stock, (iii) is non-voting and (iv) has certain rights to dividends and distributions (at the discretion of the Board).            
Preferred stock value                        
Weighted average exercise price                 $ 0.81            
Expected life (in years)                 4 years 5 years          
Restricted Stock Units (RSUs) One [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Market cap vesting thresholds, value     $ 50,000,000   $ 100,000,000                    
Restricted Stock Units (RSUs) Two [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Market cap vesting thresholds, value     100,000,000   150,000,000                    
Restricted Stock Units (RSUs) Three [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Market cap vesting thresholds, value     150,000,000   200,000,000                    
Restricted Stock Units (RSUs) Four [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Market cap vesting thresholds, value     $ 300,000,000   $ 400,000,000                    
Restricted Stock Units (RSUs) [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Expected life (in years)                 5 years            
Vesting period                 5 years            
2021 Equity Incentive Plan [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Number of additional shares authorized                       12,000,000     7,000,000
Expected life (in years)                 5 years 5 years          
Series V Preferred Stock [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Liquidation preference                 The Series V: (i) is non-convertible, (ii) has a 20% liquidation preference over the shares of common stock, (iii) is non-voting and (iv) has certain rights to dividends and distributions (at the discretion of the Board of Directors).            
Preferred stock value             $ 2,559,533   $ 2,559,533          
Common Stock [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Share based payment issued             39,894 31,848 462,983 376,842          
Number of shares issued             151,882   803,054 2,148,658          
Preferred Stock [Member] | Series V Preferred Stock [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Number of shares issued 14,542,803                            
Preferred stock value                         $ 2,560,000    
Each Independent Director [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Stock option grant date fair value   $ 50,000                          
Each Independent Director [Member] | Four Equal Installments [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Stock option grant date fair value   $ 12,500                          
Independent Directors [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Share based payment issued                 99,117            
Officer [Member] | Common Stock [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Share based compensation                 410,317            
Non-Executive Employees [Member] | Restricted Stock [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Stock option granted       25,000                      
Non-Executive Employees [Member] | 2021 Equity Incentive Plan [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Stock option granted                 35,000            
Weighted average exercise price                 $ 0.81            
Chief Technology Officer [Member] | Restricted Stock Units (RSUs) [Member] | One-Year Anniversary [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Vesting rights, percentage     20.00%                        
Chief Technology Officer [Member] | Restricted Stock Units (RSUs) [Member] | Four-Year Anniversary [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Vesting rights, percentage     80.00%                        
At-the-Market Offering Agreement [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Sale of stock, number of shares issued in transaction                 803,054            
Gross proceeds from issuance of common stock                 $ 1,161,000            
Shares issued, price per share             $ 1.45   $ 1.45            
Proceeds from issuance initial public offering, net                 $ 1,114,000            
At-the-Market Offering Agreement [Member] | H.C. Wainwright and Co., LLC [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Sale of stock, consideration received on transaction           $ 98,767,500                  
Percentage of gross proceeds of offerings           3.00%                  
XML 42 R33.htm IDEA: XBRL DOCUMENT v3.23.3
Schedule of Accrued Expenses (Details) - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Payables and Accruals [Abstract]    
Accrued compensation $ 321,144 $ 295,935
Accounts payable and accrued expenses 92,659 76,727
Accrued Expenses $ 413,803 $ 372,662
XML 43 R34.htm IDEA: XBRL DOCUMENT v3.23.3
Accrued Expenses (Details Narrative) - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Payables and Accruals [Abstract]    
Accrued bonuses current and non current $ 321,000 $ 284,000
XML 44 R35.htm IDEA: XBRL DOCUMENT v3.23.3
Employee Benefit Plans (Details Narrative) - USD ($)
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Retirement Benefits [Abstract]    
Percentage of defined comtribution plan employee 100.00%  
Defined comtribution plan employee $ 95,000 $ 45,000
XML 45 R36.htm IDEA: XBRL DOCUMENT v3.23.3
Liquidity (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]          
Accumulated deficit $ 154,554,101   $ 154,554,101   $ 151,482,208
Net income loss $ 640,071 $ 1,030,248 3,071,893 $ 14,495,664  
Operating activities     $ 2,693,405 $ 129,453  
XML 46 form10-q_htm.xml IDEA: XBRL DOCUMENT 0001436229 2023-01-01 2023-09-30 0001436229 2023-11-07 0001436229 2023-09-30 0001436229 2022-12-31 0001436229 BTCS:SeriesVPreferredStockMember 2023-09-30 0001436229 BTCS:SeriesVPreferredStockMember 2022-12-31 0001436229 2023-07-01 2023-09-30 0001436229 2022-07-01 2022-09-30 0001436229 2022-01-01 2022-09-30 0001436229 BTCS:SeriesVPreferredStockMember us-gaap:PreferredStockMember 2022-12-31 0001436229 us-gaap:CommonStockMember 2022-12-31 0001436229 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001436229 us-gaap:RetainedEarningsMember 2022-12-31 0001436229 us-gaap:CommonStockMember 2021-12-31 0001436229 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001436229 us-gaap:RetainedEarningsMember 2021-12-31 0001436229 2021-12-31 0001436229 BTCS:SeriesVPreferredStockMember us-gaap:PreferredStockMember 2023-06-30 0001436229 us-gaap:CommonStockMember 2023-06-30 0001436229 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001436229 us-gaap:RetainedEarningsMember 2023-06-30 0001436229 2023-06-30 0001436229 us-gaap:CommonStockMember 2022-06-30 0001436229 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001436229 us-gaap:RetainedEarningsMember 2022-06-30 0001436229 2022-06-30 0001436229 BTCS:SeriesVPreferredStockMember us-gaap:PreferredStockMember 2023-01-01 2023-09-30 0001436229 us-gaap:CommonStockMember 2023-01-01 2023-09-30 0001436229 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-09-30 0001436229 us-gaap:RetainedEarningsMember 2023-01-01 2023-09-30 0001436229 us-gaap:CommonStockMember 2022-01-01 2022-09-30 0001436229 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-09-30 0001436229 us-gaap:RetainedEarningsMember 2022-01-01 2022-09-30 0001436229 BTCS:SeriesVPreferredStockMember us-gaap:PreferredStockMember 2023-07-01 2023-09-30 0001436229 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001436229 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001436229 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001436229 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001436229 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001436229 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001436229 BTCS:SeriesVPreferredStockMember us-gaap:PreferredStockMember 2023-09-30 0001436229 us-gaap:CommonStockMember 2023-09-30 0001436229 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001436229 us-gaap:RetainedEarningsMember 2023-09-30 0001436229 us-gaap:CommonStockMember 2022-09-30 0001436229 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001436229 us-gaap:RetainedEarningsMember 2022-09-30 0001436229 2022-09-30 0001436229 srt:MaximumMember 2023-09-30 0001436229 srt:MinimumMember 2023-09-30 0001436229 BTCS:SeriesVPreferredStockMember us-gaap:PreferredStockMember 2023-06-02 2023-06-02 0001436229 BTCS:BoardOfDirectorsMember 2022-01-05 0001436229 us-gaap:WarrantMember 2023-01-01 2023-09-30 0001436229 us-gaap:WarrantMember 2022-01-01 2022-09-30 0001436229 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-09-30 0001436229 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-09-30 0001436229 BTCS:NonVestedRestrictedStockAwardsUnitsMember 2023-01-01 2023-09-30 0001436229 BTCS:NonVestedRestrictedStockAwardsUnitsMember 2022-01-01 2022-09-30 0001436229 us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-09-30 0001436229 us-gaap:FairValueInputsLevel1Member 2023-09-30 0001436229 us-gaap:FairValueInputsLevel2Member 2023-09-30 0001436229 us-gaap:FairValueInputsLevel3Member 2023-09-30 0001436229 us-gaap:FairValueInputsLevel1Member 2022-12-31 0001436229 us-gaap:FairValueInputsLevel2Member 2022-12-31 0001436229 us-gaap:FairValueInputsLevel3Member 2022-12-31 0001436229 BTCS:SecuritiesPurchaseAgreementMember 2021-03-01 2021-03-02 0001436229 BTCS:SecuritiesPurchaseAgreementMember 2021-03-02 0001436229 us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001436229 us-gaap:FairValueInputsLevel3Member 2021-12-31 0001436229 us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-09-30 0001436229 us-gaap:FairValueInputsLevel3Member 2022-09-30 0001436229 2023-07-11 0001436229 2023-07-12 0001436229 BTCS:AtTheMarketOfferingAgreementMember BTCS:HCWainwrightCoLLCMember 2021-09-13 2021-09-14 0001436229 BTCS:AtTheMarketOfferingAgreementMember BTCS:HCWainwrightCoLLCMember 2021-09-14 0001436229 BTCS:AtTheMarketOfferingAgreementMember 2023-01-01 2023-09-30 0001436229 BTCS:AtTheMarketOfferingAgreementMember 2023-09-30 0001436229 BTCS:EachIndependentDirectorMember 2023-01-18 2023-01-19 0001436229 BTCS:FourEqualInstallmentsMember BTCS:EachIndependentDirectorMember 2023-01-18 2023-01-19 0001436229 BTCS:IndependentDirectorsMember 2023-01-01 2023-09-30 0001436229 srt:OfficerMember us-gaap:CommonStockMember 2023-01-01 2023-09-30 0001436229 BTCS:SeriesVPreferredStockMember 2023-01-01 2023-09-30 0001436229 BTCS:SeriesVPreferredStockMember us-gaap:PreferredStockMember 2023-05-12 0001436229 BTCS:TwoThousandAndTwentyOneEquityIncentivePlanMember 2022-06-13 0001436229 BTCS:TwoThousandAndTwentyOneEquityIncentivePlanMember 2023-07-11 0001436229 BTCS:NonExecutiveEmployeesMember BTCS:TwoThousandAndTwentyOneEquityIncentivePlanMember 2023-01-01 2023-09-30 0001436229 BTCS:RestrictedStockUnitsRSUOneMember 2022-01-02 2022-01-02 0001436229 BTCS:RestrictedStockUnitsRSUTwoMember 2022-01-02 2022-01-02 0001436229 BTCS:RestrictedStockUnitsRSUThreeMember 2022-01-02 2022-01-02 0001436229 BTCS:RestrictedStockUnitsRSUFourMember 2022-01-02 2022-01-02 0001436229 BTCS:RestrictedStockUnitsRSUOneMember 2023-01-01 2023-01-01 0001436229 BTCS:RestrictedStockUnitsRSUTwoMember 2023-01-01 2023-01-01 0001436229 BTCS:RestrictedStockUnitsRSUThreeMember 2023-01-01 2023-01-01 0001436229 BTCS:RestrictedStockUnitsRSUFourMember 2023-01-01 2023-01-01 0001436229 BTCS:ChiefTechnologyOfficerMember us-gaap:RestrictedStockUnitsRSUMember BTCS:OneYearAnniversaryMember 2023-01-01 2023-01-01 0001436229 BTCS:ChiefTechnologyOfficerMember us-gaap:RestrictedStockUnitsRSUMember BTCS:FourYearAnniversaryMember 2023-01-01 2023-01-01 0001436229 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-09-30 0001436229 BTCS:NonExecutiveEmployeesMember us-gaap:RestrictedStockMember 2022-12-08 2022-12-09 0001436229 BTCS:TwoThousandAndTwentyOneEquityIncentivePlanMember 2023-01-01 2023-09-30 0001436229 BTCS:TwoThousandAndTwentyOneEquityIncentivePlanMember 2023-09-30 0001436229 BTCS:TwoThousandAndTwentyOneEquityIncentivePlanMember 2022-09-30 0001436229 BTCS:TwoThousandAndTwentyOneEquityIncentivePlanMember 2022-01-01 2022-09-30 0001436229 srt:MinimumMember 2022-09-30 0001436229 srt:MaximumMember 2022-09-30 0001436229 srt:ChiefExecutiveOfficerMember 2022-01-02 2022-01-02 0001436229 srt:ChiefExecutiveOfficerMember BTCS:MarketCapVestingThresholdsOneMember 2022-01-02 2022-01-02 0001436229 srt:ChiefExecutiveOfficerMember BTCS:MarketCapVestingThresholdsTwoMember 2022-01-02 2022-01-02 0001436229 srt:ChiefExecutiveOfficerMember BTCS:MarketCapVestingThresholdsThreeMember 2022-01-02 2022-01-02 0001436229 srt:ChiefExecutiveOfficerMember BTCS:MarketCapVestingThresholdsFourMember 2022-01-02 2022-01-02 0001436229 srt:ChiefOperatingOfficerMember 2022-01-02 2022-01-02 0001436229 srt:ChiefOperatingOfficerMember BTCS:MarketCapVestingThresholdsOneMember 2022-01-02 2022-01-02 0001436229 srt:ChiefOperatingOfficerMember BTCS:MarketCapVestingThresholdsTwoMember 2022-01-02 2022-01-02 0001436229 srt:ChiefOperatingOfficerMember BTCS:MarketCapVestingThresholdsThreeMember 2022-01-02 2022-01-02 0001436229 srt:ChiefOperatingOfficerMember BTCS:MarketCapVestingThresholdsFourMember 2022-01-02 2022-01-02 0001436229 srt:ChiefFinancialOfficerMember 2022-01-02 2022-01-02 0001436229 srt:ChiefFinancialOfficerMember BTCS:MarketCapVestingThresholdsOneMember 2022-01-02 2022-01-02 0001436229 srt:ChiefFinancialOfficerMember BTCS:MarketCapVestingThresholdsTwoMember 2022-01-02 2022-01-02 0001436229 srt:ChiefFinancialOfficerMember BTCS:MarketCapVestingThresholdsThreeMember 2022-01-02 2022-01-02 0001436229 srt:ChiefFinancialOfficerMember BTCS:MarketCapVestingThresholdsFourMember 2022-01-02 2022-01-02 0001436229 BTCS:ChiefTechnologyOfficerMember 2022-02-22 2022-02-22 0001436229 BTCS:ChiefTechnologyOfficerMember BTCS:MarketCapVestingThresholdsOneMember 2022-02-22 2022-02-22 0001436229 BTCS:ChiefTechnologyOfficerMember BTCS:MarketCapVestingThresholdsTwoMember 2022-02-22 2022-02-22 0001436229 BTCS:ChiefTechnologyOfficerMember BTCS:MarketCapVestingThresholdsThreeMember 2022-02-22 2022-02-22 0001436229 BTCS:ChiefTechnologyOfficerMember BTCS:MarketCapVestingThresholdsFourMember 2022-02-22 2022-02-22 0001436229 BTCS:MarketCapVestingThresholdsOneMember 2023-01-01 2023-09-30 0001436229 BTCS:MarketCapVestingThresholdsTwoMember 2023-01-01 2023-09-30 0001436229 BTCS:MarketCapVestingThresholdsThreeMember 2023-01-01 2023-09-30 0001436229 BTCS:MarketCapVestingThresholdsFourMember 2023-01-01 2023-09-30 0001436229 BTCS:EmployeeBonusStockAwardsMember 2023-07-01 2023-09-30 0001436229 BTCS:EmployeeBonusStockAwardsMember 2022-07-01 2022-09-30 0001436229 BTCS:EmployeeBonusStockAwardsMember 2023-01-01 2023-09-30 0001436229 BTCS:EmployeeBonusStockAwardsMember 2022-01-01 2022-09-30 0001436229 us-gaap:EmployeeStockOptionMember 2023-07-01 2023-09-30 0001436229 us-gaap:EmployeeStockOptionMember 2022-07-01 2022-09-30 0001436229 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-09-30 0001436229 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-09-30 0001436229 us-gaap:RestrictedStockUnitsRSUMember 2023-07-01 2023-09-30 0001436229 us-gaap:RestrictedStockUnitsRSUMember 2022-07-01 2022-09-30 0001436229 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-09-30 0001436229 BTCS:NonEmployeeRestrictedStockAwardsMember 2023-07-01 2023-09-30 0001436229 BTCS:NonEmployeeRestrictedStockAwardsMember 2022-07-01 2022-09-30 0001436229 BTCS:NonEmployeeRestrictedStockAwardsMember 2023-01-01 2023-09-30 0001436229 BTCS:NonEmployeeRestrictedStockAwardsMember 2022-01-01 2022-09-30 iso4217:USD shares iso4217:USD shares pure false Q3 --12-31 0001436229 P3Y P5Y P5Y 10-Q true 2023-09-30 2023 false 001-40792 BTCS Inc. NV 90-1096644 9466 Georgia Avenue #124 Silver Spring MD 20910 (202) 430-6576 Common Stock, par value $0.001 BTCS NASDAQ Yes Yes Non-accelerated Filer true false false 14373186 753233 2146783 29794 101387 982 7811809 1826307 100000 100000 100000 100000 107429 123727 8903652 4197799 12001 11152 5708624 12001 5719776 8915653 9917575 92659 76727 321144 295935 71250 213750 485053 586412 20000000 20000000 0.001 0.001 14542803 14542803 0 0 2559533 2559533 97500000 97500000 0.001 0.001 14373186 14373186 13107149 13107149 14374 13108 160410794 160800263 -154554101 -151482208 8430600 9331163 8915653 9917575 316242 344196 1013503 1421560 316242 344196 1013503 1421560 83100 82203 278726 313972 233142 261993 734777 1107588 283239 432956 1510637 1595296 148525 126857 531053 448579 409960 669792 1450546 2731713 2155 8765 11121 74249 372441 145247 1251950 12347472 58107 20126 806137 489682 1158213 1363491 3949170 16707627 -285000 -71250 -142500 -1140000 35625 285000 71250 142500 1104375 -640071 -1030248 -3071893 -14495664 -0.04 -0.04 -0.08 -0.08 -0.22 -0.22 -1.15 -1.15 14317750 14317750 12952645 12952645 13957097 13957097 12616805 12616805 13107149 13108 160800263 -151482208 9331163 803054 803 1113015 1113818 14542803 2559533 -2559533 462983 463 1057049 1057512 -3071893 -3071893 14542803 2559533 14373186 14374 160410794 -154554101 8430600 10528212 10529 147682384 -135589470 12103443 2148658 2149 11092983 11095132 376842 377 2233231 2233608 -634557 -634557 -14495664 -14495664 13053712 13055 160374041 -150085134 10301962 14542803 2559533 14181410 14182 159955610 -153914030 8615295 151882 152 187165 187317 39894 40 268019 268059 -640071 -640071 14542803 2559533 14373186 14374 160410794 -154554101 8430600 12703794 12705 159432894 -149054886 10390713 12703794 12705 159432894 -149054886 10390713 318070 318 490374 490692 31848 32 450773 450805 -1030248 -1030248 13053712 13055 160374041 -150085134 10301962 13053712 13055 160374041 -150085134 10301962 -3071893 -14495664 3521 2862 1057512 2233608 1013503 1421560 1321 -142500 -1140000 2547322 806137 489682 1251950 12347472 -29794 -16298 -117473 15932 -37842 25209 205237 -2693405 -129453 1804482 9274055 1994890 432716 5276 5408 905 186037 -8846747 630801 1113818 11095132 1113818 10464331 -1393550 1488131 2146783 1400867 753233 2888998 2559533 <p id="xdx_806_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_znyOqhqPYkg3" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 1 - <span id="xdx_828_zBYbgNoiOFa9">Business Organization and Nature of Operations</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">BTCS Inc. (formerly Bitcoin Shop, Inc.), a Nevada corporation (“BTCS” or the “Company”) was incorporated in 2008 and is an early entrant in the crypto asset (also referred to “cryptocurrencies”, “crypto”, or “tokens”) market with a primary focus on blockchain infrastructure and staking. The Company operates validator nodes on various proof-of-stake (“PoS”) and delegated proof-of-stake (“DPoS”) based blockchain networks and stakes the native crypto assets on those blockchains to earn rewards. The Company’s Staking-as-a-Service (“StaaS”) business allows crypto asset holders to earn rewards by participating in network consensus mechanisms through staking and delegating their crypto assets to Company-operated validator nodes (or “nodes”). The Company believes that StaaS provides a more accessible and cost-effective way for crypto asset holders to participate in blockchain networks’ consensus mechanisms, thereby promoting the growth and adoption of blockchain technology.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s proprietary digital asset platform StakeSeeker (“StakeSeeker”) is currently in beta. StakeSeeker is a personal finance software and education center with a comprehensive crypto dashboard for crypto asset holders to connect, monitor, track, and analyze their crypto portfolios across exchanges and wallets in a single analytics platform. The internally-developed dashboard reads user data from digital wallets and utilizes application programming interfaces (APIs) to read data from crypto exchanges and does not allow for the trading or custody of crypto assets. StakeSeeker’s Stake hub is an education center for users to learn how to earn crypto rewards by delegating to our non-custodial validator nodes. Crypto asset holders are able to delegate to our validator nodes without signing up for the StakeSeeker platform; conversely, crypto asset holders can delegate to validator nodes not operated by the Company and sign up for StakeSeeker to utilize our software. The Company is not a broker-dealer or an investment advisor and does not provide any such related services.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has addressed the majority of outstanding matters pertaining to its StakeSeeker platform and anticipates its transition from the beta phase on or before the conclusion of the first quarter of 2024. The current functionality allows for crypto asset holders to connect, monitor, track, and analyze their crypto portfolios across exchanges and wallets in a single analytics platform. In the future, the Company may expand support for additional blockchains and introduce additional analytic tools, with associated costs expected to align with historical research and development expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s business is subject to various risks and uncertainties, including risks associated with the evolving regulatory landscape for crypto assets, risks associated with the volatility of crypto asset prices, and risks associated with the development and adoption of blockchain technology. The Company’s future success is dependent on various factors, including the growth of the crypto asset market, the adoption of blockchain technology, and the Company’s ability to effectively operate and grow its blockchain infrastructure operations and StaaS business.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company plans to expand its PoS operations to secure other disruptive blockchain protocols that also allow for delegating and asset leveraging. The growth of both StakeSeeker’s user base as well as the number and size of staked crypto assets by delegators to Company-run validator nodes are critical to the Company’s strategy and success.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_80E_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zqLXG0BdDvCc" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 2 - <span id="xdx_828_zBBeqvTB9t5b">Basis of Presentation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information, the instructions to Form 10-Q and the rules and regulations of the SEC. Accordingly, since they are interim statements, the accompanying unaudited condensed financial statements do not include all of the information and notes required by GAAP for annual financial statements, but in the opinion of the Company’s management, reflect all adjustments consisting of normal, recurring adjustments, that are necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods presented. Interim results for the three and nine months ended September 30, 2023 are not necessarily indicative of results for the full year ended December 31, 2023. The unaudited condensed financial statements and notes should be read in conjunction with the financial statements and notes for the year ended December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_80D_eus-gaap--SignificantAccountingPoliciesTextBlock_zcpiQLDOPfFk" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 3 - <span id="xdx_82E_zrEFrajB5lZb">Summary of Significant Accounting Policies</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There have been no material changes in the Company’s significant accounting policies to those previously disclosed in the 2022 Annual Report.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zR7YJNtXFWUl" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86C_z91FRh6Yoboi">Basis of presentation</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying financial statements have been prepared in accordance with United States generally accepted accounting principles (“GAAP”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zEOWsrTjTnd2" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_864_zTaogXHJwvje">Reclassifications</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain prior period amounts have been reclassified in order to conform with the current period presentation. These reclassifications have no impact on the Company’s previously reported net income (loss).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zAlw6VS66hBj" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86B_zBHERHyZZyUl">Cash and cash equivalents</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">The Company considers all highly liquid investments with original maturities of three months or less when purchased to be cash and cash equivalents. The Company maintains cash and cash equivalent balances at financial institutions that are insured by the FDIC. As of September 30, 2023 and December 31, 2022, the Company had approximately $<span id="xdx_903_eus-gaap--Cash_iI_c20230930_zE8BHk2xxcUa" title="Cash">753,000</span> and $<span id="xdx_908_eus-gaap--Cash_iI_c20221231_zIblIh1ag529" title="Cash">2,147,000</span> in cash. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk on cash.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash deposits. Accounts at each institution are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $<span id="xdx_90E_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20230930__srt--RangeAxis__srt--MaximumMember_zBCxJDw7Y6s7" title="Cash, FDIC insured amount">250,000</span>. As of September 30, 2023 and December 31, 2022, the Company had approximately $<span id="xdx_90A_eus-gaap--CashFDICInsuredAmount_iI_c20230930_zleSnh8QUBxk" title="Cash, FDIC insured amount">102,000</span> and $<span id="xdx_907_eus-gaap--CashFDICInsuredAmount_iI_c20221231_zflmhTejYUoj" title="Cash, FDIC insured amount">1,682,000</span> in excess of the FDIC insured limit, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_ecustom--StableCoinsPolicyTextBlock_zyJRkrMXm8zh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_867_zhzHQvi3n3V7">Stablecoins</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company holds stablecoins, such as USDT (Tether) and USDC (USD Coin), which are crypto assets that are pegged to the value of one U.S. dollar and can be redeemed on demand for one U.S. dollar. Our stablecoins are typically held in secure digital wallets or on crypto asset exchanges. The Company acquires and holds stablecoins primarily to facilitate crypto asset transactions, including, but not limited to, payments to third-party vendors. While not accounted for as cash or cash equivalents, these stablecoins are considered a liquidity resource.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--RevenueRecognitionPolicyTextBlock_zt9W1lGjH0Qh" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_865_zGUzWwlpKD64">Revenue Recognition</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes revenue under Accounting Standards Codification (“ASC”) 606<i>, Revenue from Contracts with Customers</i>. The core principle of the new revenue standard is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. The following five steps are applied to achieve that core principle:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 1: Identify the contract with the customer</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 2: Identify the performance obligations in the contract</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 3: Determine the transaction price</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 4: Allocate the transaction price to the performance obligations in the contract</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 5: Recognize revenue when the Company satisfies a performance obligation</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue is recognized when control of the promised goods or services is transferred to the customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. The Company generates revenue through staking rewards.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has entered into network-based smart contracts by running its own crypto asset validator nodes as well as by staking crypto assets on nodes run by third-party operators (either directly or through crypto exchanges). Through these contracts, the Company provides crypto assets to stake on a node for the purpose of validating transactions and adding blocks to a respective blockchain network. The term of a smart contract can vary based on the rules of the respective blockchain and typically last a few weeks to months after it is cancelled by the operator and requires that the crypto assets staked remain locked up during the duration of the smart contract. In exchange for staking the crypto assets and validating transactions on blockchain networks, the Company is entitled to all of the fixed crypto asset award for running the Company’s own node and is entitled to a fractional share of the fixed crypto asset award a third-party node operator receives (less crypto asset transaction fees payable to the node operator or exchanges, which are immaterial and are recorded as a deduction from revenue), for successfully validating or adding a block to the blockchain. The Company’s fractional share of awards received from delegating to a third-party validator node is based on the proportion of crypto assets the Company staked to the node to the total crypto assets staked by delegators to the node.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The provision of validating blockchain transactions is an output of the Company’s ordinary activities. Each separate block creation or validation under a smart contract with a network represents a performance obligation. The transaction consideration the Company receives - the crypto asset award - is a non-cash consideration, which the Company measures at fair value on the date received. The fair value of the crypto asset award received is determined using the quoted price of the related crypto assets on the date of receipt. The satisfaction of the performance obligation for processing and validating blockchain transactions occurs at a point in time when confirmation is received from the network indicating that the validation is complete, and the awards are available for transfer. At that point, revenue is recognized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zcLoTya9VIgg" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86A_zCFPAJNLmSqf">Cost of Revenues</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s cost of revenue primarily includes direct production costs associated with transaction validation on the network, cloud-based server hosting expenses related to our validator nodes, and allocated employee salaries dedicated to node maintenance and support. Additionally, the cost of revenue encompasses fees, including equity compensation stock-based fees, paid to third parties for their assistance in software maintenance and node operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zzmieN15vGha" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86A_zdMfF8NdB4R9">Crypto Assets Translations and Remeasurements</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for its crypto assets as indefinite-lived intangible assets in accordance with ASC 350, <i>Intangibles – Goodwill and Other</i>. An intangible asset with an indefinite useful life is not amortized but assessed for impairment annually, or more frequently, when events or changes in circumstances occur indicating that it is more likely than not that the indefinite-lived asset is impaired. Impairment exists when the carrying amount exceeds its fair value. In testing for impairment, the Company has the option to first perform a qualitative assessment to determine whether it is more likely than not that an impairment exists. If it is determined that it is not more likely than not that an impairment exists, a quantitative impairment test is not necessary. If the Company concludes otherwise, it is required to perform a quantitative impairment test. To the extent an impairment loss is recognized, the loss establishes the new cost basis of the asset. Subsequent reversal of impairment losses is not permitted.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Crypto assets held are included in the balance sheets as either current assets or other assets if they are staked and locked up for over one year. The Company’s crypto assets are initially recorded at fair value upon receipt (or “carrying value”). The fair value of crypto assets is determined using the U.S. dollar spot price of the related crypto asset. On a quarterly basis, crypto assets are measured at carrying value, net of any impairment losses incurred since receipt. The Company will record impairment losses as the fair value falls below the carrying value of the crypto assets at any time during the period, as determined using the lowest intraday U.S. dollar spot price of the related crypto asset subsequent to its acquisition. The crypto assets can only be marked down when impaired and not marked up when their value increases.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">Such impairment in the value of crypto assets is recorded as a component of costs and expenses in our Statements of Operations. The Company recorded impairment losses related to crypto assets of approximately $<span id="xdx_90F_eus-gaap--ImpairmentLossesRelatedToRealEstatePartnerships_c20230101__20230930_zX7UChWWlxAh" title="Impairment losses">1,252,000</span> and $<span id="xdx_902_eus-gaap--ImpairmentLossesRelatedToRealEstatePartnerships_c20220101__20220930_z6nuCYHuvzFh" title="Impairment losses">12,347,000</span> during the nine months ended September 30, 2023, and 2022, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">Impairment losses cannot be recovered for any subsequent increase in fair value until the sale or disposal of the asset. Realized gain (loss) on sale of crypto assets are included in other income (expense) in the Statements of Operations. The Company recorded realized gains (losses) on crypto assets of approximately $<span id="xdx_90E_eus-gaap--RealizedInvestmentGainsLosses_c20230101__20230930_z4pFKyPnwoee" title="Realized investment gains losses">806,000</span> and $<span id="xdx_909_eus-gaap--RealizedInvestmentGainsLosses_c20220101__20220930_zvWh2BmPnv5k" title="Realized investment gains losses">490,000</span> during the nine months ended September 30, 2023 and 2022, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The presentation of purchases and sales of crypto assets on the Statement of Cash Flows is determined by the nature of the crypto assets, which can be characterized as productive (i.e. purchased for purposes of staking) or non-productive. The purchase of non-productive crypto assets and currencies are included as an operating activity, whereas the purchase of productive crypto assets and currencies are included as investing activities in accordance with <i>ASC 230-10-20 Investing activities. </i>Productive crypto assets that are staked with a lock-up period of less than 12 months are presented on the Balance Sheet as current assets. Staked crypto assets with remaining lock-up periods of greater than 12 months are presented as long-term other assets on the Balance Sheet.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zjDW3r1q0Imk" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_868_zY1j9NCHrwy">Internally Developed Software</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Internally developed software consists of the core technology of the Company’s StakeSeeker platform, which is being designed to allow users to track, monitor and analyze their aggregate crypto asset portfolio holdings by connecting their crypto exchanges and digital wallets as well as providing a non-custodial delegation process to earn staking rewards on crypto asset holdings. For internally developed software, the Company uses both its own employees as well as the services of external vendors and independent contractors. The Company accounts for computer software used in the business in accordance with ASC 985-20 and ASC 350.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC 985-20, <i>Software-Costs of Computer Software to Be Sold, Leased, or Otherwise Marketed,</i> requires that software development costs incurred in conjunction with product development be charged to research and development expense until technological feasibility is established. Thereafter, until the product is released for sale, software development costs must be capitalized and reported at the lower of unamortized cost or net realizable value of the related product. Some companies use a “tested working model” approach to establishing technological feasibility (i.e., beta version). Under this approach, software under development will pass the technological feasibility milestone when the Company has completed a version that contains essentially all the functionality and features of the final version and has tested the version to ensure that it works as expected.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC 350, <i>Intangibles-Goodwill and Other</i>, requires computer software costs associated with internal use software to be charged to operations as incurred until certain capitalization criteria are met. Costs incurred during the preliminary project stage and the post-implementation stages are expensed as incurred. Certain qualifying costs incurred during the application development stage are capitalized as property, equipment and software. These costs generally consist of internal labor during configuration, coding, and testing activities. Capitalization begins when (i) the preliminary project stage is complete, (ii) management with the relevant authority authorizes and commits to the funding of the software project, and (iii) it is probable both that the project will be completed, and that the software will be used to perform the function intended.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_z8nBCU252MV5" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86D_zmvjBJYfEND4">Property and Equipment</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment consists of computer, equipment and office furniture and fixtures, all of which are recorded at cost. Depreciation and amortization are recorded using the straight-line method over the respective useful lives of the assets ranging from <span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dxL_c20230930__srt--RangeAxis__srt--MinimumMember_zXeg6PvGUpg2" title="Property, plant and equipment, estimated useful lives::XDX::P3Y"><span style="-sec-ix-hidden: xdx2ixbrl0605">three</span></span> to <span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dc_c20230930__srt--RangeAxis__srt--MaximumMember_z38533kqxdPd" title="Property, plant and equipment, estimated useful lives">five years</span>. Long-lived assets are reviewed for impairment whenever events or circumstances indicate that the carrying amount of these assets may not be recoverable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--UseOfEstimates_z9MBIVzRnqxi" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86F_ziyUGBdyaOUf">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying financial statements have been prepared in conformity with U.S. GAAP. This requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the period. The Company’s significant estimates and assumptions include the recoverability and useful lives of indefinite life intangible assets, stock-based compensation, and the valuation allowance related to the Company’s deferred tax assets. Certain of the Company’s estimates, including the carrying amount of the indefinite life intangible assets, could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible that these external factors could have an effect on the Company’s estimates and could cause actual results to differ from those estimates and assumptions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--IncomeTaxPolicyTextBlock_zfka2u4Q9Bx4" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_865_zXcpRkqwvVRh">Income Taxes</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes income taxes on an accrual basis based on tax positions taken or expected to be taken in its tax returns. A tax position is defined as a position in a previously filed tax return or a position expected to be taken in a future tax filing that is reflected in measuring current or deferred income tax assets and liabilities. <span id="xdx_90A_eus-gaap--IncomeTaxExaminationLikelihoodOfUnfavorableSettlement_c20230101__20230930_zHMDBzbYS9T2" title="Income tax likelihood percentage description">Tax positions are recognized only when it is more likely than not (i.e., likelihood of greater than 50%), based on technical merits, that the position would be sustained upon examination by taxing authorities. Tax positions that meet the more likely than not threshold are measured using a probability-weighted approach as the largest amount of tax benefit that is greater than 50% likely of being realized upon settlement.</span> Income taxes are accounted for using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the Company’s financial statements or tax returns. A valuation allowance is established to reduce deferred tax assets if all, or some portion, of such assets will more than likely not be realized. Should they occur, the Company’s policy is to classify interest and penalties related to tax positions as income tax expense. Since the Company’s inception, no such interest or penalties have been incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_ecustom--AccountingForWarrantsPolicyTextBlock_zRLv5qwXK5Xg" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_867_z4Oy55TTSgC7">Accounting for Warrants</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for the issuance of Common Stock purchase warrants issued in connection with the equity offerings in accordance with the provisions of ASC 815, Derivatives and Hedging (“ASC 815”). The Company classifies as equity any contracts that (i) require physical settlement or net-share settlement or (ii) gives the Company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement). The Company classifies as assets or liabilities any contracts that (i) require net-cash settlement (including a requirement to net-cash settle the contract if an event occurs and if that event is outside the control of the Company) or (ii) gives the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement). In addition, Under ASC 815, registered Common Stock warrants that require the issuance of registered shares upon exercise and do not expressly preclude an implied right to cash settlement are accounted for as derivative liabilities. The Company classifies these derivative warrant liabilities on the balance sheet as a current liability.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company assessed the classification of Common Stock purchase warrants as of the date of each offering and determined that such instruments originally met the criteria for equity classification; however, as a result of the Company no longer being in control of whether the warrants may be cash settled, the instruments no longer qualify for equity classification. Accordingly, the Company classified the warrants as a liability at their fair value and adjusts the instruments to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until the warrants are exercised or expired, and any change in fair value is recognized as “change in the fair value of warrant liabilities” in the statements of operations. The fair value of the warrants has been estimated using a Black-Scholes valuation model (see Note 4).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zB1Wy2H7nzX6" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_866_z11h9L6yTarb">Stock-based compensation</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for stock-based compensation in accordance with ASC 718 Compensation – Stock Compensation (“ASC 718”). ASC 718 addresses all forms of share-based payment awards including shares issued under employee stock purchase plans and stock incentive shares. Under ASC 718 awards result in a cost that is measured at fair value on the awards’ grant date, based on the estimated number of awards that are expected to vest and will result in a charge to operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share-based payment awards exchanged for services are accounted for at the fair value of the award on the estimated grant date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Options</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock options issued under the Company’s long-term incentive plans are granted with an exercise price equal to no less than the market price of the Company’s stock at the date of grant and expire up to ten years from the date of grant. These options often vest over a one-year period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company estimates the fair value of stock option grants using the Black-Scholes option pricing model and the assumptions used in calculating the fair value of stock-based awards represent management’s best estimates and involve inherent uncertainties and the application of management’s judgment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Restricted Stock Units (RSUs)</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For awards vesting upon the achievement of a service condition, compensation cost measured on the grant date will be recognized on a straight-line basis over the vesting period. Stock-based compensation expense for the market-based restricted stock units with explicit service conditions is recognized on a straight-line basis over the longer of the derived service period or the explicit service period, regardless of whether the market condition is satisfied. However, in the event that the explicit service period is not met, previously recognized compensation cost would be reversed. Market-based restricted stock units subject to market-based performance targets require achievement of the performance target as well as a service condition in order for these RSUs to vest.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company estimates the fair value of market-based RSUs as of the grant date and expected derived term using a Monte Carlo simulation that incorporates pricing inputs covering the period from the grant date through the end of the derived service period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_ecustom--DividendsPolicyTextBlock_zVQJGm0GJv74" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_860_zTOvjKxbmnmc">Dividends</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective January 27, 2023, the Company’s Board of Directors (the “Board”) approved the issuance of a newly designated Series V Preferred Stock (“Series V”) on a one-for-one basis to the Company’s shareholders (including restricted stock unit holders and warrant holders who were entitled to such distribution). The distribution of Series V shares was approved and completed on June 2, 2023 to shareholders as of the record date of May 12, 2023. <span id="xdx_908_eus-gaap--PreferredStockConversionBasis_c20230101__20230930_zsQ0ODMfdXse" title="Liquidation preference">The Series V: (i) is non-convertible, (ii) has a 20% liquidation preference over the shares of common stock, (iii) is non-voting and (iv) has certain rights to dividends and distributions (at the discretion of the Board).</span> A total of <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230602__20230602__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__custom--SeriesVPreferredStockMember_z398oPtF2Oa4" title="Number of shares issued">14,542,803 </span>shares of Series V Preferred Stock were distributed to shareholders on June 2, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 5, 2022, the Board declared a non-recurring special dividend of $<span id="xdx_90F_eus-gaap--DividendsPayableAmountPerShare_iI_pid_c20220105__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember_zxa3ruEY8X57" title="Dividend per share">0.05</span> for each outstanding share of Common Stock of the Company, payable to holders of record as of the close of business on March 17, 2022. The dividend distributions were considered a return of capital as the distributions were in excess of the Company’s current and accumulated earnings and profits. The return of capital distribution reduces the Company’s additional paid in capital balance. Dividend distributions amounted to $<span id="xdx_90C_eus-gaap--PaymentsOfDividends_pp0p0_c20230101__20230930_zxNV35MBtCwl" title="Payments of dividends">0</span> and $<span id="xdx_904_eus-gaap--PaymentsOfDividends_pp0p0_c20220101__20220930_zq6dRGrvobMc" title="Payments of dividends">635,000</span> during the nine months ended September 30, 2023 and 2022, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company will evaluate the appropriateness of potential future dividends as the Company continues to grow its operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--AdvertisingCostsPolicyTextBlock_zQvRzPwhoHW" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86F_zhu6mdtFOhng">Advertising Expense</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advertisement costs are expensed as incurred and included in marketing expenses. Advertising and marketing expenses amounted to approximately $<span id="xdx_90C_eus-gaap--MarketingAndAdvertisingExpense_pp0p0_c20230101__20230930_zoSJ7nsHVsra" title="Advertising and marketing expenses">11,000</span> and $<span id="xdx_90C_eus-gaap--MarketingAndAdvertisingExpense_pp0p0_c20220101__20220930_zhI171yOr017" title="Advertising and marketing expenses">74,000</span> for the nine months ended September 30, 2023 and 2022, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--EarningsPerSharePolicyTextBlock_zLupi3UpE8O3" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86B_z4OY2b1uUKn4">Net Loss per Share</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic loss per share is computed by dividing the net income or loss applicable to common shares by the weighted average number of common shares outstanding during the period. Diluted earnings per share is computed using the weighted average number of common shares and, if dilutive, potential common shares outstanding during the period. Potential common shares consist of the Company’s convertible preferred stock, convertible notes, restricted stock units, options and warrants. Diluted loss per share excludes the shares issuable upon the conversion of preferred stock, notes and warrants from the calculation of net loss per share if their effect would be anti-dilutive.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zjbc4yJE2epi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following financial instruments were not included in the diluted loss per share calculation as of September 30, 2023 and 2022 because their effect was anti-dilutive:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zBUioimGtSad" style="display: none">Schedule of Earnings Per Share Anti-diluted</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center; vertical-align: bottom"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" id="xdx_492_20230101__20230930_zpUf9SweLv3k" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; vertical-align: bottom">2023</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" id="xdx_49B_20220101__20220930_zQJYJ3oByXPd" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; vertical-align: bottom">2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center; vertical-align: bottom"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; vertical-align: bottom">As of September 30,</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center; vertical-align: bottom"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; vertical-align: bottom">2023</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; vertical-align: bottom">2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td></tr> <tr id="xdx_40F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_z4njEmBHStPd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Warrants to purchase common stock</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">712,500</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">945,837</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zWYVRczWPKh9" style="vertical-align: bottom; background-color: White"> <td>Options</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,150,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,285,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--NonVestedRestrictedStockAwardsUnitsMember_zqCtBlGZj9l3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">Non-vested restricted stock awards units</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,631,399</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,612,350</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zlNCXpkTrPCh" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; padding-left: 10pt; font-weight: bold">Total</td><td style="padding-bottom: 2.5pt; font-weight: bold"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"> </td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">3,493,899</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt; font-weight: bold"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"> </td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">3,843,187</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zxopYnvwSJlc" style="display: none; vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; padding-left: 10pt; font-weight: bold">Anti-dilutive securities</td><td style="padding-bottom: 2.5pt; font-weight: bold"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"> </td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">3,493,899</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt; font-weight: bold"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"> </td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">3,843,187</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p id="xdx_8AD_zlIJGQbRY0vl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zBd1XiBax0Tj" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_868_zK3X5pvTaZ35">Recent Accounting Pronouncements</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have evaluated all recently issued accounting pronouncements and believe such pronouncements do not have a material effect on our financial statements.</span></p> <p id="xdx_856_zY3EigAckOYc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_843_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zR7YJNtXFWUl" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86C_z91FRh6Yoboi">Basis of presentation</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying financial statements have been prepared in accordance with United States generally accepted accounting principles (“GAAP”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zEOWsrTjTnd2" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_864_zTaogXHJwvje">Reclassifications</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain prior period amounts have been reclassified in order to conform with the current period presentation. These reclassifications have no impact on the Company’s previously reported net income (loss).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zAlw6VS66hBj" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86B_zBHERHyZZyUl">Cash and cash equivalents</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">The Company considers all highly liquid investments with original maturities of three months or less when purchased to be cash and cash equivalents. The Company maintains cash and cash equivalent balances at financial institutions that are insured by the FDIC. As of September 30, 2023 and December 31, 2022, the Company had approximately $<span id="xdx_903_eus-gaap--Cash_iI_c20230930_zE8BHk2xxcUa" title="Cash">753,000</span> and $<span id="xdx_908_eus-gaap--Cash_iI_c20221231_zIblIh1ag529" title="Cash">2,147,000</span> in cash. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk on cash.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash deposits. Accounts at each institution are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $<span id="xdx_90E_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20230930__srt--RangeAxis__srt--MaximumMember_zBCxJDw7Y6s7" title="Cash, FDIC insured amount">250,000</span>. As of September 30, 2023 and December 31, 2022, the Company had approximately $<span id="xdx_90A_eus-gaap--CashFDICInsuredAmount_iI_c20230930_zleSnh8QUBxk" title="Cash, FDIC insured amount">102,000</span> and $<span id="xdx_907_eus-gaap--CashFDICInsuredAmount_iI_c20221231_zflmhTejYUoj" title="Cash, FDIC insured amount">1,682,000</span> in excess of the FDIC insured limit, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 753000 2147000 250000 102000 1682000 <p id="xdx_84A_ecustom--StableCoinsPolicyTextBlock_zyJRkrMXm8zh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_867_zhzHQvi3n3V7">Stablecoins</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company holds stablecoins, such as USDT (Tether) and USDC (USD Coin), which are crypto assets that are pegged to the value of one U.S. dollar and can be redeemed on demand for one U.S. dollar. Our stablecoins are typically held in secure digital wallets or on crypto asset exchanges. The Company acquires and holds stablecoins primarily to facilitate crypto asset transactions, including, but not limited to, payments to third-party vendors. While not accounted for as cash or cash equivalents, these stablecoins are considered a liquidity resource.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--RevenueRecognitionPolicyTextBlock_zt9W1lGjH0Qh" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_865_zGUzWwlpKD64">Revenue Recognition</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes revenue under Accounting Standards Codification (“ASC”) 606<i>, Revenue from Contracts with Customers</i>. The core principle of the new revenue standard is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. The following five steps are applied to achieve that core principle:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 1: Identify the contract with the customer</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 2: Identify the performance obligations in the contract</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 3: Determine the transaction price</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 4: Allocate the transaction price to the performance obligations in the contract</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 5: Recognize revenue when the Company satisfies a performance obligation</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue is recognized when control of the promised goods or services is transferred to the customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. The Company generates revenue through staking rewards.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has entered into network-based smart contracts by running its own crypto asset validator nodes as well as by staking crypto assets on nodes run by third-party operators (either directly or through crypto exchanges). Through these contracts, the Company provides crypto assets to stake on a node for the purpose of validating transactions and adding blocks to a respective blockchain network. The term of a smart contract can vary based on the rules of the respective blockchain and typically last a few weeks to months after it is cancelled by the operator and requires that the crypto assets staked remain locked up during the duration of the smart contract. In exchange for staking the crypto assets and validating transactions on blockchain networks, the Company is entitled to all of the fixed crypto asset award for running the Company’s own node and is entitled to a fractional share of the fixed crypto asset award a third-party node operator receives (less crypto asset transaction fees payable to the node operator or exchanges, which are immaterial and are recorded as a deduction from revenue), for successfully validating or adding a block to the blockchain. The Company’s fractional share of awards received from delegating to a third-party validator node is based on the proportion of crypto assets the Company staked to the node to the total crypto assets staked by delegators to the node.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The provision of validating blockchain transactions is an output of the Company’s ordinary activities. Each separate block creation or validation under a smart contract with a network represents a performance obligation. The transaction consideration the Company receives - the crypto asset award - is a non-cash consideration, which the Company measures at fair value on the date received. The fair value of the crypto asset award received is determined using the quoted price of the related crypto assets on the date of receipt. The satisfaction of the performance obligation for processing and validating blockchain transactions occurs at a point in time when confirmation is received from the network indicating that the validation is complete, and the awards are available for transfer. At that point, revenue is recognized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zcLoTya9VIgg" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86A_zCFPAJNLmSqf">Cost of Revenues</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s cost of revenue primarily includes direct production costs associated with transaction validation on the network, cloud-based server hosting expenses related to our validator nodes, and allocated employee salaries dedicated to node maintenance and support. Additionally, the cost of revenue encompasses fees, including equity compensation stock-based fees, paid to third parties for their assistance in software maintenance and node operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zzmieN15vGha" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86A_zdMfF8NdB4R9">Crypto Assets Translations and Remeasurements</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for its crypto assets as indefinite-lived intangible assets in accordance with ASC 350, <i>Intangibles – Goodwill and Other</i>. An intangible asset with an indefinite useful life is not amortized but assessed for impairment annually, or more frequently, when events or changes in circumstances occur indicating that it is more likely than not that the indefinite-lived asset is impaired. Impairment exists when the carrying amount exceeds its fair value. In testing for impairment, the Company has the option to first perform a qualitative assessment to determine whether it is more likely than not that an impairment exists. If it is determined that it is not more likely than not that an impairment exists, a quantitative impairment test is not necessary. If the Company concludes otherwise, it is required to perform a quantitative impairment test. To the extent an impairment loss is recognized, the loss establishes the new cost basis of the asset. Subsequent reversal of impairment losses is not permitted.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Crypto assets held are included in the balance sheets as either current assets or other assets if they are staked and locked up for over one year. The Company’s crypto assets are initially recorded at fair value upon receipt (or “carrying value”). The fair value of crypto assets is determined using the U.S. dollar spot price of the related crypto asset. On a quarterly basis, crypto assets are measured at carrying value, net of any impairment losses incurred since receipt. The Company will record impairment losses as the fair value falls below the carrying value of the crypto assets at any time during the period, as determined using the lowest intraday U.S. dollar spot price of the related crypto asset subsequent to its acquisition. The crypto assets can only be marked down when impaired and not marked up when their value increases.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">Such impairment in the value of crypto assets is recorded as a component of costs and expenses in our Statements of Operations. The Company recorded impairment losses related to crypto assets of approximately $<span id="xdx_90F_eus-gaap--ImpairmentLossesRelatedToRealEstatePartnerships_c20230101__20230930_zX7UChWWlxAh" title="Impairment losses">1,252,000</span> and $<span id="xdx_902_eus-gaap--ImpairmentLossesRelatedToRealEstatePartnerships_c20220101__20220930_z6nuCYHuvzFh" title="Impairment losses">12,347,000</span> during the nine months ended September 30, 2023, and 2022, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">Impairment losses cannot be recovered for any subsequent increase in fair value until the sale or disposal of the asset. Realized gain (loss) on sale of crypto assets are included in other income (expense) in the Statements of Operations. The Company recorded realized gains (losses) on crypto assets of approximately $<span id="xdx_90E_eus-gaap--RealizedInvestmentGainsLosses_c20230101__20230930_z4pFKyPnwoee" title="Realized investment gains losses">806,000</span> and $<span id="xdx_909_eus-gaap--RealizedInvestmentGainsLosses_c20220101__20220930_zvWh2BmPnv5k" title="Realized investment gains losses">490,000</span> during the nine months ended September 30, 2023 and 2022, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The presentation of purchases and sales of crypto assets on the Statement of Cash Flows is determined by the nature of the crypto assets, which can be characterized as productive (i.e. purchased for purposes of staking) or non-productive. The purchase of non-productive crypto assets and currencies are included as an operating activity, whereas the purchase of productive crypto assets and currencies are included as investing activities in accordance with <i>ASC 230-10-20 Investing activities. </i>Productive crypto assets that are staked with a lock-up period of less than 12 months are presented on the Balance Sheet as current assets. Staked crypto assets with remaining lock-up periods of greater than 12 months are presented as long-term other assets on the Balance Sheet.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1252000 12347000 806000 490000 <p id="xdx_843_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zjDW3r1q0Imk" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_868_zY1j9NCHrwy">Internally Developed Software</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Internally developed software consists of the core technology of the Company’s StakeSeeker platform, which is being designed to allow users to track, monitor and analyze their aggregate crypto asset portfolio holdings by connecting their crypto exchanges and digital wallets as well as providing a non-custodial delegation process to earn staking rewards on crypto asset holdings. For internally developed software, the Company uses both its own employees as well as the services of external vendors and independent contractors. The Company accounts for computer software used in the business in accordance with ASC 985-20 and ASC 350.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC 985-20, <i>Software-Costs of Computer Software to Be Sold, Leased, or Otherwise Marketed,</i> requires that software development costs incurred in conjunction with product development be charged to research and development expense until technological feasibility is established. Thereafter, until the product is released for sale, software development costs must be capitalized and reported at the lower of unamortized cost or net realizable value of the related product. Some companies use a “tested working model” approach to establishing technological feasibility (i.e., beta version). Under this approach, software under development will pass the technological feasibility milestone when the Company has completed a version that contains essentially all the functionality and features of the final version and has tested the version to ensure that it works as expected.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC 350, <i>Intangibles-Goodwill and Other</i>, requires computer software costs associated with internal use software to be charged to operations as incurred until certain capitalization criteria are met. Costs incurred during the preliminary project stage and the post-implementation stages are expensed as incurred. Certain qualifying costs incurred during the application development stage are capitalized as property, equipment and software. These costs generally consist of internal labor during configuration, coding, and testing activities. Capitalization begins when (i) the preliminary project stage is complete, (ii) management with the relevant authority authorizes and commits to the funding of the software project, and (iii) it is probable both that the project will be completed, and that the software will be used to perform the function intended.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_z8nBCU252MV5" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86D_zmvjBJYfEND4">Property and Equipment</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment consists of computer, equipment and office furniture and fixtures, all of which are recorded at cost. Depreciation and amortization are recorded using the straight-line method over the respective useful lives of the assets ranging from <span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dxL_c20230930__srt--RangeAxis__srt--MinimumMember_zXeg6PvGUpg2" title="Property, plant and equipment, estimated useful lives::XDX::P3Y"><span style="-sec-ix-hidden: xdx2ixbrl0605">three</span></span> to <span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dc_c20230930__srt--RangeAxis__srt--MaximumMember_z38533kqxdPd" title="Property, plant and equipment, estimated useful lives">five years</span>. Long-lived assets are reviewed for impairment whenever events or circumstances indicate that the carrying amount of these assets may not be recoverable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> P5Y <p id="xdx_84B_eus-gaap--UseOfEstimates_z9MBIVzRnqxi" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86F_ziyUGBdyaOUf">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying financial statements have been prepared in conformity with U.S. GAAP. This requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the period. The Company’s significant estimates and assumptions include the recoverability and useful lives of indefinite life intangible assets, stock-based compensation, and the valuation allowance related to the Company’s deferred tax assets. Certain of the Company’s estimates, including the carrying amount of the indefinite life intangible assets, could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible that these external factors could have an effect on the Company’s estimates and could cause actual results to differ from those estimates and assumptions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--IncomeTaxPolicyTextBlock_zfka2u4Q9Bx4" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_865_zXcpRkqwvVRh">Income Taxes</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes income taxes on an accrual basis based on tax positions taken or expected to be taken in its tax returns. A tax position is defined as a position in a previously filed tax return or a position expected to be taken in a future tax filing that is reflected in measuring current or deferred income tax assets and liabilities. <span id="xdx_90A_eus-gaap--IncomeTaxExaminationLikelihoodOfUnfavorableSettlement_c20230101__20230930_zHMDBzbYS9T2" title="Income tax likelihood percentage description">Tax positions are recognized only when it is more likely than not (i.e., likelihood of greater than 50%), based on technical merits, that the position would be sustained upon examination by taxing authorities. Tax positions that meet the more likely than not threshold are measured using a probability-weighted approach as the largest amount of tax benefit that is greater than 50% likely of being realized upon settlement.</span> Income taxes are accounted for using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the Company’s financial statements or tax returns. A valuation allowance is established to reduce deferred tax assets if all, or some portion, of such assets will more than likely not be realized. Should they occur, the Company’s policy is to classify interest and penalties related to tax positions as income tax expense. Since the Company’s inception, no such interest or penalties have been incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> Tax positions are recognized only when it is more likely than not (i.e., likelihood of greater than 50%), based on technical merits, that the position would be sustained upon examination by taxing authorities. Tax positions that meet the more likely than not threshold are measured using a probability-weighted approach as the largest amount of tax benefit that is greater than 50% likely of being realized upon settlement. <p id="xdx_844_ecustom--AccountingForWarrantsPolicyTextBlock_zRLv5qwXK5Xg" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_867_z4Oy55TTSgC7">Accounting for Warrants</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for the issuance of Common Stock purchase warrants issued in connection with the equity offerings in accordance with the provisions of ASC 815, Derivatives and Hedging (“ASC 815”). The Company classifies as equity any contracts that (i) require physical settlement or net-share settlement or (ii) gives the Company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement). The Company classifies as assets or liabilities any contracts that (i) require net-cash settlement (including a requirement to net-cash settle the contract if an event occurs and if that event is outside the control of the Company) or (ii) gives the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement). In addition, Under ASC 815, registered Common Stock warrants that require the issuance of registered shares upon exercise and do not expressly preclude an implied right to cash settlement are accounted for as derivative liabilities. The Company classifies these derivative warrant liabilities on the balance sheet as a current liability.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company assessed the classification of Common Stock purchase warrants as of the date of each offering and determined that such instruments originally met the criteria for equity classification; however, as a result of the Company no longer being in control of whether the warrants may be cash settled, the instruments no longer qualify for equity classification. Accordingly, the Company classified the warrants as a liability at their fair value and adjusts the instruments to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until the warrants are exercised or expired, and any change in fair value is recognized as “change in the fair value of warrant liabilities” in the statements of operations. The fair value of the warrants has been estimated using a Black-Scholes valuation model (see Note 4).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zB1Wy2H7nzX6" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_866_z11h9L6yTarb">Stock-based compensation</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for stock-based compensation in accordance with ASC 718 Compensation – Stock Compensation (“ASC 718”). ASC 718 addresses all forms of share-based payment awards including shares issued under employee stock purchase plans and stock incentive shares. Under ASC 718 awards result in a cost that is measured at fair value on the awards’ grant date, based on the estimated number of awards that are expected to vest and will result in a charge to operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share-based payment awards exchanged for services are accounted for at the fair value of the award on the estimated grant date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Options</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock options issued under the Company’s long-term incentive plans are granted with an exercise price equal to no less than the market price of the Company’s stock at the date of grant and expire up to ten years from the date of grant. These options often vest over a one-year period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company estimates the fair value of stock option grants using the Black-Scholes option pricing model and the assumptions used in calculating the fair value of stock-based awards represent management’s best estimates and involve inherent uncertainties and the application of management’s judgment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Restricted Stock Units (RSUs)</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For awards vesting upon the achievement of a service condition, compensation cost measured on the grant date will be recognized on a straight-line basis over the vesting period. Stock-based compensation expense for the market-based restricted stock units with explicit service conditions is recognized on a straight-line basis over the longer of the derived service period or the explicit service period, regardless of whether the market condition is satisfied. However, in the event that the explicit service period is not met, previously recognized compensation cost would be reversed. Market-based restricted stock units subject to market-based performance targets require achievement of the performance target as well as a service condition in order for these RSUs to vest.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company estimates the fair value of market-based RSUs as of the grant date and expected derived term using a Monte Carlo simulation that incorporates pricing inputs covering the period from the grant date through the end of the derived service period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_ecustom--DividendsPolicyTextBlock_zVQJGm0GJv74" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_860_zTOvjKxbmnmc">Dividends</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective January 27, 2023, the Company’s Board of Directors (the “Board”) approved the issuance of a newly designated Series V Preferred Stock (“Series V”) on a one-for-one basis to the Company’s shareholders (including restricted stock unit holders and warrant holders who were entitled to such distribution). The distribution of Series V shares was approved and completed on June 2, 2023 to shareholders as of the record date of May 12, 2023. <span id="xdx_908_eus-gaap--PreferredStockConversionBasis_c20230101__20230930_zsQ0ODMfdXse" title="Liquidation preference">The Series V: (i) is non-convertible, (ii) has a 20% liquidation preference over the shares of common stock, (iii) is non-voting and (iv) has certain rights to dividends and distributions (at the discretion of the Board).</span> A total of <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230602__20230602__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__custom--SeriesVPreferredStockMember_z398oPtF2Oa4" title="Number of shares issued">14,542,803 </span>shares of Series V Preferred Stock were distributed to shareholders on June 2, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 5, 2022, the Board declared a non-recurring special dividend of $<span id="xdx_90F_eus-gaap--DividendsPayableAmountPerShare_iI_pid_c20220105__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember_zxa3ruEY8X57" title="Dividend per share">0.05</span> for each outstanding share of Common Stock of the Company, payable to holders of record as of the close of business on March 17, 2022. The dividend distributions were considered a return of capital as the distributions were in excess of the Company’s current and accumulated earnings and profits. The return of capital distribution reduces the Company’s additional paid in capital balance. Dividend distributions amounted to $<span id="xdx_90C_eus-gaap--PaymentsOfDividends_pp0p0_c20230101__20230930_zxNV35MBtCwl" title="Payments of dividends">0</span> and $<span id="xdx_904_eus-gaap--PaymentsOfDividends_pp0p0_c20220101__20220930_zq6dRGrvobMc" title="Payments of dividends">635,000</span> during the nine months ended September 30, 2023 and 2022, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company will evaluate the appropriateness of potential future dividends as the Company continues to grow its operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> The Series V: (i) is non-convertible, (ii) has a 20% liquidation preference over the shares of common stock, (iii) is non-voting and (iv) has certain rights to dividends and distributions (at the discretion of the Board). 14542803 0.05 0 635000 <p id="xdx_841_eus-gaap--AdvertisingCostsPolicyTextBlock_zQvRzPwhoHW" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86F_zhu6mdtFOhng">Advertising Expense</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advertisement costs are expensed as incurred and included in marketing expenses. Advertising and marketing expenses amounted to approximately $<span id="xdx_90C_eus-gaap--MarketingAndAdvertisingExpense_pp0p0_c20230101__20230930_zoSJ7nsHVsra" title="Advertising and marketing expenses">11,000</span> and $<span id="xdx_90C_eus-gaap--MarketingAndAdvertisingExpense_pp0p0_c20220101__20220930_zhI171yOr017" title="Advertising and marketing expenses">74,000</span> for the nine months ended September 30, 2023 and 2022, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 11000 74000 <p id="xdx_840_eus-gaap--EarningsPerSharePolicyTextBlock_zLupi3UpE8O3" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86B_z4OY2b1uUKn4">Net Loss per Share</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic loss per share is computed by dividing the net income or loss applicable to common shares by the weighted average number of common shares outstanding during the period. Diluted earnings per share is computed using the weighted average number of common shares and, if dilutive, potential common shares outstanding during the period. Potential common shares consist of the Company’s convertible preferred stock, convertible notes, restricted stock units, options and warrants. Diluted loss per share excludes the shares issuable upon the conversion of preferred stock, notes and warrants from the calculation of net loss per share if their effect would be anti-dilutive.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zjbc4yJE2epi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following financial instruments were not included in the diluted loss per share calculation as of September 30, 2023 and 2022 because their effect was anti-dilutive:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zBUioimGtSad" style="display: none">Schedule of Earnings Per Share Anti-diluted</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center; vertical-align: bottom"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" id="xdx_492_20230101__20230930_zpUf9SweLv3k" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; vertical-align: bottom">2023</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" id="xdx_49B_20220101__20220930_zQJYJ3oByXPd" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; vertical-align: bottom">2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center; vertical-align: bottom"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; vertical-align: bottom">As of September 30,</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center; vertical-align: bottom"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; vertical-align: bottom">2023</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; vertical-align: bottom">2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td></tr> <tr id="xdx_40F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_z4njEmBHStPd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Warrants to purchase common stock</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">712,500</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">945,837</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zWYVRczWPKh9" style="vertical-align: bottom; background-color: White"> <td>Options</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,150,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,285,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--NonVestedRestrictedStockAwardsUnitsMember_zqCtBlGZj9l3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">Non-vested restricted stock awards units</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,631,399</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,612,350</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zlNCXpkTrPCh" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; padding-left: 10pt; font-weight: bold">Total</td><td style="padding-bottom: 2.5pt; font-weight: bold"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"> </td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">3,493,899</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt; font-weight: bold"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"> </td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">3,843,187</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zxopYnvwSJlc" style="display: none; vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; padding-left: 10pt; font-weight: bold">Anti-dilutive securities</td><td style="padding-bottom: 2.5pt; font-weight: bold"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"> </td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">3,493,899</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt; font-weight: bold"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"> </td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">3,843,187</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p id="xdx_8AD_zlIJGQbRY0vl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zjbc4yJE2epi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following financial instruments were not included in the diluted loss per share calculation as of September 30, 2023 and 2022 because their effect was anti-dilutive:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zBUioimGtSad" style="display: none">Schedule of Earnings Per Share Anti-diluted</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center; vertical-align: bottom"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" id="xdx_492_20230101__20230930_zpUf9SweLv3k" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; vertical-align: bottom">2023</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" id="xdx_49B_20220101__20220930_zQJYJ3oByXPd" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; vertical-align: bottom">2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center; vertical-align: bottom"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; vertical-align: bottom">As of September 30,</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center; vertical-align: bottom"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; vertical-align: bottom">2023</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; vertical-align: bottom">2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td></tr> <tr id="xdx_40F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_z4njEmBHStPd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Warrants to purchase common stock</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">712,500</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">945,837</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zWYVRczWPKh9" style="vertical-align: bottom; background-color: White"> <td>Options</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,150,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,285,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--NonVestedRestrictedStockAwardsUnitsMember_zqCtBlGZj9l3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">Non-vested restricted stock awards units</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,631,399</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,612,350</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zlNCXpkTrPCh" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; padding-left: 10pt; font-weight: bold">Total</td><td style="padding-bottom: 2.5pt; font-weight: bold"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"> </td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">3,493,899</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt; font-weight: bold"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"> </td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">3,843,187</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zxopYnvwSJlc" style="display: none; vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; padding-left: 10pt; font-weight: bold">Anti-dilutive securities</td><td style="padding-bottom: 2.5pt; font-weight: bold"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"> </td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">3,493,899</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt; font-weight: bold"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"> </td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">3,843,187</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> 712500 945837 1150000 1285000 1631399 1612350 3493899 3843187 3493899 3843187 <p id="xdx_841_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zBd1XiBax0Tj" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_868_zK3X5pvTaZ35">Recent Accounting Pronouncements</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have evaluated all recently issued accounting pronouncements and believe such pronouncements do not have a material effect on our financial statements.</span></p> <p id="xdx_808_eus-gaap--FairValueDisclosuresTextBlock_zRK7NjqerWia" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span>Note 4 – <span id="xdx_823_zXsI1IulX0Ol">Fair Value of Financial Assets and Liabilities</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company measures certain assets and liabilities at fair value. The Company defines fair value as the price that would be received from selling an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market in an orderly transaction between market participants at the measurement date. Fair value is estimated by applying the following hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2 – Observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3 – Inputs that are generally unobservable and typically reflect management’s estimate of assumptions that market participants would use in pricing the asset or liability.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments, including cash and cash equivalents, accounts and other receivables, accounts payable and accrued liabilities are carried at cost, which management believes approximates fair value due to the short-term nature of these instruments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zqQOIFd7ZGq5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following tables present the Company’s assets and liabilities that are measured at fair value on a recurring basis and the Company’s estimated level within the fair value hierarchy of those assets and liabilities as of September 30, 2023 and December 31, 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B9_zJoUDzjc74s1" style="display: none">Schedule of Fair Value of Assets and Liabilities Valued on Recurring Basis</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; vertical-align: bottom; text-align: center"> </td><td style="padding-bottom: 1.5pt; vertical-align: bottom; text-align: center; font-weight: bold"> </td> <td colspan="14" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-weight: bold">Fair Value Measured at September 30, 2023</td><td style="padding-bottom: 1.5pt; vertical-align: bottom; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; vertical-align: bottom; text-align: center"> </td><td style="padding-bottom: 1.5pt; vertical-align: bottom; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-weight: bold"><p style="margin-top: 0; margin-bottom: 0">Total at</p> <p style="margin-top: 0; margin-bottom: 0">September 30,</p> <p style="margin-top: 0; margin-bottom: 0">2023</p></td><td style="padding-bottom: 1.5pt; vertical-align: bottom; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; vertical-align: bottom; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-weight: bold">Quoted prices in active markets (Level 1)</td><td style="padding-bottom: 1.5pt; vertical-align: bottom; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; vertical-align: bottom; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-weight: bold">Significant other observable inputs (Level 2)</td><td style="padding-bottom: 1.5pt; vertical-align: bottom; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; vertical-align: bottom; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-weight: bold">Significant unobservable inputs (Level 3)</td><td style="padding-bottom: 1.5pt; vertical-align: bottom; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; padding-left: 10pt; width: 36%">Investments</td><td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--InvestmentsFairValueDisclosure_iI_pp0p0_c20230930_zPx5rQ4b0Ud2" style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right" title="Investments">100,000</td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td><td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--InvestmentsFairValueDisclosure_iI_pp0p0_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zBJogipemKGk" style="border-bottom: Black 1.5pt solid; text-align: right; width: 12%" title="Investments">      <span style="-sec-ix-hidden: xdx2ixbrl0664">-</span></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td><td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--InvestmentsFairValueDisclosure_iI_pp0p0_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zWrmrkdEV4je" style="border-bottom: Black 1.5pt solid; text-align: right; width: 12%" title="Investments">          <span style="-sec-ix-hidden: xdx2ixbrl0666">-</span></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td><td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--InvestmentsFairValueDisclosure_iI_pp0p0_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zbr9aWiUBKg3" style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right" title="Investments">100,000</td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Warrant Liabilities</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20230930_zDbJ63wT0ct5" style="text-align: right" title="Warrant liabilities">71,250</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zLnbZtPFCRm4" style="text-align: right" title="Warrant liabilities"><span style="-sec-ix-hidden: xdx2ixbrl0672">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zKh3WS4wh4ob" style="text-align: right" title="Warrant liabilities"><span style="-sec-ix-hidden: xdx2ixbrl0674">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zgqrg9GaaEvc" style="text-align: right" title="Warrant liabilities">71,250</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center; vertical-align: bottom"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="14" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; vertical-align: bottom">Fair Value Measured at December 31, 2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center; vertical-align: bottom"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; vertical-align: bottom"><p style="margin-top: 0; margin-bottom: 0">Total at</p> <p style="margin-top: 0; margin-bottom: 0">December 31,</p> <p style="margin-top: 0; margin-bottom: 0">2022</p></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; vertical-align: bottom">Quoted prices in active markets (Level 1)</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; vertical-align: bottom">Significant other observable inputs (Level 2)</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; vertical-align: bottom">Significant unobservable inputs (Level 3)</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; padding-left: 10pt; width: 36%">Investments</td><td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--InvestmentsFairValueDisclosure_iI_pp0p0_c20221231_zRX7V3HCNwO7" style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right" title="Investments">100,000</td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td><td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--InvestmentsFairValueDisclosure_iI_pp0p0_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zNDhAgPJ023k" style="border-bottom: Black 1.5pt solid; text-align: right; width: 12%" title="Investments">      <span style="-sec-ix-hidden: xdx2ixbrl0680">-</span></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td><td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--InvestmentsFairValueDisclosure_iI_pp0p0_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zj34hWbPaUHa" style="border-bottom: Black 1.5pt solid; text-align: right; width: 12%" title="Investments">          <span style="-sec-ix-hidden: xdx2ixbrl0682">-</span></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td><td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--InvestmentsFairValueDisclosure_iI_pp0p0_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zmmLDTOSGYg8" style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right" title="Investments">100,000</td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Warrant Liabilities</td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20221231_zXY2rNDPvmkd" style="text-align: right" title="Warrant liabilities">213,750</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zGAoKNO11mOj" style="text-align: right" title="Warrant liabilities"><span style="-sec-ix-hidden: xdx2ixbrl0688">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zFv7cAOiS60f" style="text-align: right" title="Warrant liabilities"><span style="-sec-ix-hidden: xdx2ixbrl0690">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z5rqI2Yy8ec7" style="text-align: right" title="Warrant liabilities">213,750</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8A7_zS4A6o1J74j6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company did not make any transfers between the levels of the fair value hierarchy during the nine months ended September 30, 2023 and 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Level 3 Valuation Techniques</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3 financial assets consist of private equity investments for which there is no current public market for these securities such that the determination of fair value requires significant judgment or estimation. As of September 30, 2023 and December 31, 2022, the Company’s Level 3 investments were carried at original cost of the investments, with a value of $<span id="xdx_909_eus-gaap--InvestmentsFairValueDisclosure_iI_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zXrK6a9emLd8" title="Investments fair value">100,000</span>. The Company has elected to apply the measurement alternative under ASC 321, <i>Investments—Equity Securities</i>, for these investments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3 financial liabilities consist of the warrant liabilities for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes in fair value measurements categorized within Level 3 of the fair value hierarchy are analyzed each period based on changes in estimates or assumptions and recorded as appropriate.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A significant decrease in the volatility or a significant decrease in the Company’s stock price, in isolation, would result in a significantly lower fair value measurement. Changes in the values of the warrant liabilities are recorded in “change in fair value of warrant liabilities” in the Company’s statements of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 2, 2021, the Company entered into a securities purchase agreement with certain purchasers which closed on March 4, 2021 pursuant to which the Company sold an aggregate of (i) <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20210301__20210302__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zgj4Gd43d7c4" title="Shares of common stock">950,000</span> shares of Common Stock, and (ii) Common Stock warrants (the “Warrants”) to purchase up to <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20210302__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zaJcszrcE0j1" title="Common stock warrants">712,500</span> shares of Common Stock for gross proceeds of $<span id="xdx_901_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_pn5n6_c20210301__20210302__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zY9etkDaiBX9" title="Gross proceeds from private placement">9.5</span> million in a private placement offering.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Warrants require, at the option of the holder, a net-cash settlement following certain fundamental transactions (as defined in the Warrants) at the Company. At the time of issuance, the Company maintained control of certain fundamental transactions and as such the Warrants were initially classified in equity. As of December 31, 2022, the Company no longer maintained control of certain fundamental transactions as they did not control a majority of shareholder votes. As such, the Company may be required to cash settle the Warrants if a fundamental transaction occurs which is outside the Company’s control. Accordingly, the Warrants are classified as liabilities. The Warrants have been recorded at their fair value using the Black-Scholes valuation model, and will be recorded at their respective fair value at each subsequent balance sheet date. This model incorporates transaction details such as the Company’s stock price, contractual terms, maturity, risk-free rates, as well as volatility.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Warrants require the issuance of registered shares upon exercise, do not expressly preclude an implied right to cash settlement and are therefore accounted for as derivative liabilities. The Company classifies these derivative warrant liabilities on the balance sheet as a current liability.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_895_eus-gaap--FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock_zSJclhrhPID2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of quantitative information with respect to the valuation methodology and significant unobservable inputs used for the Company’s warrant liabilities that are categorized within Level 3 of the fair value hierarchy at the date of issuance and, as of September 30, 2023 and December 31, 2022, is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_zK97EMZDNNil" style="display: none">Summary of Valuation Methodology and Significant Unobservable Inputs Warrant Liabilities</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center; vertical-align: bottom"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; vertical-align: bottom">September 30, 2023</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; vertical-align: bottom">December 31, 2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Risk-free rate of interest</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230101__20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zbu8247uz7I2" title="Risk-free rate of interest">5.03</span></td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20220101__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zEF6TvzMib97" title="Risk-free rate of interest">3.99</span></td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expected volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230101__20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zdQY4j2qHb9f" title="Expected volatility">108.3</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20220101__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zI2TvPESwrt6" title="Expected volatility">152.8</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected life (in years)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zHWF1Tz6WO0d" title="Expected life (in years)">2.43</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zoBen2f0nGDl" title="Expected life (in years)">3.18</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expected dividend yield</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20230101__20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zL9dM8AeMhk8" style="text-align: right" title="Expected dividend yield"><span style="-sec-ix-hidden: xdx2ixbrl0716">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20220101__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zpYrczjiRdc8" style="text-align: right" title="Expected dividend yield"><span style="-sec-ix-hidden: xdx2ixbrl0718">-</span></td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8A0_zTFyMmBIEgSi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The risk-free interest rate was based on rates established by the Federal Reserve Bank. For the Warrants, the Company estimates expected volatility giving primary consideration to the historical volatility of its Common Stock. The general expected volatility is based on the standard deviation of the Company’s underlying stock price’s daily logarithmic returns. The expected life of the warrants was determined by the expiration date of the warrants. The expected dividend yield was based on the fact that the Company has not historically paid dividends on its Common Stock and does not expect to pay recurring dividends on its Common Stock in the future.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zAw6P3qr09Hd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets forth a summary of the changes in the fair value of the Company’s Level 3 financial assets and liabilities for the nine months ended September 30, 2023 and 2022, that are measured at fair value on a recurring basis:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_zU22jtNfLQn5" style="display: none">Schedule of Changes in Fair Value and Other Adjustments of Warrants</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center; vertical-align: bottom"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; vertical-align: bottom">Fair Value of Level 3 Financial Assets</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center; vertical-align: bottom"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; vertical-align: bottom">September 30, 2023</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; vertical-align: bottom">September 30, 2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Beginning balance</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--InvestmentsFairValueDisclosure_iS_c20230101__20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zoZnnkDNdyD9" style="width: 16%; text-align: right" title="Investment, beginning balance">100,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--InvestmentsFairValueDisclosure_iS_c20220101__20220930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_za37OWNmk4t" style="width: 16%; text-align: right" title="Investment, beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl0724">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Purchases</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--InvestmentPurchases_c20230101__20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z8D9gAEEidBi" style="text-align: right" title="Purchases"><span style="-sec-ix-hidden: xdx2ixbrl0726">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_ecustom--InvestmentPurchases_c20220101__20220930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zCwmNyAk7gQ9" style="text-align: right" title="Purchases"><span style="-sec-ix-hidden: xdx2ixbrl0728">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: left">Unrealized appreciation (depreciation)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_ecustom--InvestmentOwnedUnrecognizedUnrealizedAppreciationDepreciation_c20230101__20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z4Ln8rawDUb4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Unrealized appreciation (depreciation)"><span style="-sec-ix-hidden: xdx2ixbrl0730">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_981_ecustom--InvestmentOwnedUnrecognizedUnrealizedAppreciationDepreciation_c20220101__20220930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zvZ7zteiJWya" style="border-bottom: Black 1.5pt solid; text-align: right" title="Unrealized appreciation (depreciation)"><span style="-sec-ix-hidden: xdx2ixbrl0732">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Ending balance</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--InvestmentsFairValueDisclosure_iE_c20230101__20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zp0637P6d4Si" style="border-bottom: Black 2.5pt double; text-align: right" title="Investment, ending balance">100,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--InvestmentsFairValueDisclosure_iE_c20220101__20220930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z8PUdmcTMJIe" style="border-bottom: Black 2.5pt double; text-align: right" title="Investment, ending balance">            <span style="-sec-ix-hidden: xdx2ixbrl0736">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center; vertical-align: bottom"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; vertical-align: bottom">Fair Value of Level 3 Financial Liabilities</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center; vertical-align: bottom"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; vertical-align: bottom">September 30, 2023</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; vertical-align: bottom">September 30, 2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Beginning balance</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--DerivativeLiabilities_iS_c20230101__20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zUTKzOws5n4j" style="width: 16%; text-align: right" title="Warrant liabilities, beginning balance">213,750</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--DerivativeLiabilities_iS_c20220101__20220930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z6FYCSNjOpRa" style="width: 16%; text-align: right" title="Warrant liabilities, beginning balance">1,852,500</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Warrant liabilities classification</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--WarrantLiabilitiesClassification_c20230101__20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z5PHHvFGP3Q4" style="text-align: right" title="Warrant liabilities classification"><span style="-sec-ix-hidden: xdx2ixbrl0742">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_ecustom--WarrantLiabilitiesClassification_c20220101__20220930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zY1r5sK2ZY68" style="text-align: right" title="Warrant liabilities classification"><span style="-sec-ix-hidden: xdx2ixbrl0744">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: left">Fair value adjustment of warrant liabilities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--FairValueAdjustmentOfWarrants_c20230101__20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zpNH6T2Tm1Ak" style="border-bottom: Black 1.5pt solid; text-align: right" title="Fair value adjustment of warrant liabilities">(142,500</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--FairValueAdjustmentOfWarrants_c20220101__20220930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z16G18m2sfj7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Fair value adjustment of warrant liabilities">(1,140,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Ending balance</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--DerivativeLiabilities_iE_c20230101__20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zmsLrQXkfMsf" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrant liabilities, ending balance">71,250</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--DerivativeLiabilities_iE_c20220101__20220930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zb1nBgKJwFG3" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrant liabilities, ending balance">712,500</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A0_zNHPvnSffxde" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p id="xdx_890_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zqQOIFd7ZGq5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following tables present the Company’s assets and liabilities that are measured at fair value on a recurring basis and the Company’s estimated level within the fair value hierarchy of those assets and liabilities as of September 30, 2023 and December 31, 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B9_zJoUDzjc74s1" style="display: none">Schedule of Fair Value of Assets and Liabilities Valued on Recurring Basis</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; vertical-align: bottom; text-align: center"> </td><td style="padding-bottom: 1.5pt; vertical-align: bottom; text-align: center; font-weight: bold"> </td> <td colspan="14" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-weight: bold">Fair Value Measured at September 30, 2023</td><td style="padding-bottom: 1.5pt; vertical-align: bottom; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; vertical-align: bottom; text-align: center"> </td><td style="padding-bottom: 1.5pt; vertical-align: bottom; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-weight: bold"><p style="margin-top: 0; margin-bottom: 0">Total at</p> <p style="margin-top: 0; margin-bottom: 0">September 30,</p> <p style="margin-top: 0; margin-bottom: 0">2023</p></td><td style="padding-bottom: 1.5pt; vertical-align: bottom; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; vertical-align: bottom; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-weight: bold">Quoted prices in active markets (Level 1)</td><td style="padding-bottom: 1.5pt; vertical-align: bottom; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; vertical-align: bottom; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-weight: bold">Significant other observable inputs (Level 2)</td><td style="padding-bottom: 1.5pt; vertical-align: bottom; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; vertical-align: bottom; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-weight: bold">Significant unobservable inputs (Level 3)</td><td style="padding-bottom: 1.5pt; vertical-align: bottom; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; padding-left: 10pt; width: 36%">Investments</td><td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--InvestmentsFairValueDisclosure_iI_pp0p0_c20230930_zPx5rQ4b0Ud2" style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right" title="Investments">100,000</td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td><td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--InvestmentsFairValueDisclosure_iI_pp0p0_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zBJogipemKGk" style="border-bottom: Black 1.5pt solid; text-align: right; width: 12%" title="Investments">      <span style="-sec-ix-hidden: xdx2ixbrl0664">-</span></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td><td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--InvestmentsFairValueDisclosure_iI_pp0p0_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zWrmrkdEV4je" style="border-bottom: Black 1.5pt solid; text-align: right; width: 12%" title="Investments">          <span style="-sec-ix-hidden: xdx2ixbrl0666">-</span></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td><td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--InvestmentsFairValueDisclosure_iI_pp0p0_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zbr9aWiUBKg3" style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right" title="Investments">100,000</td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Warrant Liabilities</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20230930_zDbJ63wT0ct5" style="text-align: right" title="Warrant liabilities">71,250</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zLnbZtPFCRm4" style="text-align: right" title="Warrant liabilities"><span style="-sec-ix-hidden: xdx2ixbrl0672">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zKh3WS4wh4ob" style="text-align: right" title="Warrant liabilities"><span style="-sec-ix-hidden: xdx2ixbrl0674">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zgqrg9GaaEvc" style="text-align: right" title="Warrant liabilities">71,250</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center; vertical-align: bottom"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="14" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; vertical-align: bottom">Fair Value Measured at December 31, 2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center; vertical-align: bottom"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; vertical-align: bottom"><p style="margin-top: 0; margin-bottom: 0">Total at</p> <p style="margin-top: 0; margin-bottom: 0">December 31,</p> <p style="margin-top: 0; margin-bottom: 0">2022</p></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; vertical-align: bottom">Quoted prices in active markets (Level 1)</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; vertical-align: bottom">Significant other observable inputs (Level 2)</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; vertical-align: bottom">Significant unobservable inputs (Level 3)</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; padding-left: 10pt; width: 36%">Investments</td><td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--InvestmentsFairValueDisclosure_iI_pp0p0_c20221231_zRX7V3HCNwO7" style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right" title="Investments">100,000</td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td><td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--InvestmentsFairValueDisclosure_iI_pp0p0_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zNDhAgPJ023k" style="border-bottom: Black 1.5pt solid; text-align: right; width: 12%" title="Investments">      <span style="-sec-ix-hidden: xdx2ixbrl0680">-</span></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td><td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--InvestmentsFairValueDisclosure_iI_pp0p0_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zj34hWbPaUHa" style="border-bottom: Black 1.5pt solid; text-align: right; width: 12%" title="Investments">          <span style="-sec-ix-hidden: xdx2ixbrl0682">-</span></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td><td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--InvestmentsFairValueDisclosure_iI_pp0p0_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zmmLDTOSGYg8" style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right" title="Investments">100,000</td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Warrant Liabilities</td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20221231_zXY2rNDPvmkd" style="text-align: right" title="Warrant liabilities">213,750</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zGAoKNO11mOj" style="text-align: right" title="Warrant liabilities"><span style="-sec-ix-hidden: xdx2ixbrl0688">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zFv7cAOiS60f" style="text-align: right" title="Warrant liabilities"><span style="-sec-ix-hidden: xdx2ixbrl0690">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--DerivativeLiabilities_iI_pp0p0_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z5rqI2Yy8ec7" style="text-align: right" title="Warrant liabilities">213,750</td><td style="text-align: left"> </td></tr> </table> 100000 100000 71250 71250 100000 100000 213750 213750 100000 950000 712500 9500000 <p id="xdx_895_eus-gaap--FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock_zSJclhrhPID2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of quantitative information with respect to the valuation methodology and significant unobservable inputs used for the Company’s warrant liabilities that are categorized within Level 3 of the fair value hierarchy at the date of issuance and, as of September 30, 2023 and December 31, 2022, is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_zK97EMZDNNil" style="display: none">Summary of Valuation Methodology and Significant Unobservable Inputs Warrant Liabilities</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center; vertical-align: bottom"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; vertical-align: bottom">September 30, 2023</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; vertical-align: bottom">December 31, 2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Risk-free rate of interest</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230101__20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zbu8247uz7I2" title="Risk-free rate of interest">5.03</span></td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20220101__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zEF6TvzMib97" title="Risk-free rate of interest">3.99</span></td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expected volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230101__20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zdQY4j2qHb9f" title="Expected volatility">108.3</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20220101__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zI2TvPESwrt6" title="Expected volatility">152.8</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected life (in years)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zHWF1Tz6WO0d" title="Expected life (in years)">2.43</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zoBen2f0nGDl" title="Expected life (in years)">3.18</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expected dividend yield</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20230101__20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zL9dM8AeMhk8" style="text-align: right" title="Expected dividend yield"><span style="-sec-ix-hidden: xdx2ixbrl0716">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20220101__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zpYrczjiRdc8" style="text-align: right" title="Expected dividend yield"><span style="-sec-ix-hidden: xdx2ixbrl0718">-</span></td><td style="text-align: left"> </td></tr> </table> 0.0503 0.0399 1.083 1.528 P2Y5M4D P3Y2M4D <p id="xdx_898_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zAw6P3qr09Hd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets forth a summary of the changes in the fair value of the Company’s Level 3 financial assets and liabilities for the nine months ended September 30, 2023 and 2022, that are measured at fair value on a recurring basis:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_zU22jtNfLQn5" style="display: none">Schedule of Changes in Fair Value and Other Adjustments of Warrants</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center; vertical-align: bottom"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; vertical-align: bottom">Fair Value of Level 3 Financial Assets</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center; vertical-align: bottom"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; vertical-align: bottom">September 30, 2023</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; vertical-align: bottom">September 30, 2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Beginning balance</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--InvestmentsFairValueDisclosure_iS_c20230101__20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zoZnnkDNdyD9" style="width: 16%; text-align: right" title="Investment, beginning balance">100,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--InvestmentsFairValueDisclosure_iS_c20220101__20220930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_za37OWNmk4t" style="width: 16%; text-align: right" title="Investment, beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl0724">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Purchases</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--InvestmentPurchases_c20230101__20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z8D9gAEEidBi" style="text-align: right" title="Purchases"><span style="-sec-ix-hidden: xdx2ixbrl0726">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_ecustom--InvestmentPurchases_c20220101__20220930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zCwmNyAk7gQ9" style="text-align: right" title="Purchases"><span style="-sec-ix-hidden: xdx2ixbrl0728">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: left">Unrealized appreciation (depreciation)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_ecustom--InvestmentOwnedUnrecognizedUnrealizedAppreciationDepreciation_c20230101__20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z4Ln8rawDUb4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Unrealized appreciation (depreciation)"><span style="-sec-ix-hidden: xdx2ixbrl0730">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_981_ecustom--InvestmentOwnedUnrecognizedUnrealizedAppreciationDepreciation_c20220101__20220930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zvZ7zteiJWya" style="border-bottom: Black 1.5pt solid; text-align: right" title="Unrealized appreciation (depreciation)"><span style="-sec-ix-hidden: xdx2ixbrl0732">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Ending balance</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--InvestmentsFairValueDisclosure_iE_c20230101__20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zp0637P6d4Si" style="border-bottom: Black 2.5pt double; text-align: right" title="Investment, ending balance">100,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--InvestmentsFairValueDisclosure_iE_c20220101__20220930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z8PUdmcTMJIe" style="border-bottom: Black 2.5pt double; text-align: right" title="Investment, ending balance">            <span style="-sec-ix-hidden: xdx2ixbrl0736">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center; vertical-align: bottom"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; vertical-align: bottom">Fair Value of Level 3 Financial Liabilities</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center; vertical-align: bottom"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; vertical-align: bottom">September 30, 2023</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; vertical-align: bottom">September 30, 2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Beginning balance</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--DerivativeLiabilities_iS_c20230101__20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zUTKzOws5n4j" style="width: 16%; text-align: right" title="Warrant liabilities, beginning balance">213,750</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--DerivativeLiabilities_iS_c20220101__20220930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z6FYCSNjOpRa" style="width: 16%; text-align: right" title="Warrant liabilities, beginning balance">1,852,500</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Warrant liabilities classification</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--WarrantLiabilitiesClassification_c20230101__20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z5PHHvFGP3Q4" style="text-align: right" title="Warrant liabilities classification"><span style="-sec-ix-hidden: xdx2ixbrl0742">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_ecustom--WarrantLiabilitiesClassification_c20220101__20220930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zY1r5sK2ZY68" style="text-align: right" title="Warrant liabilities classification"><span style="-sec-ix-hidden: xdx2ixbrl0744">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: left">Fair value adjustment of warrant liabilities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--FairValueAdjustmentOfWarrants_c20230101__20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zpNH6T2Tm1Ak" style="border-bottom: Black 1.5pt solid; text-align: right" title="Fair value adjustment of warrant liabilities">(142,500</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--FairValueAdjustmentOfWarrants_c20220101__20220930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z16G18m2sfj7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Fair value adjustment of warrant liabilities">(1,140,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Ending balance</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--DerivativeLiabilities_iE_c20230101__20230930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zmsLrQXkfMsf" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrant liabilities, ending balance">71,250</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--DerivativeLiabilities_iE_c20220101__20220930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zb1nBgKJwFG3" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrant liabilities, ending balance">712,500</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 100000 100000 213750 1852500 -142500 -1140000 71250 712500 <p id="xdx_800_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zuLQ6AyJ1sgc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 5 – <span id="xdx_829_zeUaKVMo56E6">Stockholders’ Equity</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Common Stock</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company received shareholder approval on July 11, 2023 to amend our Articles of Incorporation to increase the number of authorized shares of common stock from <span id="xdx_904_eus-gaap--CommonStockSharesAuthorized_iI_c20230930_zw00KrStqgi7" title="Common stock, shares authorized">97,500,000</span> shares to <span id="xdx_909_eus-gaap--CommonStockSharesAuthorized_iI_c20230711_zhslbglVkh6h" title="Common stock, shares authorized">975,000,000</span>. On July 12, 2023, the Company filed a Certificate of Amendment to the Articles of Incorporation to effectuate the increase of our authorized shares of common stock to <span id="xdx_900_eus-gaap--CommonStockSharesAuthorized_iI_c20230712_zeFjdj3BZTwl" title="Common stock, shares authorized">975,000,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>At-The-Market Offering Agreement</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 14, 2021, the Company entered into an At-The-Market Offering Agreement (the “ATM Agreement”) with H.C. Wainwright &amp; Co., LLC, as agent (“H.C. Wainwright”), pursuant to which the Company may offer and sell, from time-to-time through H.C. Wainwright, shares of the Company’s Common Stock having an aggregate offering price of up to $<span id="xdx_90B_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20210913__20210914__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketOfferingAgreementMember__dei--LegalEntityAxis__custom--HCWainwrightCoLLCMember_zPhMe2b02mLb" title="Sale of stock, consideration received on transaction">98,767,500</span> (the “Shares”). The Company will pay H.C. Wainwright a commission rate equal to <span id="xdx_909_ecustom--PercentageOfGrossProceedsOfOfferings_iI_pid_dp_uPure_c20210914__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketOfferingAgreementMember__dei--LegalEntityAxis__custom--HCWainwrightCoLLCMember_z3hYfD5gDQl8" title="Percentage of gross proceeds of offerings">3.0</span>% of the aggregate gross proceeds from each sale of Shares.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the nine months ended September 30, 2023, the Company sold a total of <span id="xdx_90F_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230101__20230930__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketOfferingAgreementMember_zGW0Pn746lC3" title="Sale of stock, number of shares issued in transaction">803,054</span> shares of Common Stock under the ATM Agreement for aggregate total gross proceeds of approximately $<span id="xdx_905_ecustom--GrossProceedsFromIssuanceOfCommonStock_pp0p0_c20230101__20230930__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketOfferingAgreementMember_zIODT2kkXnjb" title="Gross proceeds from issuance of common stock">1,161,000</span> at an average selling price of $<span id="xdx_905_eus-gaap--SharesIssuedPricePerShare_iI_c20230930__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketOfferingAgreementMember_zAd9eSxFMas8" title="Shares issued, price per share">1.45</span> per share, resulting in net proceeds of approximately $<span id="xdx_90B_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pp0p0_c20230101__20230930__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketOfferingAgreementMember_zrx38hlAfPA" title="Proceeds from issuance initial public offering, net">1,114,000</span> after deducting commissions and other transaction costs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Share Based Payments</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective January 19, 2023, The Board of Directors of the Company approved the issuance of $<span id="xdx_902_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_c20230118__20230119__srt--TitleOfIndividualAxis__custom--EachIndependentDirectorMember_zgf4z3GFCIph" title="Stock option grant date fair value">50,000</span> of common stock to each independent director. The shares will be issued in four equal installments ($<span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_c20230118__20230119__srt--TitleOfIndividualAxis__custom--EachIndependentDirectorMember__srt--StatementScenarioAxis__custom--FourEqualInstallmentsMember_zn0xYYa76WSk" title="Stock option grant date fair value">12,500</span>) at the end of each calendar quarter beginning March 31<sup>st</sup>, subject to continued service on each applicable issuance date. The number of shares issuable will be based on the closing price of the Company’s common stock on the last trading day prior to the end of the applicable calendar quarter. For the nine months ended September 30, 2023, <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationGross_c20230101__20230930__srt--TitleOfIndividualAxis__custom--IndependentDirectorsMember_zw07LqpgKM2b" title="Share based payment issued">99,117</span> shares of common stock were issued to independent directors.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the nine months ended September 30, 2023, <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_c20230101__20230930__srt--TitleOfIndividualAxis__srt--OfficerMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zT0sHySMtRn4" title="Share based compensation">410,317</span> shares of common stock were issued to officers related to payment of 2022 accrued bonus compensation. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Preferred Stock</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Series V</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective January 27, 2023, the Board approved the issuance of a newly designated Series V Preferred Stock (“Series V”) on a one-for-one basis to the Company’s shareholders (including restricted stock unit holders and warrant holders). The distribution of Series V shares was approved and completed on June 2, 2023 to shareholders as of the record date of May 12, 2023. <span id="xdx_90C_eus-gaap--PreferredStockConversionBasis_c20230101__20230930__us-gaap--StatementClassOfStockAxis__custom--SeriesVPreferredStockMember_zkyuYbelTsD2" title="Liquidation preference">The Series V: (i) is non-convertible, (ii) has a 20% liquidation preference over the shares of common stock, (iii) is non-voting and (iv) has certain rights to dividends and distributions (at the discretion of the Board of Directors).</span> A total of <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230602__20230602__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__custom--SeriesVPreferredStockMember_zIRxB8ALQnoj" title="Number of shares issued">14,542,803</span> shares of Series V Preferred Stock were distributed to shareholders on June 2, 2023. The Series V is listed to trade on Upstream, the trading app for digital securities and NFTs powered by Horizon Fintex and MERJ Exchange Limited, under the ticker symbol BTCSP.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">The fair value of the Preferred stock as of the record date, May 12, 2023, amounted to approximately $<span id="xdx_90F_eus-gaap--PreferredStockValue_iI_c20230512__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__custom--SeriesVPreferredStockMember_ziBQC1zedzc5" title="Preferred stock value">2,560,000</span>. The Company used a probability valuation model to determine the fair value of the preferred stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">2021 Equity Incentive Plan</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s 2021 Equity Incentive Plan (the “2021 Plan”) was effective on January 1, 2021 and approved by shareholders on March 31, 2021 and amended on June 13, 2022. The Company received shareholder approval on July 11, 2023 to increase the authorized amount under the 2021 Plan from <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_c20220613__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyOneEquityIncentivePlanMember_zRg3YtKM8ts2" title="Number of shares authorized">7,000,000</span> shares to <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_c20230711__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyOneEquityIncentivePlanMember_zyqi8se8aeO6" title="Number of additional shares authorized">12,000,000</span> shares.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Options</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the nine months ended September 30, 2023, the Company granted <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyOneEquityIncentivePlanMember__srt--TitleOfIndividualAxis__custom--NonExecutiveEmployeesMember_zpzOAXkpaCO8" title="Stock options , granted">35,000</span> stock options with a weighted average exercise price of $<span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyOneEquityIncentivePlanMember__srt--TitleOfIndividualAxis__custom--NonExecutiveEmployeesMember_zKbrvLqDyw5l" title="Weighted average exercise price">0.81</span> to non-executive employees.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following weighted-average assumptions were used to estimate the fair value of options granted on the deemed grant date during the nine months ended September 30, 2023 and 2022 for both the Black-Scholes formula:</span></p> <p id="xdx_890_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandAndTwentyOneEquityIncentivePlanMember_z511niIdVwl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zW7xRS8rqOw7" style="display: none">Schedule of Weighted-Average Assumptions Used to Estimate Fair Value</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 82%; margin-right: auto"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center; vertical-align: bottom"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; vertical-align: bottom"><p style="margin-top: 0; margin-bottom: 0">Nine Months Ended</p> <p style="margin-top: 0; margin-bottom: 0">September 30,</p></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center; vertical-align: bottom"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; vertical-align: bottom">2023</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; vertical-align: bottom">2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%">Exercise price</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_uUSDPShares_c20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyOneEquityIncentivePlanMember_zTOIWufdRvBh" title="Exercise price">0.81</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_uUSDPShares_c20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyOneEquityIncentivePlanMember_zWJiXCuHP9yc" title="Exercise price">1.51</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Term (years)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyOneEquityIncentivePlanMember_zv6CGQGqexhk" title="Term (years)">5.00</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyOneEquityIncentivePlanMember_zeUUquKoQ4P4" title="Term (years)">5.00</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected stock price volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyOneEquityIncentivePlanMember_z63wz1M4YQ5f" title="Expected stock price volatility">151.6</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp0_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyOneEquityIncentivePlanMember_zypuJrHlvmJ3" title="Expected stock price volatility">165.8</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Risk-free rate of interest</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyOneEquityIncentivePlanMember_zaRUnTP7Qwh2" title="Risk-free rate of interest">4.15</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp0_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyOneEquityIncentivePlanMember_zBmjRW3iVnka" title="Risk-free rate of interest">2.77</span></td><td style="text-align: left">%</td></tr> </table> <p id="xdx_8A8_zRXdwqN9hcI7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Expected Volatility</i>: The Company uses historical volatility as it provides a reasonable estimate of the expected volatility. Historical volatility is based on the most recent volatility of the stock price over a period of time equivalent to the expected term of the option.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Risk-Free Interest Rate</i>: The risk-free interest rate is based on the U.S. treasury zero-coupon yield curve in effect at the time of grant for the expected term of the option.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Expected Term</i>: The Company’s expected term represents the weighted-average period that the Company’s stock options are expected to be outstanding. The expected term is based on the expected time to post-vesting exercise of options by employees. The Company uses historical exercise patterns of previously granted options to derive employee behavioral patterns used to forecast expected exercise patterns.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For awards vesting upon the achievement of the market conditions which were met at the date of grant, compensation cost measured on the date of grant was immediately recognized. For awards vesting upon the achievement of the market conditions which were not met at the date of grant, compensation cost measured on the grant date will be recognized on a straight-line basis over the vesting period based on estimation using a Monte-Carlo simulation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zpjl1Cw7TU35" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of option activity under the Company’s stock option plan for nine months ended September 30, 2023 is presented below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B6_zJoq5UwBbOX8" style="display: none">Summary of Option Activity</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total Intrinsic Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Average Remaining Contractual Life (in years)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%">Outstanding as of December 31, 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20230101__20230930_zAA4dlwxBD3l" style="width: 11%; text-align: right" title="Number of shares outstanding, beginning balance">1,150,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20230101__20230930_zRx70LzX5hP3" style="width: 11%; text-align: right" title="Weighted average exercise price, beginning balance">2.15</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_c20230101__20230930_zJ14Qx7SugZk" style="width: 11%; text-align: right" title="Total Intrinsic value, beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl0820">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20230930_z8UelRt6vq93" title="Weighted average remaining contractual life (in years), beginning balance">3.3</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Employee options granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230101__20230930_z7evMQ0W0ozi" style="text-align: right" title="Number of shares outstanding, Employee options granted">35,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20230101__20230930_zL1ZDzYtNmp1" style="text-align: right" title="Weighted average exercise price, employee options granted">0.81</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_c20230101__20230930_zxPkcIbgIgEi" style="text-align: right" title="Total intrinsic value, employee options granted"><span style="-sec-ix-hidden: xdx2ixbrl0828">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGrantsInPeriod_dtY_c20230101__20230930_z0Lrrvb4GdE6" title="Weighted average remaining contractual life (in years), employee options granted">4.9</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">Employee options forfeited</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20230101__20230930_zVFzMqIjy0z" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of shares outstanding, Employee options forfeited">(35,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20230101__20230930_zvy8i6APJoD9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average exercise price, employee options forfeited">1.02</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue_c20230101__20230930_zCXUVopzq9ha" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total intrinsic value, employee options forfeited">11,100</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Outstanding as of September 30, 2023</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20230101__20230930_zm9gGBBDRoNe" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of shares outstanding, ending balance">1,150,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20230101__20230930_zKuOPKZS4jva" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average exercise price, ending balance">2.14</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_c20230101__20230930_zAplZi6mQTK4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total Intrinsic value, ending balance"><span style="-sec-ix-hidden: xdx2ixbrl0842">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_907_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20230101__20230930_zyYIQcK5Pjna" title="Weighted average remaining contractual life (in years), ending balance">2.5</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Options vested and exercisable as of September 30, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_c20230101__20230930_zhVTuAqSAbS6" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of shares outstanding, options vested and exercisable">1,135,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iE_c20230101__20230930_zWfIcD2pE0bd" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, options vested and exercisable">2.16</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iE_c20230101__20230930_zOAA8Un9aVrf" style="border-bottom: Black 2.5pt double; text-align: right" title="Total intrinsic value, options vested and exercisable"><span style="-sec-ix-hidden: xdx2ixbrl0850">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20230930_zYYnOsZLtCSk" title="Weighted average remaining contractual life (in years), options vested and exercisable">2.5</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A5_z1jXLGWKTbSl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>RSUs</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective January 2, 2022, the Board of Directors of the Company ratified the following arrangements approved by its Compensation Committee:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s executive officers were granted RSUs as part of a long-term incentive plan (“LTI”), with vesting terms set for when the Company’s market capitalization reaches and sustains a market capitalization for 30 consecutive days above four defined market capitalization thresholds of $<span id="xdx_909_ecustom--DefinedMarketCapitalizationVestingThresholdsValue_pn6n6_c20220102__20220102__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsRSUOneMember_zdqeXhn9RiKg" title="Market cap vesting thresholds, value">100</span> million, $<span id="xdx_90E_ecustom--DefinedMarketCapitalizationVestingThresholdsValue_pn6n6_c20220102__20220102__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsRSUTwoMember_zAFazvZPLaFe" title="Market cap vesting thresholds, value">150</span> million, $<span id="xdx_90C_ecustom--DefinedMarketCapitalizationVestingThresholdsValue_pn6n6_c20220102__20220102__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsRSUThreeMember_zGHb6plhiAOl" title="Market cap vesting thresholds, value">200</span> million and $<span id="xdx_904_ecustom--DefinedMarketCapitalizationVestingThresholdsValue_pn6n6_c20220102__20220102__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsRSUFourMember_zt8Qv3kE8UTg" title="Market cap vesting thresholds, value">400</span> million.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective February 22, 2022, upon appointment of Manish Paranjape as Chief Technology Officer of the Company, Mr. Paranjape was also granted RSUs as part of the LTI plan, with consistent vesting terms set for when the Company’s market capitalization above the same four defined market capitalization thresholds.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective January 1, 2023 (the “LTI RSU Amendment Date”), upon recommendation of the Compensation Committee of the Board of Directors approved an amendment to the LTI plan, whereby the market capitalization threshold targets were lowered to $<span id="xdx_900_ecustom--DefinedMarketCapitalizationVestingThresholdsValue_pn6n6_c20230101__20230101__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsRSUOneMember_zoH4WJBsMkvb" title="Market cap vesting thresholds, value">50</span> million, $<span id="xdx_909_ecustom--DefinedMarketCapitalizationVestingThresholdsValue_pn6n6_c20230101__20230101__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsRSUTwoMember_z9GJJixbAU7k" title="Market cap vesting thresholds, value">100</span> million, $<span id="xdx_900_ecustom--DefinedMarketCapitalizationVestingThresholdsValue_pn6n6_c20230101__20230101__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsRSUThreeMember_zv91pFBCcoU6" title="Market cap vesting thresholds, value">150</span> million, and $<span id="xdx_90B_ecustom--DefinedMarketCapitalizationVestingThresholdsValue_pn6n6_c20230101__20230101__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsRSUFourMember_ziGfTrR8tjGj" title="Market cap vesting thresholds, value">300</span> million.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_895_eus-gaap--ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_zKf7ZGyRPpHi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The RSUs granted to each executive employee are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B1_zgBxgko2CYJb" style="display: none">Schedule of Restricted Stock Units</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; padding-bottom: 1.5pt; text-align: center"> </td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 1.5pt; text-align: center"> </td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 1.5pt; text-align: center"> </td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; padding-bottom: 1.5pt; text-align: center"><b>Total</b></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td> <td colspan="14" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Market Cap Vesting Thresholds</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Officer Name</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Title</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Grant<br/> Date</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"> RSUs<br/> Granted</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">$ 50<br/> million</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">$ 100<br/> million</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">$ 150<br/> million</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">$ 300<br/> million</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; width: 14%; text-align: left"><span id="xdx_90A_ecustom--OfficerName_c20220102__20220102__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zRrJd5STTLo">Charles Allen</span></td><td style="width: 2%"> </td> <td style="vertical-align: bottom; width: 19%; text-align: center">Chief Executive Officer</td><td style="width: 2%"> </td> <td style="text-align: center; width: 8%; vertical-align: bottom"><span id="xdx_903_ecustom--StockIssuedDuringPeriodRestrictedStockAwardGrantDate_dd_c20220102__20220102__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zctvVLLFpcY4">1/2/2022</span></td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20220102__20220102__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zMohq4h43jl" style="width: 7%; text-align: right" title="Number of restricted stock units granted and vested, shares">694,444</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20220102__20220102__us-gaap--AwardTypeAxis__custom--MarketCapVestingThresholdsOneMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zd02MpYfpSZd" style="width: 7%; text-align: right" title="Number of restricted stock units granted and vested, shares">173,611</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20220102__20220102__us-gaap--AwardTypeAxis__custom--MarketCapVestingThresholdsTwoMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zwdZzQAzpnia" style="width: 7%; text-align: right" title="Number of restricted stock units granted and vested, shares">173,611</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20220102__20220102__us-gaap--AwardTypeAxis__custom--MarketCapVestingThresholdsThreeMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zUnmfk8VHRt3" style="width: 7%; text-align: right" title="Number of restricted stock units granted and vested, shares">173,611</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20220102__20220102__us-gaap--AwardTypeAxis__custom--MarketCapVestingThresholdsFourMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zn0pC8cFChpb" style="width: 7%; text-align: right" title="Number of restricted stock units granted and vested, shares">173,611</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-align: left"><span id="xdx_90F_ecustom--OfficerName_c20220102__20220102__srt--TitleOfIndividualAxis__srt--ChiefOperatingOfficerMember_zOhF3gLsWtXi">Michal Handerhan</span></td><td> </td> <td style="vertical-align: bottom; text-align: center">Chief Operations Officer</td><td> </td> <td style="text-align: center; vertical-align: bottom"><span id="xdx_900_ecustom--StockIssuedDuringPeriodRestrictedStockAwardGrantDate_dd_c20220102__20220102__srt--TitleOfIndividualAxis__srt--ChiefOperatingOfficerMember_zrFcfmhlNMp">1/2/2022</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20220102__20220102__srt--TitleOfIndividualAxis__srt--ChiefOperatingOfficerMember_zp5mvi8UvcNa" style="text-align: right" title="Number of restricted stock units granted and vested, shares">444,444</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20220102__20220102__us-gaap--AwardTypeAxis__custom--MarketCapVestingThresholdsOneMember__srt--TitleOfIndividualAxis__srt--ChiefOperatingOfficerMember_za6I7r24pg54" style="text-align: right" title="Number of restricted stock units granted and vested, shares">111,111</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20220102__20220102__us-gaap--AwardTypeAxis__custom--MarketCapVestingThresholdsTwoMember__srt--TitleOfIndividualAxis__srt--ChiefOperatingOfficerMember_zxf88cWgGj5l" style="text-align: right" title="Number of restricted stock units granted and vested, shares">111,111</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20220102__20220102__us-gaap--AwardTypeAxis__custom--MarketCapVestingThresholdsThreeMember__srt--TitleOfIndividualAxis__srt--ChiefOperatingOfficerMember_zu0IvbLnzeMe" style="text-align: right" title="Number of restricted stock units granted and vested, shares">111,111</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20220102__20220102__us-gaap--AwardTypeAxis__custom--MarketCapVestingThresholdsFourMember__srt--TitleOfIndividualAxis__srt--ChiefOperatingOfficerMember_zHE0VxiJynJh" style="text-align: right" title="Number of restricted stock units granted and vested, shares">111,111</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left"><span id="xdx_901_ecustom--OfficerName_c20220102__20220102__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_zVDllhX1Ntgi">Michael Prevoznik</span></td><td> </td> <td style="vertical-align: bottom; text-align: center">Chief Financial Officer</td><td> </td> <td style="text-align: center; vertical-align: bottom"><span id="xdx_900_ecustom--StockIssuedDuringPeriodRestrictedStockAwardGrantDate_dd_c20220102__20220102__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_zm2jBkx5XDle">1/2/2022</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20220102__20220102__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_zKPcMEPC1JM9" style="text-align: right" title="Number of restricted stock units granted and vested, shares">222,224</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20220102__20220102__us-gaap--AwardTypeAxis__custom--MarketCapVestingThresholdsOneMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_zBAfdAAsZe3f" style="text-align: right" title="Number of restricted stock units granted and vested, shares">55,556</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20220102__20220102__us-gaap--AwardTypeAxis__custom--MarketCapVestingThresholdsTwoMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_z6CApp4uFL5f" style="text-align: right" title="Number of restricted stock units granted and vested, shares">55,556</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20220102__20220102__us-gaap--AwardTypeAxis__custom--MarketCapVestingThresholdsThreeMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_zz5Vxt8HYx6j" style="text-align: right" title="Number of restricted stock units granted and vested, shares">55,556</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20220102__20220102__us-gaap--AwardTypeAxis__custom--MarketCapVestingThresholdsFourMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_zsBPkFgYMYlj" style="text-align: right" title="Number of restricted stock units granted and vested, shares">55,556</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; padding-bottom: 1.5pt; text-align: left"><span id="xdx_90A_ecustom--OfficerName_c20220222__20220222__srt--TitleOfIndividualAxis__custom--ChiefTechnologyOfficerMember_zdCVrcfclQCe" title="Officer Name">Manish Paranjape</span></td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; vertical-align: bottom; text-align: center">Chief Technology Officer</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: center; vertical-align: bottom"><span id="xdx_90D_ecustom--StockIssuedDuringPeriodRestrictedStockAwardGrantDate_dd_c20220222__20220222__srt--TitleOfIndividualAxis__custom--ChiefTechnologyOfficerMember_zAQhoV6SgPRe" title="Grant Date">2/22/2022</span></td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20220222__20220222__srt--TitleOfIndividualAxis__custom--ChiefTechnologyOfficerMember_zhnL39CfpBJh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of restricted stock units granted and vested, shares">160,184</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20220222__20220222__us-gaap--AwardTypeAxis__custom--MarketCapVestingThresholdsOneMember__srt--TitleOfIndividualAxis__custom--ChiefTechnologyOfficerMember_zOii2qZ5n8s2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of restricted stock units granted and vested, shares">40,046</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20220222__20220222__us-gaap--AwardTypeAxis__custom--MarketCapVestingThresholdsTwoMember__srt--TitleOfIndividualAxis__custom--ChiefTechnologyOfficerMember_zgMPgavQqCCi" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of restricted stock units granted and vested, shares">40,046</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_989_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20220222__20220222__us-gaap--AwardTypeAxis__custom--MarketCapVestingThresholdsThreeMember__srt--TitleOfIndividualAxis__custom--ChiefTechnologyOfficerMember_zv6tE5TwZvQ4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of restricted stock units granted and vested, shares">40,046</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20220222__20220222__us-gaap--AwardTypeAxis__custom--MarketCapVestingThresholdsFourMember__srt--TitleOfIndividualAxis__custom--ChiefTechnologyOfficerMember_zJbfNwJg4TWj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of restricted stock units granted and vested, shares">40,046</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: center; vertical-align: bottom"> </td><td> </td> <td style="text-align: center; vertical-align: bottom"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td id="xdx_980_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20230101__20230930_zD54bzidmF3i" style="font-weight: bold; text-align: right" title="Number of restricted stock units granted and vested, shares">  1,521,296</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td id="xdx_989_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20230101__20230930__us-gaap--AwardTypeAxis__custom--MarketCapVestingThresholdsOneMember_zVNCl28TKpz6" style="font-weight: bold; text-align: right" title="Number of restricted stock units granted and vested, shares">  380,324</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20230101__20230930__us-gaap--AwardTypeAxis__custom--MarketCapVestingThresholdsTwoMember_zpzc4NiWDhs8" style="font-weight: bold; text-align: right" title="Number of restricted stock units granted and vested, shares">  380,324</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td id="xdx_980_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20230101__20230930__us-gaap--AwardTypeAxis__custom--MarketCapVestingThresholdsThreeMember_zodGtvoDocy3" style="font-weight: bold; text-align: right" title="Number of restricted stock units granted and vested, shares">  380,324</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20230101__20230930__us-gaap--AwardTypeAxis__custom--MarketCapVestingThresholdsFourMember_zZShrADxqaJ2" style="font-weight: bold; text-align: right" title="Number of restricted stock units granted and vested, shares">  380,324</td><td style="font-weight: bold; text-align: left"> </td></tr> </table> <p id="xdx_8A7_z69ziL3kGaa8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To the extent any market capitalization targets set forth above for Mr. Prevoznik and Mr. Paranjape are achieved, the RSUs will also be subject to the following five-year vesting schedule: <span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_pid_dp_uPure_c20230101__20230101__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--ChiefTechnologyOfficerMember__us-gaap--VestingAxis__custom--OneYearAnniversaryMember_zAKnFaheY5hl" title="Vesting rights, percentage">20</span>% of the LTI RSUs which have met a market capitalization criteria will vest on the one-year anniversary of the grant date, and the remaining <span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_pid_dp_uPure_c20230101__20230101__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--ChiefTechnologyOfficerMember__us-gaap--VestingAxis__custom--FourYearAnniversaryMember_z8XWgEL4c7Fe" title="Vesting rights, percentage">80</span>% of the LTI RSUs which have met a market capitalization criteria will vest annually on each subsequent calendar year-end date over the four years following the one year anniversary of the grant date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For awards vesting upon the achievement of a service condition, compensation cost measured on the grant date will be recognized on a straight-line basis over the vesting period. Stock-based compensation expense for the market-based restricted stock units with explicit service conditions is recognized on a straight-line basis over the longer of the derived service period or the explicit service period, regardless of whether the market condition is satisfied. However, in the event that the explicit service period is not met, previously recognized compensation cost would be reversed. Market-based restricted stock units subject to market-based performance targets require achievement of the performance target as well as a service condition in order for these RSUs to vest.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company estimates the fair value of market-based RSUs as of the grant date and expected derived term using a Monte Carlo simulation that incorporates pricing inputs covering the period from the grant date through the end of the derived service period. As of the LTI RSU Amendment Date, the Company determined the pre-modification and post-modification estimated fair value of the LTI RSUs accounting for the amended market cap criteria. The increase in fair value of the LTI RSUs attributable to the modification was added to the related unrecognized compensation expense in accordance with <i>ASC 718 – Share-Based Compensation</i>, whereby any previously recognized compensation cost that has not vested as of the modification date should be adjusted to reflect the new fair value of the equity awards on the date of the modification.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zb8lY5Wuwgwe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following weighted-average assumptions were used to estimate the fair value of options granted during the nine months ended September 30, 2023 and 2022 for the Monte-Carlo simulation:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_z4vIYulCjzce" style="display: none">Schedule of Weighted-Average Assumptions Used to Estimate Fair Value</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Valuation Dates</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">January 1, 2023<br/> (Modification)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">January 2, 2022<br/> (Original Issuance)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Vesting Hurdle Price</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_c20230930__srt--RangeAxis__srt--MinimumMember_zG56MQlLy3z1" title="Exercise price">3.81</span> - $<span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_c20230930__srt--RangeAxis__srt--MaximumMember_zU2VaqVo2BS4" title="Exercise price">30.52</span> </span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_c20220930__srt--RangeAxis__srt--MinimumMember_zKMXO1akWzj2" title="Exercise price">8.07</span> - $<span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_c20220930__srt--RangeAxis__srt--MaximumMember_zqNk3UvtFy18" title="Exercise price">36.99</span> </span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 60%; text-align: left">Term (years)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20230930_zYmYx7VbjGwb" title="Term (years)">4.00</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20220930_zlZGSc8CbOlg" title="Term (years)">5.00</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected stock price volatility</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230101__20230930_zvqWi2EeEE78" style="text-align: right" title="Expected stock price volatility">97.30</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20220101__20220930_z2Bgm9Jnx902" style="text-align: right" title="Expected stock price volatility">103.72</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Risk-free rate of interest</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230101__20230930_zrgNLyYYMnUl" style="text-align: right" title="Risk-free rate of interest">4.10</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20220101__20220930_z3dasvSYgYo6" style="text-align: right" title="Risk-free rate of interest">1.32</td><td style="text-align: left">%</td></tr> </table> <p id="xdx_8A6_z1nD9jyDdAAd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Expected Volatility</i>: The Company uses historical volatility as it provides a reasonable estimate of the expected volatility. Historical volatility is based on the most recent volatility of the stock price over a period of time equivalent to the expected term of the RSUs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Risk-Free Interest Rate</i>: The risk-free interest rate is based on the U.S. treasury zero-coupon yield curve in effect at the time of grant for the expected term of the RSUs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Expected Term</i>: The Company’s expected term represents the weighted-average period that the Company’s RSUs are expected to be outstanding. The expected term is based on the stipulated <span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zIRnUWhnrnra" title="Expected life (in years)::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl0958">five-year</span></span> period from the grant date until the market-based criteria are achieved. If the market-based criteria are not achieved within the <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dxL_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zvdnFUgQzQBl" title="Vesting period::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl0960">five-year</span></span> period from the grant date, the RSUs will not vest and shall expire.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Vesting Hurdle Price:</i> The vesting hurdle price is determined as the average of the vesting Market Cap criteria divided by the shares outstanding as of the valuation dates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 9, 2022, upon recommendation of the Compensation Committee, the Board of Directors approved the grant of <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20221208__20221209__srt--TitleOfIndividualAxis__custom--NonExecutiveEmployeesMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zN1Mb0u8n7Xc" title="Stock option granted">25,000</span> RSUs to Mr. Prevoznik and Mr. Paranjape each, effective January 1, 2023, which vest annually over a five-year period with the first vesting date being on the one-year anniversary of the execution date of the effective grant date, subject to continued employment on each applicable vesting date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_eus-gaap--NonvestedRestrictedStockSharesActivityTableTextBlock_zVeyGxZIvl81" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of the Company’s restricted stock units granted under the 2021 Plan during the nine months ended September 30, 2023 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_zyFsv0FesUl3" style="display: none">Summary of Restricted Stock</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of<br/> Restricted <br/> Stock Units</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Average<br/> Grant Day <br/> Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Nonvested at December 31, 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20230101__20230930_zhZIIxfjBjL4" style="width: 16%; text-align: right" title="Number of restricted stock units nonvested, beginning balance">1,590,552</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20230101__20230930_zq09oXTETBB6" style="width: 16%; text-align: right" title="Weighted average grant day fair value nonvested, beginning balance">3.34</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20230101__20230930_z9ARPQQIaAUb" style="text-align: right" title="Number of restricted stock units, granted">50,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230101__20230930_zvbJkjbEdLV7" style="text-align: right" title="Weighted average grant day fair value, granted">0.63</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Vested</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di_c20230101__20230930_zoIV5OZ5mxV5" style="text-align: right" title="Number of restricted stock units, vested">(9,153</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20230101__20230930_zfC553tDspnl" style="text-align: right" title="Weighted average grant day fair value, forfeited">4.37</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 1.5pt; text-align: left">Forfeited</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_di_c20230101__20230930_zMyAMcrvXaHl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of restricted stock units, forfeited"><span style="-sec-ix-hidden: xdx2ixbrl0978">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c20230101__20230930_z9WXw3uX5jtb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average grant day fair value, vested"><span style="-sec-ix-hidden: xdx2ixbrl0980">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left">Nonvested at September 30, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: right"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_c20230101__20230930_zUHEhXI5Qf0k" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of restricted stock units nonvested, ending balance">1,631,399</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20230101__20230930_zAdjJLRl1bUe" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average grant day fair value nonvested, ending balance">3.25</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A9_zdbfq8CLLIe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stock Based Compensation</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_893_eus-gaap--ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_zIhsyeMnwDAd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock-based compensation expense is recorded as a part of selling, general and administrative expenses, compensation expenses and cost of revenues. Stock-based compensation expense for the three and nine months ended September 30, 2023 and 2022 was as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B5_ztH1JQvMUqk1" style="display: none">Schedule of Stock-based Compensation Expense</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" id="xdx_49E_20230701__20230930_zKvpJdBYMjBd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" id="xdx_49F_20220701__20220930_zLvMG6DlRPBl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" id="xdx_499_20230101__20230930_zvMHe3BTRNol" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" id="xdx_490_20220101__20220930_z7zrDwbP6gea" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Three Months Ended</p> <p style="margin-top: 0; margin-bottom: 0">September 30,</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Nine Months Ended</p> <p style="margin-top: 0; margin-bottom: 0">September 30,</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_409_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--AwardTypeAxis__custom--EmployeeBonusStockAwardsMember_z3djBWB5AkNk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left">Employee bonus stock awards</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0988">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0989">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0990">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">894,027</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z3YquDYgbihc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Employee stock option awards</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">441</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16,455</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(4,871</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">98,901</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zN8EndWjBNpd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Employee restricted stock unit awards</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">230,118</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">434,349</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">726,409</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,182,053</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--AwardTypeAxis__custom--NonEmployeeRestrictedStockAwardsMember_zhMKjEApBuhd" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">Non-employee restricted stock awards</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">21,536</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">30,480</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">45,777</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">202,218</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--AllocatedShareBasedCompensationExpense_zu7TNpupJ3a1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock-based compensation</span></td><td style="padding-bottom: 2.5pt; font-weight: bold"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">252,095</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt; font-weight: bold"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">481,284</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt; font-weight: bold"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">767,315</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt; font-weight: bold"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">2,377,199</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p id="xdx_8AD_z1f9GWoo8D0j" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 97500000 975000000 975000000 98767500 0.030 803054 1161000 1.45 1114000 50000 12500 99117 410317 The Series V: (i) is non-convertible, (ii) has a 20% liquidation preference over the shares of common stock, (iii) is non-voting and (iv) has certain rights to dividends and distributions (at the discretion of the Board of Directors). 14542803 2560000 7000000 12000000 35000 0.81 <p id="xdx_890_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandAndTwentyOneEquityIncentivePlanMember_z511niIdVwl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zW7xRS8rqOw7" style="display: none">Schedule of Weighted-Average Assumptions Used to Estimate Fair Value</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 82%; margin-right: auto"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center; vertical-align: bottom"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; vertical-align: bottom"><p style="margin-top: 0; margin-bottom: 0">Nine Months Ended</p> <p style="margin-top: 0; margin-bottom: 0">September 30,</p></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center; vertical-align: bottom"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; vertical-align: bottom">2023</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; vertical-align: bottom">2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%">Exercise price</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_uUSDPShares_c20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyOneEquityIncentivePlanMember_zTOIWufdRvBh" title="Exercise price">0.81</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_uUSDPShares_c20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyOneEquityIncentivePlanMember_zWJiXCuHP9yc" title="Exercise price">1.51</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Term (years)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyOneEquityIncentivePlanMember_zv6CGQGqexhk" title="Term (years)">5.00</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyOneEquityIncentivePlanMember_zeUUquKoQ4P4" title="Term (years)">5.00</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected stock price volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyOneEquityIncentivePlanMember_z63wz1M4YQ5f" title="Expected stock price volatility">151.6</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp0_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyOneEquityIncentivePlanMember_zypuJrHlvmJ3" title="Expected stock price volatility">165.8</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Risk-free rate of interest</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20230101__20230930__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyOneEquityIncentivePlanMember_zaRUnTP7Qwh2" title="Risk-free rate of interest">4.15</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp0_c20220101__20220930__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyOneEquityIncentivePlanMember_zBmjRW3iVnka" title="Risk-free rate of interest">2.77</span></td><td style="text-align: left">%</td></tr> </table> 0.81 1.51 P5Y P5Y 1.516 1.658 0.0415 0.0277 <p id="xdx_89F_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zpjl1Cw7TU35" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of option activity under the Company’s stock option plan for nine months ended September 30, 2023 is presented below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B6_zJoq5UwBbOX8" style="display: none">Summary of Option Activity</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total Intrinsic Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Average Remaining Contractual Life (in years)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%">Outstanding as of December 31, 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20230101__20230930_zAA4dlwxBD3l" style="width: 11%; text-align: right" title="Number of shares outstanding, beginning balance">1,150,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20230101__20230930_zRx70LzX5hP3" style="width: 11%; text-align: right" title="Weighted average exercise price, beginning balance">2.15</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_c20230101__20230930_zJ14Qx7SugZk" style="width: 11%; text-align: right" title="Total Intrinsic value, beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl0820">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20230930_z8UelRt6vq93" title="Weighted average remaining contractual life (in years), beginning balance">3.3</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Employee options granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230101__20230930_z7evMQ0W0ozi" style="text-align: right" title="Number of shares outstanding, Employee options granted">35,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20230101__20230930_zL1ZDzYtNmp1" style="text-align: right" title="Weighted average exercise price, employee options granted">0.81</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_c20230101__20230930_zxPkcIbgIgEi" style="text-align: right" title="Total intrinsic value, employee options granted"><span style="-sec-ix-hidden: xdx2ixbrl0828">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGrantsInPeriod_dtY_c20230101__20230930_z0Lrrvb4GdE6" title="Weighted average remaining contractual life (in years), employee options granted">4.9</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">Employee options forfeited</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20230101__20230930_zVFzMqIjy0z" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of shares outstanding, Employee options forfeited">(35,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20230101__20230930_zvy8i6APJoD9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average exercise price, employee options forfeited">1.02</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue_c20230101__20230930_zCXUVopzq9ha" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total intrinsic value, employee options forfeited">11,100</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Outstanding as of September 30, 2023</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20230101__20230930_zm9gGBBDRoNe" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of shares outstanding, ending balance">1,150,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20230101__20230930_zKuOPKZS4jva" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average exercise price, ending balance">2.14</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_c20230101__20230930_zAplZi6mQTK4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total Intrinsic value, ending balance"><span style="-sec-ix-hidden: xdx2ixbrl0842">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_907_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20230101__20230930_zyYIQcK5Pjna" title="Weighted average remaining contractual life (in years), ending balance">2.5</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Options vested and exercisable as of September 30, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_c20230101__20230930_zhVTuAqSAbS6" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of shares outstanding, options vested and exercisable">1,135,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iE_c20230101__20230930_zWfIcD2pE0bd" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, options vested and exercisable">2.16</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iE_c20230101__20230930_zOAA8Un9aVrf" style="border-bottom: Black 2.5pt double; text-align: right" title="Total intrinsic value, options vested and exercisable"><span style="-sec-ix-hidden: xdx2ixbrl0850">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20230930_zYYnOsZLtCSk" title="Weighted average remaining contractual life (in years), options vested and exercisable">2.5</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1150000 2.15 P3Y3M18D 35000 0.81 P4Y10M24D 35000 1.02 11100 1150000 2.14 P2Y6M 1135000 2.16 P2Y6M 100000000 150000000 200000000 400000000 50000000 100000000 150000000 300000000 <p id="xdx_895_eus-gaap--ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_zKf7ZGyRPpHi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The RSUs granted to each executive employee are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B1_zgBxgko2CYJb" style="display: none">Schedule of Restricted Stock Units</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; padding-bottom: 1.5pt; text-align: center"> </td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 1.5pt; text-align: center"> </td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 1.5pt; text-align: center"> </td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; padding-bottom: 1.5pt; text-align: center"><b>Total</b></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td> <td colspan="14" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Market Cap Vesting Thresholds</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Officer Name</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Title</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Grant<br/> Date</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"> RSUs<br/> Granted</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">$ 50<br/> million</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">$ 100<br/> million</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">$ 150<br/> million</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">$ 300<br/> million</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; width: 14%; text-align: left"><span id="xdx_90A_ecustom--OfficerName_c20220102__20220102__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zRrJd5STTLo">Charles Allen</span></td><td style="width: 2%"> </td> <td style="vertical-align: bottom; width: 19%; text-align: center">Chief Executive Officer</td><td style="width: 2%"> </td> <td style="text-align: center; width: 8%; vertical-align: bottom"><span id="xdx_903_ecustom--StockIssuedDuringPeriodRestrictedStockAwardGrantDate_dd_c20220102__20220102__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zctvVLLFpcY4">1/2/2022</span></td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20220102__20220102__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zMohq4h43jl" style="width: 7%; text-align: right" title="Number of restricted stock units granted and vested, shares">694,444</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20220102__20220102__us-gaap--AwardTypeAxis__custom--MarketCapVestingThresholdsOneMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zd02MpYfpSZd" style="width: 7%; text-align: right" title="Number of restricted stock units granted and vested, shares">173,611</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20220102__20220102__us-gaap--AwardTypeAxis__custom--MarketCapVestingThresholdsTwoMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zwdZzQAzpnia" style="width: 7%; text-align: right" title="Number of restricted stock units granted and vested, shares">173,611</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20220102__20220102__us-gaap--AwardTypeAxis__custom--MarketCapVestingThresholdsThreeMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zUnmfk8VHRt3" style="width: 7%; text-align: right" title="Number of restricted stock units granted and vested, shares">173,611</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20220102__20220102__us-gaap--AwardTypeAxis__custom--MarketCapVestingThresholdsFourMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zn0pC8cFChpb" style="width: 7%; text-align: right" title="Number of restricted stock units granted and vested, shares">173,611</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-align: left"><span id="xdx_90F_ecustom--OfficerName_c20220102__20220102__srt--TitleOfIndividualAxis__srt--ChiefOperatingOfficerMember_zOhF3gLsWtXi">Michal Handerhan</span></td><td> </td> <td style="vertical-align: bottom; text-align: center">Chief Operations Officer</td><td> </td> <td style="text-align: center; vertical-align: bottom"><span id="xdx_900_ecustom--StockIssuedDuringPeriodRestrictedStockAwardGrantDate_dd_c20220102__20220102__srt--TitleOfIndividualAxis__srt--ChiefOperatingOfficerMember_zrFcfmhlNMp">1/2/2022</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20220102__20220102__srt--TitleOfIndividualAxis__srt--ChiefOperatingOfficerMember_zp5mvi8UvcNa" style="text-align: right" title="Number of restricted stock units granted and vested, shares">444,444</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20220102__20220102__us-gaap--AwardTypeAxis__custom--MarketCapVestingThresholdsOneMember__srt--TitleOfIndividualAxis__srt--ChiefOperatingOfficerMember_za6I7r24pg54" style="text-align: right" title="Number of restricted stock units granted and vested, shares">111,111</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20220102__20220102__us-gaap--AwardTypeAxis__custom--MarketCapVestingThresholdsTwoMember__srt--TitleOfIndividualAxis__srt--ChiefOperatingOfficerMember_zxf88cWgGj5l" style="text-align: right" title="Number of restricted stock units granted and vested, shares">111,111</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20220102__20220102__us-gaap--AwardTypeAxis__custom--MarketCapVestingThresholdsThreeMember__srt--TitleOfIndividualAxis__srt--ChiefOperatingOfficerMember_zu0IvbLnzeMe" style="text-align: right" title="Number of restricted stock units granted and vested, shares">111,111</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20220102__20220102__us-gaap--AwardTypeAxis__custom--MarketCapVestingThresholdsFourMember__srt--TitleOfIndividualAxis__srt--ChiefOperatingOfficerMember_zHE0VxiJynJh" style="text-align: right" title="Number of restricted stock units granted and vested, shares">111,111</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left"><span id="xdx_901_ecustom--OfficerName_c20220102__20220102__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_zVDllhX1Ntgi">Michael Prevoznik</span></td><td> </td> <td style="vertical-align: bottom; text-align: center">Chief Financial Officer</td><td> </td> <td style="text-align: center; vertical-align: bottom"><span id="xdx_900_ecustom--StockIssuedDuringPeriodRestrictedStockAwardGrantDate_dd_c20220102__20220102__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_zm2jBkx5XDle">1/2/2022</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20220102__20220102__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_zKPcMEPC1JM9" style="text-align: right" title="Number of restricted stock units granted and vested, shares">222,224</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20220102__20220102__us-gaap--AwardTypeAxis__custom--MarketCapVestingThresholdsOneMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_zBAfdAAsZe3f" style="text-align: right" title="Number of restricted stock units granted and vested, shares">55,556</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20220102__20220102__us-gaap--AwardTypeAxis__custom--MarketCapVestingThresholdsTwoMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_z6CApp4uFL5f" style="text-align: right" title="Number of restricted stock units granted and vested, shares">55,556</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20220102__20220102__us-gaap--AwardTypeAxis__custom--MarketCapVestingThresholdsThreeMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_zz5Vxt8HYx6j" style="text-align: right" title="Number of restricted stock units granted and vested, shares">55,556</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20220102__20220102__us-gaap--AwardTypeAxis__custom--MarketCapVestingThresholdsFourMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_zsBPkFgYMYlj" style="text-align: right" title="Number of restricted stock units granted and vested, shares">55,556</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; padding-bottom: 1.5pt; text-align: left"><span id="xdx_90A_ecustom--OfficerName_c20220222__20220222__srt--TitleOfIndividualAxis__custom--ChiefTechnologyOfficerMember_zdCVrcfclQCe" title="Officer Name">Manish Paranjape</span></td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; vertical-align: bottom; text-align: center">Chief Technology Officer</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: center; vertical-align: bottom"><span id="xdx_90D_ecustom--StockIssuedDuringPeriodRestrictedStockAwardGrantDate_dd_c20220222__20220222__srt--TitleOfIndividualAxis__custom--ChiefTechnologyOfficerMember_zAQhoV6SgPRe" title="Grant Date">2/22/2022</span></td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20220222__20220222__srt--TitleOfIndividualAxis__custom--ChiefTechnologyOfficerMember_zhnL39CfpBJh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of restricted stock units granted and vested, shares">160,184</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20220222__20220222__us-gaap--AwardTypeAxis__custom--MarketCapVestingThresholdsOneMember__srt--TitleOfIndividualAxis__custom--ChiefTechnologyOfficerMember_zOii2qZ5n8s2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of restricted stock units granted and vested, shares">40,046</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20220222__20220222__us-gaap--AwardTypeAxis__custom--MarketCapVestingThresholdsTwoMember__srt--TitleOfIndividualAxis__custom--ChiefTechnologyOfficerMember_zgMPgavQqCCi" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of restricted stock units granted and vested, shares">40,046</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_989_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20220222__20220222__us-gaap--AwardTypeAxis__custom--MarketCapVestingThresholdsThreeMember__srt--TitleOfIndividualAxis__custom--ChiefTechnologyOfficerMember_zv6tE5TwZvQ4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of restricted stock units granted and vested, shares">40,046</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20220222__20220222__us-gaap--AwardTypeAxis__custom--MarketCapVestingThresholdsFourMember__srt--TitleOfIndividualAxis__custom--ChiefTechnologyOfficerMember_zJbfNwJg4TWj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of restricted stock units granted and vested, shares">40,046</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: center; vertical-align: bottom"> </td><td> </td> <td style="text-align: center; vertical-align: bottom"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td id="xdx_980_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20230101__20230930_zD54bzidmF3i" style="font-weight: bold; text-align: right" title="Number of restricted stock units granted and vested, shares">  1,521,296</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td id="xdx_989_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20230101__20230930__us-gaap--AwardTypeAxis__custom--MarketCapVestingThresholdsOneMember_zVNCl28TKpz6" style="font-weight: bold; text-align: right" title="Number of restricted stock units granted and vested, shares">  380,324</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20230101__20230930__us-gaap--AwardTypeAxis__custom--MarketCapVestingThresholdsTwoMember_zpzc4NiWDhs8" style="font-weight: bold; text-align: right" title="Number of restricted stock units granted and vested, shares">  380,324</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td id="xdx_980_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20230101__20230930__us-gaap--AwardTypeAxis__custom--MarketCapVestingThresholdsThreeMember_zodGtvoDocy3" style="font-weight: bold; text-align: right" title="Number of restricted stock units granted and vested, shares">  380,324</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20230101__20230930__us-gaap--AwardTypeAxis__custom--MarketCapVestingThresholdsFourMember_zZShrADxqaJ2" style="font-weight: bold; text-align: right" title="Number of restricted stock units granted and vested, shares">  380,324</td><td style="font-weight: bold; text-align: left"> </td></tr> </table> Charles Allen 2022-01-02 694444 173611 173611 173611 173611 Michal Handerhan 2022-01-02 444444 111111 111111 111111 111111 Michael Prevoznik 2022-01-02 222224 55556 55556 55556 55556 Manish Paranjape 2022-02-22 160184 40046 40046 40046 40046 1521296 380324 380324 380324 380324 0.20 0.80 <p id="xdx_891_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zb8lY5Wuwgwe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following weighted-average assumptions were used to estimate the fair value of options granted during the nine months ended September 30, 2023 and 2022 for the Monte-Carlo simulation:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_z4vIYulCjzce" style="display: none">Schedule of Weighted-Average Assumptions Used to Estimate Fair Value</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Valuation Dates</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">January 1, 2023<br/> (Modification)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">January 2, 2022<br/> (Original Issuance)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Vesting Hurdle Price</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_c20230930__srt--RangeAxis__srt--MinimumMember_zG56MQlLy3z1" title="Exercise price">3.81</span> - $<span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_c20230930__srt--RangeAxis__srt--MaximumMember_zU2VaqVo2BS4" title="Exercise price">30.52</span> </span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_c20220930__srt--RangeAxis__srt--MinimumMember_zKMXO1akWzj2" title="Exercise price">8.07</span> - $<span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_c20220930__srt--RangeAxis__srt--MaximumMember_zqNk3UvtFy18" title="Exercise price">36.99</span> </span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 60%; text-align: left">Term (years)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20230930_zYmYx7VbjGwb" title="Term (years)">4.00</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20220930_zlZGSc8CbOlg" title="Term (years)">5.00</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected stock price volatility</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230101__20230930_zvqWi2EeEE78" style="text-align: right" title="Expected stock price volatility">97.30</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20220101__20220930_z2Bgm9Jnx902" style="text-align: right" title="Expected stock price volatility">103.72</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Risk-free rate of interest</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230101__20230930_zrgNLyYYMnUl" style="text-align: right" title="Risk-free rate of interest">4.10</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20220101__20220930_z3dasvSYgYo6" style="text-align: right" title="Risk-free rate of interest">1.32</td><td style="text-align: left">%</td></tr> </table> 3.81 30.52 8.07 36.99 P4Y P5Y 0.9730 1.0372 0.0410 0.0132 25000 <p id="xdx_896_eus-gaap--NonvestedRestrictedStockSharesActivityTableTextBlock_zVeyGxZIvl81" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of the Company’s restricted stock units granted under the 2021 Plan during the nine months ended September 30, 2023 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_zyFsv0FesUl3" style="display: none">Summary of Restricted Stock</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of<br/> Restricted <br/> Stock Units</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Average<br/> Grant Day <br/> Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Nonvested at December 31, 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20230101__20230930_zhZIIxfjBjL4" style="width: 16%; text-align: right" title="Number of restricted stock units nonvested, beginning balance">1,590,552</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20230101__20230930_zq09oXTETBB6" style="width: 16%; text-align: right" title="Weighted average grant day fair value nonvested, beginning balance">3.34</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20230101__20230930_z9ARPQQIaAUb" style="text-align: right" title="Number of restricted stock units, granted">50,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230101__20230930_zvbJkjbEdLV7" style="text-align: right" title="Weighted average grant day fair value, granted">0.63</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Vested</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di_c20230101__20230930_zoIV5OZ5mxV5" style="text-align: right" title="Number of restricted stock units, vested">(9,153</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20230101__20230930_zfC553tDspnl" style="text-align: right" title="Weighted average grant day fair value, forfeited">4.37</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 1.5pt; text-align: left">Forfeited</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_di_c20230101__20230930_zMyAMcrvXaHl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of restricted stock units, forfeited"><span style="-sec-ix-hidden: xdx2ixbrl0978">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c20230101__20230930_z9WXw3uX5jtb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average grant day fair value, vested"><span style="-sec-ix-hidden: xdx2ixbrl0980">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left">Nonvested at September 30, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: right"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_c20230101__20230930_zUHEhXI5Qf0k" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of restricted stock units nonvested, ending balance">1,631,399</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20230101__20230930_zAdjJLRl1bUe" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average grant day fair value nonvested, ending balance">3.25</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1590552 3.34 50000 0.63 9153 4.37 1631399 3.25 <p id="xdx_893_eus-gaap--ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_zIhsyeMnwDAd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock-based compensation expense is recorded as a part of selling, general and administrative expenses, compensation expenses and cost of revenues. Stock-based compensation expense for the three and nine months ended September 30, 2023 and 2022 was as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B5_ztH1JQvMUqk1" style="display: none">Schedule of Stock-based Compensation Expense</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" id="xdx_49E_20230701__20230930_zKvpJdBYMjBd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" id="xdx_49F_20220701__20220930_zLvMG6DlRPBl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" id="xdx_499_20230101__20230930_zvMHe3BTRNol" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" id="xdx_490_20220101__20220930_z7zrDwbP6gea" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Three Months Ended</p> <p style="margin-top: 0; margin-bottom: 0">September 30,</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Nine Months Ended</p> <p style="margin-top: 0; margin-bottom: 0">September 30,</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_409_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--AwardTypeAxis__custom--EmployeeBonusStockAwardsMember_z3djBWB5AkNk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left">Employee bonus stock awards</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0988">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0989">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0990">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">894,027</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z3YquDYgbihc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Employee stock option awards</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">441</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16,455</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(4,871</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">98,901</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zN8EndWjBNpd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Employee restricted stock unit awards</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">230,118</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">434,349</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">726,409</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,182,053</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--AwardTypeAxis__custom--NonEmployeeRestrictedStockAwardsMember_zhMKjEApBuhd" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">Non-employee restricted stock awards</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">21,536</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">30,480</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">45,777</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">202,218</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--AllocatedShareBasedCompensationExpense_zu7TNpupJ3a1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock-based compensation</span></td><td style="padding-bottom: 2.5pt; font-weight: bold"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">252,095</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt; font-weight: bold"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">481,284</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt; font-weight: bold"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">767,315</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt; font-weight: bold"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">2,377,199</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> 894027 441 16455 -4871 98901 230118 434349 726409 1182053 21536 30480 45777 202218 252095 481284 767315 2377199 <p id="xdx_80F_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_z1B3EUuLf7K7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 6 – <span id="xdx_821_zhckvkawUPZh">Accrued Expenses</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_zVM3CsV6TGn9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued expenses consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BE_zidCe8hSOTF" style="display: none">Schedule of Accrued Expenses</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" id="xdx_49A_20230930_zRH0JkCKWicj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">September 30, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" id="xdx_494_20221231_z8hRMjz4L4N8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40B_eus-gaap--AccruedEmployeeBenefitsCurrent_iI_maALCz8ai_z44LsmNYf8M1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Accrued compensation</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">321,144</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">295,935</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--OtherAccountsPayableAndAccruedLiabilities_iI_maALCz8ai_zat3QZb09Lh4" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">Accounts payable and accrued expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">92,659</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">76,727</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--AccruedLiabilitiesCurrent_iTI_mtALCz8ai_zkTAdrrDLdg4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued Expenses</span></td><td style="padding-bottom: 2.5pt; font-weight: bold"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">413,803</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt; font-weight: bold"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">372,662</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p id="xdx_8A2_zCoySbMcNk91" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued compensation includes approximately $<span id="xdx_90E_eus-gaap--AccruedBonusesCurrentAndNoncurrent_iI_c20230930_z66uTKYihEO" title="Accrued bonuses current and non current">321,000</span> and $<span id="xdx_90E_eus-gaap--AccruedBonusesCurrentAndNoncurrent_iI_c20221231_ziGsJgsXzbVh" title="Accrued bonuses current and non current">284,000</span> related to performance bonus accruals as of September 30, 2023 and December 31, 2022, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_zVM3CsV6TGn9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued expenses consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BE_zidCe8hSOTF" style="display: none">Schedule of Accrued Expenses</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" id="xdx_49A_20230930_zRH0JkCKWicj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">September 30, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" id="xdx_494_20221231_z8hRMjz4L4N8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40B_eus-gaap--AccruedEmployeeBenefitsCurrent_iI_maALCz8ai_z44LsmNYf8M1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Accrued compensation</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">321,144</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">295,935</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--OtherAccountsPayableAndAccruedLiabilities_iI_maALCz8ai_zat3QZb09Lh4" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">Accounts payable and accrued expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">92,659</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">76,727</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--AccruedLiabilitiesCurrent_iTI_mtALCz8ai_zkTAdrrDLdg4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued Expenses</span></td><td style="padding-bottom: 2.5pt; font-weight: bold"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">413,803</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt; font-weight: bold"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">372,662</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> 321144 295935 92659 76727 413803 372662 321000 284000 <p id="xdx_800_eus-gaap--CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock_zHGwtc0dYNx9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 7 – <span id="xdx_82C_zETt3gEXM0ua">Employee Benefit Plans</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains defined contribution benefit plans under Section 401(k) of the Internal Revenue Code covering substantially all qualified employees of the Company (the “401(k) Plan”). Under the 401(k) Plan, the Company may make discretionary contributions of up to <span id="xdx_905_eus-gaap--DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_pid_dp_uPure_c20230101__20230930_zh2XbgyvyPC2" title="Percentage of defined comtribution plan employee">100</span>% of employee contributions. For the nine months ended September 30, 2023 and 2022, the Company made contributions to the 401(k) Plan of $<span id="xdx_90A_eus-gaap--DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount_pp0p0_c20230101__20230930_zDxWtlfyxVF3" title="Defined comtribution plan employee">95,000</span> and $<span id="xdx_90F_eus-gaap--DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount_pp0p0_c20220101__20220930_zqlrvABit401" title="Defined comtribution plan employee">45,000</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1 95000 45000 <p id="xdx_806_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zzuSJZ2lPYjg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 8 – <span id="xdx_82B_zBCfPizuJ2Aj">Liquidity</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows “<i>Presentation of Financial Statements—Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern</i>”. The Company’s financial statements have been prepared assuming that it will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As reflected in the financial statements, the Company has historically incurred a net loss and has an accumulated deficit of approximately $<span id="xdx_908_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pn3d_di_c20230930_zhxuZ1oaJwN" title="Accumulated deficit">154,554,000</span> at September 30, 2023, a net loss for the nine months ended September 30, 2023 of approximately $<span id="xdx_906_eus-gaap--NetIncomeLoss_iN_pn3d_di_c20230101__20230930_zs7FfHAEvi4i" title="Net income loss">3,072,000</span> and net cash used in operating activities of approximately $<span id="xdx_902_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pn3d_di_c20230101__20230930_zHoWDE1vNCk5" title="Operating activities">2,693,000 </span>for the reporting period then ended. The Company is implementing its business plan and generating revenue; however, the Company’s cash position and liquid crypto assets are sufficient to support its daily operations over the next twelve months.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> -154554000 -3072000 -2693000 <p id="xdx_80A_eus-gaap--SubsequentEventsTextBlock_zWQRZ5fOf0j1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 9 – <span id="xdx_827_zI5gLeBaZK71">Subsequent Events</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company evaluates events that have occurred after the balance sheet date but before the financial statements are issued. Based upon the evaluation, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the financial statements other than disclosed.</span></p> EXCEL 47 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( %*):5<'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " !2B6E749+G8^T K @ $0 &1O8U!R;W!S+V-O&ULS9+! M2L0P$(9?17)O)TE!,'1[6?&D(+B@> O)[&ZP:4(RTN[;V\;=+J(/X#$S?[[Y M!J8U49F0\#F%B(D4WS,QT@:O.A M#PB2\UOP2-IJTK J[@26==:HTQ"32&=\=:L^/B9^@*S!K!'CP-E$+4 UBT3 MXVGJ6[@"%AAA\OF[@'8EENJ?V-(!=DY.V:VI<1SKL2FY>097)PC$ 8 )PG 3 >&PO=&AE M;64O=&AE;64Q+GAM;.U:6W/:.!1^[Z_0>&?V;0O&-H&VM!-S:7;;M)F$[4X? MA1%8C6QY9)&$?[]'-A#+E@WMDDVZFSP$+.G[SD5'Y^@X>?/N+F+HAHB4\GA@ MV2_;UKNW+][@5S(D$4$P&:>O\, *I4Q>M5II ,,X?+&A T%116F]?(+3E'S/X%/F7/Z3H=,H%N,!M8('_.;Z?D3EJ(X53"Q,!J9S]6:\?1 MTDB @LE]E 6Z2?:CTQ4(,@T[.IU8SG9\]L3MGXS*VG0T;1K@X_%X.+;+THMP M' 3@4;N>PIWT;+^D00FTHVG09-CVVJZ1IJJ-4T_3]WW?ZYMHG J-6T_3:W?= MTXZ)QJW0> V^\4^'PZZ)QJO0=.MI)B?]KFNDZ19H0D;CZWH2%;7E0-,@ %AP M=M;,T@.67BGZ=90:V1V[W4%<\%CN.8D1_L;%!-9ITAF6-$9RG9 %#@ WQ-%, M4'RO0;:*X,*2TER0UL\IM5 :")K(@?5'@B'%W*_]]9>[R:0S>IU].LYKE']I MJP&G[;N;SY/\<^CDGZ>3UTU"SG"\+ GQ^R-;88C'(CN]WV6'WV3T=N(]>IP+,BUY1&)$6?R"VZ MY!$XM4D-,A,_")V&F&I0' *D"3&6H8;XM,:L$> 3?;>^",C?C8CWJV^:/5>A M6$G:A/@01AKBG'/F<]%L^P>E1M'V5;SC MFED)O816:I^JAS0^J!XR"@7QN1X^Y7IX"C>6QKQ0KH)[ ?_1VC?"J_B"P#E_ M+GW/I>^Y]#VATK\>WZV22$KYI9+2,6D$N!LT$DN/R+RO JQ GH9%LE" M0AMNZ5/U2I77Y:^Y*+@\6^3IKZ%T/BS/^3Q?Y[3-"S-#MW)+ZK:4OK4F.$KT ML@'37[]EUVY".E,%.70[@:0KX#;;J=W#HXGIB1N0K3 M4I!OP_GIQ7@:XCG9!+E]F%=MY]C1T?OGP5&PH^\\EAW'B/*B(>ZAAIC/PT.' M>7M?F&>5QE T%&ULK"0L1K=@N-?Q+!3@9& MH >#KU$"\E)58#%;Q@,KD*)\ M3(Q%Z'#GEUQ?X]&2X]NF9;5NKREW&6TB4CG":9@39ZO*WF6QP54=SU5;\K"^ M:CVT%4[/_EFMR)\,$4X6"Q)(8Y07IDJB\QE3ON>;G*YZ(G;ZEW?! M8/+]<,E'#^4[YU_T74.N?O;=X_INDSM(3)QYQ1$!=$4"(Y4U#VT%SU&\Z.9X!ZSAW.;>KC"1:S_6-8>^3+?.7#;.MX#7N83 M+$.D?L%]BHJ $:MBOKJO3_DEG#NT>_&!()O\UMND]MW@#'S4JUJE9"L1/TL' M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5 MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$% @ M4HEI5]?;'[W)!0 Q!X !@ !X;"]W;W)K,N,> X21>L3=,XZ] ->Z EVA8JB2I%V;:3ZEJZ$T.0Q"N/TO+/2.GG7ZZ7>2D0\ M/9:)B.',0JJ(:]A5RUZ:*,']7!2%/>8X@U[$@[@S/LN/W:GQF17? G$)GVV30S*7,IO9N?&/^\XID4B%)XV%AS^K,54A*%Q@G9\ MWYIVRM\TPN?;._?K'!Y@YCP54QG^%?AZ==XY[1!?+'@6ZGNY^5UL@4Z,GR?# M-/^?;(IK^_T.\;)4RV@KAA9$05S\Y8_;&_%,X)[4"-A6P%X(:-TON%N!FX,6 M+L<$>8P MU]*>*2Z_E>MCX@QM\A^:XY;WQ\W]7/3^_#.9IUI!E_O7=H<*A[[=P3R'[]*$ M>^*\ P]:*M1:=,:_OJ8#YS<;WO]D]@-LOX3M8^[C2^EE\(AJ\O"4"!LI+J=. M][,-"54U1#HID4[0-DV Q\^9KD.^M#'A^@4/4]NMF**RAE"#$FIP6)T^9UQI MH<(G,,2;WA@-U0UD<.=RI'R]KA$M4WY!R5G*/#.*^#U./A#O<:#EM?-;C; M9RL?JFG(1YWJ[>G\%.%7P54]WQZSNA+BLJ:,SQ("19LUS91ZB8CUV#UVW2YE M79=:05%E4U!6@3*T95>Q#O03<(:"W&;17"@K'F[B.+3;=X8C9@5$M4T!JRQ# MT?2P [P7R\#$&:CI+8_L-<2-+AZFLU=N(/+3*/!1/*EM>Z'5201;(48_(3,,H1*0B4YE!P:'N MTK?W:-S]]HL5N8T81*L<1/'PLD6>^#ZXIT>[#?(!KB.?8CLG;CGJ#P:O"/Q[ M+V#N'W R68LX$^0U9?:BMY&3:!64*)YO7MZ!J=F#:C_(36REWQ.7@M!,YV:) M"F+;9&"*ZYOB5GF)XA'G)6[9N^^47 >Q9Z\X[OGQT@K:1FYB56YB>-1Y"7HG M4PV#]=]!4OL [W%DSH@ZUN\%;:0G5J4GMB<]Y9Q*\'HPW. -Q,*W5K VTA*K MTA+#@\X'F4?ZE8RQM+3'I.\ZW<')<&#E:R,LL2HL,3SC/ 0:S-^2 MF? R!;6T0N).4QE%,LY'W9F6WK)?6*ZQ_&K]9"(%A*91^&<)];&7>YYPFP M 1._,+3RMA&"6!6"V$$A:!;Q,"0760JG4WNOQ7WJ/FWBLH9X;A5]W(.BSU4D M('_#4_D>'/0*TD&4\-A:USV&M9\X<5U3T"KYN'APV=5Q):".&!YN4X_71OYQ MJ_SC'O2UJ'BY[U[LLWP9C7S*-.39V+?/,BYPYY]>,2K<3G(WLVR['M.^.W3I M*<2J]7/&WK-U0M/]\N73E'AFZEPL&99'RR7:2;XPV:LN+]9W/W+3>U,2B@5( MG>,A_+PJEDR+'2V3?-5Q+K664;ZY$MP7REP YQ=2ZMV.^8%RX7K\'U!+ P04 M " !2B6E7]Y.:'LH% O&0 & 'AL+W=OQ#R3FTXU^!GD9?J?++1NCJ=S52Z MX053)Z+BI?EF+63!M+F5MS-523K\\D%.EW@Q#HT%M\R_J#VKH$-Y4:(.WOS:74^@981SWFJ+00S?^[Y@N>Y M13(\?FQ!)[MG6L?]ZR?TWYK@33 W3/&%R+]G*[TYG\03L.)K5N?ZBWCXG6\# M(A8O%;EJ?H.'K2V<@+166A1;9\.@R,KV+_NY3<2> PI''/#6 ;_4(=@Z!$V@ M+;,FK"NFV?Q,B@<@K;5!LQ=-;AIO$TU6VF5<:FF^S8R?GE^RG)4I!TN+H, ' M\'5Y!=Z__>5LI@VZM9FE6Z3+%@F/("UY=0(". 48XL#AOO"[7_'4N*/&'1^Z MSTQ,N\#P+C#(M:2EYJP)0R@9VZXFD!0C> K9]35;&4GT],@2@N[_ED M_NX-BN!'5W1' CN(-=C%&OC0YPNF-H"5*Y#:"_ZCSNY9;H)7KJA;J*B!LD5^ M/Z(9F&(41C3N[ ZKACFKHI;K4[,:4L,A*)[G6F>P_-:%)V./F M?80[U\"39K+C3OQIEH^5%ML=Y6)/!NP11$%,>_2'9DF,W6F-=M2BY])ZQ\WZ M/\3>FE^*N^YTH7=FE/ -##;M.;@_4(H M#=XB"*<00F?KH8[,VI\>[6?-#EC'.]:QE_6UY!7+5H#_-.*IN(M?['@P#7$_ MK0XS'% \DM5DQR_Q\OM+:)8;L=AO>"Z2R>#I<0*#B. >RZ%=B!)*D\1-$\%. M:Z"W)_^I-USZ.O+6_T@M^5AHA]'N*2MZ9MN884OJQZ8SVZ9SHI1;IW4;D*R[5NS<_(Z?%^#DMYFMNEFD%E,U".W@Z MH_;BO$+2C@!T&.O>P=>OY M1%*)L YV"A$Y).U@#M6'2-N]:;X3,_C7),"/X M6WABA,XT,MDF90I0. UH,$5QU+0U9"XAG:(P>0+(E+)=Q'XI:JVTNK56:[HRGO9O3/2G.VKC)3[DZRCO$A@J%)V^#HZC:-(32GJQ'2 MW1"!_4.$:>]U4>=,F\59\7669LY!$P]'A ^(A(08POV)QVV+PACCT21W$P7V MGZ?;]JE&VY*3_/#P'(F6/]Q\O9BOEH4CH1VF(%NRL#Q4071 M.[.\.O8CH1W&WHTNV#^ZO%P0D^&+0$(2,GAAZ'_@*P1OMO4%,,LGT[W]YH434ON&^$UJ)H+C>TDW7[];* 44N>K6BZ"#>=]>,OXH$@")GK(T%Q,KD;*XLFT1 M)9 1T6,%Y.K*DO&,2#7E*UL4'$AV!FAN16.RW,S'H[96J8TAQE' M8IUEA/^YAI1M)Y9C/9^XHZM$ZA-V."[("N8@[XL95S.[<8EI!KF@+$<P1N+7!/%7BUP"L3KU\73F[>YSG4/20AR^1BUW/()\>EM] I.1.*7>[FAGX!-Z&#]&]N;-OK1L ZB MUR!Z!Q%G:@<#YQ CM>S1XR42B5H-@$P [SH&$>G,%\L+*#DRI[+*I#&324P?F5I4*LS54-7A7+\;W 4SSE0EZ>"JT(? @]*B!'AV$G@.G"O,! MO3QP OTZSL) M)B12:[E/S+U^^ETUA*H77.FDJ/Z2IQKK.1.RVA=&ITTPO$$:9_5_^;41XBP M\N !O G@=D!?"Z()$,]MP6D"G.>VX#8!%?5IS;T2;B&-G-WD^HGD)1JRE1>5 M^E4TZ!5G9:$\F!Q^C2'.S!Z,- HZWA1$K\F?.Y7+L@,+\NIC)O=1;%3TFKPE M'Q\6Y-6/KV^F!MHL(Z>K)O]=G9_WY!?DO<[,MB#++%(1$K\8C@\'XJ? ]428 M'PG?\<&$#VIW101]0SCE GF?^?/#.4;G_[6^?''K%V*(4^^+*I_HR7>O#BK; MJP+KUSK2P2/+^>NZV,F5NIW !%6H_* FLY]^8![]&1-US&2+,9,M1TIV(;]S MDM\9RC[[)),XDD;G,.56'4%>9; VP$!<*U6@HZU.Z%4)RT7@,!/,XPX4P^%< M;P3F."ST+F&++HQ1)EPJ+G%+!.=PYGKTA+O@[Y[XNX/\_])&)D?N:!'6\>[W MZ"(PC&X7AM-%<$-TO1-=;W"TS751=>X086_,43=FLL68R98C);OH!O_4#?XS M1YWZ"GZKP#O"[]1 (!BE5N$A*,[M>EIT4=P/?&Z5Y[(+$TR$/L>K+CC1#0;I M_I;KHB"[7*]C@Q$-NB\G!.L,,03FL3"TJ79AOG!\W[>H=F&,4=\- IQK>.(: M#HZPQK]DFU/77F.4PS$'V9C)%F,F6XZ4[*(G&&V-)1VN.Y5!9R1$9A&1$5C7 MN#!EYQP4ZB)IM[X"P45HE2&"X/HV_2[.A>G+M5"!L:AIX]ZR(XSPO]D-LJ M='',<:GKV#,O N2^8#X3/3JT!IL-&LC9>YE_4>6,A/(5W6:9V^GS+BKP/=?F MVD4QQCBSF79AOL.=OOYNG2P;MK+OTIV,\[*\25*N-]#KJ_S;SF@BBT(9O+N= M[H+G=+TUL/ZMNW/0$&9%10[@0V800I M(&%@[UV7:$['@JQPU[3X77UP6$8^\_,*0(79^& MMM5$CG=_J0XUK>=W['K.D.<+=KVL#V_;]/59,NQP-^56)U%K M:(I>^?"Z>7T\6]\8O:O.'Q^U,3JM+K=*P@ N ?#[6FMSO"D;.!V2S_X%4$L# M!!0 ( %*):5>.X=8)T0@ %E$ 8 >&PO=V]R:W-H965T&ULQ5QM;^,V$OXK@N]PUP*;-5_ULI<$V+4EM ?T$&QN>Q\.]T&QF5A8 M6W(E.6G__5&R8UGDB+'3 M55UO/TRGU6*E-FGUOMBJ7'_R6)2;M-:7Y=.TVI8J7;:--NLI(\2?;M(LG]Q> MM^_=E;?7Q:Y>9[FZ*[UJM]FDY6^?U+IXN9G0R>L;G[.G5=V\,;V]WJ9/ZE[5 M7[9WI;Z:'E&6V4;E55;D7JD>;R8?Z8=$M U:BY\S]5*=O/::6WDHBJ_-Q8_+ MFPEI>J36:E$W$*G^\ZQF:KUND'0_?CF 3HX^FX:GKU_1D_;F]O_ M9,MZ=3,))]Y2/::[=?VY>/E!'6Y(-GB+8EVU_WLO!ULR\1:[JBXVA\:Z!YLL MW_]-?ST$XJ2!C 8:L$,#9C1@;* !/S3@1@/N#S00AP;"]! ,-)"'!M)H0/E M __0P&]COP]6&^EY6J>WUV7QXI6-M49K7K1TM:UU@+.\&5GW=:D_S72[^O:^ M3FNE1TI=><6C-UNE^9.JO"SW[NMB\755K)>JK/[NQ;_LLOHW[[LO>;I;9K5: M?N]=>5_NY]YW?_W^>EKKCC1PT\7!Z:>]4S;@]$Z/'E66:KGWXOWW)[5Y4.7_ MO'M59MK]S]Z0!>!KYO8U*S:;(G\;9NZ&^;C4MZU3(5U[=VFVO-(1FJ7;K-;7 M#M#8#?I9U3KW]4W&:9EG^5/EPDK<6/\N=%_ZS:9Z+!P'!#L."-;BB &<3^DZ MS1?*2VMOKA;O/4[?>8PP"K'L1&KFQ _5-EVHFXF>]"I5/JO)[=_^0GWR#XC& M/9C?@C7SX?,M)9)%U]/G4Y8 *Q'X(>.AZ%O&MN45Y5*&D0A(WS0!0!DE7 A^ M-.S%DA]CR<^)Y3NO6J4Z F?%U(DX-J9[,&G$-&24&6'%]!IC@B5(8#W^Q)$_ MX>3OQZK:M2B@>!09EO4\LX9YP:*75!Q\"4@OWY)(0S*CC&.+@H MQJX4<2*.C75@W1?7B[HP5RE,GS$F6(($UF,O/+(7.MG[EY[4UD4%LN1L.9:E M"\"@43Q'PHE#:]1<42$BZ?O&7C YQ[(7^^@8^\@9^WGVG"U5OO266567V<.N M21N0"2?.6"8N .9B.RX^%Q(:UW*NMWF&3=H?- M0&WJA!I+Q0&M)QXXD=*8N@YFO=V03W@@B# 7"\#TBDI"0KUU,@6#)%U2_,2I:@H76I[&3\_1L/?_/7?X& M?:B"GD*R.B!69C";91D)SK12-S/#-M7S>$2D"$/?S P EO"(!'1 U--.U=/1 MLO[MT*+J>@H(>QU:'I@AFZ/ZC5'1$BRT/HV=N*=N=3]&6;BA1M-G"W9N36FV M?!:2!(&IUB_I&;@VPP[#DWSMQ[F3Z]2MUR]1%V[(T?&V)3BGH3 %.*K3&!4M MP4+K<]B)<.I6X2Z-X6XZFBLDK3S' HJIK;JOFDT6,P=0P$.W4K]C^PKNSV/)K]T%ZHJ#5MVNI:[\FT MM#%7*B3=G\ ._6A(\G1BGKK5_#>H++M[,)H?6U!K?HCY@&N.ZC5&14NPT/I/ M.[O* <.K'+BA1C_P/*]RP,ZO' "F@Y4#"-99.6!=Y8#A5P[W;E -5O MC(J68*'U:3PY"'#120"8O@LJ!]#F>Q2A&:(2+-NA^HU1D5+L-#ZG'>U".:N19QR?CPPN#T>&&SY!XFT MG^@S*2/)C029N?V/T+P,J > +F,LEPD"4)^6KD+!W!6*5UH[IYLRN % B M V+N9V*L;B4#'B4=4DM=T8&YBPZ7E,?=D*/7)+N*('S[8. 4&L\S M02[HF7L P) *JZ8YYT"AP2=":ROKX35@JG6HD%);4S-:MFTH./$)&0A6)^KY M6:)^J#8#!PT0V_#2#%KR@%/S\?SS;:K',X^HT'K&',^V;>A3R:*!A\N\4^7< MKTC/VV0&HI^:LJ=-6_LP/"36U'%:GD@&' M,AI(JTXP\\L$LS-/4!_820SL'/ ML(#F6$ QAX[F"Z(5FKF5>]NP_UW+3D.+BY[$@ULX83\[A_>]@"&DXR"S 1T' MF [J.,#6J>-$)WK%[WK&#@<-$*OPOA>T!'6!CE:Y_QV+_45=;-O?77@HZKK8M"]7*EVJLC'0GS\6 M1?UZT?R4P_'71&[_#U!+ P04 " !2B6E7"%E",O4& "M'0 & 'AL M+W=O_5FG.- M?M15H\YF:ZTW)XN%RM>\9NJ]V/ &?ED)63,-M_)NH3:2L\(NJJL%"8)X4;.R MF2U/[;-KN3P5K:[*AE]+I-JZ9O+I@E?B\6R&9\\/OI1W:VT>+):G&W;';[C^ MNKF6<+?8:2G*FC>J% V2?'4V.\+>W'PLSF:! M0<0KGFNC@L&_!W[)J\IH AS?MTIGNW>:A?O7S]H_6./!F%NF^*6H_BH+O3Z; MI3-4\!5K*_U%//[)MP9%1E\N*F7_HL=.-HEG*&^5%O5V,2"HRZ;[SWYL';&W M /2X%Y#M C)<$$XLH-L%U!K:(;-F73'-EJ=2/")II$&;N;"^L:O!FK(Q8;S1 M$GXM89U>WFBF.81%*R16Z)*I-?H H57HZ&O#VJ+4O#A&<_3UY@H=_7I\NM#P M3K-RD6_U7W3ZR83^#'T2C5XK]$=3\.)P_0*P[@"39\ 7Q*OPAF_>(QJ\0R0@ MU('G\N7+B0<.W?F/6GUT0M]GJ#3KM97U6JMX@592U @*33)=-G==II:ZY.K$ MY;].?^C6;ZKX1&U8SL]F4*:*RP<^6_[V"XZ#WUW&OY&R U>$.U>$/NW6%950 MRF5DMS*V*TUG>5C.:9#@-(,0/NP;X!#$89A%<1SN) _013MTD3=0Y\7?4$U= MIFL!'2@735Y6'#5;V.:IN,HIOI.S 3_'.3[$WBE<1',L1-*8N .9[ F7H W6N3W<].Z"Y2+V@"T M8%T@D]'[<1 E$28#G&,Y0BB-@]0--=U!3;U0O[&J+)@6$M+M@3>MTY'IZ-US M'& :!.(E>N9^,0T;T\.K (!SVK!5Z;+M>LN>.F@E>LE.B!52TW!/?(I&0-%'S) M;LO*EK.3TP*GKZ,@&,3$*8C#( @F@H+WB!G[\YQ5%K*)PD:*HK4##\KETP8Z M%5.*:S=VK]I71&:KZ* JHC"A9** ,>E-(U[3OG HC'^@?N],TD&?.3 *:0B1 M8G;,XG4S+ZWL)T0Y42:1>/L(5F2A<-P_0>Z1CX#>JK&?JZ^EAS2L'BFZ2Z$ M0J^YA*V#E"8[/>DX)F<QK'?AX_SW/1FFELPYY,'"QX MEN>RY;U%3N .5H\R.N1TA]B<)FDX54,]J6,_JY]O,?YL^,!CPB81";(A3H=8 M$)&]9G:(LZ=U[.?USR\99IW QYP\)W%&PR :8G=(8I*%T41VD)[ 2>!O5/V> MRFZGRN:!JY<,XL0[&+RV0[V5MD,O]#, \<\ UZV$P4S9.6!J!D K80<<,VF" M?YP^&3/Y'*=!&*;#HG%)9B2!R$<3$>U)G_A)_WF>>Z(G?J(?1 J2#_93L6_M^7&# !.W&,>H76+AU*Z#]"Q/ M_#OQ/5>_%' X0I*-JMW_UM<3'>F9FOB9>M?*P**'LH!V=ON$CK9][=C9')Q6 MCAD=IW$PFAL=R4JJ%J'(S(M2P-5#FR&*!SO4<9K-YS>0]+!&K%9=3#7L\$V",:8J'TYE3 M,,@B3"?&'-*/#^2%X\-^S;G2U6F 8UOO-L A&(1Q2.E$7&@_0E#_&8 QX*C@ MN>30OX\79=-=F4G(V.4\BW5MYVE&H]$>S2&)PS3%D[![SJ=^SC<=XAVZY7=E MTQA'FSX.B2(*)V#''AU#HTJ'AT<.07-,D<83'8WVO$[]O-[A-<7L1SIFZ"2B MA(Z CN5(FJ99-L&*=.^DWG]4?]-N-I7]UL$JTWARV+FW0W!-M+:%$2*M^>N:*KO6;M],+X\)Y$41:- M8_Q6@\1B[\-7S>6=_1ZHD-U8=I^4=D]WWQS/[9>VP?,+?'+9?3GLU70?,C\Q M"96H4,57H#)XGT!FRN[;8'>CQ<9^7KL56HO:7JXY*[@T O#[2@C]?&->L/M" MN_P74$L#!!0 ( %*):5>HKB@6X@< .X3 8 >&PO=V]R:W-H965T M&ULM5A=;]PV%GW7KR"F0)$ 8\]X[+9I8AN(W2V:AZ9&G>T^ M+/:!(UU)K"E2):F93'[]GDM*,])D;.P"NT 0:RCR?IY[[J6NM]8]^9HHB,^- M-OYF5H?0OETL?%Y3(_VY;RB(<:O5@ME]\O&JG,[/8Z MKCVXVVO;!:T,/3CANZ:1;G='VFYO9A>S8>%W5=6!%Q:WUZVLZ)'"W]L'AU^+ MO91"-62\LD8X*F]F[R_>WEWQ_KCA#T5;/WH6[,G:VB?^\:&XF2W9(-*4!Y8@ M\6=#]Z0U"X(9?_4R9WN5?'#\/$C_.?H.7];2T[W5_U!%J&]F;V:BH%)V.OQN MM[]0[\]W+"^WVL?_Q;;?NYR)O//!-OUA6- HD_[*SWT<_I,#J_[ *MJ=%$4K M?Y)!WEX[NQ6.=T,:/T17XVD8IPPGY3$XO%4X%V[O.H\5[\5OKI)&?9$I5J80 M'V7H' E;BM]:7R[E8+5>7+\B[W ?@,LJ[?$;>V.^YN(>35JOB$(8'1YY, M2 L(QL_*2),KJ<4C%@GX#%[\\_W:!P>$_>M4A)(!5Z<-X*I[ZUN9T\VL95UN M0[/;;[^Y^'[Y[@7WKO;N7;TD_7^0WQ?EG[;^HPV478@S\=]I%W>?[A^S#R8_ M%Z^8;LCIG;A3(;?*B,?:MG/!+U_/A10?:2,+*7+K6IN.BU???O-FM5J^8RGQ M\>*=L$Z$FD3_YMXVK32[_N5KL95>*#/(H (_ *OE&[8P4QY_!$DV DEVT@1^ MS^)RMVN#%=)[L.8KJ;UE?B+G( +KO;:T*^^P#,"0[]7.I^_WJS"U?Q'L$UAO ML#(#63Y!SU:%&HZW3C%[BA*2O8#;:VWSI[P&_\*\TDD L13EE(;IVUY1G^L03*AN ^V,=]^%A^ 7ZM M8NRF!_;9^&E\@OFS&%ML*,3^L[<51G"$C62RG@2:K$GCK+>BQ_>>2Y5CL*9]&?R[!$@5?G!0KR4(Q,'R$J-AN6GN:ZM+LCY[$BI M6.]$*UU0N6IAN*G$P35 U(! /$+:$&PVRC?LH[-=50_I&8>2?R($RAUYCZ?> MK;,^?T5VG+]7!Q#%A<&K:?K7I!5M8J1E$-%]SMY&L0@I&LO8R7,$0:UU@E%N M?3BCLJ381%$X#,#!PFP2'#;T$ SB4)Q(>)^:D]&9L_^..*C.-G:(B*C ?5P# ML$<6MAT8^2 ]"Y!AK+;5+GJ<'>, \E _%+B "E6I !I/QK=:!N:<"!7,(O1$ M;HR086V/$]!#*NT ?F ?(?5\E@&@26&EHLL3>>40 MA#-]D>>PVU'-L\^A"@KIZ[4%WD:A%U^%'@$UR-(<:30*R$ PT9B>YI'3)"S9 M?:$IOD!^<%TK"WMS9P%]^LRIJ"B5Y1:5P "$DU*@.*J("0A"BOT^< EBBKW M.[T[*P Q#:06(\/CV)AU:!-8#%*4R.\^$8,>UMD%I=47-J!MM>ICA.Q53C9- M*C H*M%W /KW#Q_\:_:=Q8\$]_Y-O2DL'HP-6:SO&$K&%H)4L%R.+$]=Q8ZA M-:G 278GU$*B[M:B;QC'*64-['',CHZT44-Q3R%9KV+$)&,>L,)V7-SF+%G% M<\=1T9^+^U-0B!#C\F7D]"0]R#NF#48=!O;,J\JPVJ[=QV4,Z"'5L6HW4$)Z M-S\-Q!R1&&L]UH@$#%VH8)_#@9ZRV I@R6#&V 2(ZJ$1'1F*:8J^ M2M'KV4R4G8D7)F0,3O1=\ 7&R5YB'/%_99P/:1PK.QYWYMD(1(@VIK;/;<12 MU[+"Z -2I9)SDR&"MX%1G$7QTGC3H!5^XJ(U[_G9>XL; (."^R);WR( Z$ABR?RY:RXX1# MZ/.B($ER58:O2)/'U9PM8B.?%S".R+B]9Y/V+H[:^U=C7@("EVW>!ZT@A+=@ ML:/1%FT#WD["-!HO^DH9>]&/X'$N>6;T&-F6G TG[)/K%"3F_F&6TOMQ/!YC M(V*M/SO69_9P8>(3:7X;D#)E)Y1*/R*G4F#!F,?%2 1>>LKC78RG+G1C[[HV M3GDC$\"*N,J@!-+,&*\\AP8ZZE@Q>S'S&CEULN++1_9I$MXU-)WLI7$PX#L" M1(@M:1[.TG6@:]:4B-I'[B_39:$XFI$/W=.ZR<3L.O/5L,P=,@=3QP+%WE,9 MXUM]H&J75"=E]"/8-G[102"#;>)CC=&''&_ ^]+B M[_8 7[ M3WRW_P902P,$% @ 4HEI5UX"F;?C P _ @ !@ !X;"]W;W)KOC9*NUE2 M>]_>I:DK:FR$&YD6-=U4QC;"T]9N4]=:%&50:E2:9]FKM!%2)_-I.%O9^=1T M7DF-*PNN:QIA]TM49C=+QLGAX(/\0'5(J!B,:7 M'C,YFF3%\_4!_>?@._FR$0X?C/I+EKZ>);<)E%B)3OD/9OX4\\(Z& LLWPHOYU)H=6)8F M-%X$5X,VD9.:D[+VEFXEZ?GY4CCIP%2PLNA0>\&QFJ:>H%D@+7J8983)GX#Y M"=X;[6L';W6)Y;?Z*5$Z\LH/O);Y5< UMB.89$/(LWQR!6]R]',2\"9/X"V* MPG3:2[V%E5&RD.C@[\7&>4MU\<\EAR/>S64\?BMWKA4%SI*6(VPY7IT572H\E M%(:2JQVM*JF%+J10X$@-Z9%Z![5X1-@@:B!CK; D)_G9%<:6)(U4V;X.^SX1 MK94$TBI*Q18U6J'4GN^Q)6L#TO4UPD<=;*_9CH,?GC^[S?/L_I?%8A66X_L? M@5H36?)H97/&3.K8LLBI84"2FK+=A6;@P!O@5PWC[,7O('09)&S'7'AG<=NI MH.L&%"&^7+]]&,$B>$/DU7X(3K)7=$>L+1XIG$(2[?Z_:)8&M/$$6JBNI)0H M!3V1,\<"5Q(CUA:_=))COMD#1R=$16C=$>PE T/8= P?($TK-8:2S0.9H&D2Y40EIHS^NQIW1RH35.AJ02%4>]-Y0P#2D;TQ5"4@A70T4# MQP7<&+68'1*4IG0'(UB.X%U_=< [J/C:(L80T\.")G8XY X':R[29H-V<&A2 MT1]*V<$G2=4L=2D+P8.'6?[70-51$/H%JBF:5)SFDGU4Z?C* P/\=NHGE7>">7 \PK%? 27^EUZ-I$:M-LP=[E( MZ.G'X70\/8[V19QH)_'X7?!>V"T]75!8D6HV>OTR 1MG;=QXTX;YMC&>IF58 MUN0T6A:@^\J0,_VP_>.;_ E!+ P04 " !2B6E7>VZ#?YP9 !82 M& 'AL+W=O MA2TQ,?[L5_^)STYG6>2MOK;5[Z;LUB^.+H]4J9=Y7W4?[-W/VIWG NL5MFKY M_^I.QIZ?':FB;SN[<9.)@HVIY=_\J^-#-.%R=F#"W$V8,]VR$5/Y.N_RE\\; M>Z<:C*;5\(&/RK.).%/C4FZZAKXU-*][>2.7H>Q2W9A5;9:FR.M.716%[>O. MU"OUWE:F,+I]_K"C_3#K8>'6?B5KSP^L_43]8NMNW:HW=:G+=/Y#HC,0._?$ MOII_<\$;O9VJL]E$S6?SLV^L=Q8.?\;KG1U8;\\IU?]>+=JN(6'YOWT'EO7. M]Z\'!7K:;O-"OS@B#6EUZT=DZO]5JH76M:DO2VNG&Y)4JUGF]HC&F5MU:JVN[V>;U M_3]^N)R?/G[6JC9:.A^6WOJE.TO3;*L547AK;-]6]ZHT;5'1L](O2I(Q5U=U MW>=5]D%O;=--U:N\-6U&Q//1ZBYG>T"49MB&B2,[85Y3TFA-ZMJMU:?:=/3-#>:U:J5KW>05D4?C]!;?Q.=I#.VRK6C@ M,_YX^NS!5'W0196W+;,"E+;J6C<=V=>,IMI&;8F;EI;<8,68 MPB9,%"J)1-V ;86M8;Z%5G"IZ)N&CN>7BODR!6.(RN%FMZ;O2)[PM(=8+>Z9GS^]?GL]55=,^@V$9[.@2_1&CUGV6A?NZ2D_G4_B MFZ![(N'8;AO[U4#UB&,_JL<79Y/9;*;FD]/SQ_SI)T]6!K*:7AC)5&U)[TE6 M68+;?O$'.=!D Y&H@L8THDI$:D%',)UJ3/M9;JWMO*3S.A@")I4D$ZTAEGKK MP3S2>;'.(O;L98PNH55T>EY!O<77K(+7MB%!$U*\2H&-7J54OP7-/ZKYQ8S/ M?CJ;R[^31Y?RB31W04#!XE9C 5S;JFQA#_RW$^)(09?>JD\WKS^JXX^::&L> ML!30DVMU3/\GBDS]8$)29C"6SE(T]ULB@11*=]'=;_5J)>*'$Y+P]!J$S^H94.\Q0,F.JWO5-3#;OUMUO29EQ M&VM=L85H-5D"359T93IB[1U]"?IXP83F3']UUIOM0Q"%O""A;R#H1,@.LR ! MY#A,Q3*SS M3&9C(9&E%4E2W.8,T8B^)3-679"@G:M%W9&\Z4O@-F]?.3K)M M?N\D%3PS37E"1KF[5[>Z+FU#U/V^-I7F:<[F:N%0[M25/H[5F]6'3-Z87][Z MP'X[JV,ZF+76DN70L-2T;:_)T126?%=P*YX[C3S_D_C3R%#5U[#)D>/'C]Y M1LOK;7;Z5+TMH=)+4:7"S8H=@DQ,Y\U'\\A=W7Y?U%S\51]\+<2+H6]06SA M6EJJ7<*!Y >V"7=OVN&:2UF)=R8DS\X'<,5N#+S,RMJ2E0OXRL ]T&0^WE(W MS6 '_&6P-I!F.5 [_TE1/26)K,UN[ MP;2RN)+!:%!HVV Y0F+:P(Z3):3+[."OFG!"MUZP@ ]P1OE*[$8X0.J'Z=YO M#7:6!3)O_"U3JF%B)@\VA/BP)7@7VH6NH!(L,:!NO3RY!R$,(LX8'.[B=DNWR1!VP M M[LFMM)X7I=!1ZDJOG$S8$0]3$X4K2K2*; )BH@":4U08.2"1]2ZK2.&17*PHO=.+$SX\\:X^8;"8K.5%.%YRHW,$*Q+PY:;Q6%XV+L$' M+T-"Z3 H*1'$'Q6,-2"WE(DFQ!80;SAJZ/X'7'&,UL=,!+2X,,*W8P M@[9EK&TLQ$X03%TR0.;C.P<121/<"UT(Q3!Z(MZ)OG61,$>'=#?I6#)1167[4@!5QHF[A@*QEGD$$%BW#-I$)D@> M*'09XRCA5>Y =ZDTL=#>:P@&Q9) P62(3>%78&O$21!=LWQ@=MMO)=EV1;97 MK&AU/\D$I*8LT34GW5H0!N<1Q7P5*+3-5&X,I!&-VI/8I'"/W5V,9L0:O&C6\7" M=OI,_9,P^YVI*DX*O6/\>IU 30[S)97"LA>RI"X_I;ANP.0Y_.L3@]YJD//F MYYY"-@[WO*9S.MA[P&&F1IAQXZ[3IL(0-L@PX :M&>E'S13N; M3_L'*XV4/5GGFZ'Z0./>1?9IG%OBI7?O.K+V(Q"PW$D,GT[F%RX9.I^T([(ATC4#E1/Y%*C6V8 MBZ=K5#_VZ^\D$^3J^?(J(>DE"8?VRF%#8,%1(&?I*>8#I=U/Q M,8BH3X:IPD\_$V/3[T?I$,YML]?A(E]RI[E$(')5@)L29-P#@6L(FL^:A*UV MME%_O4W&WAG%I&@/HP_ZX_G9[.1T=C(G/=DS"PD&8BGCG^PU09Z*Z"_5C0,A M\;=E^-9#%%\Z"8D7VAV9FV)=V\JN[@^%83?PQ3=:?R;YWY+R [K[, 4AJ :- MA/3,J@ZY"#+[?8M4,8 4R0%!R8TE+^PR,3G1>/^G]HAJM6H06(["%$"^I:V, MY=P_;<*).#I$C6R16'^:/?V*5[ MTE]E!U^:D)0-H4 R2TBJAVB7RQ9I447 9 :E@]/HD3X+,M)'Y>X%G"RX<$!6 MGUQ>0%"QM8.24WS(Y/DDB.7)M752=^WW"Q)+''Q%-HC8-U'_AG6G?XDP!IQW MAO3N%SC/#H^Q]!BNGGB8J@:8^KZ!4G?W['_?D!_?LG5+'NOP.%8*SXY)]#U& MV^42$&+9-R3"L']<&3-?\1D!CN3>AMQ3C#+ABJ>H*])#(\)%L[-\@TS-GWDH M2(8Y [)!JPCZ?D[04$'XKEO;4@#P*&U*E[;L*U5Q1BUV>N2NP2GT'TBTBVKU M$E, GUOUJ>4,P1NR,QM.P/\W?0NN$0 AEO0M (BA^P "R'C%I5\I\,]7XG*0 MQD6Z6@<*V#RT;;_9L@/-I)RY7"*J+:158:C]^S8%N,G!%%T>/@QI@'T$^8@T06$[N'9_"!-WJR2LR2+6>!_C M*&#D)&>XYTW'4C$$B?1LJ7=CQ$D2#<=A\G!28"[)M;&5SR5B")!PG_^@75T% M*O_J=IKZKI-#/B<<.H[?DT!"..TS2M]Q-C)[%+ 2,A%A$DP3["@)A:061CNB M8M+7YDNO1\=CCKAFG(R87]N-*:)ER%5W@M+SUM;Y@GP!X9N62?+I)5H[$+ 4 M8^W(9 TC>*)%\ ^TPZ2B(3.+G.X=D*'/$;&U?25EH=+04HVW SC609T#R@#, MS3[F7]-,5%QT=E"XXS%62HE%T6!;CE&CW#3=.[=52&\*Z7LM:?NMW(.4$>4Y MB00<(:8TFNPKJ+E*5L@8F"X9E7+DX[]@-Q6W""U-Y:1.EN+L_3#\T/XY&7JV M\IA):X2$(-\F%T@)U]% B;BY*N@R&P@^O+0/_#E@9DCU$\9X+^"JO1Q?2D#) M6V^ UBKS&5$ D8-2390PQ GB-NW"V;23.VZ"U:[_*)=&&N;LP53PHQ3"!L",KXL'1C7<5V?AIU5#!J^IUL4/[-)!V;)%(HR7 S M[B'X2T@:U8H04MSY=3 T^-#:M12']@F7MK307T;!NW L<^4?*<&PM0G,Z"]G-H"?>8\V M._X;9'SST$.V,L45W^)!H#B+-C\>_$KN!WH0-#IAVDACENP*;OD$KMH!N+^4 M?>4+DG#;=R@D#9-#FXB7T@=[&"Y]3(U4&/\VUX7;ZN]Q.WM;_Z*!,I@?X>"0&.+;X+;%J-4S\^VR%:J7 MOM?"<#V>6>9+,0EQSRB,OB-I;B9R3$$O(XB(IN_*$GQOG-DV24\4.4P. B'T MX4B;_#ZTX,I-EA,'&X?NU&'=+X1AT)5VD%#Q"*A.KZK[M"TC:I+&8T^"M!R$ M^W(1AFGB1*9TW_S1MZYTNQLVL&6MZ&RX@>SZXJKVDNU M1QF<=_*9B39)M]I1NC5=+3D%>L8XOJIQBGQNR?\B6ACB'8$NI M*W7<4N2,=Q;4.7F+FR%.RI)RXD%$<"BR.I1;>7QZR3(5QOFZG*AM\E7LR6E> M\.297XAL+2R=EDYW!.F29H6!=#2YUE=?T!Y*2UF[C@\QVP1#!.X@,I'>2=L6$ MF\[JGAO;D2R0C4.K=!P*W#*4K$M?\XIH6P-H=JG5Z>>6!036#?$[794G-;2>[P<(Q2K+(D5RR!)Y=^NH[TE7) M585^C62&?Z/$G]LN,8/O$/D0TFM;ZQ.L$"=<@HX.,? N_X5,65@V:Z/D7&HN MW"@<&P/$9H0FD2AGX_.K!)6*ON+*PQX+&%N+H"2NR!.ESP)'%SAO&L^;^M96 MM["PJ&;0M+YVZ;.0%V/:M@1WBMQWY^Q9^X^^7$D8](%VH -"E<0*X%X9\R22UBFP&@OJ[50:I%]UB3F/*T%&R!4R1U>/G-B0<)"C3 ^X[O-S )V;S$@+TC M6?<)9.: EP.VW#Y+@C=AR8-)ML$^FWO9H8X"P MI?GHP MX95E=[>D)=#&QLWS&.< #G\=WECA--"M ]IQ#(C>SCNNO2&/S@[S1J/5+/M- MO6]\?DY,F,=.,D#]%E9G!87OH%L^L4$]#^2X&=\@C877":- ?Z_L9GX@HPP' M=OVSN[4EZ6O2URHXOBH-UEKP.VPN8Q$_DG?ZY!0>M=U!A#V;N$KM.AAA@+)_ M]72LN=P'[Q(?8A!%U_;CW>XO%$R=NEE"A=_U*:= V 34)Z0O)%P=\MT323FL M69_FG'G#ZTYB K9\(9JOSIL^1[U4Y#:^2X^7&3:XM9T/1X_-K2P?"D2PJB[M M[67158("O^B>/ 0Q;='HN$&5!8UX?'H^N3B?3RYG9^I='63X(GXQ4D2VQ NM M\BX7:&OPZAMK%FIT7%MV=.!0/ZK9=':A9NK1V45HX4@ZK;2$']J[Z,:2YM+? MM3/DX25*GZJ.CIFFT:38U,F+6X1339A,?OCG'96]=!,&XD.F4^/3[G?WXE@/EO2YS8 MHI+,V26\A5UP/Q$_E)23Z]CM7:V'>>2M7?36,#)[F.B@D'O3P$N>B*)K?QE2 MT*BU42PPA!3)^ RI.+Q[QZT1NS6_UZ9BJM!;P"G=_40/:/-[-P9S)\@,EMB! M#.\D&V0E'?D7)+X_,,V_?WL VT=JK[;!UHK^9O&7!!-0W=OOW",&G?6EON/'U.7'WBWFP_&OU^PT%PBS%)R MN1LJHO2IHM!&EWTE#0)>3M\'C;L*HRDK;GW?+HVU Y(04+68/8QJO' MY%HN2,>?G%],+L\>9SZZ/9V<^O>K)_-+-IO9K_ ")#_[,**+1 0JGDX>G9U. MSIX\P2>T(E[,LH_\JLO9Y/S)V>22OJ'_GY]-3B\?9UT*QL//80R%8W1]!CG+ALS95.W[V9"'T:^];#3!8?RF32M% OGAE_ T_&S. ME?Q:S#!&ULW5I;<]LV%G[GK\"XEXEG9%F2[<:Y M><;.9=J99IN-D_9A9Q\@$I)04P0#@);57[_?.0!)4):=MKM/.QE'(@DU\^/CUV^4FOIQJ96%9XLC%U+CTN[/':U5;+@ M3>OR>#:9_'"\EKHZN'C)]S[8BY>F\:6NU 2[N]4J79O#J8'K0W/NKE MRM.-XXN7M5RJ:^4_UQ\LKHX[*H5>J\II4PFK%J\.+J?/KTYI/2_X5:N-2[X+ MDF1NS U=_%2\.I@00ZI4N2<*$A^WZK4J2R($-KY$F@?=D;0Q_=Y2?\>R0Y:Y M=.JU*7_3A5^].C@_$(5:R*;T'\WF1Q7E.2-ZN2D=_R\V8>WITP.1-\Z;==P, M#M:Z"I_R+NHAV7 ^>6##+&Z8,=_A(.;RC?3RXJ4U&V%I-:C1%Q:5=X,Y79%1 MKKW%4XU]_N*=U%;\*LM&";,0[W0EJUS+4EPZI[P3LBK$SUK.=:F]5N[EL<>9 MM/,XC_2O OW9 _2?B?>F\BLGWE:%*H;[C\%KQ_"L9?AJ]BC!:U6/Q(3ATX[AT\>H_P\L]BC]_=S_PWB5G8KOOSF?3:RU6=>RVHJUDD'#N;(>H"%DOZ=,]D@O%G3*+9TR)A*B)8&@ \\N M>0XBPF-%;76N\ V;-Z8I"S%70(Y<(? +L;!FG0$/(/ 2QX6#A;&BEKH0W@C8 MNW(+987L.-F*)UBI[K0/M \%.(XG0>0:,H/ VC@O9'$K*P\@,XU#A-H;$"?Q M*JPHE"VW@;YD-,KFRF^4JMJ%M;1>$[W*L^AT1-04$-"+0GHHX5TOL'9".:\! M2Y!LOA6RKLLM"48[%Z8$V-+52BLK;;[:CL1FI?,5\6TL-/R'8HUENJH;'-DX MQ2J(9Z:JU16I9F65$J6Z564P%2%AT'D.%I:@^8=DF-UHOXHZZ@X736W"+; % MM@,A5GJA<^B$K;,:L)5HY[GXF>AET\X_/U>R M^!W@":&^-(8^V'J.#<)Y("K>!6>1$%GF6. TG[[? -"K%;K )9@J1Z*IX,<> MA.F Z,;&9HD7CR-GLXZS7^8442QC5+W!49;8J+[*Z^#\!P)GM$-EL"?#A=-K M*-GV# _"#H3SJ]_K3#V5)5<#ZBVE0) Z0LOZU) M%WB$ H"J [!5(6[)SDSNZ8L^N(@-L-"L:_+N>,">H,T"WB".2(6D^S88.YCI M,&7<(R;B#Q[4T-'0,R"E; K:F$NW8F;YB_K2:'A]6 0_-4T5#1_,$B".!$R? MUW+;R8R;ME$["&LI>*W5JL@@5 X0:U&B5P@,6FKHVA'"6'/'2AE ;X&_&)YN M9:P_8NM5TA..!".R4CHY&,[(>3@,Z)4"6D.PQC44S3CV8P!PM0;GBU7H.([4U"R]\ M XN%NU.^.WLNKE%O%TVI,LJH@_SZ0%;EYP4)^;$3\8I$S)+M[Q/-W.R1#G9;W!L.B!5V+?BZ70T.TNWAAL/*>R>E7I]W7OT M_ZBNV?1D]'2@K_9.6M$5J)XJ0ZAX0V"S[>HH)]HJAU-_*!XBK.\-J:*Q+6I6 MJ/!05W'KH*AU>""2,M)]GP[(AJ$.^:3R5:6_-!"D?;CHZM08LCD07:,< 4\P MVRW!/4$MJCZ=Z) 258!%LA677I41%'$$5W4S+W7>I@1:&P#/44P&1;J&]X:J M(BL4 218839Q=*(*2\=3<9S6/K\WQ9*A&+0C2&'G&+#P5P!FM!?THN\,Y-VH M/C&0JZ.V6X+=DC-$:[]DPXBA$DA[VP)6[W6)+_*9LQ=O@X*O>_7<-T\*HXF- MZ-Q-=-1TR>,&^M.6$0/+9/^%95ZCF%LBJ@ "^RM6UU?-T'',-*TM'HL0+E1A MBRWM4Y(*>H6*/M3CG OR<#8!4)O1')5]:1%##H*T2'T)%:XAM2,"N,FXS%(1 M"Y5;\*W:ON?6E!"2.R,B*AY;NYO%G3?Y30#($1>:CHF9:A2[->BW*4/7E#*! M2HWZ!ON ,CM]=SS2"O>8QY :.P5@%[$XF[P(NA,#LY$?["'!.U!W/B@J=!DL MC?T&1F)!4?O\4F7OR99BQG$Y'<0EH XNR#RAI)*IJ]8--I%RY1*M&'L=AUW; M1K?/@;HA%FB4$5PBG'<:SJ.%KH$T&4[HHJ9C "8IN#E>XIAE+("?Z$/Q["Q$ M]-/I;'2&SV?C,\X",7.X-D)&;?=DZA;@N!<$767Q4%3*'W%5"PCV99"D+P9; M<19-54AZ!CA(^F:D._AK& 4K?);%@XS.2@?X&.].O,L)E=0N=.QJ\A*A!T\._(;\TH+WXRA-*%8:>*3] MFSQF82S2I^AVKP3!WVD.P&6L6R$>@H$0WY[:J\L@V*ZBMF&@PH;F>4%BR($2 MA$;;E/*5)7P)D\.M6S\%6AO4,>A1]T929!DLY12O\)%R.QJ>Q8U,KV4(/6@5 M/Z7&64F49'.J27H 9"?1 WAI7%N(7)4ROSE"<6ZH2;GMZHNU*50Y8B_8:/2L M<[6'(@"M5J$,3(=5/F/HINX7NN0N2Y;DF"(,XL.TY],*JN%CJ#$TMN:6VJ46 MII0E=1F], [!'H5=5B&_>A*H@!1EX%^$#>9C1C!W-A"J3NE,VU RN%89]4=]3Y.40*/JG_I0PG M]+HNR9B6INH[GL:0P>%G5<8I'\E=M8TO3?HXWT$Y7-21]N\Y1.O3G=^X6!TD MF_9ECCC'&MI+(M*Z>B-I\Y%*P[L.TL<7 EWM VE=A?WM'MH/:DNIH.CD?TY+IV6Q\GJXI]4(AHU9BJZ1UAV(V/CT! MH>EYOZ30MS2R*\16*Z3C(_RCD.O#L^.#&=M 95W]%S "SZ "#??D$1P9Z)TJ M:"(F/H:9OKB2UTH;S3CG25I 4II6R[38 MV$5 I"$:P!.S"1AVCPM *)682PD87*W1S5D%2*PB5*B!Y895)864ZQJ'7MG8 MHZ,BVL!(=^T0WK'WP)XA[@@95L/J1J#:8P#M55QN,WZ7T=)CN-I5-,=,891K MT3?"3BVWR:SL<1+M7*RA(=_>>9YP<6#-G6$"@_S*8%BOIQ.[_09L<>A>![\S M=,M:X/NSXX.NZ/KK@\3AQ"YI09)A$IWP"T]X+OE]1-<1=/7(<-+7RKG[1FT? M7MV[-VH 51Z#Z$FA^JM#7OJV M*AZF^C41OH*[?U*.?A8U'9V?<0_23:T&\X*8T/,@S%'+8"R].C.(_7V=>#(] M#0W.(;Z.IJ=!SL/[*NAFB6U'M._=[G'R9GZM[))_?T!%+0J5\)*^N]O]Q.$R MO-GOEX??1Z"+@U90VZH%MD[&3\\.0G747GA3\WO^N?'>K/GK2DD@'RW \X5! M;1\OZ(#NAQ\7_P%02P,$% @ 4HEI5SU#):3K#0 &B< !D !X;"]W M;W)K&ULO5I9<]NV%G['K\"X3B>9H6ANVK+-.$[2 MI)-M8B=]N',?*!&2<$,1*A&;E=%M=W&^?4+D:K#LQ/_I'[P6:XW)3TX M>_YT%Z_%I2B_[#[EN#MKJ"1R*[)"JHSG8O7LY-Q__"*B]7K!5RD.1>JALV'F'=D0V V!YMLY.O"<5H,:?="BZMU@3F9DE,LR MQ[<2^\KGEZ5:?MNH-!%Y\?-/L\"?/N&O?J]D>?WTK 1]6G6VM+1>&%K!$5IS M_EYEY:;@K[)$)/W]9^"K82ZHF7L1W$GP4NQ<'GH.#[P@O(->V @;:GKA$7I& M,/ZO\T51YO"'?P_):$A$PR0H1AX7NW@IGIT@" J1[\7)\Y]_\B?>DSL8C!H& MH[NH_Z U[J0US.D'50HVYIJV_X0?/X]?J.U694ROX%<;P?!@%V?7B,2E0" E MO-C$N3";>;S;Y6H?IQR!]FN57G/?-U;CI>(Q@CCAJLKY>5[*92H*KE;\;;94 M^4[EL8Y.+)/9$K!2"%YN!,^J[0)TL2ZNRHW*Y1_UB07#PZ7FCA>:NU6NMGP^ M=<:>YWB>AX]CNM[Z?%Z.(,CH?9Q_ ]I]7*U$+K,U/U_G0H!%/(*\8E<*?;0? M:0D@!_%32X]E(@$(^SG>[I[@5-?A[]Y=.#PN.#"2Z%E:-S;4U!R^J_*BBK$2#!XV-5 M?!/O21/04;R&S.NX%.9D>KK+Y9)N>;4C/D_Y?.9,)]J$/'0]_K*B94Q[ OR: M;PVP" (6WMJHQH:^C0KX)(]!MR2'7/&9%SK>..*^XT]\[0F^&XWI%C:FVTN2 MBKV [R7\4WQ-U@&(@5>=,MBO<58A87%_7I\&D_,7*LX3(O]2(B1*E=]4BPT* MT*2'LB"K&*%/^=AXI!]HB8N2S^?@9LJ1:?C]A8Y\SPFQZQ,RF3+ASC/R>WM MLT>NME(B:=^BTB #D6KVF/7D P56+3^1 ;+L4D'G:"B#&8(6R7K,52QSCJ10B7I7ZS3&B(,J M='H*!/1M596100AQR53?):HQ ;\\A6W&$Q-*!-7,YBZD%H0PW)Y_2H$_G>S5 M^!DMY\/+NXBME]'3%JW!LZC#2OM(C0XF76AU-QZUN.[Y#,-ZI I@9T2A"*+'NU(AI? 0-@SW[@#C@56%\ 8B@'4$? MT/_5=Y$L):YOD>FJT>XID-_;9EW:B ZIF MYUZE0)Z40L,?^^Z$/^#^9.S.^ /V61;?1BM4,#RW8"=U080,%KG^&"L#=SK% MI2;,OK;$].;7V,S>UIL^$Y5FK682*9#% ', TIY,#/-4.VO >+F18F\**PL< M6U-Y 4P3:9U$%SW:5;;XIH8PRZ\VOJ-A'JVE0=BE BM;1$J5=YP%&UB]08>] MW,)[I($>PJMU1M'DZJ3]3W&(C%*Z!=O]-8!+W>!V(HW^D61\?Z@@8-"+Z6!X-<_-SRP#XTO<6E M2:-U\E@-T(9+ [H-+45HA(<117IWR$NCADKU"0"G#Q]UH@+4!9=_@+=*\!>Z8U0F"7,@6 M4\+H,4:)#Q824#&966*@=4*WI+;-%5;1DL!X7=Q7IJB.E79 M>E02ULFF\M .7]?0[Z[>MOV<;@_KL*1="!51,@J.PT9D@[%40TR\D_!<^8<1 M!+4 ,I*IEHNJH#J0ZLWAQ40_] BEBEJ^)+[&^@44A6_1S2=BA>A,V# !])"B MH"JE,"T/N1@\![;S>(2_UK"OQ2(WEFU,J_$35E%(+S5VOH\S66S0H$&Q_XEW MVJ,N@*XK?B66FTRE:GU-'3C9X(83H*3,WH9B76,1'MA!6T6:P+2 M!(IC8N:6-?A?L(91I"[F4?_]F$;=H>[4AE.W?"41(!H_IP)3Z_$E,D/K6UK- ME!^VM"#N%OC#(7"\_&>=+LH4M/H\V^9U=+E!<"#,NIGPB)B\C/.U*&T\(6[U MY$6/"^!'M3^%N%)IO =X\RO&I9KDOY9<*;3PF0>.5$4<7\:.A/?/W9E[U%.@.$W,27;35Q3 M_HBD'AN,OD4:9 UI2@9$:OAJ2(N4.KF]^B.3WRSMUS*+LZ7$J;=(!PCH((CX M>.R,QY/!"[L5VT<#&T0M71^=GS^+ ":.%TT&+\QWQH'O!/,)#V>>$X*+8]RO"U?P<#)#]7"E*?;5()0 M,MVW)6PK9,O@K7/-UPZGR6>>(,AU&@3Z877.AOH *F-)_(*J%9>_ =Z!$P=% M@CEAK_%T8SN#(P>:V8_N(1PJBO=2546O7^DIFFDS'U25)L:8.+&@T]_?0^$= M5^W9!YSHMX4TL:K#)1>_5S(?[(^\KZC%!,3 GZ+%=%VJ6K8ZOFU+6=LJU'^@"KM<+\9N]D+86D\V+#E'H M#INVR&R'8ALR[44S@; 6-./X/@=V(&\LGR5W^R1:L*);Q$ PUJ\ ^D.91) L M5'@8-G(QVJH$1?/25BHX< <_Z3^M]9KPVW,^>RK4N5S2J$GCES)N7P^[6GCE MRQQM22YC,^]JIE8P\UVD2S.HU,V%1@[K(2Q)3#9@98TK\LBH[$@T-[,A, M8 2+'2GP9^.LO12-PS^UBBK3=GM)RLMZTK[F-X\-E. >:\)^I'J M_&A+W'O#8V %WP>FZ^[-:X;ZER/P7WOCT!CY?A[:F:OF@O6*\I:CFS5Y9WQS M./0TXN%D[9 MZV9V,N*C_C&#$XT)S@SGW4+'# MUR*#\*EYD9 QND-3FQZ'D.D< 91KK#ONPI-CU)_5HG"9?F59NCXL+QYO7KOH7KGD&:>ME!958\K M;;E-$ZOV;X8VS0NF[8[>:--NB2(T51,G&H_YP\B937VXVGSFS#V_W3?\TM,2 M","HCX04A9$31G,^#4#-F],X;18XWC@D-QV)H[1J,@B*<$)21V@AHK$SG4Y) M8"?P9\==X13@@4/F-)F,9NBP9C0'I#?XH9Y6!DXXG3H^(F#H5S%GG=\K;04J M/OI5%A5#*!7,3Y>:I\T/O\[-[YW:Y>978ZA3US3&2L4*6SUW.CXQ[S;KFU+M M]*^?%JHLU59_W(@8B$4+\/U*J;*^H0.:G\,]_R]02P,$% @ 4HEI5YL[ MY,NC @ \ 4 !D !X;"]W;W)K&ULC51-;]LP M#+WG5Q!NT5-0V[+SV21 TG;8#AV"!ML.PPZ*S<1&9^KY(,"ZIN18G;.)\2SF;B$JSG.-2@JJ*@LK# IG83;W0.SJ>\VVFK<.? M34JZQ17J;^52&LMO6=*\0*YRP4'B9NK-P_$BMO$NX'N..W6R!YO)6H@7:WQ) MIUY@!2'#1%L&:I97O$?&+)&1\;OA]-HK+?!T?V3_Y'(WN:RIPGO!?N2ISJ;> MT(,4-[1B^EGL/F.33\_R)8(I]X5='1M%'B25TJ)HP$9!D?-ZI?OF'4X P^ # M &D Q.FN+W(J'ZBFLXD4.Y VVK#9C4O5H8VXG-NBK+0TI[G!Z=D\262%*3SN M39D5JHFO#:L]\Y.&85$SD \81O DN,X4//(4T[=XWZAI)9&CI 6Y2+C"\A:B MH LD(-$%OJA-,7)\T0=\2WJ@:X8**$_!Y4N9@I_SM=+2_!2_SJ5<,\;G&6VC MC%5)$YQZIA,4RE?T9C=783^XNZ W;O7&E]C_JR07&<[K^RHT=OIP" ;][H ,.O^D=@UQ&'6'062O&)C8/FG3?:,@YPFK4ONKE*44^]QT/;)# M(RP( B##V*WGRNR?=&&!Q28EEKP( & 9 >&PO=V]R:W-H965T\_<./SEN MS,$:7"8+I5;.>$Z'0>0$H<#$.@9&TQHG*(0C(AEO#6>P#^F A^L=^U>?.^6R M8 8G2OSBJ?:\25*&#_"IO;M4L2D,E85#9CL@LMZ M9N_-?S@ W$6? .(&$'O==2"O\@NS;#30:@/:>1.;6_A4/9K$<>DN96XUG7+" MV=%340JU180Q2LRXA:E@T@Q"2]S.(TP:GG'-$W_"=8PC5?[SB?*Y8'4[($AP%5@T&]QF!T?M:YB?HGU/;V:GNGV/_C6D[R'%?Y M75ELW<+YV5W"SXD6-KHHJ2R2VXZK;T&??@*40*"=VVYHO*E]:B 98> M6-$+T#!ORJX7=2Y6EZ RL#G"L[2H)1,PPS7*"F&B4B2R-6HNE]0:Z$*8M)P) ML04:X*UB@F<I#EBYNJRK!*NA$$=Q?7T4T]>KIV)6'!U59H%[ZWF.(LY*V M+M#][KZ]/=95_<^][HTO3"_=WQ>8$31JWUX'H.M^4QM6E;[&%\I2Q_#+G%HT M:N= YYFB.V\,%V#?]$=_ 5!+ P04 " !2B6E7$%MZP>T" !-!@ &0 M 'AL+W=O=77*53M4FL"0'Z MP9<$W;I-6C=4UNUAVH-);HA5QTYMIY3]^ET[D+4217V V-?W')\;7Y^,UDK? MF1S1PF,AI!D'N;7E( Q-DF/!S(DJ4=)*IG3!+$WU*C2E1I9Z4"'".(I.PX)Q M&4Q&/C;7DY&JK. 2YQI,511,;V8HU'H<=()=X(:O8'2<"5!8S8.IIW!K.?R?<)/CFOS9 RNDJ52=V[R)1T'D1.$ A/K&!@] M'O 2A7!$).-^RQDT6SK@T_&._ M/_O>4"V@MU^ NU #4[($QT'I]M(/&$R.CSJGT?! >;VFO-XA]L-'=Q"Z7]@W M9;%U#L='YW&G,X2&'G[DV+I41]0\\8#S\I+E?N&!+4 M$MXNJJ55)4_HM/OO>]&[ 7S@)A'*5!H=TZW+LV0KEJ,!MB1':3%)S69)DZ<\ M&QJ8+KEP&JURS);+"H%1.CS?;6I:=-N=%6 *7(+-$;)&JFFDMOW*KMB]B39> M.:TMXG]Z;;373*^X-" P(VATM4N@]4Q1 MIVPG;H/F"S+Y!U!+ P04 " !2B6E7 <;",:<" #X!0 &0 'AL+W=O M=7[)@93C1VG$#Y2#)#*)WV M0(E"L=:PB2T:28^BO[TIV3#J%#!=;VMWW])[EW6FCS;TM$!T\EE+9 M650X5YW'LVD4'AKP-9ER5LSBE98_!'?%+#J-@&/.:NGN=/,).S_'GB_3TH8G M-&UM>A9!5ENGRPY,"DJAVC=[[+[##N T>060=H TZ&X/"BH_,,?F4Z,;,+Z: MV/PB6 UH$B>4OY2E,Y05A'/S9;VR^%"C=QHYH?3+..HI%2Y&^0G$& M-UJYPL*UXLC_Q<4;C4MTKV$2ZR&,$Z.($W2\1Z^<>]Q'/C&;_4(/R]7 MUAGZ(WZ]9+=EF[S,YKODW%8LPUE$;6#1;#":'QZ,3I*+/5HGO=;)/O:WW<=^ MBB_:X> ,#@].T]'H OYW_[7 P94N*Z:> #=,ULRAI55(NH(Y*-@&06=9;0QR M8+E#0PFD_U\RE2&T\X(3#E:U@Q72=,!0D0M%%8))L([29>!DE!36ULB'L* 6 MXE!7U)%4/^C.IP8]"OBM+BXX*.U <&(0^1/XH,%,KY7X0P3:4%J]VXG89Y^[ M5AI=2]X:,I06P1#_39WEM7D>+FPFM:T-#H1ZW82FC/\*3&T19.>E&X]WNK%$ MLPXSQT*F:^7:QNRC_5B[;+OYN;R=B3?,K(6R(#$G:#)\?QR!:>=,NW&Z"KV] MTHXF15@6-)K1^ +*YYI^AF[C#^B'_?PO4$L#!!0 ( %*):5<]Y[>LPQH M (-1 9 >&PO=V]R:W-H965T_YLFYOJY/5W_.Q]_?H[V[6EJ?3[6C7= M=IO7CV]T:1^^/YF?^ VGW?N:_GH6H!1FJZO&V$K5 M>O7]R?7\Y9O%# OXC7\;_=!$GQ6.?O>LI:T!X-G2;?-&MED&>!#F<,[^P O+$#_^_U M7=/6)#?_-W9@@7<^#@_*]++9Y4O]_0EI2Z/K>WWR^F]_F3^?O3J"[7G ]OP8 M]-=O\L8TX!G#KMH<$CZ&Y%$PXT@R[&P 6WW?4(*JU,E5=+DY>J MH53O;W^Y6BQFK_Y^??V>/\Y?/9VJ(]2\"-2\.$K- M#WI9YDW#LH_#-F.4/ IBG))[<-6-KENRE!F=RM9JI^D?.NT6AXV)5X>%0D"B MGJY5:]725C#$0L9VH\E"U#51WH.*638%SQH= ?-8\$:5S0PQ<]DJXBY W0AO M0=GYY:L&L.Z-[1IB#/'2UF!,16Z"^&&W6CTI;=,% M6N*#_JTS]WD)>1KCPU%0XWP _&P,/DNU.S=HVQBBCJY8:\1P$V MWFE!90RG:?:Q9X:"7X7$- <7D$\JH5J$=ALI)2UI3=L)P]L-?4?:B*<=E/+N MD5G^X]MW-U-US:C?0O6V=R1GWJHRR=[JI7LZYZ>+22PL)$HDO[M=;;\8HH0F MBOU575Z<36:SF5I,YN>7_.E'CU8&M.I.",E8[6Q+?QC6_Z:[^P\YZV0#$?HE MO5.+(2)4EW0$TZK:-)^%:TWK[03#P2L@4D%BVQ@BJ7=G3".=+S=91)Y1PN@" M-HE.SQ#4.WS-!NS&UJ0+@HHW2""C-TBJVP'GOZK%Q8S//I\MY-_)\ROY=$1C M+H/&7![5&#*==Q376#-NJXXN'M>1"&*B%1M;%@U,O/]V0FQ:DB0VZM/MVX_J MR4=-!*N?LFC2DQOUA/Y/9#+5TPF)OL&[1.!E_;@CNI ATFTDD#N]7HM.@.PD MT9T&^VREU:?I[30K;%GFM9/["HI#7-+D;0J8K8(B5/J&3&)8H63%5/W2U3': MO%O[N",C"!'9Z)(M:Z/)@FI5D#:WQ.\'^A+X,< $YTQ_(?VMUKIANQKD,U^2 M)M;0/D)DCU@02PJO3,F"O,J7IC3P>@EH1:)=-3E'J41>DN.R*\CW3=1=UY*= M;LD*;=ECMG:2[?)'ISZ@F:F+4_*S[:.ZUU5A:\+NUXTI-2]S;E0+A7)G0^CC MT.:P3I.K&-++FT2X9&<*30MWT%@R9_JH\;\*HGSU!\Z7,">ND[.T%'\>"F2. M CGD?AER%D%.1+N6Y[\3\VJ'1%?!T4:Q(*E%5>0UTIN+XT3F-&P[GR<-D?_O+B^>7+UX1>+W+YB_5NP)&<"7&9^E6 MQ5Y>%J;K%H-U% -PE@8S9>]*LW;NWE0)V!3(V4LRI4[? M/W^IKLO2+B'$HZ][7?XF;"Y>>CGX70>FL/^,?4)#H)H57&Y^8!O/ALPT/9L+ M@<0[4Y[%[IKP)$89^.6UM05K/L3'P*'28C[>2M=U;Z0\,UA52>U=_"8VC5)* MY)N-/R.K#Z.4Q2?07W;R%L<"X&%;R@X$TEL:UMIV8TDQ]W!+C9"$T&TDR!2( MV&Z]@49_AAS7^@%2/$UM.YD$VEM+F$Z;4WB''/KTC@.5ABQ7&QC5P#?6754! MG(&-?$@M)*RW*?*6L*QL >:0V%.VC7]IJ<)LCB?'N+9G*SH[:P M$BI(D+-\0'9V>_?(T(4I+EBON])'G/H >.#2.SQ* <@AJ!7*)%H+8BY.S5>T M.;$4\KZ$(I$/+#(7"7DF,+A:.V?'LLXBGKAUIAQ>0]BJ@ K]10%102$R2$4+ MZ&.(X_!W>MHI15J)_&=>;/8W T*'^$#P]PD]$ #3)(J'H-_AM#)?Z%GB_7.H M#TN"5X&QE DJP2(#W(;PR24(>DB9-W"O![=3LEV>J , 9X$=I B:&$ZZP3G& MH7B"&$[O4,P Q^XM&*,8(-%_07GBB,UL$='72"98K&M.)9&*%J0LA!Q]Z-PF M<';.]%#4!S)1D$AFJEEU$+Z(39 D49!<6.21ZOF5V+9 VQ'J"5<:3XM"\"AT MJ==.)NR AJF) HL2K2*;@$0WI!EIR!HY()%SP3QC4.X4K448.:H5I% .-9BT MB!5BE-D>-6[KB&"1'"I4_4#Y#_D1 M(@A\N/" ,BIQ4D09OS=A(N'0GDGBN"3W:H7J@)0=#OMC9^,BN4Q\8T)<+]G9 MZ9[2.[TXY<,3[:I3CF036%Z$8Y!;G2.]DQ0Y-[5/-&3C G3P,B28]B]ECK0C M: 2Q(VP*'T.1O6N\>?BMLPB^)2P*MKK,VX&Z-PDF]")#WK6"BT0[0C:/S8&H M!XI'<@3%8PU++>0A2;)+RH&8-L0^BOU;CM',5H=X:650_\8.IM>VC+6-A=@) M@JD*#I#Y^,Y!1-($]T(,H01+3\0[T?=.A:'0^7UN2K93['%=Y$7)>^M+!83; M)(0X26AW-!5Y$5*1%\?K4+9A57+!XVAJ?13"@?(3@/DTS"YY0DNN+R

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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 49 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 50 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 143 216 1 false 42 0 false 4 false false R1.htm 00000001 - Document - Cover Sheet http://btcs.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Balance Sheets Sheet http://btcs.com/role/BalanceSheets Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Balance Sheets (Parenthetical) Sheet http://btcs.com/role/BalanceSheetsParenthetical Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Statements of Operations (Unaudited) Sheet http://btcs.com/role/StatementsOfOperations Statements of Operations (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Statements of Changes in Stockholders' Equity (Unaudited) Sheet http://btcs.com/role/StatementsOfChangesInStockholdersEquity Statements of Changes in Stockholders' Equity (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - Statements of Cash Flows (Unaudited) Sheet http://btcs.com/role/StatementsOfCashFlows Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 00000007 - Disclosure - Business Organization and Nature of Operations Sheet http://btcs.com/role/BusinessOrganizationAndNatureOfOperations Business Organization and Nature of Operations Notes 7 false false R8.htm 00000008 - Disclosure - Basis of Presentation Sheet http://btcs.com/role/BasisOfPresentation Basis of Presentation Notes 8 false false R9.htm 00000009 - Disclosure - Summary of Significant Accounting Policies Sheet http://btcs.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 9 false false R10.htm 00000010 - Disclosure - Fair Value of Financial Assets and Liabilities Sheet http://btcs.com/role/FairValueOfFinancialAssetsAndLiabilities Fair Value of Financial Assets and Liabilities Notes 10 false false R11.htm 00000011 - Disclosure - Stockholders??? Equity Sheet http://btcs.com/role/StockholdersEquity Stockholders??? Equity Notes 11 false false R12.htm 00000012 - Disclosure - Accrued Expenses Sheet http://btcs.com/role/AccruedExpenses Accrued Expenses Notes 12 false false R13.htm 00000013 - Disclosure - Employee Benefit Plans Sheet http://btcs.com/role/EmployeeBenefitPlans Employee Benefit Plans Notes 13 false false R14.htm 00000014 - Disclosure - Liquidity Sheet http://btcs.com/role/Liquidity Liquidity Notes 14 false false R15.htm 00000015 - Disclosure - Subsequent Events Sheet http://btcs.com/role/SubsequentEvents Subsequent Events Notes 15 false false R16.htm 00000016 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://btcs.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://btcs.com/role/SummaryOfSignificantAccountingPolicies 16 false false R17.htm 00000017 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://btcs.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://btcs.com/role/SummaryOfSignificantAccountingPolicies 17 false false R18.htm 00000018 - Disclosure - Fair Value of Financial Assets and Liabilities (Tables) Sheet http://btcs.com/role/FairValueOfFinancialAssetsAndLiabilitiesTables Fair Value of Financial Assets and Liabilities (Tables) Tables http://btcs.com/role/FairValueOfFinancialAssetsAndLiabilities 18 false false R19.htm 00000019 - Disclosure - Stockholders??? Equity (Tables) Sheet http://btcs.com/role/StockholdersEquityTables Stockholders??? Equity (Tables) Tables http://btcs.com/role/StockholdersEquity 19 false false R20.htm 00000020 - Disclosure - Accrued Expenses (Tables) Sheet http://btcs.com/role/AccruedExpensesTables Accrued Expenses (Tables) Tables http://btcs.com/role/AccruedExpenses 20 false false R21.htm 00000021 - Disclosure - Schedule of Earnings Per Share Anti-diluted (Details) Sheet http://btcs.com/role/ScheduleOfEarningsPerShareAnti-dilutedDetails Schedule of Earnings Per Share Anti-diluted (Details) Details 21 false false R22.htm 00000022 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) Sheet http://btcs.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative Summary of Significant Accounting Policies (Details Narrative) Details http://btcs.com/role/SummaryOfSignificantAccountingPoliciesTables 22 false false R23.htm 00000023 - Disclosure - Schedule of Fair Value of Assets and Liabilities Valued on Recurring Basis (Details) Sheet http://btcs.com/role/ScheduleOfFairValueOfAssetsAndLiabilitiesValuedOnRecurringBasisDetails Schedule of Fair Value of Assets and Liabilities Valued on Recurring Basis (Details) Details 23 false false R24.htm 00000024 - Disclosure - Summary of Valuation Methodology and Significant Unobservable Inputs Warrant Liabilities (Details) Sheet http://btcs.com/role/SummaryOfValuationMethodologyAndSignificantUnobservableInputsWarrantLiabilitiesDetails Summary of Valuation Methodology and Significant Unobservable Inputs Warrant Liabilities (Details) Details 24 false false R25.htm 00000025 - Disclosure - Schedule of Changes in Fair Value and Other Adjustments of Warrants (Details) Sheet http://btcs.com/role/ScheduleOfChangesInFairValueAndOtherAdjustmentsOfWarrantsDetails Schedule of Changes in Fair Value and Other Adjustments of Warrants (Details) Details 25 false false R26.htm 00000026 - Disclosure - Fair Value of Financial Assets and Liabilities (Details Narrative) Sheet http://btcs.com/role/FairValueOfFinancialAssetsAndLiabilitiesDetailsNarrative Fair Value of Financial Assets and Liabilities (Details Narrative) Details http://btcs.com/role/FairValueOfFinancialAssetsAndLiabilitiesTables 26 false false R27.htm 00000027 - Disclosure - Schedule of Weighted-Average Assumptions Used to Estimate Fair Value (Details) Sheet http://btcs.com/role/ScheduleOfWeighted-averageAssumptionsUsedToEstimateFairValueDetails Schedule of Weighted-Average Assumptions Used to Estimate Fair Value (Details) Details 27 false false R28.htm 00000028 - Disclosure - Summary of Option Activity (Details) Sheet http://btcs.com/role/SummaryOfOptionActivityDetails Summary of Option Activity (Details) Details 28 false false R29.htm 00000029 - Disclosure - Schedule of Restricted Stock Units (Details) Sheet http://btcs.com/role/ScheduleOfRestrictedStockUnitsDetails Schedule of Restricted Stock Units (Details) Details 29 false false R30.htm 00000030 - Disclosure - Summary of Restricted Stock (Details) Sheet http://btcs.com/role/SummaryOfRestrictedStockDetails Summary of Restricted Stock (Details) Details 30 false false R31.htm 00000031 - Disclosure - Schedule of Stock-based Compensation Expense (Details) Sheet http://btcs.com/role/ScheduleOfStock-basedCompensationExpenseDetails Schedule of Stock-based Compensation Expense (Details) Details 31 false false R32.htm 00000032 - Disclosure - Stockholders??? Equity (Details Narrative) Sheet http://btcs.com/role/StockholdersEquityDetailsNarrative Stockholders??? Equity (Details Narrative) Details http://btcs.com/role/StockholdersEquityTables 32 false false R33.htm 00000033 - Disclosure - Schedule of Accrued Expenses (Details) Sheet http://btcs.com/role/ScheduleOfAccruedExpensesDetails Schedule of Accrued Expenses (Details) Details 33 false false R34.htm 00000034 - Disclosure - Accrued Expenses (Details Narrative) Sheet http://btcs.com/role/AccruedExpensesDetailsNarrative Accrued Expenses (Details Narrative) Details http://btcs.com/role/AccruedExpensesTables 34 false false R35.htm 00000035 - Disclosure - Employee Benefit Plans (Details Narrative) Sheet http://btcs.com/role/EmployeeBenefitPlansDetailsNarrative Employee Benefit Plans (Details Narrative) Details http://btcs.com/role/EmployeeBenefitPlans 35 false false R36.htm 00000036 - Disclosure - Liquidity (Details Narrative) Sheet http://btcs.com/role/LiquidityDetailsNarrative Liquidity (Details Narrative) Details http://btcs.com/role/Liquidity 36 false false All Reports Book All Reports btcs-20230930.xsd btcs-20230930_cal.xml btcs-20230930_def.xml btcs-20230930_lab.xml btcs-20230930_pre.xml form10-q.htm http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true JSON 53 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "form10-q.htm": { "nsprefix": "BTCS", "nsuri": "http://btcs.com/20230930", "dts": { "schema": { "local": [ "btcs-20230930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "calculationLink": { "local": [ "btcs-20230930_cal.xml" ] }, "definitionLink": { "local": [ "btcs-20230930_def.xml" ] }, "labelLink": { "local": [ "btcs-20230930_lab.xml" ] }, "presentationLink": { "local": [ "btcs-20230930_pre.xml" ] }, "inline": { "local": [ "form10-q.htm" ] } }, "keyStandard": 187, "keyCustom": 29, "axisStandard": 12, "axisCustom": 0, "memberStandard": 17, "memberCustom": 24, "hidden": { "total": 82, "http://fasb.org/us-gaap/2023": 62, "http://btcs.com/20230930": 16, "http://xbrl.sec.gov/dei/2023": 4 }, "contextCount": 143, "entityCount": 1, "segmentCount": 42, "elementCount": 351, "unitCount": 4, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 517, "http://xbrl.sec.gov/dei/2023": 29 }, "report": { "R1": { "role": "http://btcs.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R2": { "role": "http://btcs.com/role/BalanceSheets", "longName": "00000002 - Statement - Balance Sheets", "shortName": "Balance Sheets", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R3": { "role": "http://btcs.com/role/BalanceSheetsParenthetical", "longName": "00000003 - Statement - Balance Sheets (Parenthetical)", "shortName": "Balance Sheets (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:InvestmentsAndCash", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:InvestmentsAndCash", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R4": { "role": "http://btcs.com/role/StatementsOfOperations", "longName": "00000004 - Statement - Statements of Operations (Unaudited)", "shortName": "Statements of Operations (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "From2023-07-012023-09-30", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-07-012023-09-30", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R5": { "role": "http://btcs.com/role/StatementsOfChangesInStockholdersEquity", "longName": "00000005 - Statement - Statements of Changes in Stockholders' Equity (Unaudited)", "shortName": "Statements of Changes in Stockholders' Equity (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "AsOf2021-12-31_us-gaap_CommonStockMember", "name": "us-gaap:StockholdersEquity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2021-12-31_us-gaap_CommonStockMember", "name": "us-gaap:StockholdersEquity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R6": { "role": "http://btcs.com/role/StatementsOfCashFlows", "longName": "00000006 - Statement - Statements of Cash Flows (Unaudited)", "shortName": "Statements of Cash Flows (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:NetIncomeLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:Depreciation", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R7": { "role": "http://btcs.com/role/BusinessOrganizationAndNatureOfOperations", "longName": "00000007 - Disclosure - Business Organization and Nature of Operations", "shortName": "Business Organization and Nature of Operations", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "7", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R8": { "role": "http://btcs.com/role/BasisOfPresentation", "longName": "00000008 - Disclosure - Basis of Presentation", "shortName": "Basis of Presentation", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R9": { "role": "http://btcs.com/role/SummaryOfSignificantAccountingPolicies", "longName": "00000009 - Disclosure - Summary of Significant Accounting Policies", "shortName": "Summary of Significant Accounting Policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R10": { "role": "http://btcs.com/role/FairValueOfFinancialAssetsAndLiabilities", "longName": "00000010 - Disclosure - Fair Value of Financial Assets and Liabilities", "shortName": "Fair Value of Financial Assets and Liabilities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R11": { "role": "http://btcs.com/role/StockholdersEquity", "longName": "00000011 - Disclosure - Stockholders\u2019 Equity", "shortName": "Stockholders\u2019 Equity", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R12": { "role": "http://btcs.com/role/AccruedExpenses", "longName": "00000012 - Disclosure - Accrued Expenses", "shortName": "Accrued Expenses", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R13": { "role": "http://btcs.com/role/EmployeeBenefitPlans", "longName": "00000013 - Disclosure - Employee Benefit Plans", "shortName": "Employee Benefit Plans", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R14": { "role": "http://btcs.com/role/Liquidity", "longName": "00000014 - Disclosure - Liquidity", "shortName": "Liquidity", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R15": { "role": "http://btcs.com/role/SubsequentEvents", "longName": "00000015 - Disclosure - Subsequent Events", "shortName": "Subsequent Events", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R16": { "role": "http://btcs.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "longName": "00000016 - Disclosure - Summary of Significant Accounting Policies (Policies)", "shortName": "Summary of Significant Accounting Policies (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "16", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R17": { "role": "http://btcs.com/role/SummaryOfSignificantAccountingPoliciesTables", "longName": "00000017 - Disclosure - Summary of Significant Accounting Policies (Tables)", "shortName": "Summary of Significant Accounting Policies (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "17", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R18": { "role": "http://btcs.com/role/FairValueOfFinancialAssetsAndLiabilitiesTables", "longName": "00000018 - Disclosure - Fair Value of Financial Assets and Liabilities (Tables)", "shortName": "Fair Value of Financial Assets and Liabilities (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "18", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R19": { "role": "http://btcs.com/role/StockholdersEquityTables", "longName": "00000019 - Disclosure - Stockholders\u2019 Equity (Tables)", "shortName": "Stockholders\u2019 Equity (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "19", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R20": { "role": "http://btcs.com/role/AccruedExpensesTables", "longName": "00000020 - Disclosure - Accrued Expenses (Tables)", "shortName": "Accrued Expenses (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "20", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R21": { "role": "http://btcs.com/role/ScheduleOfEarningsPerShareAnti-dilutedDetails", "longName": "00000021 - Disclosure - Schedule of Earnings Per Share Anti-diluted (Details)", "shortName": "Schedule of Earnings Per Share Anti-diluted (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "21", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R22": { "role": "http://btcs.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "longName": "00000022 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)", "shortName": "Summary of Significant Accounting Policies (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "22", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:Cash", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:Cash", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R23": { "role": "http://btcs.com/role/ScheduleOfFairValueOfAssetsAndLiabilitiesValuedOnRecurringBasisDetails", "longName": "00000023 - Disclosure - Schedule of Fair Value of Assets and Liabilities Valued on Recurring Basis (Details)", "shortName": "Schedule of Fair Value of Assets and Liabilities Valued on Recurring Basis (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "23", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:InvestmentsFairValueDisclosure", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": null }, "R24": { "role": "http://btcs.com/role/SummaryOfValuationMethodologyAndSignificantUnobservableInputsWarrantLiabilitiesDetails", "longName": "00000024 - Disclosure - Summary of Valuation Methodology and Significant Unobservable Inputs Warrant Liabilities (Details)", "shortName": "Summary of Valuation Methodology and Significant Unobservable Inputs Warrant Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "24", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-09-30_us-gaap_FairValueInputsLevel3Member", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R25": { "role": "http://btcs.com/role/ScheduleOfChangesInFairValueAndOtherAdjustmentsOfWarrantsDetails", "longName": "00000025 - Disclosure - Schedule of Changes in Fair Value and Other Adjustments of Warrants (Details)", "shortName": "Schedule of Changes in Fair Value and Other Adjustments of Warrants (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "25", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "us-gaap:InvestmentsFairValueDisclosure", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-09-30_us-gaap_FairValueInputsLevel3Member", "name": "us-gaap:FairValueAdjustmentOfWarrants", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R26": { "role": "http://btcs.com/role/FairValueOfFinancialAssetsAndLiabilitiesDetailsNarrative", "longName": "00000026 - Disclosure - Fair Value of Financial Assets and Liabilities (Details Narrative)", "shortName": "Fair Value of Financial Assets and Liabilities (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "26", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:InvestmentsFairValueDisclosure", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2021-03-012021-03-02_custom_SecuritiesPurchaseAgreementMember", "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R27": { "role": "http://btcs.com/role/ScheduleOfWeighted-averageAssumptionsUsedToEstimateFairValueDetails", "longName": "00000027 - Disclosure - Schedule of Weighted-Average Assumptions Used to Estimate Fair Value (Details)", "shortName": "Schedule of Weighted-Average Assumptions Used to Estimate Fair Value (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "27", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-30_srt_MinimumMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R28": { "role": "http://btcs.com/role/SummaryOfOptionActivityDetails", "longName": "00000028 - Disclosure - Summary of Option Activity (Details)", "shortName": "Summary of Option Activity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "28", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R29": { "role": "http://btcs.com/role/ScheduleOfRestrictedStockUnitsDetails", "longName": "00000029 - Disclosure - Schedule of Restricted Stock Units (Details)", "shortName": "Schedule of Restricted Stock Units (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "29", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R30": { "role": "http://btcs.com/role/SummaryOfRestrictedStockDetails", "longName": "00000030 - Disclosure - Summary of Restricted Stock (Details)", "shortName": "Summary of Restricted Stock (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "30", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R31": { "role": "http://btcs.com/role/ScheduleOfStock-basedCompensationExpenseDetails", "longName": "00000031 - Disclosure - Schedule of Stock-based Compensation Expense (Details)", "shortName": "Schedule of Stock-based Compensation Expense (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "31", "firstAnchor": { "contextRef": "From2023-07-012023-09-30", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-07-012023-09-30", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R32": { "role": "http://btcs.com/role/StockholdersEquityDetailsNarrative", "longName": "00000032 - Disclosure - Stockholders\u2019 Equity (Details Narrative)", "shortName": "Stockholders\u2019 Equity (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "32", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:CommonStockSharesAuthorized", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-07-12", "name": "us-gaap:CommonStockSharesAuthorized", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R33": { "role": "http://btcs.com/role/ScheduleOfAccruedExpensesDetails", "longName": "00000033 - Disclosure - Schedule of Accrued Expenses (Details)", "shortName": "Schedule of Accrued Expenses (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "33", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:AccruedEmployeeBenefitsCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:AccruedEmployeeBenefitsCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R34": { "role": "http://btcs.com/role/AccruedExpensesDetailsNarrative", "longName": "00000034 - Disclosure - Accrued Expenses (Details Narrative)", "shortName": "Accrued Expenses (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "34", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:AccruedBonusesCurrentAndNoncurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:AccruedBonusesCurrentAndNoncurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R35": { "role": "http://btcs.com/role/EmployeeBenefitPlansDetailsNarrative", "longName": "00000035 - Disclosure - Employee Benefit Plans (Details Narrative)", "shortName": "Employee Benefit Plans (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "35", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R36": { "role": "http://btcs.com/role/LiquidityDetailsNarrative", "longName": "00000036 - Disclosure - Liquidity (Details Narrative)", "shortName": "Liquidity (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "36", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:RetainedEarningsAccumulatedDeficit", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": null } }, "tag": { "BTCS_RestrictedStockUnitsRSUOneMember": { "xbrltype": "domainItemType", "nsuri": "http://btcs.com/20230930", "localname": "RestrictedStockUnitsRSUOneMember", "presentation": [ "http://btcs.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Restricted Stock Units (RSUs) One [Member]", "documentation": "Restricted Stock Units (RSUs) One [Member]" } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://btcs.com/role/StatementsOfChangesInStockholdersEquity", "http://btcs.com/role/StockholdersEquityDetailsNarrative", "http://btcs.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r8", "r87", "r103", "r104", "r105", "r113", "r114", "r115", "r117", "r123", "r125", "r137", "r156", "r157", "r189", "r242", "r243", "r244", "r257", "r258", "r264", "r265", "r266", "r267", "r268", "r269", "r271", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r311", "r312", "r313", "r325", "r392" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://btcs.com/role/BalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://btcs.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Assets", "label": "Assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r74", "r92", "r112", "r140", "r145", "r149", "r155", "r164", "r165", "r166", "r167", "r168", "r169", "r170", "r171", "r172", "r260", "r262", "r279", "r299", "r366", "r435", "r447", "r486", "r487", "r518" ] }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "presentation": [ "http://btcs.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Crypto Assets Translations and Remeasurements", "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets." } } }, "auth_ref": [ "r0", "r63" ] }, "us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable", "presentation": [ "http://btcs.com/role/ScheduleOfRestrictedStockUnitsDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table]", "documentation": "Schedule, table or text reflecting arrangements that are not equity-based payments, or pension and other postretirement benefits, with individual employees. The arrangements (for example, profit sharing, deferred bonuses or certain split-dollar life insurance arrangements) are generally based on employment contracts between the entity and one or more selected officers or key employees, and which contain a promise by the employer to pay certain amounts at designated future dates, sometimes including a period after retirement, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Disclosure also typically includes the amount of related compensation expense recognized during the reporting period and the carrying amount as of the balance sheet date of the related liability." } } }, "auth_ref": [ "r32", "r67" ] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "presentation": [ "http://btcs.com/role/ScheduleOfStock-basedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Stock-based compensation", "label": "Share-Based Payment Arrangement, Expense", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r241", "r249" ] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://btcs.com/role/SubsequentEvents" ], "lang": { "en-us": { "role": { "label": "Subsequent Events", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r287", "r288" ] }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "crdr": "credit", "calculation": { "http://btcs.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 11.0 } }, "presentation": [ "http://btcs.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Prepaid expenses and other current assets", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other." } } }, "auth_ref": [ "r4" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "presentation": [ "http://btcs.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r103", "r104", "r280", "r281", "r282", "r283", "r284", "r285" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://btcs.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "auth_ref": [] }, "us-gaap_DerivativeLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilities", "crdr": "credit", "presentation": [ "http://btcs.com/role/ScheduleOfChangesInFairValueAndOtherAdjustmentsOfWarrantsDetails", "http://btcs.com/role/ScheduleOfFairValueOfAssetsAndLiabilitiesValuedOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Warrant liabilities", "periodStartLabel": "Warrant liabilities, beginning balance", "periodEndLabel": "Warrant liabilities, ending balance", "label": "Derivative Liability", "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r98", "r99", "r278", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r367", "r369", "r370", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r421", "r530" ] }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentUsefulLife", "presentation": [ "http://btcs.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Property, plant and equipment, estimated useful lives", "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment." } } }, "auth_ref": [] }, "us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems", "presentation": [ "http://btcs.com/role/ScheduleOfRestrictedStockUnitsDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "auth_ref": [] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://btcs.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://btcs.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Stock-based compensation", "label": "Share-Based Payment Arrangement, Noncash Expense", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r4" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock", "presentation": [ "http://btcs.com/role/BasisOfPresentation" ], "lang": { "en-us": { "role": { "label": "Basis of Presentation", "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [ "r40", "r59", "r60" ] }, "us-gaap_DerivativeLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://btcs.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://btcs.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Warrant liabilities", "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r98" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://btcs.com/role/StatementsOfChangesInStockholdersEquity", "http://btcs.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r437", "r438", "r439", "r441", "r442", "r443", "r444", "r477", "r478", "r515", "r529", "r533" ] }, "BTCS_RestrictedStockUnitsRSUFourMember": { "xbrltype": "domainItemType", "nsuri": "http://btcs.com/20230930", "localname": "RestrictedStockUnitsRSUFourMember", "presentation": [ "http://btcs.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Restricted Stock Units (RSUs) Four [Member]", "documentation": "Restricted Stock Units (RSUs) Four [Member]" } } }, "auth_ref": [] }, "us-gaap_DividendsPayableAmountPerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendsPayableAmountPerShare", "presentation": [ "http://btcs.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Dividend per share", "documentation": "The per share amount of a dividend declared, but not paid, as of the financial reporting date." } } }, "auth_ref": [ "r23" ] }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://btcs.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://btcs.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts payable and accrued expense", "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits." } } }, "auth_ref": [ "r16" ] }, "us-gaap_CostOfRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfRevenue", "crdr": "debit", "calculation": { "http://btcs.com/role/StatementsOfOperations": { "parentTag": "us-gaap_GrossProfit", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://btcs.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Validator expenses", "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period." } } }, "auth_ref": [ "r51", "r112", "r155", "r164", "r165", "r166", "r167", "r168", "r169", "r170", "r171", "r172", "r279", "r486" ] }, "BTCS_RestrictedStockUnitsRSUTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://btcs.com/20230930", "localname": "RestrictedStockUnitsRSUTwoMember", "presentation": [ "http://btcs.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Restricted Stock Units (RSUs) Two [Member]", "documentation": "Restricted Stock Units (RSUs) Two [Member]" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsAbstract", "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CostOfRevenueAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfRevenueAbstract", "presentation": [ "http://btcs.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Cost of revenues" } } }, "auth_ref": [] }, "us-gaap_FairValueAdjustmentOfWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAdjustmentOfWarrants", "crdr": "debit", "calculation": { "http://btcs.com/role/StatementsOfOperations": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0, "order": 1.0 }, "http://btcs.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://btcs.com/role/ScheduleOfChangesInFairValueAndOtherAdjustmentsOfWarrantsDetails", "http://btcs.com/role/StatementsOfCashFlows", "http://btcs.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "negatedLabel": "Change in fair value of warrant liabilities", "label": "Change in fair value of warrant liabilities", "verboseLabel": "Fair value adjustment of warrant liabilities", "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability." } } }, "auth_ref": [ "r1", "r5" ] }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "presentation": [ "http://btcs.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Stock-based compensation", "label": "Share-Based Payment Arrangement [Policy Text Block]", "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost." } } }, "auth_ref": [ "r209", "r215", "r234", "r235", "r236", "r237", "r240", "r245", "r246", "r247", "r248" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeStockOptionMember", "presentation": [ "http://btcs.com/role/ScheduleOfEarningsPerShareAnti-dilutedDetails", "http://btcs.com/role/ScheduleOfStock-basedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Option [Member]", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [] }, "BTCS_FourYearAnniversaryMember": { "xbrltype": "domainItemType", "nsuri": "http://btcs.com/20230930", "localname": "FourYearAnniversaryMember", "presentation": [ "http://btcs.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Four-Year Anniversary [Member]", "documentation": "Four-Year Anniversary [Member]" } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://btcs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r466" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://btcs.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://btcs.com/role/BalanceSheets", "http://btcs.com/role/LiquidityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accumulated deficit", "negatedLabel": "Accumulated deficit", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r45", "r65", "r303", "r314", "r315", "r324", "r354", "r435" ] }, "us-gaap_Investments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Investments", "crdr": "debit", "calculation": { "http://btcs.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://btcs.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Investments, at value (Cost $100,000)", "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments." } } }, "auth_ref": [ "r298" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://btcs.com/role/StatementsOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://btcs.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net (decrease)/increase in cash", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r2", "r56" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://btcs.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "auth_ref": [] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://btcs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r458" ] }, "us-gaap_AccruedEmployeeBenefitsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedEmployeeBenefitsCurrent", "crdr": "credit", "calculation": { "http://btcs.com/role/ScheduleOfAccruedExpensesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://btcs.com/role/ScheduleOfAccruedExpensesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Accrued compensation", "label": "Accrued Employee Benefits, Current", "documentation": "Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r17" ] }, "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment", "crdr": "debit", "calculation": { "http://btcs.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://btcs.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Sale of property and equipment", "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r54" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "crdr": "debit", "presentation": [ "http://btcs.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash, beginning of period", "periodEndLabel": "Cash, end of period", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r21", "r56", "r109" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://btcs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r456" ] }, "BTCS_ChiefTechnologyOfficerMember": { "xbrltype": "domainItemType", "nsuri": "http://btcs.com/20230930", "localname": "ChiefTechnologyOfficerMember", "presentation": [ "http://btcs.com/role/ScheduleOfRestrictedStockUnitsDetails", "http://btcs.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Chief Technology Officer [Member]", "documentation": "Chief Technology Officer [Member]" } } }, "auth_ref": [] }, "us-gaap_RealizedInvestmentGainsLosses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RealizedInvestmentGainsLosses", "crdr": "credit", "presentation": [ "http://btcs.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Realized investment gains losses", "documentation": "Amount of realized gain (loss) on investment." } } }, "auth_ref": [ "r309" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://btcs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r455" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://btcs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "BTCS_RestrictedStockUnitsRSUThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://btcs.com/20230930", "localname": "RestrictedStockUnitsRSUThreeMember", "presentation": [ "http://btcs.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Restricted Stock Units (RSUs) Three [Member]", "documentation": "Restricted Stock Units (RSUs) Three [Member]" } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://btcs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r454" ] }, "us-gaap_WarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantMember", "presentation": [ "http://btcs.com/role/ScheduleOfEarningsPerShareAnti-dilutedDetails" ], "lang": { "en-us": { "role": { "label": "Warrant [Member]", "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount." } } }, "auth_ref": [ "r437", "r438", "r441", "r442", "r443", "r444" ] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityAbstract", "presentation": [ "http://btcs.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 equity:" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://btcs.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://btcs.com/role/BalanceSheets", "http://btcs.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "totalLabel": "Total stockholders\u2019 equity", "periodStartLabel": "Balance", "periodEndLabel": "Balance", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r43", "r46", "r47", "r61", "r355", "r372", "r393", "r394", "r435", "r447", "r476", "r483", "r516", "r533" ] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://btcs.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://btcs.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Additional paid in capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r44", "r435", "r532" ] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://btcs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://btcs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://btcs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "presentation": [ "http://btcs.com/role/SummaryOfOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Number of shares outstanding, Employee options granted", "documentation": "Gross number of share options (or share units) granted during the period." } } }, "auth_ref": [ "r220" ] }, "srt_StatementScenarioAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementScenarioAxis", "presentation": [ "http://btcs.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]" } } }, "auth_ref": [ "r126", "r208", "r469", "r470", "r480" ] }, "BTCS_AtTheMarketOfferingAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://btcs.com/20230930", "localname": "AtTheMarketOfferingAgreementMember", "presentation": [ "http://btcs.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "At-the-Market Offering Agreement [Member]", "documentation": "At-the-Market Offering Agreement [Member]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://btcs.com/role/ScheduleOfRestrictedStockUnitsDetails", "http://btcs.com/role/ScheduleOfStock-basedCompensationExpenseDetails", "http://btcs.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r212", "r213", "r214", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r236", "r237", "r238", "r239", "r240" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "presentation": [ "http://btcs.com/role/ScheduleOfStock-basedCompensationExpenseDetails", "http://btcs.com/role/ScheduleOfWeighted-averageAssumptionsUsedToEstimateFairValueDetails", "http://btcs.com/role/StockholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r210", "r211", "r212", "r213", "r214", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r236", "r237", "r238", "r239", "r240" ] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://btcs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "presentation": [ "http://btcs.com/role/ScheduleOfStock-basedCompensationExpenseDetails", "http://btcs.com/role/ScheduleOfWeighted-averageAssumptionsUsedToEstimateFairValueDetails", "http://btcs.com/role/StockholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "documentation": "Disclosure of information about share-based payment arrangement." } } }, "auth_ref": [ "r210", "r211", "r212", "r213", "r214", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r236", "r237", "r238", "r239", "r240" ] }, "BTCS_SecuritiesPurchaseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://btcs.com/20230930", "localname": "SecuritiesPurchaseAgreementMember", "presentation": [ "http://btcs.com/role/FairValueOfFinancialAssetsAndLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Securities Purchase Agreement [Member]", "documentation": "Securities Purchase Agreement [Member]" } } }, "auth_ref": [] }, "BTCS_NonVestedRestrictedStockAwardsUnitsMember": { "xbrltype": "domainItemType", "nsuri": "http://btcs.com/20230930", "localname": "NonVestedRestrictedStockAwardsUnitsMember", "presentation": [ "http://btcs.com/role/ScheduleOfEarningsPerShareAnti-dilutedDetails" ], "lang": { "en-us": { "role": { "label": "Non-vested Restricted Stock Awards Units [Member]", "documentation": "Non-vested Restricted Stock Awards Units [Member]" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "crdr": "debit", "calculation": { "http://btcs.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://btcs.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Accounts payable and accrued expenses", "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid." } } }, "auth_ref": [ "r4" ] }, "us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract", "presentation": [ "http://btcs.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Supplemental disclosure of non-cash financing and investing activities:" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://btcs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "BTCS_HCWainwrightCoLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://btcs.com/20230930", "localname": "HCWainwrightCoLLCMember", "presentation": [ "http://btcs.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "H.C. Wainwright and Co., LLC [Member]", "documentation": "H.C. Wainwright and Co., LLC [Member]" } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://btcs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://btcs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://btcs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "BTCS_EachIndependentDirectorMember": { "xbrltype": "domainItemType", "nsuri": "http://btcs.com/20230930", "localname": "EachIndependentDirectorMember", "presentation": [ "http://btcs.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Each Independent Director [Member]", "documentation": "Each Independent Director [Member]" } } }, "auth_ref": [] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://btcs.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Recent Accounting Pronouncements", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "us-gaap_AccruedBonusesCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedBonusesCurrentAndNoncurrent", "crdr": "credit", "presentation": [ "http://btcs.com/role/AccruedExpensesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accrued bonuses current and non current", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for incentive compensation awarded to employees and directors or earned by them based on the terms of one or more relevant arrangements." } } }, "auth_ref": [ "r38" ] }, "BTCS_RealizedGainsOnCryptoAssetCurrencyTransactions": { "xbrltype": "monetaryItemType", "nsuri": "http://btcs.com/20230930", "localname": "RealizedGainsOnCryptoAssetCurrencyTransactions", "crdr": "credit", "calculation": { "http://btcs.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://btcs.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "negatedLabel": "Realized gains on crypto asset transactions", "documentation": "Realized gains on crypto asset/currency transactions.", "label": "RealizedGainsOnCryptoAssetCurrencyTransactions" } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://btcs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r449" ] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "auth_ref": [] }, "us-gaap_PriorPeriodReclassificationAdjustmentDescription": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PriorPeriodReclassificationAdjustmentDescription", "presentation": [ "http://btcs.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Reclassifications", "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error." } } }, "auth_ref": [ "r471" ] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://btcs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://btcs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://btcs.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://btcs.com/role/LiquidityDetailsNarrative", "http://btcs.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in operating activities", "negatedLabel": "Operating activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r56", "r57", "r58" ] }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "presentation": [ "http://btcs.com/role/FairValueOfFinancialAssetsAndLiabilitiesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Fair Value of Assets and Liabilities Valued on Recurring Basis", "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r275", "r276" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1", "presentation": [ "http://btcs.com/role/SummaryOfOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average remaining contractual life (in years), options vested and exercisable", "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r233" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue", "presentation": [ "http://btcs.com/role/SummaryOfOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Total intrinsic value, employee options forfeited", "documentation": "The combined weighted average of the accumulated differences between the fair values on underlying shares and exercises prices to acquire such shares as of the grant date on options that were either forfeited or lapsed." } } }, "auth_ref": [ "r35" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://btcs.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash flows used from operating activities:" } } }, "auth_ref": [] }, "us-gaap_AssetsNoncurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsNoncurrentAbstract", "presentation": [ "http://btcs.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Other assets:" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfCommonStock", "crdr": "debit", "calculation": { "http://btcs.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://btcs.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net proceeds from issuance common stock/ At-the-market offering", "documentation": "The cash inflow from the additional capital contribution to the entity." } } }, "auth_ref": [ "r3" ] }, "us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonvestedRestrictedStockSharesActivityTableTextBlock", "presentation": [ "http://btcs.com/role/StockholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "Summary of Restricted Stock", "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock shares." } } }, "auth_ref": [ "r14" ] }, "us-gaap_TypeOfArrangementAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TypeOfArrangementAxis", "presentation": [ "http://btcs.com/role/FairValueOfFinancialAssetsAndLiabilitiesDetailsNarrative", "http://btcs.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]", "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r259" ] }, "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock", "presentation": [ "http://btcs.com/role/AccruedExpensesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Accrued Expenses", "documentation": "Tabular disclosure of the components of accrued liabilities." } } }, "auth_ref": [] }, "us-gaap_RestrictedStockUnitsRSUMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedStockUnitsRSUMember", "presentation": [ "http://btcs.com/role/ScheduleOfStock-basedCompensationExpenseDetails", "http://btcs.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Restricted Stock Units (RSUs) [Member]", "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "presentation": [ "http://btcs.com/role/SummaryOfOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average remaining contractual life (in years), beginning balance", "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r70" ] }, "us-gaap_ProceedsFromIssuanceInitialPublicOffering": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceInitialPublicOffering", "crdr": "debit", "presentation": [ "http://btcs.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Proceeds from issuance initial public offering, net", "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public." } } }, "auth_ref": [ "r3" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://btcs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://btcs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "presentation": [ "http://btcs.com/role/ScheduleOfWeighted-averageAssumptionsUsedToEstimateFairValueDetails", "http://btcs.com/role/StockholdersEquityDetailsNarrative", "http://btcs.com/role/SummaryOfValuationMethodologyAndSignificantUnobservableInputsWarrantLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Expected life (in years)", "verboseLabel": "Term (years)", "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r236" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "presentation": [ "http://btcs.com/role/FairValueOfFinancialAssetsAndLiabilitiesDetailsNarrative", "http://btcs.com/role/FairValueOfFinancialAssetsAndLiabilitiesTables", "http://btcs.com/role/ScheduleOfChangesInFairValueAndOtherAdjustmentsOfWarrantsDetails", "http://btcs.com/role/ScheduleOfFairValueOfAssetsAndLiabilitiesValuedOnRecurringBasisDetails", "http://btcs.com/role/SummaryOfValuationMethodologyAndSignificantUnobservableInputsWarrantLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Recurring and Nonrecurring [Table]", "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis." } } }, "auth_ref": [ "r275", "r276", "r277" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://btcs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r459", "r461", "r462" ] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://btcs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r465" ] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://btcs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r460" ] }, "us-gaap_ResearchAndDevelopmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchAndDevelopmentExpense", "crdr": "debit", "calculation": { "http://btcs.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://btcs.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Research and development", "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use." } } }, "auth_ref": [ "r39", "r250", "r526" ] }, "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfPrivatePlacement", "crdr": "debit", "presentation": [ "http://btcs.com/role/FairValueOfFinancialAssetsAndLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Gross proceeds from private placement", "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement." } } }, "auth_ref": [ "r3" ] }, "us-gaap_PaymentsOfDividends": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfDividends", "crdr": "credit", "presentation": [ "http://btcs.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Payments of dividends", "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests." } } }, "auth_ref": [ "r20" ] }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsFairValueHierarchyDomain", "presentation": [ "http://btcs.com/role/FairValueOfFinancialAssetsAndLiabilitiesDetailsNarrative", "http://btcs.com/role/FairValueOfFinancialAssetsAndLiabilitiesTables", "http://btcs.com/role/ScheduleOfChangesInFairValueAndOtherAdjustmentsOfWarrantsDetails", "http://btcs.com/role/ScheduleOfFairValueOfAssetsAndLiabilitiesValuedOnRecurringBasisDetails", "http://btcs.com/role/SummaryOfValuationMethodologyAndSignificantUnobservableInputsWarrantLiabilitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "auth_ref": [ "r173", "r201", "r202", "r203", "r204", "r205", "r206", "r289", "r290", "r291", "r426", "r427", "r429", "r430", "r431" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://btcs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r463" ] }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonoperatingIncomeExpenseAbstract", "presentation": [ "http://btcs.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Other income (expenses):" } } }, "auth_ref": [] }, "us-gaap_PaymentsOfDividendsCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfDividendsCommonStock", "crdr": "credit", "calculation": { "http://btcs.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://btcs.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Dividend distributions", "label": "Payments of Ordinary Dividends, Common Stock", "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity." } } }, "auth_ref": [ "r20" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage", "presentation": [ "http://btcs.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Vesting rights, percentage", "documentation": "Percentage of vesting of award under share-based payment arrangement." } } }, "auth_ref": [ "r489" ] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://btcs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "us-gaap_NonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://btcs.com/role/StatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://btcs.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Total other income (expenses)", "label": "Nonoperating Income (Expense)", "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)." } } }, "auth_ref": [ "r53" ] }, "us-gaap_FairValueInputsLevel2Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel2Member", "presentation": [ "http://btcs.com/role/ScheduleOfFairValueOfAssetsAndLiabilitiesValuedOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 2 [Member]", "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets." } } }, "auth_ref": [ "r173", "r201", "r206", "r276", "r290", "r426", "r427", "r429", "r430", "r431" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://btcs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r461" ] }, "us-gaap_MarketingAndAdvertisingExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MarketingAndAdvertisingExpense", "crdr": "debit", "presentation": [ "http://btcs.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Advertising and marketing expenses", "documentation": "The total expense recognized in the period for promotion, public relations, and brand or product advertising." } } }, "auth_ref": [ "r52" ] }, "us-gaap_Cash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Cash", "crdr": "debit", "presentation": [ "http://btcs.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cash", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r77", "r300", "r336", "r361", "r435", "r447", "r472" ] }, "us-gaap_FairValueInputsLevel1Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel1Member", "presentation": [ "http://btcs.com/role/ScheduleOfFairValueOfAssetsAndLiabilitiesValuedOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 1 [Member]", "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date." } } }, "auth_ref": [ "r173", "r201", "r206", "r276", "r289", "r429", "r430", "r431" ] }, "us-gaap_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityAbstract", "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://btcs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r464" ] }, "us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock", "presentation": [ "http://btcs.com/role/FairValueOfFinancialAssetsAndLiabilitiesTables" ], "lang": { "en-us": { "role": { "label": "Summary of Valuation Methodology and Significant Unobservable Inputs Warrant Liabilities", "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique used to measure similar asset in prior period by class of asset or liability on non-recurring basis." } } }, "auth_ref": [ "r9" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://btcs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r461" ] }, "us-gaap_FairValueInputsLevel3Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel3Member", "presentation": [ "http://btcs.com/role/FairValueOfFinancialAssetsAndLiabilitiesDetailsNarrative", "http://btcs.com/role/FairValueOfFinancialAssetsAndLiabilitiesTables", "http://btcs.com/role/ScheduleOfChangesInFairValueAndOtherAdjustmentsOfWarrantsDetails", "http://btcs.com/role/ScheduleOfFairValueOfAssetsAndLiabilitiesValuedOnRecurringBasisDetails", "http://btcs.com/role/SummaryOfValuationMethodologyAndSignificantUnobservableInputsWarrantLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 3 [Member]", "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r173", "r201", "r202", "r203", "r204", "r205", "r206", "r276", "r291", "r426", "r427", "r429", "r430", "r431" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://btcs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r448" ] }, "us-gaap_StockIssuedDuringPeriodValueOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueOther", "crdr": "credit", "presentation": [ "http://btcs.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Issuance of Series V preferred stock", "documentation": "Value of shares of stock issued attributable to transactions classified as other." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesOther": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesOther", "presentation": [ "http://btcs.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Issuanceof Series V preferred stock, shares", "documentation": "Number of shares of stock issued attributable to transactions classified as other." } } }, "auth_ref": [] }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueRecognitionPolicyTextBlock", "presentation": [ "http://btcs.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Revenue Recognition", "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources." } } }, "auth_ref": [ "r376", "r417", "r422" ] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://btcs.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 }, "http://btcs.com/role/StatementsOfOperations": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://btcs.com/role/LiquidityDetailsNarrative", "http://btcs.com/role/StatementsOfCashFlows", "http://btcs.com/role/StatementsOfChangesInStockholdersEquity", "http://btcs.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Net loss", "label": "Net loss", "negatedLabel": "Net income loss", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r49", "r58", "r76", "r88", "r100", "r101", "r105", "r112", "r116", "r118", "r119", "r120", "r121", "r124", "r125", "r131", "r140", "r144", "r148", "r150", "r155", "r164", "r165", "r166", "r167", "r168", "r169", "r170", "r171", "r172", "r273", "r279", "r307", "r374", "r390", "r391", "r424", "r445", "r486" ] }, "us-gaap_AssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsNoncurrent", "crdr": "debit", "calculation": { "http://btcs.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://btcs.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total other assets", "label": "Assets, Noncurrent", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r112", "r155", "r164", "r165", "r166", "r167", "r168", "r169", "r170", "r171", "r172", "r260", "r262", "r279", "r486", "r487", "r518" ] }, "us-gaap_CashFDICInsuredAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashFDICInsuredAmount", "crdr": "debit", "presentation": [ "http://btcs.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cash, FDIC insured amount", "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation." } } }, "auth_ref": [] }, "us-gaap_FairValueDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresAbstract", "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://btcs.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://btcs.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r18", "r90", "r112", "r155", "r164", "r165", "r166", "r167", "r168", "r169", "r170", "r171", "r172", "r261", "r262", "r263", "r279", "r435", "r486", "r518", "r519" ] }, "us-gaap_AccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://btcs.com/role/ScheduleOfAccruedExpensesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://btcs.com/role/ScheduleOfAccruedExpensesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Accrued Expenses", "label": "Accrued Liabilities, Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r17" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "presentation": [ "http://btcs.com/role/FairValueOfFinancialAssetsAndLiabilitiesDetailsNarrative", "http://btcs.com/role/FairValueOfFinancialAssetsAndLiabilitiesTables", "http://btcs.com/role/ScheduleOfChangesInFairValueAndOtherAdjustmentsOfWarrantsDetails", "http://btcs.com/role/ScheduleOfFairValueOfAssetsAndLiabilitiesValuedOnRecurringBasisDetails", "http://btcs.com/role/SummaryOfValuationMethodologyAndSignificantUnobservableInputsWarrantLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r275", "r276", "r277" ] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://btcs.com/role/StatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://btcs.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Gross profit", "label": "Gross Profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r50", "r112", "r140", "r144", "r148", "r150", "r155", "r164", "r165", "r166", "r167", "r168", "r169", "r170", "r171", "r172", "r279", "r424", "r486" ] }, "BTCS_CryptoAssetsCurrencies": { "xbrltype": "monetaryItemType", "nsuri": "http://btcs.com/20230930", "localname": "CryptoAssetsCurrencies", "crdr": "debit", "calculation": { "http://btcs.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://btcs.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Crypto assets", "documentation": "Crypto assets/currencies." } } }, "auth_ref": [] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://btcs.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r242", "r243", "r244", "r325", "r477", "r478", "r479", "r515", "r533" ] }, "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "presentation": [ "http://btcs.com/role/StockholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Restricted Stock Units", "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year." } } }, "auth_ref": [ "r34" ] }, "us-gaap_PreferredStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesIssued", "presentation": [ "http://btcs.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preferred stock, shares issued", "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt." } } }, "auth_ref": [ "r42", "r175" ] }, "us-gaap_AccruedSalariesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedSalariesCurrent", "crdr": "credit", "calculation": { "http://btcs.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://btcs.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accrued compensation", "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r17", "r420" ] }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "crdr": "credit", "presentation": [ "http://btcs.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Stock option grant date fair value", "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r35", "r42", "r43", "r65" ] }, "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock", "presentation": [ "http://btcs.com/role/FairValueOfFinancialAssetsAndLiabilitiesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Changes in Fair Value and Other Adjustments of Warrants", "documentation": "Tabular disclosure of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset) using recurring unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r10", "r13" ] }, "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "presentation": [ "http://btcs.com/role/StockholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Stock-based Compensation Expense", "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit." } } }, "auth_ref": [ "r36" ] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UseOfEstimates", "presentation": [ "http://btcs.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Use of Estimates", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r26", "r27", "r28", "r79", "r80", "r82", "r83" ] }, "us-gaap_InvestmentsAndCash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentsAndCash", "crdr": "debit", "presentation": [ "http://btcs.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Cost of investment", "documentation": "Sum of investments and unrestricted cash as of the balance sheet date." } } }, "auth_ref": [ "r527", "r528" ] }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueNewIssues", "crdr": "credit", "presentation": [ "http://btcs.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Issuance of common stock, net of offering cost / At-the-market offering", "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering." } } }, "auth_ref": [ "r8", "r42", "r43", "r65", "r325", "r392", "r410", "r446" ] }, "us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExaminationLikelihoodOfUnfavorableSettlement", "presentation": [ "http://btcs.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Income tax likelihood percentage description", "documentation": "Description of the likelihood that an uncertainty in income taxes will not be sustained as a result of the examination by the taxing authority." } } }, "auth_ref": [ "r37", "r72" ] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://btcs.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preferred stock, shares authorized", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r42", "r353" ] }, "us-gaap_PreferredStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesOutstanding", "presentation": [ "http://btcs.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preferred stock, shares outstanding", "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased." } } }, "auth_ref": [ "r42", "r353", "r372", "r533", "r534" ] }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "presentation": [ "http://btcs.com/role/StockholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "Summary of Option Activity", "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value." } } }, "auth_ref": [ "r11", "r12", "r34" ] }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "presentation": [ "http://btcs.com/role/StockholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Weighted-Average Assumptions Used to Estimate Fair Value", "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions." } } }, "auth_ref": [ "r71" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://btcs.com/role/BalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://btcs.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Liabilities and Stockholders\u2019 Equity", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r48", "r75", "r304", "r435", "r476", "r483", "r516" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://btcs.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities and Stockholders\u2019 Equity:" } } }, "auth_ref": [] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://btcs.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preferred stock, par value", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r42", "r175" ] }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesNewIssues", "presentation": [ "http://btcs.com/role/FairValueOfFinancialAssetsAndLiabilitiesDetailsNarrative", "http://btcs.com/role/StatementsOfChangesInStockholdersEquity", "http://btcs.com/role/StockholdersEquityDetailsNarrative", "http://btcs.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Issuance of common stock, net of offering cost / At-the-market offering, shares", "verboseLabel": "Number of shares issued", "terseLabel": "Shares of common stock", "documentation": "Number of new stock issued during the period." } } }, "auth_ref": [ "r8", "r42", "r43", "r65", "r320", "r392", "r410" ] }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByFairValueHierarchyLevelAxis", "presentation": [ "http://btcs.com/role/FairValueOfFinancialAssetsAndLiabilitiesDetailsNarrative", "http://btcs.com/role/FairValueOfFinancialAssetsAndLiabilitiesTables", "http://btcs.com/role/ScheduleOfChangesInFairValueAndOtherAdjustmentsOfWarrantsDetails", "http://btcs.com/role/ScheduleOfFairValueOfAssetsAndLiabilitiesValuedOnRecurringBasisDetails", "http://btcs.com/role/SummaryOfValuationMethodologyAndSignificantUnobservableInputsWarrantLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value Hierarchy and NAV [Axis]", "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r173", "r201", "r202", "r203", "r204", "r205", "r206", "r276", "r289", "r290", "r291", "r426", "r427", "r429", "r430", "r431" ] }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentLineItems", "presentation": [ "http://btcs.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "presentation": [ "http://btcs.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Share based compensation", "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r8", "r42", "r43", "r65" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://btcs.com/role/StockholdersEquityDetailsNarrative", "http://btcs.com/role/SummaryOfOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average exercise price, employee options granted", "verboseLabel": "Weighted average exercise price", "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options." } } }, "auth_ref": [ "r220" ] }, "us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock", "presentation": [ "http://btcs.com/role/EmployeeBenefitPlans" ], "lang": { "en-us": { "role": { "label": "Employee Benefit Plans", "documentation": "The entire disclosure of an entity's employee compensation and benefit plans, excluding share-based compensation and including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, life insurance, severance, health care, unemployment and other benefit plans." } } }, "auth_ref": [ "r66", "r68", "r69" ] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "presentation": [ "http://btcs.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Weighted average number of common shares outstanding, diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r128", "r134" ] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockValue", "crdr": "credit", "calculation": { "http://btcs.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://btcs.com/role/BalanceSheets", "http://btcs.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Preferred stock value", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r42", "r301", "r435" ] }, "BTCS_IssuanceOfCommonStockNetOfOfferingCostAtthemarketOffering": { "xbrltype": "monetaryItemType", "nsuri": "http://btcs.com/20230930", "localname": "IssuanceOfCommonStockNetOfOfferingCostAtthemarketOffering", "crdr": "credit", "presentation": [ "http://btcs.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "verboseLabel": "Issuance of common stock, net of offering cost / At-the-market offering", "documentation": "Issuance of common stock net of offering cost atthemarket offering.", "label": "IssuanceOfCommonStockNetOfOfferingCostAtthemarketOffering" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://btcs.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://btcs.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Assets, Current", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r89", "r97", "r112", "r155", "r164", "r165", "r166", "r167", "r168", "r169", "r170", "r171", "r172", "r260", "r262", "r279", "r435", "r486", "r487", "r518" ] }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "crdr": "credit", "calculation": { "http://btcs.com/role/StatementsOfOperations": { "parentTag": "us-gaap_Revenues", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://btcs.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Validator revenue (net of fees)", "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise." } } }, "auth_ref": [ "r141", "r142", "r143", "r146", "r147", "r151", "r152", "r153", "r198", "r199", "r294" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://btcs.com/role/StatementsOfChangesInStockholdersEquity", "http://btcs.com/role/StockholdersEquityDetailsNarrative", "http://btcs.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r8", "r19", "r87", "r103", "r104", "r105", "r113", "r114", "r115", "r117", "r123", "r125", "r137", "r156", "r157", "r189", "r242", "r243", "r244", "r257", "r258", "r264", "r265", "r266", "r267", "r268", "r269", "r271", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r311", "r312", "r313", "r325", "r392" ] }, "BTCS_OneYearAnniversaryMember": { "xbrltype": "domainItemType", "nsuri": "http://btcs.com/20230930", "localname": "OneYearAnniversaryMember", "presentation": [ "http://btcs.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "One-Year Anniversary [Member]", "documentation": "One-Year Anniversary [Member]" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "presentation": [ "http://btcs.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Weighted average number of common shares outstanding, basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r127", "r134" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "presentation": [ "http://btcs.com/role/SummaryOfOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average exercise price, employee options forfeited", "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated." } } }, "auth_ref": [ "r222" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://btcs.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r87", "r113", "r114", "r115", "r117", "r123", "r125", "r156", "r157", "r242", "r243", "r244", "r257", "r258", "r264", "r266", "r267", "r269", "r271", "r311", "r313", "r325", "r533" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrentAbstract", "presentation": [ "http://btcs.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Current assets:" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures", "presentation": [ "http://btcs.com/role/ScheduleOfRestrictedStockUnitsDetails" ], "lang": { "en-us": { "role": { "label": "Number of restricted stock units granted and vested, shares", "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited." } } }, "auth_ref": [ "r8", "r42", "r43", "r65" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "presentation": [ "http://btcs.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Net loss per share attributable to common stockholders, diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r107", "r118", "r119", "r120", "r121", "r122", "r129", "r132", "r133", "r134", "r136", "r272", "r273", "r295", "r308", "r423" ] }, "BTCS_StakedCryptoAssetsCurrencies": { "xbrltype": "monetaryItemType", "nsuri": "http://btcs.com/20230930", "localname": "StakedCryptoAssetsCurrencies", "crdr": "debit", "calculation": { "http://btcs.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://btcs.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Staked crypto assets", "documentation": "Staked crypto assets/currencies." } } }, "auth_ref": [] }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "presentation": [ "http://btcs.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Sale of stock, number of shares issued in transaction", "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction." } } }, "auth_ref": [] }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "presentation": [ "http://btcs.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Cost of Revenues", "documentation": "Disclosure of accounting policy for revenue from contract with customer." } } }, "auth_ref": [ "r85", "r190", "r191", "r192", "r193", "r194", "r195", "r196", "r197", "r417" ] }, "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SaleOfStockConsiderationReceivedOnTransaction", "crdr": "debit", "presentation": [ "http://btcs.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Sale of stock, consideration received on transaction", "documentation": "Cash received on stock transaction after deduction of issuance costs." } } }, "auth_ref": [] }, "srt_ChiefFinancialOfficerMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ChiefFinancialOfficerMember", "presentation": [ "http://btcs.com/role/ScheduleOfRestrictedStockUnitsDetails" ], "lang": { "en-us": { "role": { "label": "Chief Financial Officer [Member]" } } }, "auth_ref": [ "r482" ] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://btcs.com/role/StockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 Equity", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r64", "r111", "r174", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r183", "r184", "r185", "r186", "r189", "r270", "r395", "r396", "r414" ] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://btcs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "presentation": [ "http://btcs.com/role/FairValueOfFinancialAssetsAndLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common stock warrants", "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares." } } }, "auth_ref": [ "r188" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "presentation": [ "http://btcs.com/role/SummaryOfRestrictedStockDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Number of restricted stock units, forfeited", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period." } } }, "auth_ref": [ "r229" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://btcs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "presentation": [ "http://btcs.com/role/SummaryOfRestrictedStockDetails" ], "lang": { "en-us": { "role": { "label": "Number of restricted stock units, granted", "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r227" ] }, "srt_ChiefExecutiveOfficerMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ChiefExecutiveOfficerMember", "presentation": [ "http://btcs.com/role/ScheduleOfRestrictedStockUnitsDetails" ], "lang": { "en-us": { "role": { "label": "Chief Executive Officer [Member]" } } }, "auth_ref": [ "r482" ] }, "BTCS_FourEqualInstallmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://btcs.com/20230930", "localname": "FourEqualInstallmentsMember", "presentation": [ "http://btcs.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Four Equal Installments [Member]", "documentation": "Four Equal Installments [Member]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://btcs.com/role/SummaryOfRestrictedStockDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average grant day fair value, granted", "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r227" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "presentation": [ "http://btcs.com/role/SummaryOfRestrictedStockDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Number of restricted stock units nonvested, beginning balance", "periodEndLabel": "Number of restricted stock units nonvested, ending balance", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date." } } }, "auth_ref": [ "r224", "r225" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "presentation": [ "http://btcs.com/role/SummaryOfRestrictedStockDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Weighted average grant day fair value nonvested, beginning balance", "periodEndLabel": "Weighted average grant day fair value nonvested, ending balance", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [ "r224", "r225" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "presentation": [ "http://btcs.com/role/SummaryOfRestrictedStockDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Number of restricted stock units, vested", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period." } } }, "auth_ref": [ "r228" ] }, "srt_ChiefOperatingOfficerMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ChiefOperatingOfficerMember", "presentation": [ "http://btcs.com/role/ScheduleOfRestrictedStockUnitsDetails" ], "lang": { "en-us": { "role": { "label": "Chief Operating Officer [Member]" } } }, "auth_ref": [ "r482", "r517" ] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://btcs.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://btcs.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchase of property and equipment", "label": "Payments to Acquire Property, Plant, and Equipment", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r55" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://btcs.com/role/SummaryOfRestrictedStockDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average grant day fair value, vested", "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement." } } }, "auth_ref": [ "r228" ] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://btcs.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://btcs.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Property and equipment, net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r6", "r297", "r306", "r435" ] }, "us-gaap_MarketingExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MarketingExpense", "crdr": "debit", "calculation": { "http://btcs.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://btcs.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Marketing", "documentation": "Expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services. Costs of public relations and corporate promotions are typically considered to be marketing costs." } } }, "auth_ref": [ "r52" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://btcs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r450" ] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://btcs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "us-gaap_FairValueDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresTextBlock", "presentation": [ "http://btcs.com/role/FairValueOfFinancialAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Fair Value of Financial Assets and Liabilities", "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information." } } }, "auth_ref": [ "r274" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "presentation": [ "http://btcs.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Vesting period", "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition." } } }, "auth_ref": [ "r433" ] }, "us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent", "presentation": [ "http://btcs.com/role/EmployeeBenefitPlansDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Percentage of defined comtribution plan employee", "documentation": "Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan." } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "presentation": [ "http://btcs.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Property and Equipment", "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r6", "r81", "r84", "r305" ] }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SignificantAccountingPoliciesTextBlock", "presentation": [ "http://btcs.com/role/SummaryOfSignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies", "documentation": "The entire disclosure for all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r59", "r110" ] }, "BTCS_RealizedGainOnCryptoAssetsTransactions": { "xbrltype": "monetaryItemType", "nsuri": "http://btcs.com/20230930", "localname": "RealizedGainOnCryptoAssetsTransactions", "crdr": "credit", "calculation": { "http://btcs.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://btcs.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Realized gain on crypto assets transactions", "documentation": "Realized gain on crypto assets transactions.", "label": "RealizedGainOnCryptoAssetsTransactions" } } }, "auth_ref": [] }, "us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount", "crdr": "debit", "presentation": [ "http://btcs.com/role/EmployeeBenefitPlansDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Defined comtribution plan employee", "documentation": "Maximum amount the employee may contribute to a defined contribution plan." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "presentation": [ "http://btcs.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of additional shares authorized", "documentation": "Number of shares authorized for issuance under share-based payment arrangement." } } }, "auth_ref": [ "r434" ] }, "BTCS_IndependentDirectorsMember": { "xbrltype": "domainItemType", "nsuri": "http://btcs.com/20230930", "localname": "IndependentDirectorsMember", "presentation": [ "http://btcs.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Independent Directors [Member]", "documentation": "Independent Directors [Member]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "presentation": [ "http://btcs.com/role/SummaryOfOptionActivityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Number of shares outstanding, Employee options forfeited", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period", "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan." } } }, "auth_ref": [ "r222" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://btcs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod", "presentation": [ "http://btcs.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Stock option granted", "documentation": "Net number of share options (or share units) granted during the period." } } }, "auth_ref": [ "r496" ] }, "us-gaap_ImpairmentLossesRelatedToRealEstatePartnerships": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ImpairmentLossesRelatedToRealEstatePartnerships", "crdr": "debit", "presentation": [ "http://btcs.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Impairment losses", "documentation": "Impairment losses measured as the amount by which the carrying amount of the business or real estate partnerships exceeds the fair value of the business or partnership." } } }, "auth_ref": [ "r58", "r62" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAbstract", "presentation": [ "http://btcs.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Assets:" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "presentation": [ "http://btcs.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Net loss per share attributable to common stockholders, basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r107", "r118", "r119", "r120", "r121", "r122", "r127", "r129", "r132", "r133", "r134", "r136", "r272", "r273", "r295", "r308", "r423" ] }, "srt_OfficerMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "OfficerMember", "presentation": [ "http://btcs.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Officer [Member]" } } }, "auth_ref": [ "r154", "r531" ] }, "BTCS_NonExecutiveEmployeesMember": { "xbrltype": "domainItemType", "nsuri": "http://btcs.com/20230930", "localname": "NonExecutiveEmployeesMember", "presentation": [ "http://btcs.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Non-Executive Employees [Member]", "documentation": "Non-Executive Employees [Member]" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://btcs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "BTCS_SaleOfNonproductiveCryptoAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://btcs.com/20230930", "localname": "SaleOfNonproductiveCryptoAssets", "crdr": "debit", "calculation": { "http://btcs.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://btcs.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Sale of non-productive crypto assets", "documentation": "Sale of non-productive crypto assets." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "crdr": "debit", "presentation": [ "http://btcs.com/role/SummaryOfOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Total Intrinsic value, beginning balance", "periodEndLabel": "Total Intrinsic value, ending balance", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value", "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding." } } }, "auth_ref": [ "r33" ] }, "srt_ScenarioUnspecifiedDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScenarioUnspecifiedDomain", "presentation": [ "http://btcs.com/role/StockholdersEquityDetailsNarrative" ], "auth_ref": [ "r126", "r208", "r469", "r480" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "presentation": [ "http://btcs.com/role/SummaryOfOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Number of shares outstanding, beginning balance", "periodEndLabel": "Number of shares outstanding, ending balance", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "documentation": "Number of options outstanding, including both vested and non-vested options." } } }, "auth_ref": [ "r216", "r217" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "presentation": [ "http://btcs.com/role/SummaryOfOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Weighted average exercise price, beginning balance", "periodEndLabel": "Weighted average exercise price, ending balance", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan." } } }, "auth_ref": [ "r216", "r217" ] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://btcs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "BTCS_TwoThousandAndTwentyOneEquityIncentivePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://btcs.com/20230930", "localname": "TwoThousandAndTwentyOneEquityIncentivePlanMember", "presentation": [ "http://btcs.com/role/ScheduleOfWeighted-averageAssumptionsUsedToEstimateFairValueDetails", "http://btcs.com/role/StockholdersEquityDetailsNarrative", "http://btcs.com/role/StockholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "2021 Equity Incentive Plan [Member]", "documentation": "2021 Equity Incentive Plan [Member]" } } }, "auth_ref": [] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://btcs.com/role/BalanceSheets", "http://btcs.com/role/BalanceSheetsParenthetical", "http://btcs.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r113", "r114", "r115", "r137", "r294", "r318", "r337", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r356", "r357", "r358", "r359", "r360", "r362", "r363", "r364", "r365", "r367", "r368", "r369", "r370", "r371", "r373", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r392", "r440" ] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://btcs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "presentation": [ "http://btcs.com/role/SummaryOfValuationMethodologyAndSignificantUnobservableInputsWarrantLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Expected dividend yield", "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term." } } }, "auth_ref": [ "r238" ] }, "us-gaap_VestingAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VestingAxis", "presentation": [ "http://btcs.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Vesting [Axis]", "documentation": "Information by vesting schedule of award under share-based payment arrangement." } } }, "auth_ref": [ "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "presentation": [ "http://btcs.com/role/ScheduleOfWeighted-averageAssumptionsUsedToEstimateFairValueDetails", "http://btcs.com/role/SummaryOfValuationMethodologyAndSignificantUnobservableInputsWarrantLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Risk-free rate of interest", "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares." } } }, "auth_ref": [ "r239" ] }, "us-gaap_VestingDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VestingDomain", "presentation": [ "http://btcs.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Vesting schedule of award under share-based payment arrangement." } } }, "auth_ref": [ "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514" ] }, "us-gaap_CompensationExpenseExcludingCostOfGoodAndServiceSold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CompensationExpenseExcludingCostOfGoodAndServiceSold", "crdr": "debit", "calculation": { "http://btcs.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://btcs.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Compensation and related expenses", "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit. Other employee benefit expense includes, but is not limited to, service component of net periodic benefit cost for defined benefit plan. Excludes compensation cost in cost of good and service sold." } } }, "auth_ref": [ "r473" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "presentation": [ "http://btcs.com/role/ScheduleOfWeighted-averageAssumptionsUsedToEstimateFairValueDetails", "http://btcs.com/role/SummaryOfValuationMethodologyAndSignificantUnobservableInputsWarrantLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Expected volatility", "verboseLabel": "Expected stock price volatility", "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period." } } }, "auth_ref": [ "r237" ] }, "BTCS_ValidatorRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://btcs.com/20230930", "localname": "ValidatorRevenue", "crdr": "credit", "calculation": { "http://btcs.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://btcs.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Validator revenue", "documentation": "Validator revenue.", "label": "ValidatorRevenue" } } }, "auth_ref": [] }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ArrangementsAndNonarrangementTransactionsMember", "presentation": [ "http://btcs.com/role/FairValueOfFinancialAssetsAndLiabilitiesDetailsNarrative", "http://btcs.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r259" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://btcs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r452" ] }, "us-gaap_PreferredStockConversionBasis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockConversionBasis", "presentation": [ "http://btcs.com/role/StockholdersEquityDetailsNarrative", "http://btcs.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Liquidation preference", "documentation": "Describe the conversion features of preferred stock if preferred stock is convertible. That is, shares of preferred stock into which another convertible security was converted, or shares of preferred stock into which another class of preferred stock was converted." } } }, "auth_ref": [ "r31", "r42" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://btcs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r453" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://btcs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r457" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://btcs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue", "presentation": [ "http://btcs.com/role/SummaryOfOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Total intrinsic value, employee options granted", "documentation": "The grant-date intrinsic value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology." } } }, "auth_ref": [ "r230" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "presentation": [ "http://btcs.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r103", "r104", "r280", "r281", "r282", "r283", "r284", "r285" ] }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BasisOfAccountingPolicyPolicyTextBlock", "presentation": [ "http://btcs.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Basis of presentation", "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://btcs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r450" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice", "presentation": [ "http://btcs.com/role/ScheduleOfWeighted-averageAssumptionsUsedToEstimateFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Exercise price", "documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice", "presentation": [ "http://btcs.com/role/SummaryOfOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Weighted average exercise price, options vested and exercisable", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price", "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r233" ] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://btcs.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://btcs.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Cash and cash equivalents", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r21", "r91", "r418" ] }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsPolicyTextBlock", "presentation": [ "http://btcs.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Cash and cash equivalents", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value." } } }, "auth_ref": [ "r22" ] }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueShareBasedCompensationGross", "crdr": "credit", "presentation": [ "http://btcs.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Stock-based compensation", "documentation": "Value, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)." } } }, "auth_ref": [] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://btcs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue", "crdr": "debit", "presentation": [ "http://btcs.com/role/SummaryOfOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Total intrinsic value, options vested and exercisable", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value", "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r233" ] }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationGross", "presentation": [ "http://btcs.com/role/StatementsOfChangesInStockholdersEquity", "http://btcs.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Stock-based compensation, shares", "verboseLabel": "Share based payment issued", "documentation": "Number, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)." } } }, "auth_ref": [] }, "us-gaap_OtherAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAccountsPayableAndAccruedLiabilities", "crdr": "credit", "calculation": { "http://btcs.com/role/ScheduleOfAccruedExpensesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://btcs.com/role/ScheduleOfAccruedExpensesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Accounts payable and accrued expenses", "label": "Other Accounts Payable and Accrued Liabilities", "documentation": "Amount of liabilities incurred and payable to vendors for goods and services received classified as other, and expenses incurred but not yet paid, payable within one year or the operating cycle, if longer." } } }, "auth_ref": [] }, "us-gaap_Depreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Depreciation", "crdr": "debit", "calculation": { "http://btcs.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://btcs.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Depreciation expense", "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation." } } }, "auth_ref": [ "r5", "r30" ] }, "us-gaap_SharesIssuedPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesIssuedPricePerShare", "presentation": [ "http://btcs.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Shares issued, price per share", "documentation": "Per share or per unit amount of equity securities issued." } } }, "auth_ref": [] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalOther", "crdr": "credit", "presentation": [ "http://btcs.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Dividend distributions", "documentation": "Amount of other increase (decrease) in additional paid in capital (APIC)." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber", "presentation": [ "http://btcs.com/role/SummaryOfOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Number of shares outstanding, options vested and exercisable", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number", "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r233" ] }, "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "presentation": [ "http://btcs.com/role/AccruedExpenses" ], "lang": { "en-us": { "role": { "label": "Accrued Expenses", "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period." } } }, "auth_ref": [ "r15" ] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://btcs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r451" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://btcs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r450" ] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://btcs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://btcs.com/role/BalanceSheets", "http://btcs.com/role/BalanceSheetsParenthetical", "http://btcs.com/role/StatementsOfChangesInStockholdersEquity", "http://btcs.com/role/StockholdersEquityDetailsNarrative", "http://btcs.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "auth_ref": [ "r86", "r93", "r94", "r95", "r112", "r129", "r130", "r132", "r134", "r138", "r139", "r155", "r164", "r166", "r167", "r168", "r171", "r172", "r175", "r176", "r178", "r181", "r187", "r279", "r320", "r321", "r322", "r323", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r337", "r353", "r375", "r392", "r409", "r410", "r411", "r412", "r413", "r468", "r475", "r481" ] }, "us-gaap_Revenues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Revenues", "crdr": "credit", "calculation": { "http://btcs.com/role/StatementsOfOperations": { "parentTag": "us-gaap_GrossProfit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://btcs.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Total revenues", "label": "Revenues [Default Label]", "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)." } } }, "auth_ref": [ "r106", "r112", "r141", "r142", "r143", "r146", "r147", "r151", "r152", "r153", "r155", "r164", "r165", "r166", "r167", "r168", "r169", "r170", "r171", "r172", "r279", "r296", "r486" ] }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesNameDomain", "presentation": [ "http://btcs.com/role/ScheduleOfEarningsPerShareAnti-dilutedDetails" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented." } } }, "auth_ref": [ "r24" ] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LegalEntityAxis", "presentation": [ "http://btcs.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "us-gaap_PrepaidExpenseCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseCurrent", "crdr": "debit", "calculation": { "http://btcs.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://btcs.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Prepaid expense", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r96", "r158", "r159", "r419" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://btcs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r450" ] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://btcs.com/role/BalanceSheets", "http://btcs.com/role/BalanceSheetsParenthetical", "http://btcs.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r113", "r114", "r115", "r137", "r294", "r318", "r337", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r356", "r357", "r358", "r359", "r360", "r362", "r363", "r364", "r365", "r367", "r368", "r369", "r370", "r371", "r373", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r392", "r440" ] }, "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubstantialDoubtAboutGoingConcernTextBlock", "presentation": [ "http://btcs.com/role/Liquidity" ], "lang": { "en-us": { "role": { "label": "Liquidity", "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern." } } }, "auth_ref": [ "r41" ] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityDomain", "presentation": [ "http://btcs.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "us-gaap_RestrictedStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedStockMember", "presentation": [ "http://btcs.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Restricted Stock [Member]", "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met." } } }, "auth_ref": [ "r24" ] }, "BTCS_BlockchainNetworkFees": { "xbrltype": "monetaryItemType", "nsuri": "http://btcs.com/20230930", "localname": "BlockchainNetworkFees", "crdr": "debit", "calculation": { "http://btcs.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://btcs.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Blockchain network fees (non-cash)", "documentation": "Blockchain network fees." } } }, "auth_ref": [] }, "BTCS_BoardOfDirectorsMember": { "xbrltype": "domainItemType", "nsuri": "http://btcs.com/20230930", "localname": "BoardOfDirectorsMember", "presentation": [ "http://btcs.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Board of Directors [Member]", "documentation": "Board of Directors [Member]" } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "auth_ref": [] }, "BTCS_SaleOfProductiveCryptoAssetsCurrencies": { "xbrltype": "monetaryItemType", "nsuri": "http://btcs.com/20230930", "localname": "SaleOfProductiveCryptoAssetsCurrencies", "crdr": "debit", "calculation": { "http://btcs.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://btcs.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Sale of productive crypto assets", "documentation": "Sale of productive crypto assets/currencies." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://btcs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r450" ] }, "us-gaap_CompensationAndRetirementDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CompensationAndRetirementDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Retirement Benefits [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "presentation": [ "http://btcs.com/role/SummaryOfRestrictedStockDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average grant day fair value, forfeited", "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event." } } }, "auth_ref": [ "r229" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://btcs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "us-gaap_RevenuesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenuesAbstract", "presentation": [ "http://btcs.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Revenues" } } }, "auth_ref": [] }, "us-gaap_OtherAssetImpairmentCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetImpairmentCharges", "crdr": "debit", "calculation": { "http://btcs.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 5.0 }, "http://btcs.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://btcs.com/role/StatementsOfCashFlows", "http://btcs.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Impairment loss on crypto assets", "documentation": "The charge against earnings resulting from the write down of long lived assets other than goodwill due to the difference between the carrying value and lower fair value." } } }, "auth_ref": [ "r474", "r484" ] }, "BTCS_IssuanceOfCommonStockNetOfOfferingCostAtthemarketOfferingShare": { "xbrltype": "sharesItemType", "nsuri": "http://btcs.com/20230930", "localname": "IssuanceOfCommonStockNetOfOfferingCostAtthemarketOfferingShare", "presentation": [ "http://btcs.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "verboseLabel": "Issuance of common stock, net of offering cost / At-the-market offering, shares", "documentation": "Issuance of common stock net of offering cost at the market offering shares.", "label": "IssuanceOfCommonStockNetOfOfferingCostAtthemarketOfferingShare" } } }, "auth_ref": [] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://btcs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r462" ] }, "us-gaap_PayablesAndAccrualsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PayablesAndAccrualsAbstract", "lang": { "en-us": { "role": { "label": "Payables and Accruals [Abstract]" } } }, "auth_ref": [] }, "us-gaap_InvestmentsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentsFairValueDisclosure", "crdr": "debit", "presentation": [ "http://btcs.com/role/FairValueOfFinancialAssetsAndLiabilitiesDetailsNarrative", "http://btcs.com/role/ScheduleOfChangesInFairValueAndOtherAdjustmentsOfWarrantsDetails", "http://btcs.com/role/ScheduleOfFairValueOfAssetsAndLiabilitiesValuedOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Investments", "periodStartLabel": "Investment, beginning balance", "periodEndLabel": "Investment, ending balance", "verboseLabel": "Investments fair value", "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method." } } }, "auth_ref": [ "r275" ] }, "us-gaap_AdvertisingCostsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdvertisingCostsPolicyTextBlock", "presentation": [ "http://btcs.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Advertising Expense", "documentation": "Disclosure of accounting policy for advertising cost." } } }, "auth_ref": [ "r78" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://btcs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r450" ] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "presentation": [ "http://btcs.com/role/BusinessOrganizationAndNatureOfOperations" ], "lang": { "en-us": { "role": { "label": "Business Organization and Nature of Operations", "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure." } } }, "auth_ref": [ "r40", "r73", "r316", "r317" ] }, "BTCS_PurchaseOfProductiveCryptoAssetsCurrenciesForValidating": { "xbrltype": "monetaryItemType", "nsuri": "http://btcs.com/20230930", "localname": "PurchaseOfProductiveCryptoAssetsCurrenciesForValidating", "crdr": "credit", "calculation": { "http://btcs.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://btcs.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchase of productive crypto assets for validating", "documentation": "Purchase of productive crypto assets/currencies for validating.", "label": "PurchaseOfProductiveCryptoAssetsCurrenciesForValidating" } } }, "auth_ref": [] }, "BTCS_SeriesVPreferredStockDistribution": { "xbrltype": "monetaryItemType", "nsuri": "http://btcs.com/20230930", "localname": "SeriesVPreferredStockDistribution", "crdr": "credit", "presentation": [ "http://btcs.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Series V Preferred Stock Distribution", "documentation": "Series V preferred stock distribution." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://btcs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://btcs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_SharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesOutstanding", "presentation": [ "http://btcs.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance, shares", "periodEndLabel": "Balance, shares", "label": "Shares, Outstanding", "documentation": "Number of shares issued which are neither cancelled nor held in the treasury." } } }, "auth_ref": [] }, "BTCS_SeriesVPreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://btcs.com/20230930", "localname": "SeriesVPreferredStockMember", "presentation": [ "http://btcs.com/role/BalanceSheets", "http://btcs.com/role/BalanceSheetsParenthetical", "http://btcs.com/role/StatementsOfChangesInStockholdersEquity", "http://btcs.com/role/StockholdersEquityDetailsNarrative", "http://btcs.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Series V Preferred Stock [Member]", "documentation": "Series V Preferred Stock [Member]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://btcs.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://btcs.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by financing activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r108" ] }, "us-gaap_IncreaseDecreaseInAccruedSalaries": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccruedSalaries", "crdr": "debit", "calculation": { "http://btcs.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://btcs.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Accrued compensation", "label": "Increase (Decrease) in Accrued Salaries", "documentation": "The increase (decrease) during the period in accrued salaries." } } }, "auth_ref": [ "r4" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://btcs.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from investing activities:" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://btcs.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://btcs.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by (used in) investing activities", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r108" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://btcs.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from financing activities:" } } }, "auth_ref": [] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://btcs.com/role/BalanceSheetsParenthetical", "http://btcs.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common stock, shares authorised", "verboseLabel": "Common stock, shares authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r43", "r353" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://btcs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r467" ] }, "BTCS_StakedDigitalAssetsCurrenciesNonCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://btcs.com/20230930", "localname": "StakedDigitalAssetsCurrenciesNonCurrent", "crdr": "debit", "calculation": { "http://btcs.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://btcs.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Staked crypto assets - long term", "documentation": "Staked digital assets currencies non-current." } } }, "auth_ref": [] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://btcs.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, shares outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r8", "r43", "r353", "r372", "r533", "r534" ] }, "BTCS_StableCoinsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://btcs.com/20230930", "localname": "StableCoinsPolicyTextBlock", "presentation": [ "http://btcs.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Stablecoins", "documentation": "Stable Coins Policy [Text Block]", "label": "Stable Coins Policy [Text Block]" } } }, "auth_ref": [] }, "us-gaap_GeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://btcs.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://btcs.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "General and administrative", "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line." } } }, "auth_ref": [ "r52", "r377" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://btcs.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://btcs.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Common stock, 97,500,000 shares authorized at $0.001 par value, 14,373,186 and 13,107,149 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r43", "r302", "r435" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "presentation": [ "http://btcs.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, shares issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r43" ] }, "BTCS_MarketCapVestingThresholdsTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://btcs.com/20230930", "localname": "MarketCapVestingThresholdsTwoMember", "presentation": [ "http://btcs.com/role/ScheduleOfRestrictedStockUnitsDetails" ], "lang": { "en-us": { "role": { "label": "Market Cap Vesting Thresholds $100 Million [Member]", "documentation": "Market Cap Vesting Thresholds $100 Million [Member]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxPolicyTextBlock", "presentation": [ "http://btcs.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Income Taxes", "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements." } } }, "auth_ref": [ "r102", "r251", "r252", "r253", "r254", "r255", "r256", "r319" ] }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "presentation": [ "http://btcs.com/role/ScheduleOfRestrictedStockUnitsDetails", "http://btcs.com/role/StockholdersEquityDetailsNarrative", "http://btcs.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "auth_ref": [] }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "presentation": [ "http://btcs.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Earnings Per Share Anti-diluted", "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities." } } }, "auth_ref": [ "r24" ] }, "us-gaap_PreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockMember", "presentation": [ "http://btcs.com/role/StatementsOfChangesInStockholdersEquity", "http://btcs.com/role/StockholdersEquityDetailsNarrative", "http://btcs.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Preferred Stock [Member]", "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company." } } }, "auth_ref": [ "r437", "r438", "r441", "r442", "r443", "r444", "r529", "r533" ] }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "presentation": [ "http://btcs.com/role/ScheduleOfEarningsPerShareAnti-dilutedDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities." } } }, "auth_ref": [ "r24" ] }, "BTCS_AccountingForWarrantsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://btcs.com/20230930", "localname": "AccountingForWarrantsPolicyTextBlock", "presentation": [ "http://btcs.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Accounting for Warrants", "documentation": "Accounting For Warrants Policy [Text Block]" } } }, "auth_ref": [] }, "BTCS_DividendsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://btcs.com/20230930", "localname": "DividendsPolicyTextBlock", "presentation": [ "http://btcs.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Dividends", "documentation": "Dividends Policy [Text Block]" } } }, "auth_ref": [] }, "BTCS_MarketCapVestingThresholdsOneMember": { "xbrltype": "domainItemType", "nsuri": "http://btcs.com/20230930", "localname": "MarketCapVestingThresholdsOneMember", "presentation": [ "http://btcs.com/role/ScheduleOfRestrictedStockUnitsDetails" ], "lang": { "en-us": { "role": { "label": "Market Cap Vesting Thresholds $50 Million [Member]", "documentation": "Market Cap Vesting Thresholds $50 Million [Member]" } } }, "auth_ref": [] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://btcs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r462" ] }, "us-gaap_EarningsPerSharePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerSharePolicyTextBlock", "presentation": [ "http://btcs.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Net Loss per Share", "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements." } } }, "auth_ref": [ "r24", "r25" ] }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "presentation": [ "http://btcs.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Table]", "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r6" ] }, "BTCS_InvestmentPurchases": { "xbrltype": "monetaryItemType", "nsuri": "http://btcs.com/20230930", "localname": "InvestmentPurchases", "crdr": "debit", "presentation": [ "http://btcs.com/role/ScheduleOfChangesInFairValueAndOtherAdjustmentsOfWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Purchases", "documentation": "Investment purchases." } } }, "auth_ref": [] }, "us-gaap_OperatingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingExpenses", "crdr": "debit", "calculation": { "http://btcs.com/role/StatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://btcs.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Total operating expenses", "label": "Operating Expenses", "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://btcs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r462" ] }, "BTCS_DistributionsToWarrantHolders": { "xbrltype": "monetaryItemType", "nsuri": "http://btcs.com/20230930", "localname": "DistributionsToWarrantHolders", "crdr": "debit", "calculation": { "http://btcs.com/role/StatementsOfOperations": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://btcs.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "negatedLabel": "Distributions to warrant holders", "documentation": "Distributions to warrant holders.", "label": "DistributionsToWarrantHolders" } } }, "auth_ref": [] }, "BTCS_GrossProceedsFromIssuanceOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://btcs.com/20230930", "localname": "GrossProceedsFromIssuanceOfCommonStock", "crdr": "debit", "presentation": [ "http://btcs.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Gross proceeds from issuance of common stock", "documentation": "Gross proceeds from issuance of common stock." } } }, "auth_ref": [] }, "BTCS_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm": { "xbrltype": "durationItemType", "nsuri": "http://btcs.com/20230930", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm", "presentation": [ "http://btcs.com/role/SummaryOfOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average remaining contractual life (in years), ending balance", "documentation": "Share based compensation arrangement by share based payment award options outstanding weighted average remaining contractual term." } } }, "auth_ref": [] }, "BTCS_InvestmentOwnedUnrecognizedUnrealizedAppreciationDepreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://btcs.com/20230930", "localname": "InvestmentOwnedUnrecognizedUnrealizedAppreciationDepreciation", "crdr": "debit", "presentation": [ "http://btcs.com/role/ScheduleOfChangesInFairValueAndOtherAdjustmentsOfWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Unrealized appreciation (depreciation)", "documentation": "Investment owned unrecognized unrealized appreciation depreciation." } } }, "auth_ref": [] }, "BTCS_MarketCapVestingThresholdsFourMember": { "xbrltype": "domainItemType", "nsuri": "http://btcs.com/20230930", "localname": "MarketCapVestingThresholdsFourMember", "presentation": [ "http://btcs.com/role/ScheduleOfRestrictedStockUnitsDetails" ], "lang": { "en-us": { "role": { "label": "Market Cap Vesting Thresholds $300 Million [Member]", "documentation": "Market Cap Vesting Thresholds $300 Million [Member]" } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://btcs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r461" ] }, "BTCS_WarrantLiabilitiesClassification": { "xbrltype": "monetaryItemType", "nsuri": "http://btcs.com/20230930", "localname": "WarrantLiabilitiesClassification", "crdr": "debit", "presentation": [ "http://btcs.com/role/ScheduleOfChangesInFairValueAndOtherAdjustmentsOfWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Warrant liabilities classification", "documentation": "Warrant liabilities classification." } } }, "auth_ref": [] }, "BTCS_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGrantsInPeriod": { "xbrltype": "durationItemType", "nsuri": "http://btcs.com/20230930", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGrantsInPeriod", "presentation": [ "http://btcs.com/role/SummaryOfOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average remaining contractual life (in years), employee options granted", "documentation": "Share based compensation arrangement by share based payment award options outstanding weighted average remaining contractual term grants in period." } } }, "auth_ref": [] }, "us-gaap_PlanNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameAxis", "presentation": [ "http://btcs.com/role/ScheduleOfWeighted-averageAssumptionsUsedToEstimateFairValueDetails", "http://btcs.com/role/StockholdersEquityDetailsNarrative", "http://btcs.com/role/StockholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "Plan Name [Axis]", "documentation": "Information by plan name for share-based payment arrangement." } } }, "auth_ref": [ "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514" ] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://btcs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r461" ] }, "BTCS_OfficerName": { "xbrltype": "stringItemType", "nsuri": "http://btcs.com/20230930", "localname": "OfficerName", "presentation": [ "http://btcs.com/role/ScheduleOfRestrictedStockUnitsDetails" ], "lang": { "en-us": { "role": { "label": "Officer Name", "documentation": "It denotes the name of the officer." } } }, "auth_ref": [] }, "us-gaap_OperatingExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingExpensesAbstract", "presentation": [ "http://btcs.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Operating expenses:" } } }, "auth_ref": [] }, "BTCS_StockIssuedDuringPeriodRestrictedStockAwardGrantDate": { "xbrltype": "dateItemType", "nsuri": "http://btcs.com/20230930", "localname": "StockIssuedDuringPeriodRestrictedStockAwardGrantDate", "presentation": [ "http://btcs.com/role/ScheduleOfRestrictedStockUnitsDetails" ], "lang": { "en-us": { "role": { "label": "Grant Date", "documentation": "Stock issued during period restricted stock award grant date." } } }, "auth_ref": [] }, "BTCS_PercentageOfGrossProceedsOfOfferings": { "xbrltype": "percentItemType", "nsuri": "http://btcs.com/20230930", "localname": "PercentageOfGrossProceedsOfOfferings", "presentation": [ "http://btcs.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Percentage of gross proceeds of offerings", "documentation": "Percentage of gross proceeds of offerings." } } }, "auth_ref": [] }, "BTCS_DefinedMarketCapitalizationVestingThresholdsValue": { "xbrltype": "monetaryItemType", "nsuri": "http://btcs.com/20230930", "localname": "DefinedMarketCapitalizationVestingThresholdsValue", "crdr": "credit", "presentation": [ "http://btcs.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Market cap vesting thresholds, value", "documentation": "Defined market capitalization thresholds, value." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://btcs.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r450" ] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://btcs.com/role/ScheduleOfWeighted-averageAssumptionsUsedToEstimateFairValueDetails", "http://btcs.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [ "r160", "r161", "r162", "r163", "r200", "r207", "r237", "r238", "r239", "r292", "r293", "r310", "r345", "r346", "r397", "r398", "r399", "r400", "r408", "r415", "r416", "r425", "r428", "r432", "r436", "r439", "r485", "r488", "r521", "r522", "r523", "r524", "r525" ] }, "BTCS_EmployeeBonusStockAwardsMember": { "xbrltype": "domainItemType", "nsuri": "http://btcs.com/20230930", "localname": "EmployeeBonusStockAwardsMember", "presentation": [ "http://btcs.com/role/ScheduleOfStock-basedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Employee Bonus Stock Awards [Member]", "documentation": "Employee Bonus Stock Awards [Member]" } } }, "auth_ref": [] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "presentation": [ "http://btcs.com/role/ScheduleOfEarningsPerShareAnti-dilutedDetails" ], "lang": { "en-us": { "role": { "label": "Antidilutive Securities [Axis]", "documentation": "Information by type of antidilutive security." } } }, "auth_ref": [ "r24" ] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MaximumMember", "presentation": [ "http://btcs.com/role/ScheduleOfWeighted-averageAssumptionsUsedToEstimateFairValueDetails", "http://btcs.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "auth_ref": [ "r160", "r161", "r162", "r163", "r207", "r293", "r310", "r345", "r346", "r397", "r398", "r399", "r400", "r408", "r415", "r416", "r425", "r428", "r432", "r436", "r488", "r520", "r521", "r522", "r523", "r524", "r525" ] }, "BTCS_MarketCapVestingThresholdsThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://btcs.com/20230930", "localname": "MarketCapVestingThresholdsThreeMember", "presentation": [ "http://btcs.com/role/ScheduleOfRestrictedStockUnitsDetails" ], "lang": { "en-us": { "role": { "label": "Market Cap Vesting Thresholds $150 Million [Member]", "documentation": "Market Cap Vesting Thresholds $150 Million [Member]" } } }, "auth_ref": [] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://btcs.com/role/ScheduleOfWeighted-averageAssumptionsUsedToEstimateFairValueDetails", "http://btcs.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "auth_ref": [ "r160", "r161", "r162", "r163", "r200", "r207", "r237", "r238", "r239", "r292", "r293", "r310", "r345", "r346", "r397", "r398", "r399", "r400", "r408", "r415", "r416", "r425", "r428", "r432", "r436", "r439", "r485", "r488", "r521", "r522", "r523", "r524", "r525" ] }, "us-gaap_PlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameDomain", "presentation": [ "http://btcs.com/role/ScheduleOfWeighted-averageAssumptionsUsedToEstimateFairValueDetails", "http://btcs.com/role/StockholdersEquityDetailsNarrative", "http://btcs.com/role/StockholdersEquityTables" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement." } } }, "auth_ref": [ "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "presentation": [ "http://btcs.com/role/ScheduleOfEarningsPerShareAnti-dilutedDetails" ], "lang": { "en-us": { "role": { "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MinimumMember", "presentation": [ "http://btcs.com/role/ScheduleOfWeighted-averageAssumptionsUsedToEstimateFairValueDetails", "http://btcs.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "auth_ref": [ "r160", "r161", "r162", "r163", "r207", "r293", "r310", "r345", "r346", "r397", "r398", "r399", "r400", "r408", "r415", "r416", "r425", "r428", "r432", "r436", "r488", "r520", "r521", "r522", "r523", "r524", "r525" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://btcs.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, par value", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r43" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://btcs.com/role/ScheduleOfEarningsPerShareAnti-dilutedDetails" ], "lang": { "en-us": { "role": { "label": "Anti-dilutive securities", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r135" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://btcs.com/role/ScheduleOfRestrictedStockUnitsDetails", "http://btcs.com/role/ScheduleOfStock-basedCompensationExpenseDetails", "http://btcs.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r212", "r213", "r214", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r236", "r237", "r238", "r239", "r240" ] }, "BTCS_NonEmployeeRestrictedStockAwardsMember": { "xbrltype": "domainItemType", "nsuri": "http://btcs.com/20230930", "localname": "NonEmployeeRestrictedStockAwardsMember", "presentation": [ "http://btcs.com/role/ScheduleOfStock-basedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Non-Employee Restricted Stock Awards [Member]", "documentation": "Non-Employee Restricted Stock Awards [Member]" } } }, "auth_ref": [] }, "BTCS_IncreaseDecreaseInStableCoins": { "xbrltype": "monetaryItemType", "nsuri": "http://btcs.com/20230930", "localname": "IncreaseDecreaseInStableCoins", "crdr": "debit", "calculation": { "http://btcs.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://btcs.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Stablecoins", "documentation": "Increase decrease in stable coins.", "label": "IncreaseDecreaseInStableCoins" } } }, "auth_ref": [] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://btcs.com/role/BalanceSheets", "http://btcs.com/role/BalanceSheetsParenthetical", "http://btcs.com/role/StatementsOfChangesInStockholdersEquity", "http://btcs.com/role/StockholdersEquityDetailsNarrative", "http://btcs.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "documentation": "Information by the different classes of stock of the entity." } } }, "auth_ref": [ "r86", "r93", "r94", "r95", "r112", "r129", "r130", "r132", "r134", "r138", "r139", "r155", "r164", "r166", "r167", "r168", "r171", "r172", "r175", "r176", "r178", "r181", "r187", "r279", "r320", "r321", "r322", "r323", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r337", "r353", "r375", "r392", "r409", "r410", "r411", "r412", "r413", "r468", "r475", "r481" ] }, "BTCS_StableCoins": { "xbrltype": "monetaryItemType", "nsuri": "http://btcs.com/20230930", "localname": "StableCoins", "crdr": "debit", "calculation": { "http://btcs.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://btcs.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Stablecoins", "documentation": "Stable coins." } } }, "auth_ref": [] }, "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock", "presentation": [ "http://btcs.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Internally Developed Software", "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets." } } }, "auth_ref": [ "r7", "r29" ] }, "srt_TitleOfIndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "TitleOfIndividualAxis", "presentation": [ "http://btcs.com/role/ScheduleOfRestrictedStockUnitsDetails", "http://btcs.com/role/StockholdersEquityDetailsNarrative", "http://btcs.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "auth_ref": [ "r482", "r517" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "4", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482338/360-10-05-4" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "13", "SubTopic": "10", "Topic": "480", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481766/480-10-25-13" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "30", "Topic": "350", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Subparagraph": "(c)", "Paragraph": "2", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a),20,24)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19,20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.21)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "710", "SubTopic": "10", "Section": "25", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483070/710-10-25-11" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "15", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.15(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "985", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//205/tableOfContent" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "40", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//205-40/tableOfContent" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.1,2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "275", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//275/tableOfContent" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-2" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.CC)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480091/360-10-S99-2" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//505/tableOfContent" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "710", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//710/tableOfContent" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "710", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483043/710-10-30-1" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "712", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//712/tableOfContent" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "715", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//715/tableOfContent" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(e)(1)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(f)(2)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "15", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482669/740-10-15-2" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//810/tableOfContent" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r77": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "210", "Topic": "946", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-20" }, "r78": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "SubTopic": "35", "Topic": "720", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483406/720-35-50-1" }, "r79": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r80": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r81": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1" }, "r82": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11" }, "r83": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12" }, "r84": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6" }, "r85": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org//606/tableOfContent" }, "r86": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(a)", "Publisher": "SEC" }, "r87": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r88": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r89": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r90": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5" }, "r91": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r92": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r93": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r94": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r95": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r96": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r97": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r98": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3" }, "r99": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-10" }, "r100": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r101": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r102": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1" }, "r103": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r104": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r105": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r106": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r107": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r108": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r109": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r110": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1" }, "r111": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(e)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r112": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r113": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r114": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r115": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r116": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r117": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r118": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r119": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r120": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r121": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r122": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r123": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r124": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 11.M.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-17" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-19" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//718/tableOfContent" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.C.Q3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.1.Q5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.3.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "730", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "808", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//855/tableOfContent" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1)(h))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-1" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-2" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(h)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-21" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5A", "Subparagraph": "(SX 210.12-13A(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1" }, "r417": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r418": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r419": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r420": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "8", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-8" }, "r421": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22" }, "r422": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r423": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r424": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r425": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A" }, "r426": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B" }, "r427": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C" }, "r428": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r429": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r430": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r431": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17" }, "r432": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r433": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r434": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r435": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r436": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F" }, "r437": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r438": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r439": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r440": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r441": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r442": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r443": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r444": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r445": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r446": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11" }, "r447": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r448": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r449": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r450": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r451": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r452": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r453": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r454": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r455": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r456": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r457": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r458": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r459": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r460": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r461": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r462": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r463": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r464": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r465": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r466": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r467": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" }, "r468": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3" }, "r469": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-10" }, "r470": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-3" }, "r471": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "205", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483504/205-10-50-1" }, "r472": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r473": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(b)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r474": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r475": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r476": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r477": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r478": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r479": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r480": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r481": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "55", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55" }, "r482": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13" }, "r483": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r484": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-2" }, "r485": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r486": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r487": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r488": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r489": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r490": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r491": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r492": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r493": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r494": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r495": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r496": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r497": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r498": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r499": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r500": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r501": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r502": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r503": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r504": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r505": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r506": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r507": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r508": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r509": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r510": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r511": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r512": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r513": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r514": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r515": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r516": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r517": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2" }, "r518": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r519": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r520": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r521": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r522": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r523": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r524": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r525": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r526": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "912", "SubTopic": "730", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1" }, "r527": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r528": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r529": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r530": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r531": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r532": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r533": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r534": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" } } } ZIP 54 0001493152-23-040107-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-23-040107-xbrl.zip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